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Abstract 
There is increased evidence of the important roles of telomere capping proteins Cdc13 and Stn1 
for cell survival in budding yeast (Saccharomyces cerevisiae). Dysfunctional telomeres due to 
alterations in telomere capping proteins activate DNA damage response and genomic instability 
causing cellular senescence and eventually cell death. The main aim of this study was to 
investigate the roles of Cdc13 and Stn1 in ageing and cellular senescence.  
Based on the phenomenon of non-essentiality of CDC13 gene in the absence of EXO1 gene, 
CDC13 full gene deletion and its N-and C-termini disrupted variants were generated using 
target oriented PCR based approach and verified by automated DNA sequencing. Loss of Cdc13 
and/or Stn1 or the presence of defective Cdc13 with truncated N- or C-termini, manifested 
heterogeneous telomeric DNA profiles with various sizes of unique telomeric bands comparable 
to type I and type II survivors. 
The mutants with telomere capping dysfunctions in the absence of Cdc13 and/or Stn1 disclosed 
significant differences in survival time under different metabolic conditions. The reduction in 
viability of the combined deletion mutants (cdc13Δ and stn1Δ) was much slower in water at 4°C 
compared to synthetic complete (SC) medium at 30°C, and a similar mortality rate observed at 
day 6 in (SC) medium was only observed at day 35 in water. The dramatic loss of viability in 
combined deletion mutant highlighted additive effects of the two capping proteins on 
chronological survival. The Stn1 deletion mutants (stn1::HIS exo1 LEU2 rad24::TRP) showed 
significantly reduced lifespan as compared to Cdc13 deletion mutants. However, the N- and C-
truncated variants of Cdc13 manifested large differences in ageing as compared to WT, 
indicating different roles of the Cdc13 domains in cell survival. 
The strong inhibition of cellular growth of combined deletions mutants of cdc13 and stn1 (in the 
absence of EXO1 and RAD24 genes) in responses to genotoxic agents (UV, MMS and HU) 
suggest the interaction of cdc13Δ and stn1Δ cooperatively. However, the absence of Stn1 protein 
made cells highly resistant to H2O2-mediated oxidative stress as compared to the combined 
deletion and cdc13Δ mutants.  Different extent of growth inhibition was observed for cdc13Δ 
mutants, and its N- and C-terminus truncated variants with the allele dosage effect in N/C-
heterozygous diploids. 
In conclusion, this study highlighted the significance of Cdc13 and Stn1 in the integrity of 
telomeres and revealed their important roles in preventing senescence and in cellular responses 
to oxidative and genotoxic stress. The previously unknown role of Stn1 in chronological lifespan 
and in cellular responses to oxidative stress observed in this study warrants further investigations 
about Stn1 in genetic stability, checkpoint control and cellular senescence in the integrated 
scenario of ageing. 
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Budding yeast nomenclature 
 
Wild type gene CDC13 uppercase italic for dominant 
Mutant allele / 
Recessive mutant cdc13-1 gene symbol, a hyphen and an italic 
Arabic number 
Deletion (null) mutant cdc13∆ lowercase italic for recessive 
Wild type protein Cdc13p/Cdc13 gene symbol, non-italic, initial letter 
uppercase and with the suffix 
‘p’(optional) 
Mutant protein  Cdc13-1p/Cdc13-1 
Dominant allele uppercase 
Recessive allele lowercase 
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List of proteins 
Protein name (name description), protein description 
(annotations from the Saccharomyces Genome Database (SGD)) 
 Bar1p (BARrier to the alpha factor response) Aspartyl protease secreted into the periplasmic 
space of mating type a cells, helps cells find mating partners, cleaves and inactivates alpha 
factor allowing cells to recover from alpha-factor-induced cell cycle arrest. 
 Cdc13p (Cell Division Cycle) Single stranded DNA-binding protein found at TG1-3 telomere 
G-tails; regulates telomere replication through recruitment of specific sub-complexes, but the 
essential function is telomere capping. 
 Cdk1p/Cdc28p (Cell Division Cycle) Catalytic subunit of the main cell cycle cyclin-dependent 
kinase (CDK); alternately associates with G1 cyclins (CLNs) and G2/M cyclins (CLBs) which 
direct the CDK to specific substrates. 
 Chk1p (CHeckpoint Kinase) Serine/threonine kinase and DNA damage checkpoint effector, 
mediates cell cycle arrest via phosphorylation of Pds1p; phosphorylated by checkpoint signal 
transducer Mec1p; homolog of S. pombe and mammalian Chk1 checkpoint kinase. 
 Ddc1p (DNA Damage Checkpoint) DNA damage checkpoint protein; part of a PCNA-like 
complex required for DNA damage response, required for pachytene checkpoint to inhibit cell 
cycle in response to unrepaired recombination intermediates; potential Cdc28p substrate; forms 
nuclear foci upon DNA replication stress. 
 Dna2p (DNA synthesis defective) Tripartite DNA replication factor with single-stranded DNA-
dependent ATPase, ATP-dependent nuclease, and helicase activities; required for Okazaki 
fragment processing; involved in DNA repair; cell-cycle dependent localization. 
 Ebs1p (Est1-like Bcy1 Suppressor) Protein involved in inhibition of translation and nonsense-
mediated decay; interacts with cap binding protein Cdc33p and with Nam7p; localises to P-
bodies upon glucose starvation; mRNA abundance regulated by mRNA decay factors. 
 Est1p (Ever Shorter Telomeres) TLC1 RNA-associated factor involved in telomere length 
regulation as recruitment subunit of telomerase; has G-quadruplex promoting activity that is 
required for telomere elongation; possible role in activating telomere-bound Est2p-TLC1-RNA. 
 Est2p (Ever Shorter Telomeres) Reverse transcriptase subunit of the telomerase holoenzyme, 
essential for telomerase core catalytic activity, involved in other aspects of telomerase assembly 
and function; mutations in human homolog are associated with aplastic anemia ; Also known as 
TERT. 
 Exo1p (EXOnuclease) 5'-3' exonuclease and flap-endonuclease involved in recombination, 
double-strand break repair and DNA mismatch repair; member of the Rad2p nuclease family, 
with conserved N and I nuclease domains. 
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 Kem1p/Sep1p/Ski1p/ Xrn1p (Kar-Enhancing Mutations) Evolutionarily-conserved 5'-3' 
exonuclease component of cytoplasmic processing (P) bodies involved in mRNA decay; plays a 
role in microtubule-mediated processes, filamentous growth, ribosomal RNA maturation, and 
telomere maintenance. 
 Lag1p (Longevity Assurance Gene) Ceramide synthase component; involved in synthesis of 
ceramide from C26 (acyl)-coenzyme A and dihydrosphingosine or phytosphingosine, 
functionally equivalent to Lac1p; forms ER foci upon DNA replication stress; homolog of 
human CERS2, a tumor metastasis suppressor gene whose silencing enahnces 
invasion/metastasis of prostate cancer cells; LAG1 has a paralog, LAC1, that arose from the 
whole genome duplication. 
 Mcd1p/Scc1p (Mitotic Chromosome Determinant) Essential subunit of the cohesin complex 
required for sister chromatid cohesion in mitosis and meiosis; apoptosis induces cleavage and 
translocation of a C-terminal fragment to mitochondria; expression peaks in S-phase. 
 Mec1p (Mitosis Entry Checkpoint) Genome integrity checkpoint protein and PI kinase 
superfamily member; signal transducer required for cell cycle arrest and transcriptional 
responses prompted by damaged or unreplicated DNA; monitors and participates in meiotic 
recombination. 
 Mec3p (Mitosis Entry Checkpoint) DNA damage and meiotic pachytene checkpoint protein; 
subunit of a heterotrimeric complex (Rad17p-Mec3p-Ddc1p) that forms a sliding clamp, loaded 
onto partial duplex DNA by a clamp loader complex; homolog of human and S. pombe Hus1. 
 Mrc1p (Mediator of the Replication Checkpoint) S-phase checkpoint protein required for DNA 
replication; interacts with and stabilizes Pol2p at stalled replication forks during stress, where it 
forms a pausing complex with Tof1p and is phosphorylated by Mec1p; protects uncapped 
telomeres. 
 Mre11p (Meiotic REcombination) Subunit of a complex with Rad50p and Xrs2p (MRX 
complex) that functions in repair of DNA double-strand breaks and in telomere stability, 
exhibits nuclease activity that appears to be required for MRX function; widely conserved. 
 Pdl1p (Protein Disulfide Isomerase) Protein disulfide isomerase; multifunctional protein of ER 
lumen, essential for formation of disulfide bonds in secretory and cell-surface proteins, 
unscrambles non-native disulfide bonds; key regulator of Ero1p; forms complex with Mnl1p 
that has exomannosidase activity, processing unfolded protein-bound Man8GlcNAc2 
oligosaccharides to Man7GlcNAc2, promoting degradation in unfolded protein response; PDI1 
has a paralog, EUG1, that arose from the whole genome duplication. 
 Pds1 (Precocious Dissociation of Sisters) Securin; inhibits anaphase by binding separin Esp1p; 
blocks cyclin destruction and mitotic exit, essential for meiotic progression and mitotic cell 
cycle arrest; localization is cell-cycle dependent and regulated by Cdc28p phosphorylation. 
 Rad17p (RADiation sensitive) Checkpoint protein, involved in the activation of the DNA 
damage and meiotic pachytene checkpoints; with Mec3p and Ddc1p, forms a clamp that is 
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loaded onto partial duplex DNA; homolog of human and S. pombe Rad1 and U. maydis Rec1 
proteins. 
 Rad24p (RADiation sensitive) Checkpoint protein, involved in the activation of the DNA 
damage and meiotic pachytene checkpoints; subunit of a clamp loader that loads Rad17p-
Mec3p-Ddc1p onto DNA; homolog of human and S. pombe Rad17 protein; Also known as RS1. 
 Rad50p (RADiation sensitive) Subunit of MRX complex, with Mre11p and Xrs2p, involved in 
processing double-strand DNA breaks in vegetative cells, initiation of meiotic DSBs, telomere 
maintenance, and nonhomologous end joining. 
 Rad53p (RADiation sensitive) Protein kinase, required for cell-cycle arrest in response to DNA 
damage; activated by trans autophosphorylation when interacting with hyperphosphorylated 
Rad9p; also interacts with ARS1 and plays a role in initiation of DNA replication. 
 Rad9p (RADiation sensitive) DNA damage-dependent checkpoint protein, required for cell-
cycle arrest in G1/S, intra-S, and G2/M; transmits checkpoint signal by activating Rad53p and 
Chk1p; hyperphosphorylated by Mec1p and Tel1p; potential Cdc28p substrate. 
 Rap1p (Repressor Activator Protein) DNA-binding protein involved in either activation or 
repression of transcription, depending on binding site context; also binds telomere sequences 
and plays a role in telomeric position effect (silencing) and telomere structure. 
 Rfa1 (Replication Factor A) Subunit of heterotrimeric Replication Protein A (RPA), which is a 
highly conserved single-stranded DNA binding protein involved in DNA replication, repair, and 
recombination. 
 RFC1 (Replication Factor C) Subunit of heteropentameric Replication factor C (RF-C); RF-C 
is a DNA binding protein and ATPase that acts as a clamp loader of the proliferating cell 
nuclear antigen (PCNA) processivity factor for DNA polymerases delta and epsilon. 
 Rif1p (RAP1-Interacting Factor) Protein that binds to the Rap1p C-terminus and acts 
synergistically with Rif2p to help control telomere length and establish telomeric silencing; 
deletion results in telomere elongation. 
 Rtg2p (ReTroGrade regulation) Sensor of mitochondrial dysfunction; regulates the subcellular 
location of Rtg1p and Rtg3p, transcriptional activators of the retrograde (RTG) and TOR 
pathways; Rtg2p is inhibited by the phosphorylated form of Mks1p. 
 San1p (Sir ANtagonist) Ubiquitin-protein ligase; involved in the proteasome-dependent 
degradation of aberrant nuclear proteins; targets substrates with regions of exposed 
hydrophobicity containing 5 or more contiguous hydrophobic residues; contains intrinsically 
disordered regions that contribute to substrate recognition. 
 Sae2 (Sporulation in the Absence of spo Eleven) Endonuclease required for telomere 
elongation; also required for telomeric 5' C-rich strand resection; involved in processing hairpin 
DNA structures with MRX complex; involved in double-strand break repair; sumoylation and 
phosphorylation both required for function; exists in form of inactive oligomers that are 
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transiently released into smaller active units by a series of phosphorylations; DNA damage 
triggers removal of Sae2p, so active Sae2p is present only transiently. 
 Sch9p (provisional name) AGC family protein kinase; functional ortholog of mammalian S6 
kinase; phosphorylated by Tor1p and required for TORC1-mediated regulation of ribosome 
biogenesis, translation initiation, and entry into G0 phase; involved in transactivation of 
osmostress-responsive genes; regulates G1 progression, cAPK activity and nitrogen activation 
of the FGM pathway; integrates nutrient signals and stress signals from sphingolipids to 
regulate lifespan; Protein serine/threonine kinase involved in regulation of transcription by RNA 
polymerases I, II, and III; involved in regulation of sphingolipid biosynthesis, cell aging and 
responses to both oxidative and osmotic stresses; localizes to the nucleus, cytoplasm and 
vacuole membranes. 
 Sgs1 (Slow Growth Suppressor) Nucleolar DNA helicase of the RecQ family involved in 
genome integrity maintenance; regulates chromosome synapsis and meiotic joint 
molecule/crossover formation; similar to human BLM and WRN proteins implicated in Bloom 
and Werner syndromes. 
 Sir2p (Silent Information Regulator) Conserved NAD+ dependent histone deacetylase of the 
Sirtuin family involved in regulation of lifespan; plays roles in silencing at HML, HMR, 
telomeres, and the rDNA locus; negatively regulates initiation of DNA replication. 
 Sir4p (Silent Information Regulator) SIR4 is one of four silent information regulator genes in 
budding yeast; SIR protein involved in assembly of silent chromatin domains; silent information 
regulator (SIR) along with SIR2 and SIR3; involved in assembly of silent chromatin domains at 
telomeres and the silent mating-type loci; Sir4p participates in silencing the cryptic mating type 
loci HML and HMR, and helps maintain a repressed chromatin structure near telomeres; unlike 
repressors that act by binding to promoters, the Sir proteins help repress transcription by 
creating a silent chromatin structure in a gene- and promoter-independent manner via histones 
and other DNA binding proteins; Sir4p seems to act in the maintenance rather than the initiation 
of silencing at HML and HMR; potentially phosphorylated by Cdc28p; some alleles of SIR4 
prolong lifespan. 
 Stn1p (Suppressor of Cdc ThirteeN) Telomere end-binding and capping protein; plays a key 
role with Pol12p in linking telomerase action with completion of lagging strand synthesis, and 
in a regulatory step required for telomere capping; similar to human Stn1. 
 Swi4p (SWItching deficient) DNA binding component of the SBF complex (Swi4p-Swi6p); a 
transcriptional activator that in concert with MBF (Mbp1-Swi6p) regulates late G1-specific 
transcription of targets including cyclins and genes required for DNA synthesis and repair; 
Slt2p-independent regulator of cold growth; acetylation at two sites, K1016 and K1066, 
regulates interaction with Swi6p. 
 Swi6p (SWItching deficient) Transcription cofactor; forms complexes with Swi4p and Mbp1p 
to regulate transcription at the G1/S transition; involved in meiotic gene expression; also binds 
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Stb1p to regulate transcription at START; cell wall stress induces phosphorylation by Mpk1p, 
which regulates Swi6p localization; required for the unfolded protein response, independently 
of its known transcriptional coactivators. 
 Ten1p (TElomeric pathways with STn1) Protein that regulates telomeric length; protects 
telomeric ends in a complex with Cdc13p and Stn1p; similar to human Ten1 which is critical for 
the telomeric function of the CST (Cdc13p-Stn1p-Ten1p) complex. 
 Tel1p (TELomere maintenance) Protein kinase primarily involved in telomere length 
regulation; contributes to cell cycle checkpoint control in response to DNA damage; acts with 
Red1p and Mec1p to promote interhomolog recombination by phosphorylation of Hop1; 
functionally redundant with Mec1p; regulates P-body formation induced by replication stress; 
homolog of human ataxia-telangiectasia mutated (ATM) gene. 
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1. Introduction 
1.1. Ageing and cellular senescence 
Ageing is a complex multifactorial process that leads to progressive loss of functionality, 
increase in the chance of diseases and eventually to death.  Ageing therefore results from “a 
decreasing ability to survive stress,” (Weinert and Timiras, 2003).  Evolutionary question “Why 
do we age?” addresses the biological and evolutionary significance and benefits of ageing, 
while the question “How do we age?” is mainly concerned with the mechanisms and 
manifestations of ageing process (Davidovic et al., 2010). 
 
Ageing is regulated by complex interplay of mechanisms at molecular and cellular levels.  
Many genetic, epigenetic and environmental factors are involved in the ageing process.  
Accumulation of genetic mutations due to oxidative stress and radiation, reactive oxygen 
species-induced damage to mitochondrial functions, accumulation of damaged proteins, 
alterations of the epigenome and modification of molecular pathways due to changes in 
nutrition are examples of those.  At cellular level methylation of DNA is a part of regulatory 
mechanisms that drive ageing and could be responsible for ageing-induced changes in gene 
expression.  Patterns of DNA methylation change during ageing and contribute to the ageing 
process (Jung and Pfeifer, 2015).  Tissue culture studies in human have demonstrated that 
cultured cells lose methylated gene fragments with an increased number of cell divisions  (Bork 
et al., 2010). 
More than 300 theories exist to explain the nature of the ageing process (Vina et al., 2007).  The 
main theories have been categorised as evolutionary, gene regulation, cellular senescence, free 
radical and immune theories (Weinert and Timiras, 2003).  These theories explain various 
aspects of the ageing process at different levels and attempt to identify particular causes or 
consequences of ageing process.  Ageing itself is described as a sum of all changes that occur at 
physiological, genetics and molecular level with the passage of time (Rattan, 2008, Weinert and 
Timiras, 2003). 
The main theories of ageing are briefly described below.  Three of these, the theory of 
programmed death, the mutation accumulation theory of ageing, and the antagonistic pleiotropy 
theory of ageing have been considered as evolutionary theories of ageing as these are closely 
related to the genetics of ageing (Gavrilov and Gavrilova, 2002).   
At present there is no unifying theory of ageing which can explain ageing process completely.  
These theories have their own strengths and limitations and have been validated on the basis of 
available experimental data over time.  Among these theories, the mutation accumulation theory 
of ageing is widely employed and considered as the most viable one.  The free radical theory of 
ageing is also universally recognised. 
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1.1.1. Programmed ageing  
This concept suggests that ageing is genetically determined i.e., pre-programmed in DNA or 
genes that encode the lifespan of an organism.  Modern theories of programmed ageing 
emphasise that ageing is under tight control of biological timetable that regulates maintenance, 
repair and defence responses by switching on/off certain genes at different stages of 
development.  In a multicellular organism differentiating cells lose some potential to translate 
genetic information that eventually leads to senescence.  Ageing in higher organisms could be a 
result of evolved balance between functionality and counteracting events (Strehler, 1986).  
Genetic instability (manifested as chromosome aberrations) is involved in ageing and 
senescence.  DNA damages are different from classical mutations and the changes in DNA 
could be both endogenous and exogenous.  Genome crisis due to accumulation of DNA 
damages leads to irreversible cell cycle arrest (senescence) or programmed cell death 
(apoptosis) (Weinert and Timiras, 2003).   
 
The genetic control of ageing by underlying groups of genes (the programmed ageing) has been 
supported by experimental work on worm, Caenorhabditis elegans (Hekimi et al., 2001), a fruit 
fly (Drosophila melanogaster) (Ja et al., 2007) and mouse (Swindell, 2007, Park et al., 2009).  
The overexpression or silencing of genes, or a specific gene disruption/knockout can also delay 
or initiate early senescence.  A number of mutations have been discovered that extend the 
lifespan in model organisms (e.g., yeast, fruit flies and mice).  Mutations in RAS2, CYR1 and 
SCH9 extend the chronological lifespan in S. cerevisiae by activating stress resistance 
transcription factors and mitochondrial superoxide dismutase (Sod2), however, the 
overexpression of Sod2 shorten the RLS in yeast (Fabrizio et al., 2004, Fabrizio et al., 2003).  
These genes act through evolutionary conserved pathways (IGF, TOR and mitochondrial 
pathways) that regulate growth (Fabrizio and Longo, 2003). 
 
Intrinsic ageing can be counteracted to extend lifespan of organisms to some extent by genetic 
factors that determine lifespan of organisms under the influence of environmental factors.  
Many other factors (like specific dietary restrictions, active life style and regular exercise) also 
affect ageing positively (Davidovic et al., 2010).  Two factors, “starvation and “delayed 
reproduction”, extend the lifespan cooperatively with species-specific genetic makeup 
(Davidovic et al., 2010).  Caloric restriction and prolonged lifespan are not correlated in all 
organisms including humans (Shanley and Kirkwood, 2006).  Many other factors including 
improved antioxidant defences, increased responsiveness to insulin, reduced blood sugar levels, 
reduced body size, and delayed sexual maturation are involved in the longevity mechanisms.  
For example, the increased level of antioxidants can reduce the level of free radicals or ROS to 
control the oxidative stress damages and delay ageing. 
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1.1.2. Mutation accumulation theory 
From the evolutionary perspective, ageing is considered as the “decreasing force of natural 
selection with increasing ageing” (Gavrilov and Gavrilova, 2002).  Environmental assaults 
induce damages at various levels.  The mutations with negative effects accumulate passively 
over successive generations in the population and ultimately lead to pathology, senescence and 
an increase in mortality rates late in life. 
The detrimental late-acting mutations accumulate in the population at a much faster rate as 
compared to early-acting mutations.  The accumulation of DNA damage eventually overtakes 
the ability of the cells to repair them (cell impairment), leading to cell senescence and death. 
 
1.1.3. Antagonistic pleiotropy theory 
The competing model to explain senescence is antagonistic pleiotropy hypothesis.  It refers to 
the expression of a gene with multiple competing effects; some beneficial but others detrimental 
to the organism (unrelated traits).  Expression of genes beneficial at younger age could be 
deleterious at older ages.  Selection will favour actively the retention and accumulation of late-
acting deleterious genes in populations if they have any beneficial effects early in life (Weinert 
and Timiras, 2003, Kirkwood and Melov, 2011). 
 
An antagonistically pleiotropic gene selected for beneficial effects in the prime of life yet has 
unselected deleterious effects with age, thereby contributing directly to senescence.  
Antagonism between reproduction and longevity in Drosophila and Caenorhabditis elegans is 
an example in which limiting reproduction by destroying germ line cells can extend lifespan in 
both (Sgro and Partridge, 1999, Arantes-Oliveira et al., 2002).  
 
Another example is of p53, a key regulator of cell checkpoint responses.  It plays an active role 
in cell cycle arrest, apoptosis and senescence.  Studies show that p53-mediated senescence 
suppresses tumour formation (Donehower, 2002) by preventing the replicative potential of cells. 
On the contrary, incidence of cancer and cellular senescence prevalence increase in old age.  It 
suggests that selection of cellular senescence in the early life suppresses cancer whereas 
unselected effects manifest cancer in the old age.  The senescent cells release factors that 
stimulate neighbouring cells to proliferate and increase in the occurrence of cancer, an age-
related pathology (Krtolica and Campisi, 2002, Coppe et al., 2010). 
 
1.1.4. Disposable soma theory 
T. B. Kirkwood proposed disposable soma theory of the evolution of ageing in 1977 (Kirkwood, 
1977, Kirkwood, 2002).  This theory explains why different organisms live for a certain period 
of time and why do they age.  It was suggested that organism live with reduced protection of 
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soma (non-reproductive aspects) to enhance development and specifically reproduction.  
Reduced accuracy and protection of soma due to accumulation of random errors and damages 
lead to a deterioration of the organism and eventual death.  According to this theory, high level 
of accuracy is maintained in germ line cells with the elimination of any defective cells 
(Kirkwood and Holliday, 1979).  More resources are allocated to develop and to increase the 
reproductive capacity of organism rather than protecting soma to live longer.  The nurturing of 
somatic cells is to ensure continued reproductive success while soma becomes disposable after 
reproduction.  According to this theory ageing is not adaptive, and organisms must compromise 
between energy allocation to growth and reproduction, or somatic maintenance and repair 
(Kirkwood, 1977, Kirkwood and Rose, 1991, Kirkwood, 2002). 
 
Inherent in this theory is the idea that longevity (somatic maintenance) has a cost: the balance of 
resources is invested in it adopting an energy saving strategy of reduced accuracy, and 
reproductive fitness dictates the lifespan.  The disposable soma theory, however, does not 
postulate the specific cause of ageing.  This theory is in agreement with antagonistic pleiotropy 
theory as ageing could be a biological trade-off between beneficial aspect of life (reproduction) 
and the linked adverse aspect ageing (Kirkwood and Holliday, 1979). 
 
1.1.5. Oxidative stress hypothesis of ageing 
It postulates that oxidative damage cause age-related decline in physiological functions (Sohal 
et al., 2002).  This hypothesis is supported by the evidence that oxidative damage of 
macromolecules i.e., proteins, lipids and carbohydrates increases with age (Harman, 2006).  An 
additional evidence for a direct link between oxidative damage and ageing is still required.  
 
Oxidative metabolism produces highly reactive free radicals.  It was postulated that toxicity of 
oxygen is due to its partially reduced form (Gerschman et al., 1954).  This idea was further 
developed by D. Harman who proposed the free radical theory of ageing (Harman, 1956, 
Harman, 1981, Harman, 1992a, Harman, 1992b, Harman, 2006).  According to this theory free 
radicals produced during oxygen metabolism are implicated in ageing process by causing 
damage to cell and tissues.  It was suggested that the ageing could be a cumulative effect of the 
deleterious free radicals reactions initiated first by UV radiation from the sun in oxygen-free 
environment of a protocell in the beginning of life, and then by ongoing enzymatic and non-
enzymatic reactions within cells during the evolution of life.  Within a cell, free radicals are 
mainly generated in mitochondria during cytochrome P450 metabolism and by, peroxisomes 
(Inoue et al., 2003).  The formation of free radicals (reactive chemical species) or oxygen-free 
radicals (reactive oxygen species, ROS) is ubiquitous in biological systems.  Since free radicals 
are the main by-product of aerobic metabolism, their level increases with increased utilisation of  
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oxygen in cells (Rahman, 2007).  These free radical reactions cause damage of cells and tissues.  
Due to their high reactivity, free radicals oxidise proteins (Lobo et al., 2010), carbohydrates 
(Gutteridge, 1981, Baynes and Thorpe, 1999) DNA (Valko et al., 2004) and polyunsaturated 
lipids (Gutteridge, 1995) in a random manner, and induce oxidative stress.  The damages caused 
by free radicals increases with the age of the organism (Hekimi et al., 2011).  It accelerates the 
ageing process and progressively increase the chances of age-related diseases such as cancer, 
cardiovascular diseases, strokes, Alzheimer’s disease, immune system diseases and ultimately 
death (Valko et al., 2004).   
 
Many free radicals has been identified including superoxide; hydrogen peroxide; hypochlorous 
acid; hydroxyl (Gutteridge, 1995).  The deleterious effects of free radicals are influenced by 
endogenous antioxidant system, environment and genetics factors to various levels (Rahman, 
2007).  The enzymatic antioxidants such as peroxidases; catalases, glutathione peroxidase, 
superoxide dismutase and DNA repair mechanisms counteract the oxidative stress damage 
(Mates et al., 1999, Mittler, 2002, Valko et al., 2006).  Non-enzymatic antioxidants involve 
vitamin C, vitamin E, carotenoids (CAR), selenium and others (Valko et al., 2004, McCall and 
Frei, 1999).  The dietary manipulation can also lower the rate of production of free radical 
(decrease oxygen consumption) and their detrimental effects and might decrease the symptoms 
of ageing and increase the lifespan of an organism.  In rodents, calorie restriction reduces the 
formation of ROS and decreases the accumulation of oxidative damages and prolongs lifespan 
(McCall and Frei, 1999). 
 
The free radical theory operates with several hypotheses based on the type of damaged 
molecules and the roles of specific organelles in the ageing process.  These hypotheses include: 
enhanced rate of oxidant production due to mutations in mitochondrial DNA; accumulation of 
oxidized proteins) and accumulation of genetic mutations in somatic cells.  Despite the growing 
evidences on the involvement of free radicals in degenerative senescence, there is no consensus 
on the hypothesis that free radicals are the only causes of ageing, as genetic data do not provide 
a strong support to the free radical theory of ageing.  However, they are considered as major 
contributors in the ageing process. 
 
1.1.6. Cell senescence and telomeres  
Cellular senescence theory of ageing was described as limited replicative capacity of normal 
cells in culture followed by irreversible cell cycle arrest and manifestation of altered physiology 
(Hayflick, 2000, Campisi, 2003b).  Senescence could be replicative senescence (as a result of 
telomere shortening:) or stress induced senescence (due to other molecular causes) (Weinert and 
Timiras, 2003).  
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Replicative senescence is the ultimate result of telomere shortening and altered telomere 
structure (dysfunctional telomeres) due to loss of telomeric DNA during successive cell 
divisions.  Telomeres are the specialised DNA-protein structures at the end of linear 
chromosomes (Blackburn, 2000).  Stress-induced senescence is caused by other DNA damages 
including double strand breaks, disrupted heterochromatin and strong signalling from oncogene 
expression etc. (Weinert and Timiras, 2003). 
 
Normal somatic cells undergo irreversible growth arrest after a finite number of divisions and 
acquire replicative senescence state.  Senescent cells exhibit phenotypic changes with altered 
physiology that may contribute to ageing and age-related diseases, including cancer (Dimri et 
al., 1995, Krtolica and Campisi, 2002).  In contrast, escape from cellular senescence is 
uncontrolled replication or malignant cancer.  In cancer cells, telomere length is maintained 
either by the expression of telomerase enzyme (Kim et al., 1994) or by adopting alternate 
pathways for telomere elongation (Reddel, 2000).  The cellular senescence is controlled by the 
p53 and RB tumour suppressor proteins through a potent anticancer mechanism (Campisi, 
2003a).  The p53 transcription factor is a key regulator in controlling cell cycle arrest, apoptosis, 
and senescence.  Cellular senescence is a defence response to prevent aged cells, cells with 
severe damage or dysfunctional telomere from proliferation by inducing a permanent cell cycle 
arrest. 
 
Senescent cells resemble quiescent cells in culture and are identified by their inability to 
undergo DNA synthesis. They are detected by histochemical stain of cells for stress induced 
biomarkers such as beta-galactosidase (Itahana et al., 2007).  Cellular senescence can be 
determined by the reproductive capacity of the cell (Piper, 2006).  Chronological ageing reflects 
the time period an organism can remain viable in a non-dividing state (Bitterman et al., 2003).  
In higher eukaryotes, telomere lengths are associated with ageing (Hayflick, 2000).  In 
mammals germ line cells, early embryonic cells and some stem cells express telomerase, in 
contrast to most somatic cells which do not express telomerase to regulate their length.  The 
telomeres shorten on each cell division due to the “end replication problem” (Allsopp et al., 
1995).  The process of telomere shortening begins in embryonic development (Kalmbach et al., 
2013).  The critical length of the telomere and telomere uncapping cause genomic instability 
and the onset of ageing and cellular senescence, due to the accumulation of single-stranded 
DNA, an established form to explore cellular senescence in yeast due to dysfunctional telomeres 
(Hayflick and Moorhead, 1961, Hayflick, 2000, Aubert and Lansdorp, 2008).  
 
 
 
8 
 
1.2. Telomeres 
Telomeres are the specialised DNA-protein structure at the ends of eukaryotic chromosomes 
with multiple repeats of TG-rich specific nucleotide sequences (Figure 1.1).  Telomeres vary in 
their length in different eukaryotes (yeast, ciliates, mammals and plants) but share the structural 
patterns of the conserved sub-telomeric and telomeric repeat DNA and telomerase mediated end 
replication functions (Chakhparonian and Wellinger, 2003).  Conserved structural composition 
of telomeres also indicates their functional homology in different eukaryotes.  In humans, 
telomeres are composed of several kilobases of repetitive sequences (TTAGGG)n followed by 
single stranded overhangs of ~100 nt as compared to 12-14 nt in yeast (Chakhparonian and 
Wellinger, 2003).   
 
 
Figure 1.1.  Organisation of telomeric DNA in different eukaryotes. 
Telomeres show variable length in different eukaryotes ranging from a few hundred bp to several kb.  
They have conserved structural patterns of the sub-telomeric and telomeric repeat DNA.  In humans, 
double stranded telomeres repeat sequences (TTAGGG)n are followed by single stranded overhangs 
of ~100 nt as compared to 12-14 nt in yeast.  The middle sub-telomeric DNA contains conserved 
repeat sequences of X and Y’ elements.  (Taken from Chakhparonian and Wellinger, 2003). 
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In yeast the telomeric repeat DNA contain 200-300 bp of double stranded DNA flanked by 
middle sub-telomeric DNA of repeat sequences of X and Y’ conserved elements.  The sub-
telomeric X elements are of various sizes (0.3 to 3 kb) and a common feature of yeast 
chromosomes.  The Y’ elements of specific sizes (5.2 kb and 6.5/6.7 kb in yeast) together with 
X-sequences are used to distinguish the telomere length differences in different mutants.  The X 
and Y’ repeats contain intergenic located 100-200 bp long autonomously replicating sequence 
(ARS) elements, which are capable of maintaining extrachromosomal plasmids (Poloumienko et 
al., 2001).  Distinct patterns of telomeric DNA are exhibited in mutants with dysfunctional 
telomere as a result of homologous replication.   
 
Telomeres are characterised by extended single-strand 3' G-overhangs at their end (de Lange, 
2002).  The G-overhangs in some telomeres fold back and make a loop-like structure with one 
of the duplex strands to sequester itself within the “large duplex T-loop” generating another 
small displacement loop (D-loop (Figure 1.2) (de Lange, 2004, Griffith et al., 1999).  A number 
of specialised proteins bind with telomeres to single or double strands at specific sequences to 
form a protective nucleoprotein complex known as a “telosome” (Liu et al., 2004) or “shelterin” 
(de Lange, 2005) (Figure 1.3).  Telomere binding proteins also influence the formation of T-
loops (Griffith et al., 1999).  The resulting structural conformation ensures genomic stability by 
protecting (capping) chromosome ends during the DNA replication process against degradation, 
rearrangement and end-fusion- by DNA repair machinery.   
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Figure 1.2.  Telomeric structure and associated main capping proteins. 
Telomeric proteins distinguish chromosome ends from DNA breaks.  In mammals, six most important 
proteins protect chromosome ends and regulate telomere length.  Their specific binding and association 
can bring the single-stranded overhang (G-strand) into close proximity to double-stranded telomeric 
sequences.  Resulting interactions could generate a closed conformation of a telomere in which the 
single-stranded overhang is fold back and tethered to internal telomeric repeats of homologous 
sequences through a protein bridge.  There could be various possible conformations including 
linear/open arrangements, T-loops, and other structures which are likely to be interconverted between 
all of their conformers.  Trf1 (Telomeric repeat binding factor 1): binds to double-stranded TTAGGG 
repeats, interacts with Pot1 protein indirectly; Trf2 (Telomere repeat factor-2): binds to double-stranded 
TG rich repeats; recruits hRap1 and Mre11 complex to telomere; Pot1 (protection of telomeres): binds 
to single-stranded TTAGGG repeats; hRap1 (human repressor activator protein 1): binds indirectly to 
TRF2 through Tpp1 and Tin2 proteins; Tin2 (TRF1-interacting nuclear factor 2): binds directly to TRF1 
and TRF2 protein to improve localisation of TRF2 and its function to mediate telomere protection; Tpp1 
(Three prime phosphatase: TINT1/PIP1/PTOP1 in mammals): Interacts with Pot1 to make Tpp1/Pot1 
heterodimers to recruit telomerase and also binds to Trf2.  (Adapted from Baumann, 2006). 
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Owing to their structural conformation, the ends of telomeres are different from double-stranded 
DNA breaks (DSBs) (Lydall, 2003) and do not activates DNA damage checkpoint pathways.  
Telomeres are not recognised as DSBs.  In mammals, this is most likely achieved due to 
protective G-rich T-loop structure conformation that protect chromosome terminus by 
preventing inappropriate recombination and nucleolytic attacks.  Conversely there is no reported 
evidence of T-loop conformation in yeast, possibly due to short length of telomere i.e., 200-300 
bp (Lydall, 2003).  However signalling at telomeres and double-strand breaks employs many of 
the same factors and is supported by increasing evidence that DNA damage response proteins 
are also involved in telomere maintenance (Slijepcevic, 2006). 
 
Telomereic DNA is considered inert and appears not to induce DNA checkpoint and damage 
repair responses (Lydall, 2003).  Telomere-associated proteins that cap the telomeric ends might 
function in activating cell cycle checkpoints in response to chromosomal insults.  How do cells 
differentiate between DSBs and telomere ends to prevent chromosome fusion and to ensure 
genetic stability?  With growing knowledge about telomere proteins it is now clear that many 
DNA damage checkpoint and repair proteins are associated with telomeres.  Figure 1.3 shows 
the various components of DNA-protein complexes of human and yeast telomeres.  Telomere 
capping proteins either bind to the double-stranded DNA (dsDNA) or to the single-stranded 
telomere DNA (ssDNA).  For example, proteins of mammals Trf1, Trf2, Tin2, tankyrase 
(Tank1 and 2) and hRap1, and proteins of yeast Rap1, Sir2 (silent information regulator 2), Sir3, 
Sir4 and Yku70/Yku80 bind to duplex region of telomeric DNA.  The human Pot1 and yeast 
Cdc13 proteins, however, bind to telomere at ssDNA.  Telomeric proteins play their defined 
roles in telomere end protection by limiting DNA degradation, preventing ATM (Ataxia 
telangiectasia mutated) and ATR-activation (signalling) and blocking HR (homologous 
recombination) and NHEJ (Non-homologous end joining) in human (O'Sullivan and Karlseder, 
2010).  Other proteins those are involved in DNA replication machinery including Est1 (subunit 
of telomerase) and Est2 are also associated with telomere DNA.   
 
The number of DNA damage response (DDR) proteins, DNA repair and checkpoint proteins is 
growing with increasing knowledge of mechanisms involved in cell cycle arrest and in DNA 
damage pathways.  It is still not fully understood how the cell avoids checkpoint/DNA repair 
activation under normal conditions.   
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Figure 1.3.  The Interactions between different components of the structural DNA-protein complexes 
associated with telomeres in budding yeast (top) and humans (bottom). 
Red line: G-rich telomeric repeat strand (the 3′ single-stranded overhang) extended by telomerase; 
green line: complementary C-rich strand; black lines: sub-telomeric DNA.  The 3′ terminal single-
stranded telomeric DNA in human telomeres might be in alternative forms: either bound by Pot1 
protein or engaged in T-loop formation.  (Adapted from Blackburn, 2001). 
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1.2.1. Telomere maintenance, regulation and genomic instability 
The roles of telomeres in chromosome maintenance (Hemann and Greider, 2000, Hemann et al., 
2001, Price et al., 2010) and replication (Blackburn, 1991), in ageing and cellular senescence 
(Aragona et al., 2000, von Zglinicki et al., 2005) are well established.  Telomere capping 
proteins stabilise DNA physically by preventing chromosome end fusion and rearrangements 
and ensure genome integrity.  In humans, functional telomere capping with T-loop 
conformation protects chromosome ends from HR, NHEJ, inhibit recruitment of telomerase and 
checkpoint proteins, and in association with signalling proteins controls their length (Wu et al., 
2006, Longhese, 2008).  Otherwise, DDR proteins may sense chromosome ends as damaged or 
double strand DNA breaks and, as a result activate damage response pathways to repair the 
damage.  Studies on budding yeast cells showed that disruption of telomere functions cause 
strand specific DNA degradation due to dysfunctional capping (Longhese, 2008).  It leads to 
cell cycle arrest and cause genomic instability (Wellinger, 2009).  In higher eukaryotes, 
telomere integrity ensures genetic stability and plays a crucial role to protect organisms from 
different diseases like cancer and ageing (d'Adda di Fagagna, 2008, Stewart and Weinberg, 
2006).  Telomere integrity is maintained through complex interaction of mechanisms involving 
telomere capping proteins (mostly shelterin proteins), telomerase, and DNA damage sensor and 
repair proteins (Slijepcevic, 2006, Sedivy, 2007, Baumann, 2006). 
 
1.2.1.1. Telomere capping proteins and telomere maintenance 
There are a number of proteins that bind telomere to protect chromosome ends and regulate cell 
proliferation through intracellular signalling (Figure 1.4; Table 1.1).  In vertebrates, there are 
two conserved complexes of telomere binding and capping proteins: the “shelterin complex” 
that consists of six proteins (Palm and de Lange, 2008, de Lange, 2009) and a recently reported 
“CST complex” which contains three proteins (Slijepcevic, 2006, Miyake et al., 2009, 
Wellinger, 2009).  Within ‘shelterin’, two proteins TRF1/TRF2 are negative regulators of 
telomere length, which bind to the double-stranded TTAGGG repeats at telomere T-loops and 
recruit four more capping proteins (TIN2, RAP1, TPP1 and POT1).  The hetero-trimeric 
complex in mammals, consisting of CTC1, STN1 and TEN1, is an analogue of the S. cerevisiae 
Cdc13-Stn1-Ten1 (CST) complex (Figure 1.4).  
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Figure 1.4.  Telomere capping complexes in vertebrates and yeast. 
The shelterin complex consists of six proteins that bind to single- and double-strand regions of the 
vertebrate telomeric DNA.  In budding yeast the trimeric (CST) complex protect telomere by binding to 
single- strand G-rich overhangs of telomeres.  The dsDNA region of telomere is protected with another 
complex of proteins containing Rap1, Rif1 and Rif2.  In fission yeast, the protecting complex of six 
proteins resembles shelterin-like complex and contributes to chromosome end protection by interacting 
with other checkpoint components and DNA damage response proteins.  These three complexes show 
functional and structural homologies that underline conserved regulatory pathways (taken from Price et 
al., 2010). 
 
In lower organisms (e.g., ciliate Oxytricha nova), a heterodimeric protein (TEBP-αβ) protects 
telomeric G-rich overhangs (Horvath et al., 1998).  In humans, the alpha-homologue of this 
protein is POT1 (protection of telomeres 1) and the β-homologue of this protein is TPP1 (three 
prime phosphatase 1) (Wang and Lei, 2011).  POT1 binds the telomeric G-rich overhang at 
single-stranded DNA (ssDNA) and interacts with TRF1 (double-strand binding protein) and 
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links the double-stranded telomere region to the single- stranded 3’ overhang through the TPP1 
protein to facilitate communication between (Baumann, 2006, Xin et al., 2007).  TPP1 interacts 
with POT1 through the N-terminal and the resulting association increases its affinity for 
telomeric ssDNA.  TRF2 also stabilises the G-strand overhang and prevents telomeric fusion 
(Figure 1.4).  Moreover, it recruits the MRE11 complex (meiotic recombination nuclease 
subunit of the heterotrimeric MRN complex: Mre11/Rad50/NBS1) that is the key component of 
the HR and NHEJ pathways involved in DNA double strand break repair (Baumann, 2006).  In 
human the MRN complex plays important roles in the detection and signalling of DSBs, as well 
as in the repair pathways of HR and NHEJ (Xin et al., 2007). 
 
Table 1.1.  Telomere binding proteins in mammalian cells. 
 
Name  Name description Role at telomeres 
Telomerase 
(Tert-Terc)  
Telomerase Reverse 
Transcriptase-Telomerase 
RNA Component 
Elongates telomeres; additional roles in cell survival and 
proliferation 
hPOT1  
Human Protection of 
Telomeres 
Binds single-stranded TTAGGG repeats; necessary for 
telomere length maintenance and telomere protection 
TRF1  
 
Telomere Repeat Factor-
1, amino terminus with 
an acidic region  
TRF1 present in T-loops; binds double-stranded TTAGGG 
repeats; a negative regulator of telomere length 
(telomerase-dependent); interacts with Pot1 and 
conveys information from double stranded telomeric 
region to single stranded 3’ overhangs 
TRF2  
Telomere Repeat Factor-
2, amino terminus with a 
basic region 
Present in T-loops; binds double-stranded TTAGGG 
repeats; negative regulator of telomere length 
(telomerase-independent); recruits hRAP1 and MRE11 
complex to telomere; loss of function causes end-to-end 
fusions and leads to apoptosis and replicative 
senescence 
TANK1 and 
TANK2  
Tankyrase 
Telomere-associated poly (ADP-ribose) polymerase 1/2 
(PARP); binds to telomere-binding protein TRF1; 
ribosylates TRF1; overexpression increases telomere 
length; positive regulator of telomere length 
TIN2/TENF2  
TERF1 (TRF1)-Interacting 
Nuclear Factor 2 
TRF1-binding protein; negative regulator of telomere 
length 
hRAP1  
Human Repressor 
Activator Protein 
TRF2-binding protein; regulates telomere length; (yRAP1 
is yeast homologue of hRAP1 that binds to both 
telomeres and to extra-telomeric sequence sites 
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Name  Name description Role at telomeres 
through the (TTAGGG)2 consensus motif; deficiency 
increase telomere recombination) 
TPP1 
Three Prime Phosphatase 
(TINT1/PIP1/PTOP1 in 
mammals) 
Homolog of human polynucleotide kinase/3'-
phosphatase; Interacts with POT1 to recruit telomerase 
BRCA1 Human breast Cancer 1 Telomere maintenance 
hRAD9 
Human RADiation 
sensitive 
DDR protein, involved in telomere maintenance 
RAD50  Radiation sensitive DNA repair complex that binds TRF2 
RAD51D Radiation sensitive 
DNA repair protein; DNA double strand break repair 
protein 
MRE11  
 
Meiotic Recombination; 
nuclease subunit of the 
heterotrimeric MRN 
complex (Mre11/Rad50/ 
NBS1) 
Negative regulator of telomere length; role in telomere 
capping; DNA double strand break repair protein; 
deficiency cause end to end chromosome fusion 
NBS1 
(Xrs2p is the 
yeast 
homologue of 
NBS1) 
Nijmegen Breakage 
Syndrome 1 protein 
Possible role in T-loop formation; DNA double strand 
break repair protein; mediates elongation by telomerase 
Ku  
(heterodimer, 
Ku86/Ku70 
complex;  
Regulatory 
component of 
DNA-PK) 
 
‘Ku’ derives from the 
surname of the prototype 
Japanese patient 
(Protein complex 
composed of a 70 kDa 
and a 83/86 kDa subunits) 
Associates to telomeric repeats and recognizes the ends 
of linear duplex DNA; recruits and activates the DNA-PK 
catalytic subunit; role in non-homologous end joining in 
mammals (Ku86); Prevents telomeric fusions 
independently of the length of TTAGGG repeats and the 
G-strand overhang; physically binds to and repairs DNA 
double-strand breaks (DSB); deficiency leads to telomere 
shortening in yeast (Ku86); gene inactivation results in 
cells with growth retardation, premature senescence 
and increase in chromosomal aberrations in mammals 
DNA-PKcs 
DNA-dependent Protein 
Kinase catalytic subunit 
Role in telomere capping; putative role in post-
replicative processing of telomeres; DNA double strand 
break repair protein; control non homologous end 
joining pathways for double DNA break repair 
(Adapted from: (Blasco, 2003, Baumann, 2006, Slijepcevic, 2006, Martinez et al., 2010) 
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DNA-dependent protein kinase complex (DNA-PK) consists of three proteins Ku70, Ku86 and 
the DNA-PK catalytic subunit (DNA-PKcs).  These proteins play dual roles, by protecting 
telomere capping and also by regulating telomere length.  Removal of these proteins results in 
as end-to-end fusion of TTAGGG telomere regions, due to the loss of telomere capping (Dynan 
and Yoo, 1998).  Deficiency in Ku86 or DNA-PKcs also influences telomere length.  Ku86 acts 
as a negative regulator of telomerase e.g., its deficiency causes telomerase-mediated telomere 
elongation while DNA-PKcs regulates telomere length positively and its deficiency causes 
telomere shortening (Espejel et al., 2002). 
 
In humans, telomere protection is facilitated by the formation of T-loop structure which 
impedes chromosome end fusions (NHEJ and HR).  The ssDNA binding protein, POT1 blocks 
recruitment of RPA and inhibits ATR mediated signal transduction pathways and repairing 
(Figure 1.5).  The ATM activation is prevented by dsDNA-binding protein TRF2 (Longhese, 
2008).  POT1 DNA binding domain is homologous to that in yeast Cdc13.  It binds to the 3’ 
single strand DNA overhang and blocks the accessibility of MRX (DNA damage response 
complex, composed of Mre11, Rad50 and Xrs2 proteins), RPA, Mec1 (mitosis entry 
checkpoint) and telomerase at telomeres.  The deletion of CDC13 is lethal for yeast cells due to 
its essential role in telomere capping.  Cdc13 inactivation by mutation of cdc13-1 results in 
telomeric single stranded DNA (ssDNA) formation, recombination and Mec1-dependent cell 
cycle arrest (Figure 1.5) (Jia et al., 2004).   
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Figure 1.5.  Chromosome end protection in humans and budding yeast. 
(A) In humans T-loop conformation protects the telomere ends. 
Formation of T-loop structure at telomere end may protect the chromosome ends from NHEJ and HR 
and also inhibits the recruitment of telomerase and checkpoint proteins, ATM-MRN and ATR complexes 
to telomere.  In the absence of T-loop, the ssDNA-binding protein POT1 prevents the recruitment of RPA 
protein and telomerase and inhibits ATR activation.   
(B) In S. cerevisiae, ssDNA-binding protein Cdc13 and dsDNA-binding protein Rap1 protect telomeres. 
Cdc13 prevents nucleases from binding at single-stranded telomere sequences whereas Rap1 inhibit the 
recruitment of MRX complex, RPA, Mec1, and telomerase at telomeres, which inhibit RPA recruitment 
and subsequent Mec1-dependent cell cycle checkpoint activation.  (Taken from Longhese, 2008). 
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Beside their roles in telomere binding and telomere length regulation, capping proteins play 
essential roles in intracellular signalling (Sedivy, 2007).  Critically short telomeres are 
processed as damaged DNA and senescence signalling is activated.  Telomere uncapping and 
DSB can trigger checkpoint response (Figure 1.6).  The ends of the uncapped or dysfunctional 
telomeres are presumably recognised as DSBs, which activate checkpoint response cascade.  
This may be the underlying cause of cell cycle arrest/senescence lead by telomere shortening.  It 
is more likely that the capping proteins are unable to bind very short telomeres and to protect 
telomere.   
 
In yeast, an uncapped telomere (dysfunctional telomere) recruits the phosphatidylinositol 3-
kinase-related kinase (PIKK), Mec1 a central player of DNA damage checkpoint signalling 
(Harrison and Haber, 2006), Tel1 (telomerase maintenance; the ATM orthologue), the 
checkpoint protein Rad9, and the MRX complex (Lydall, 2003).  This type of telomere is a 
weak inhibitor of cell division based on the fact that the TEL1-dependent response to un-
resected DSBs is weak and that Tel1p overexpression causes transient arrest (Clerici et al., 
2001).  Tel1 is a key regulator of checkpoint response to BSBs.  It promotes lengthening of 
short telomeres.  Tel1 defective strain show chromosomal aberrations and short telomere 
indicating its role in genomic stability.  It is a potent activator of telomerases and contributes to 
telomere capping (Arneric and Lingner, 2007, Di Domenico et al., 2014). 
 
The eukaryotic telomeres are protected from checkpoint activation, end fusions and other 
events) that might lead to the repair of intra-chromosomal DNA breaks.  The involvement of 
DDR proteins in the regulation of telomere suggest that functional telomere can also be 
recognised as DNA breaks (Longhese, 2008).   
 
In mammals, during the late S phase after the completion of DNA replication the telomere 
become susceptible to Clb–Cdk1-dependent (cyclin B-cyclin dependent kinase) nucleolytic 
processing which can result RPA coated ssDNA.  Telomeres exhibit short TG repeats and other 
features similar to DSBs.  The MRX complex binds to telomere and activates transient Mec1- 
and Tel1-dependent checkpoint activation that elongates telomere and also increases the 
proteins bound at TG tract.  This modification blocks telomerase and Mec1/Tel1 recruitment on 
telomere.  In the successive G1 phase the functional telomere cap could be reassembled when 
the Cdk1-dependent nucleolytic activity is low.   
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Figure 1.6.  A model for different states of budding yeast telomeres: DSB, capped, uncapped and 
eroded. 
(A) DSB-like telomere triggers a DNA damage checkpoint response and recruits the core components of 
DDR machinery including Mec1-Ddc2 (DNA damage checkpoint), Tel1-MRX complex, Rad17-Mec3-Ddc1 
proteins to the unprocessed break.  Tel1 phosphorylates Sae2 (ssDNA endodeoxyribonuclease) and 
recruits it independently of MRX to telomeres.  Exonucleases resect DSB and generates 3′-ended ssDNA 
which is the occupied with RPA protein.  RPA allow the loading of Mec1-Ddc2 complex and proceed to 
Mec1-dependent checkpoint activation.  Mec1 activation is also supported by independent loading of 
the PCNA-like Ddc1-Rad17-Mec3 complex by Rad24-RFC. 
(B) A fully capped telomeres are protected from checkpoint activation.  The presence of ssDNA- and 
dsDNA-binding proteins on full-length chromosomal ends inhibits recruitment of MRX, RPA, nucleases, 
telomerase, and checkpoint proteins.  The protective functions of telomere are lost with the loss of 
telomeric ssDNA- and dsDNA-binding proteins (uncapped telomere) or telomerase (eroded telomere). 
(C) An un-capped telomere (dysfunctional telomere): in the absence of the ssDNA-binding protein 
Cdc13, telomerase recruitment is impaired, and nucleases can resect the chromosome end.  This could 
lead to degradation of C-rich strand and accumulation of RPA-bound ssDNA, which activates a Mec1-
dependent DNA damage checkpoint response. 
(D) Eroded telomere: RPA-bound ssDNA accumulates at telomeres also after telomere erosion, due to 
telomerase loss. Green arrows indicate phosphorylation events.  (Taken from Longhese, 2008). 
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It has been shown that nucleases are involved in the DNA replication, repair and generation of 
ssDNA tail at telomere (Longhese, 2008).  In yeast, effective checkpoint controls require the 
generation of ssDNA, a prerequisite for signalling cell cycle arrest (Maringele and Lydall, 
2002).  
 
In budding yeast, a number of DDR proteins are involved in the formation of ssDNA and its 
degradation.  Rad24, Rad17 and Mec3, members of clamp loader and sliding clamp, promote 
the generation of ssDNA while Rad9, Rad53 and Mec1 play opposite roles by inhibiting 
degradation (Lydall and Weinert, 1995, Jia et al., 2004).  The checkpoint sliding clamp, 
(Rad17-Mec3-Ddc2) loaded by Rad24 protein regulates nucleases (Figure 1.7).  The activation 
of Rad53 through Mec1 and Rad9 inhibits nuclease degradation.  It further suggests that Rad9 
inhibits ssDNA generation by both Mec1/Rad53-dependent and -independent mechanisms.  
However Exo1 (exonuclease 1) appears to be targeted by the Mec1/Rad53-dependent pathway.  
Normally Exo1 nuclease does not play important role in telomere maintenance.  However on 
uncapped telomere Exo1 (the 5'-to-3' exonuclease), plays a critical role in generating single-
stranded DNA and activating checkpoint pathways (Lydall, 2003).  RPA1 (replication protein 
A) is a ssDNA binding protein and involved in cell cycle signalling.  Its phosphorylation is also 
mediated by Mec1 (Brush and Kelly, 2000).  The generation of ssDNA is important for the 
recruitment of RPA1 on telomere.   
 
Several negative regulators of the nucleases activity at telomere have been identified.  These 
include DNA repair protein Yku70/Yku80, single stranded telomere binding protein, Cdc13, its 
partner Stn1, Ten1, DNA polymerase α, FLAP endonuclease and telomerase (Lydall, 2003).  
Many of these proteins contribute to limit ssDNA at telomeres and also have telomere capping 
roles.  The involvement of checkpoint genes in the regulation of nucleases supports the possible 
role of nucleases at uncapped telomere.  For example RAD9 a checkpoint gene inhibits ssDNA 
production in strains lacking the telomere-binding protein Cdc13 (Lydall and Weinert, 1995).  
Rad9 also inhibits ssDNA production at uncapped telomeres by mediating interactions between 
upstream and downstream checkpoint kinases (Proctor et al., 2007).  Few positive regulators of 
the nucleases at telomere have also been reported e.g., MRX, EXO1 and RAD24 genes encode or 
regulate nucleases at telomere.   
 
The Exo1 is a 5′-to-3′ exonuclease that appears to function with the MRX complex in resection 
of DSBs and DNA repair (Raynard et al., 2008, Bonetti et al., 2010).  It is one of the main 
ssDNA generating nuclease.  Exo1 is also involved in meiotic recombination (Tsubouchi and 
Ogawa, 2000) and mismatch repair (Li, 2008).  However, exo1Δ mutants show no telomere 
length defects.  Previous studies have shown that Exo1 is essential for ssDNA generation and 
cell cycle arrest (Zubko et al., 2004) under conditions of defective capping.  It is involved in 
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generation of type1 and type11 survivors through recombination mechanism (Maringele and 
Lydall, 2004).  The significance of exo1 null mutation has also been shown in the generation of 
immortal yeast cell in telomerase and recombination deficient strain (Grandin and Charbonneau, 
2009, Ngo and Lydall, 2010).  Exo1 protein is essential in the generation of ssDNA in the sub-
telomeric region of X element repeat sequence of cdc13-1 mutants (Zubko et al., 2004).  The 
previous study with mutants, cdc13-1 rad9 and cdc13-1 rad9 rad24 suggest that other nucleases 
beside Exo1 may also act on uncapped telomere though Exo1 generate ssDNA in mutant cdc13-
1.   
 
Figure 1.7.  A model of checkpoint regulation of Exo1 activity at cdc13-1 telomeres. 
According to this model Rad24 and the small RFC subunits (2, 3, 4, 5) load the checkpoint sliding clamp 
(Ddc1, Mec3, and Rad17) onto telomeres of cdc13-1 mutants at 36°C.  This sliding clamp tethers Exo1 to 
DNA.  Other unidentified nucleases (ExoX) may also have their roles, while Rad9 inhibits nuclease 
activity (taken from Zubko et al., 2004). 
 
E. M. Holstein’s model elaborates (Holstein et al., 2014) that diverse groups of proteins 
including CST complex, nonsense mediated decay (NMD), and DDR proteins, bind to telomere 
ends in mammals and yeast, and play important roles in telomere capping and replication 
(Figure 1.8).  In the presence of inactive DDR and NMD the Cdc13 essential roles might be 
bypassed, however, the need for the other two interacting component of the CST complex, the 
Stn1 and Ten1 cannot be bypassed.  This model also emphasises that Stn1 and Ten1 can 
function in the absence of Cdc13 and bind to telomeres in Cdc13 independent manner, 
indicating that these two components play more critical roles in CST complex across eukaryotes 
in telomere maintenance and replication (Holstein et al., 2014). 
23 
 
 
Figure 1.8.  Interaction of telomere capping proteins in the presence and absence of CDC13. 
(A) In the presence of wild type CDC13. (B) Without CDC13 (in cdc13 deletion mutants).   
(Taken from Holstein et al., 2014). 
 
The mechanism of telomere chromosome end protection by capping proteins is evolutionarily 
conserved.  DDR mechanisms are activated under the effect of genotoxic stresses.  Telomeres 
interact with the DNA damage repair system as a result of signalling from checkpoint proteins.  
These checkpoint proteins physiologically maintain uncapped telomeres, a phenomenon that 
makes telomeres different from ‘DNA breaks’ (Lydall, 2003). 
 
Telomere defects activate different DNA damage checkpoint proteins to induce cell cycle arrest 
(senescence) or death (apoptosis) depending upon the damage caused.  Many DNA damage 
response proteins have been implicated in telomere maintenance.  They include Brca1 (breast 
cancer 1) (McPherson et al., 2006), hRad9 (radiation sensitive) (Pandita et al., 2006), PARP1 
[TRF2-associated Poly (ADP-Ribose) Polymerase, detect ssDNA breaks and interact with 
DNA-PKcs, ATM and p53; (Gomez et al., 2006).  Cells defective in DNA double strand break 
repair proteins such as Ku, DNA-PKcs, RAD51D and MRN or having mutated signalling 
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protein ATM (Metcalfe et al., 1996) show loss of telomere functions and involve many DNA 
damage repair pathways e.g., NHEJ, HR, BER (base excision repair) and nucleotide excision 
repair (NER) in telomere maintenance.  To explain this high level of co-operation between 
telomere maintenance and DDR, P. Slijepcevic (Slijepcevic, 2006) has proposed an “integrative 
model” suggesting that telomere maintenance mechanisms are an integral part of the DNA 
damage response network (Figure 1.9).  Telomere maintenance is mediated by the interaction of 
cell cycle checkpoints with DNA damage response, signalling and repairing complexes of DNA 
damage response (Slijepcevic, 2006).   
 
According to this model, ‘chromosomal repair’ is different from DNA repair as it has to 
preserve its function, not DNA sequence.  Such chromosome end should be able to acquire 
telomeric features at chromosome breakage site or inactivate native telomere and centromere 
with the initiation of chromosomal rearrangement.  Some of these events take place in response 
to DNA damaging agents causing chromosome rearrangements.  An integrative model further 
suggests that DSB repair and chromosomal healing could be global features with telomere 
maintenance local function of the single chromosomal repair functional tool (Slijepcevic, 2006).  
Capping proteins maintain telomeres by interacting closely with DNA damage response 
networks and telomerase.  An example supporting this hypothesis was the observation that 
TRF2 (double strand binding protein at telomere) is not confined locally but migrated to the site 
of DNA breakage after exposure of cells to ionizing radiation.  Disruption of other DDR 
proteins exhibited telomere elongation or shortening, end-to-end chromosome fusions, 
accelerated telomere loss, elevated anaphase bridges, and alternative lengthening of telomere in 
telomerase independent fashion reflecting their direct link with telomere dysfunctions or 
interdependence between telomere maintenance and DNA damage response (Slijepcevic, 2006). 
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Figure 1.9.  An integrative model of telomere DNA damage response mechanisms. 
The “integrative” model emphasises the integration of telomere maintenance mechanisms into a 
complex networks of mechanisms collectively known as the DNA damage response.  The major 
components of DNA damage response include: (I) Damage processing, (II) Cell cycle checkpoint control 
and, (III) Control of apoptosis.  Arrows indicate the link between telomere maintenance and other 
components of DNA damage response.  Only representative proteins are shown for each link.  For 
example, in the loss of human TRF2 (telomere repeat factor-2, a double strand binding telomere 
protein) results in apoptosis (link no.4) or cell senescence leading to cell cycle arrest.  (Picture is taken 
from Slijepcevic, 2006). 
 
1.2.1.2. Cell cycle checkpoint and genomic instability  
Genomic instability is an increased tendency of alterations in the genome during the life cycle 
of the cell.  Accurate transmission of genetic information from parents to daughter cells is 
critical for the survival of cells.  Cell cycle checkpoint controls ensure accurate duplication of 
genome and precise division of duplicated genome in daughter cells.  The telomere defects such 
as DNA damages due to external genotoxic agents (Callegari and Kelly, 2007), telomere length 
shortening (critically short telomere) or other internal replication problems (Sedivy, 2007) are 
sensed by cell cycle signalling pathways which trigger the cell cycle checkpoints by activating 
Mec3p, Mec1p, and Ddc2p and lead to cell cycle arrest followed by activation and/or 
recruitment of telomerase to the short telomeres (Weinert, 1998).  The different models of 
telomere checkpoint propose that the DNA damage pathway signals to Mec3p, Mec1p, and 
Ddc2p and activate another parallel pathway that involve Tel1p (telomere maintenance) protein 
(Figure 1.10).  Both of these pathways also interact with the Rad9p and Rad53p.  Triggering of 
the DNA damage checkpoint leads to cell cycle arrest and also activate the DNA repair systems, 
however it does not activate telomerase (Enomoto et al., 2002).  The cell cycle is delayed by the 
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signal transduction pathway (G1 checkpoints) and the cell cycle progression is blocked to 
prevent the defective DNA to enter in replication and undergo segregation and also induce the 
transcription of several DNA repair genes (Foiani et al., 2000). 
DNA damage induces the expression of many genes that enhance DNA repair capacities 
through damage induction subset of pathways.  A number of DNA-damage un-inducible (dun) 
mutants have been reported that are sensitive to DNA damages and induce other genes through 
damage induction pathways (Zhou and Elledge, 1993). 
 
 
 
 
 
 
Figure 1.10.  The telomere checkpoint model. 
(Picture taken from Enomoto et al., 2002) 
 
1.2.1.3. Telomerase and telomere maintenance 
Telomerase is a specialised ribonucleoprotein enzyme (RNA-templated polymerase) that is 
responsible for maintaining the telomere of eukaryotic chromosome ends (Cech, 2004, Sedivy, 
2007).  It regulates telomere length by adding repeats of TTAGGG onto pre-existing telomeres 
in mammalian telomeres (Collins and Mitchell, 2002, Cech, 2004).  Telomerase complex is 
composed of two essential components, the catalytic protein subunit or reverse transcriptase 
subunit known as TERT (telomerase reverse transcriptase: hTERT in human and Est2 in 
budding yeast) and a small RNA molecule of TERC (telomerase RNA component: hTERC in 
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human and Tlc1 in yeast) unit which contains the small template for the synthesis of new 
telomeric repeats and accessory factors (the Est1 protein and dyskerin in humans and Est1, Est3, 
and Sm proteins in budding yeast (Smogorzewska and de Lange, 2004, Collins, 2000, Autexier 
and Lue, 2006) for G-rich strand.  Telomerase activity is detected only in germ cells, some 
proliferating stem cells, progenitor cells, cancer cells and transiently in some proliferative cells 
of renewable tissues (Sedivy, 2007).  In human, most normal somatic cells do not have 
sufficient telomerase.  In the absence of telomerase, telomeres are shortened by 50-200 base 
pairs with each round of replication/cell division because DNA polymerase are unable to fully 
replicate 3’ termini (end-replication problem) (Sedivy, 2007, Lingner et al., 1995, Mu and Wei, 
2002).  DNA replication in the 3’-to-5’ direction requires short terminal RNA primers.  These 
RNA primers are lost with each cycle of replication resulting in continuous shortening of the 
telomere.  Telomeres loss in the absence of telomerase activity accumulates and eventually 
results in various chromosomal aberrations like TTAGGG-exhausted chromosomes, end-to-end 
chromosome fusion and loss of cell viability (Lee et al., 1998, Herrera et al., 1999).  Telomere 
shortening destabilises the telomeric loop and increases the possibility of telomere uncapping 
(Griffith et al., 1999).  When telomeres become critically short, most cells undergo senescence 
(Shay and Wright, 2005, Samper et al., 2001).  Samper et al., (2001) has reported in a mouse 
model that reintroduction of telomerase in cultured cells in vivo can overcome the rapid loss of 
cell viability as a result of senescence triggered by short telomeres, indicating its therapeutic 
role in cellular senescence. 
 
In yeast, the emergence of post-senescence survivors (cells that escape senescence) with long 
telomeric DNA repeats have been identified (Kachouri-Lafond et al., 2009).  Yeast cells can 
produce recombination-mediated telomere elongation in the absence of telomerase TLC1 
moiety (Chen et al., 2001).  In fission yeast, deletion of single strand telomere binding protein, 
Pot1 cause rapid loss of telomere DNA and chromosome fusions in most cells (Baumann and 
Cech, 2001).  However survivors with circular chromosomes are generated as a result of intra-
chromosomal fusions.  These survivors show the ability to replicate and go through mitosis and 
bypass the need for chromosome end maintenance.  Analysis of DNA repair factors have shown 
that homologs of Rad52 are involved in the generation of telomere dysfunction-induced 
chromosomal fusions in fission yeast involving NHEJ pathways (Wang and Baumann, 2008). 
 
1.2.1.4. DDR proteins and telomere maintenance 
Telomere-induced senescence has been shown to share many components of the DDR triggered 
by DNA double strand breaks (von Zglinicki et al., 2005).  There is compelling evidence that a 
number of DDR proteins including Ku, DNA-PKcs, RAD51D and the MRN 
(MRE11/RAD51/NBS1) complex and many other are involved in telomere maintenance.  
Deletion/mutation of these repair proteins causes loss of telomere capping function with 
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dysfunctional telomeres.  Slijepcevic (2006) has reported 18 DDR mammalian proteins that are 
implicated in telomere maintenance.  The DDR is a combination of interacting mechanisms 
including activities like damage detection, signalling, repairing DNA damage and also activities 
associated with cell cycle checkpoint control and apoptosis regulation.  Alteration of any 
component of the DDR proteins results in dysfunctional telomeres and genomic instability and 
is correlated with the number of proteins mutated (due to the combined effect of all mutations).  
As a result of failure in the telomere’s protective function, the ends of chromosomes may fuse to 
other susceptible chromosomes’ ends or double-strand DNA breaks and leads to different 
chromosomal aberrations besides end-to-end fusion (Goytisolo and Blasco, 2002, Latre et al., 
2003).  The non-homologous end-joining DNA repair machinery detects and signals the 
presence of dysfunctional telomeres as damaged DNA and repairs them, leading to end-to-end 
chromosomal fusion and other chromosomal rearrangements. 
Telomeric defects could be reflected as telomeric loss (short length), telomeric fusion and 
accumulation of extra chromosomal telomeric fragments due to disruption of DDR proteins. 
 
1.2.1.5. Telomere length and ageing 
In higher eukaryotes telomeres shorten with each cycle of DNA replication due to end 
replication problem and nucleolytic processing resulting chromosome ends fusion and 
degradation.  Telomerase ribonucleoprotein (RNP) reverse transcriptase counteracts telomere 
erosion by serving G-overhang as the substrate to replenish telomeric DNA (Shay and Wright, 
2001).  However the telomerase activity in human cells (stem cells, T cells and monocytes) is 
either limited at very low level or not observed in most somatic cells after birth to prevent 
telomere shortening (Wright et al., 1996).  
 
In S. cerevisiae telomeres are ~350 base pair long with short 3’ G-rich strands (Gasparyan et al., 
2009).  It has been established in many studies that telomere length is linked to ageing and 
cellular senescence (Qin and Lu, 2006).  In higher eukaryotes, the length of telomeres plays a 
decisive role in the onset of ageing and cellular senescence.  For example, in human germ line 
cells (sperm cells), DNA shows long telomeres in comparison to short telomeres in somatic 
cells which, as a result of sufficient shortening, leads to cellular senescence.  Disruption of one 
of the DDR proteins (Brca1) results in significantly shorter telomere (Slijepcevic, 2006) and its 
deficiency causes end-to-end chromosome fusions.  In vitro studies of human fibroblasts have 
shown that shorter telomeres exhibit few doublings of cells (proliferation senescence) as 
compared to cells with longer telomeres (Bryan et al., 1995).  It has been revealed through the 
replicative lifespan (RLS) in cultured human fibroblast cells that telomere length is gradually 
decreased in ageing culture after a specific number of cell divisions (Cooke and Smith, 1986).  
Normal fibroblast human cells at the end of RLS show decrease in telomere length and after a 
specific number of divisions these cells enter in a replicative senescence state (Bodnar et al., 
29 
 
1998).  T M Bryan and colleagues have suggested in a study on telomerase that stable and 
lengthened telomeres are necessary for the immortalisation of cells (Bryan et al., 1995).  
Fibroblasts cells from Hutchinson-Gilford progeria patients show short telomeres consistent 
with the fact that short telomeres depict reduce replicative potential (few divisions).  The cells 
that express telomerase survive longer than their normal lifespan without shortening of their 
telomere (Samper et al., 2001).  
 
The interaction between the DNA repair protein Ku and the RNA component of telomerase in S. 
cerevisiae has also been shown to be crucial for maintaining telomere length (Sedivy, 2007).  
Similarly, the hRad9 mutation or its knockdown results in an elevated level of chromatin 
bridges in anaphase and end-to-end chromosome fusion in metaphase cells.  This form of 
telomere dysfunction results due to its interaction with TRF2 (a capping protein with an 
additional role of DNA damage-sensing and in cell cycle checkpoint control).  On the basis of 
telomere shortening and its correlation with ageing and cellular senescence, the telomere are 
regarded “the molecular clock” (Vaziri et al., 1994) or “biomarker of ageing” (Mather et al., 
2011). 
 
1.2.2. Dysfunctional telomeres and genomic instability 
In humans, POT1 is one of the essential proteins that binds to single-stranded overhangs and is 
responsible for telomere capping and maintenance (Wu et al., 2006) through chromosome end-
protection and telomere length regulation.  Pot1-related proteins have also been reported in 
murine/rodents, mouse (Hockemeyer et al., 2006), Arabidopsis (Shakirov et al., 2005, 
Surovtseva et al., 2007) and ciliate Euplotes crassus (Wang et al., 1992) and encoded by either 
single-copy (POT1 in human and fission yeast) or multiple genes (POT1 and POT2 in 
Arabidopsis and POT1a and POT1b in rodents/mouse).  In budding yeast, S. cerevisiae, an 
ortholog of POT1 gene is CDC13 (Baumann and Cech, 2001).  Cdc13 is multi-functional 
protein that plays an important role in telomere end protection, length regulation, telomerase 
regulation and chromosome maintenance (Lustig, 2001).  Cdc13 has been considered an 
essential telomere capping protein in budding yeast as the yeast cells that lack Cdc13 rapidly 
accumulate excessive single-stranded DNA at the telomere, arrest of cell division and then die 
(Garvik et al., 1995, Zubko and Lydall, 2006). 
 
In S. cerevisiae, Cdc13 binds the G-rich strand of telomeres in close association with two other 
essential proteins, Stn1 (suppressor of Cdc13) and Ten1 (telomeric pathways with Stn1), and 
protects the chromosome from degradation and end fusion, and prevents the formation of 
ssDNA during the S and G2-M phases of the cell cycle (Garvik et al., 1995, Grandin et al., 
1997, Grandin et al., 2001, Wellinger, 2009).  This heterotrimeric complex physically caps the 
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telomere end and blocks nuclease activity.  Stn1 also promotes telomere C-rich strand 
extension.  The Stn1 protein interacts with Cdc13 and limits ssDNA at the telomere and 
maintains telomere stability by preventing its degradation.  Overexpression of Stn1 N-terminal 
in the presence of Ten1 protein can protect the telomere even in the absence of CDC13 
(Petreaca et al., 2006, Petreaca et al., 2007).  However, Stn1 requires Pol12 (polymerase alpha-
primase regulatory subunit), critical for Cdc13-independent capping (Petreaca et al., 2006).  
Stn1 also interacts with yeast Yku70 to regulate telomerase recruitment.  This in turn controls 
Cdc13 interaction with Est1 (an essential subunit of telomerase) and plays an important role in 
telomerase regulation (Dubrana et al., 2001, Grandin et al., 2000).  Exo1 is another important 
protein that is associated with telomere regulation.  It is involved in the DNA repair mechanism 
by coding for 5’-3’ exonuclease.  In yeast, unprotected telomeres due to non-functional Cdc13p 
or Stn1p undergo a DNA degradation that is tightly regulated by the cell cycle in the G2/M, but 
not in the G1 phase of the cell cycle.  G1-arrested cells remain viable even with uncapped 
telomeres while G2-M-arrested cells fail to recover (Wellinger, 2009). 
 
Cdc13 interacts with various other capping proteins through its N-terminal region that is a 
crucial part for its protective activity (Hsu et al., 2004).  Mutations in CDC13 lead to abnormal, 
uncapped telomeres with long, exposed G-strands, resulting in dysfunctional telomeres that 
activate the DNA damaged response pathway, cause cell cycle arrest at the G2-M phase (Lin 
and Zakian, 1996), progress to an ever short telomere (EST) phenotype and eventually lead to 
cell death.  In mouse, conditional deletion of Pot1 activates DNA damage response pathways 
resulting in replicative senescence with elongated telomere and homologous recombination (Wu 
et al., 2006). 
 
Cdc13 interact with Stn1 and Ten1 proteins of CST complex to form heterotrimeric 
telomere-capping complex (CST), an activity that is central for telomere end capping and 
telomerase recruitment for end replication (Figure 1.11).  Similarly N- and C-terminus of 
Stn1 interact independently with Ten1 and Cdc13-Pol12.  N-terminus of Stn1 can bind 
Cdc13 but not to Ten1 and negatively regulate telomerase elongation (Puglisi et al., 2008, 
Sun et al., 2011).  Structural, biochemical and computational analysis of Stn1 and Ten1 
proteins revealed resemblance of these CST proteins to telomere specific replication protein 
A, RPA32 and RPA14 (Figure 1.12).  Multiple sequence alignment of Cdc13 homologs 
revealed pattern of four conserved regions consisting of 150-200 residues.  Cdc13 also 
exhibited RPA70- (largest subunit of RPA complex) like domain organisation though there 
was no primary sequence similarity between Cdc13 and RPA70 protein.  The crystal 
structure of Cdc13 N terminal-OB1 folds showed only 8% identity with RPA70 N domain.  
OB2 fold is involved in homo-dimerization of Cdc13 proteins, a conserved feature of all 
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Cdc13 proteins and also interact with pol1 (polymerase alpha) for DNA replication.  The 
dimerization of Cdc13 is also involved in telomere length regulation. 
 
An essential function of Stn1 is to cap the telomere end (Zubko and Lydall, 2006).  Stn1 
interacts with CDC13 through its C-terminus.  Gene over expression studies have shown that 
the Stn1 C-terminus interferes with the S phase checkpoint response to DNA replication stress.  
Over-expressed Stn1 distributes on chromosomal DNA outside of the telomere, restores the S 
phase checkpoint in association with DNA polymerase and maintains genomic stability 
(Gasparyan et al., 2009).  Moreover, Stn1 C/N-terminus suppresses cdc13-1 temperature 
sensitivity to some extent but cannot bypass the CDC13 essential function (Petreaca et al., 
2006).  Functional loss of Stn1 leads to excessive ssDNA at the telomere that is a marker of 
senescence (Petreaca et al., 2007, Grandin et al., 1997). 
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Figure 1.11.  The CST and RPA complexes: organisation of conserved domains. 
The sequence analysis of Cdc13 shows homology to RPA70 component of RPA-complex.  There are four 
oligosaccharide/oligonucleotide binding (OB) folds in Cdc13 and RPA70 that revealed pattern of 
conserved regions from N to C-terminus and consisted of 150-200 residues.  Cdc13 binds to Pol1 (alpha) 
through its N-terminal OB-1 fold while it interacts with Stn1 through its C-terminal OB4-fold.  (Picture 
taken from Sun et al., 2011). 
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Figure 1.12.  A diagram of the Cdc13 protein and its OB2 monomer. 
Cdc13 protein exists as a dimer in crystal and in solution form.  At least five conserved oligosaccharide 
binding domains (OBD) exist in Cdc13 protein (A).  The conserved motifs include Cdc13N-terminus 
oligosaccharide binding 1 (OB1), recruitment domain (RD), central OB2, DNA binding domain 
(DBD/OB3), and C-terminus domain (CTD/OB4).  The domains between the recruitment domain (RD) 
and DNA binding domain (DBD) is OB2 that involved in Cdc13 dimerization.  In Cdc13-1 the 
oligomerisation of OB2 is disrupted that affect the Stn1 and Cdc13 binding and telomere maintenance 
(adapted from Mason et al., 2013). 
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The conditional telomere capping dysfunction leads to sister chromatid rearrangements and 
genetic instability.  The telomere lead genomic instability has been suggested to be regulated 
due to cellular DNA repair activation (Wellinger, 2009).  It has been reported in recent studies 
in S. cerevisiae strains that cdc13 deletion mutants can survive without Sgs1 (helicase), Exo1 
and Rad9, important damage response proteins and maintain linear chromosomes (Ngo and 
Lydall, 2010).  Though continuous sub-culturing of such strains results in progressively shorter 
telomeres but cells can maintain them by recombination and thus can survive indefinitely. 
 
1.3. Model organisms  
Model organisms have been used historically in research to elucidate fundamental and basic 
principles in evolution, genetics and developmental biology.  The animal models have helped to 
discover many of the conserved pathways underpinning the complex physiology and chemistry 
of higher mammals.  Animal research in medical field has played a vital role in expanding our 
understanding of different disease (Festing and Wilkinson, 2007).  About 60% of the genes 
involved in different human disease have their counterpart in the fruit fly and worm (Edwards, 
1999) and these organisms have been studied universally to characterise the molecular pathways 
these genes are involved in.  The ultimate goal of present day research is to translate scientific 
finding from model organism into human to improve their health conditions.   
 
At present a range of model systems (Table 1.2) are being utilised to explore the molecular and 
genetic mechanisms of ageing in relation to mammals.  In telomere studies, the significance of 
ciliates was a powerful tool because of large amount of telomere DNA, budding yeast offered 
the ease of genetic manipulation; the human cell lines have advantages of their direct 
applicability to humans (Dehe and Cooper, 2010).  There are many aspects to consider when 
choosing a model organism e.g., it should be simple, economical and easy to manipulate in the 
laboratory.  An important criterion for choosing a model organism is its suitability to address 
the research question.  Due to its high level of conservation with mammalian telomere budding 
yeast has presents a valuable model for telomere and ageing research. 
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Table 1.2.  Models organisms used in research with their relative advantages and disadvantages. 
 
 Advantages Disadvantages 
Human A higher eukaryote; directly relevant to 
human biology.  
 
Ethical limitations for conducting many 
experiments on human; complex 
organism; long lifespan; complex and 
slow ageing process; long term 
development; virtually impossible to 
study human ageing in vivo. 
Human cells Simplified models for human biology; 
possibility for studying human ageing at 
cellular level; relatively short life cycle 
(dividing time of ~18-20 hours for most 
mammalian cells); availability of 
immortalised cells; convenient to model 
genetic, biomedical and biochemical 
events (e.g., cancerous processes), 
availability of embryonic stem cells to 
investigate growth and differentiation; 
suitable for uncovering mitosis: nuclear 
envelope breaks down during mitosis; 
microtubules nucleated by centrosomes. 
Subject to tissue act laws; In vitro 
results do not always representative in 
vivo process; not suitable for studying 
systemic processes. 
Bacteria 
E. coli 
Simple prokaryotic systems; valuable 
model with well understood biology; a 
good tool for fundamental biological 
research; simple and easy to apply 
techniques; easy to handle and to 
manipulate; suitable for cellular and 
molecular studies of gene expression; a 
crucial model to study infectious 
diseases of gut; inexpensive; no ethical 
issues involved.  
Different from human genetic 
constitution (circular naked DNA) and 
physiology (not representing human 
ageing).  
Baker’s yeast 
S. cerevisiae 
The simplest unicellular eukaryotic 
model with entire genome sequenced; 
total ~6500 genes on 16 chromosome; 
short cell cycle (90 min); economical; 
not a subject of ethical issues; easy to 
grow and to maintain in laboratory; 
easily manipulable by genetic methods; 
No features of multicellular systems; 
compartmentalized mitosis: nuclear 
envelope does not break down during 
mitosis; microtubules nucleated by 
spindle pole bodies. 
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 Advantages Disadvantages 
asymmetrical division (daughter and 
mother cells); is ideal model for genetic 
research of ageing; stable haploid and 
diploid states; simple molecular tools for 
gene manipulation; many conserved 
genes involved in human disease; ideal 
for fundamental and applied research; 
observable phenotypes of the mutations 
in haploids; many genes have human 
homologs; powerful tool to study 
checkpoints, telomere maintenance and 
ageing (replicative cell senescence and 
chronological lifespan); availability of 
deletion mutants for functional analysis.  
Fruit fly 
Drosophila 
melanogaster 
Invertebrate model; multicellular; small, 
easy to grow and to maintain; easy 
breeding in laboratory; short generation 
times with large numbers of offspring; 
short life cycle (~2 weeks); inexpensive 
to culture; availability of full genome 
sequenced (14000-16000 genes); 
independent embryo development;  
excellent model for genetics and 
pathology; easy to apply molecular tools 
to generate gene knockout or to create 
mutants; mitotic cell cycle; suitable for 
studying behaviour, learning and 
memory formation; suitable for high 
throughput mutation screening; 
availability of vast biological 
information. 
Restricted to basic biological research; 
telomere composition is different from 
human: no evidence of shelterin 
proteins or t-loop at telomere; 
Telomere elongation through 
telomerase independent mechanisms 
such as chromosome end capping with 
non-LTR retrotransposons and 
chromosome end elongation by gene 
conversion or recombination. 
Roundworm 
Nematode 
Caenorhabditis 
elegans 
Multicellular; simple eukaryotic model; 
short lifespan of two weeks; easy to 
manipulate; economical; quick to grow 
(3-4 days); first multicellular organism 
with entire genome sequenced; total 
genome with ~20000 genes with 6 pairs 
of chromosomes; 40% genes have 
Expensive to cultivate in vitro. 
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 Advantages Disadvantages 
human homologs; a model to study cell 
division and developmental processes; 
easy to conduct gene knockout using 
RNAi; ease of mating, isolating and 
manipulating gene; less than 1000 
somatic cells with fixed position in the 
body; a hermaphrodite with large 
numbers of eggs; a useful model for 
genetics and developmental research; 
transparent embryo, easy for 
developmental manipulations; self-
fertilisation. 
Rodents  
(Mice, 
Mus musculus; 
Rats, 
Rattus 
norvegicus) 
Mammalian models for developmental, 
molecular and genetic studies; 
vertebrate model closely related to 
human; small size, easy to keep; 
complete generation time of ~10 weeks; 
ideal model for deeper understanding of 
physiological mechanisms; similar to 
human genome, anatomy and 
physiology; useful to study homologous 
recombination; models for human 
diseases: transgenic mice models for 
Alzheimer’s disease, Huntington’s 
disease, sickle cell anaemia and many 
cancers. 
Not an ideal model of ageing as due to 
subject to animal licensing laws; 
complex animals with large genomes; 
internal embryo; limitation to grow 
and culture embryos; relatively long 
generation time (3 months); limited 
mutational screening; long telomeres 
and telomerase activity in most 
tissues; telomere shortening not 
correlated with lifespan (or replicative 
ageing); expensive to maintain; 
extremely long (10-80 kb) polymorphic 
telomeres; not very reliable as 
preclinical models for human disease. 
Amphibians 
African clawed 
frog (Xenopus) 
Long lifespan (~15 years); negligible or 
very slow senescence; easy to access, 
manipulation with eggs and embryos; 
rapid development (~ 4 days); well 
establish systems; extensive 
regenerative potential. 
A subject to animal licensing laws; 
complex, genomes are poorly 
characterised; cannot breed for many 
generation in laboratory; persistent 
telomerase activity in somatic cells. 
 
Zebrafish 
(Danio rerio) 
Small, economical; large, easily 
observable eggs and embryos; ease of 
breeding in the laboratory; small fully 
sequenced genome; valuable vertebrate 
model to study development (due to 
transparent embryo); convenient to 
A subject to animal licensing laws; long 
generation time (2-4 months); high 
proliferation rates of all somatic cells; 
telomerase activity in all somatic cells; 
telomerase activity related to 
regeneration not to lifespan. 
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 Advantages Disadvantages 
study fundamental aspects of blood 
(iron load or haemochromatosis); 
molecular tools to manipulate genes; 
telomere length similar to that in 
human; a unique model of ageing with 
different patterns of senescence; long 
lifespan; excellent model of 
regeneration , stem cells, DNA repair 
and cancer; recently being used in 
cardiac electrophysiology. 
Rhesus monkey A mammalian model with approximately 
same number of genes as in humans: 
most of the genes have human 
homologs; a valuable model for clinical 
studies of numerous diseases including 
cancer and autoimmune disorders. 
A subject of animal licensing laws and 
expensive; complex organism to study; 
not an ideal model to conduct 
basic/applied research. 
 
Although debatable animal research has played a vital role in scientific and medical advances 
with the benefits of better quality of life globally (Festing and Wilkinson, 2007).  Model 
organisms like yeasts, flies, fish and mice have many molecular pathways and genes in common 
with human (99% of mouse genes have their counterpart in humans) and have been widely used 
in research to explore evolution, genetics and development, as well as advanced molecular, 
biological aspects of serious human diseases (like cancer) and ageing. 
 
There is a lack of compelling evidence for in vivo telomere-induced senescence. The main 
reason for that is a fact that laboratory mice are not an ideal model system for ageing studies: 
these animals have very long telomeres, and many tissues express significant levels of 
telomerase.  A mouse that completely lacks telomerase activity, due to a germ line knockout of 
the RNA template component, has been apparently normal and healthy.  After successive 
generations, allowing for sufficient telomere shortening, the mice display premature ageing 
phenotypes (Sedivy, 2007).  Similarly, in Drosophila, another model system used to study 
telomere maintenance, there is no evidence for existence of shelterin proteins or t-loops at the 
telomere (Cenci et al., 2005), though it involves many DDR proteins for telomere maintenance.  
However, telomere maintenance in mammalian and yeast cells is terminal sequence-dependent 
and maintained by telomerase, indicating similar mechanisms of telomere maintenance.  The 
biological consideration for the suitability of an organism for a type of research question is one 
of the basic criteria to select a model organism for a study. 
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1.3.1. Yeast: Saccharomyces cerevisiae as a eukaryotic model  
Yeasts are one of the simplest, unicellular eukaryotic systems.  Commonly known baker’s yeast, 
or budding yeast, S. cerevisiae is one of the most studied yeasts in molecular genetics.  It has 
also been studied extensively to explore the fundamental mechanisms of ageing (Steinkraus et 
al., 2008).  The biggest advantage of using S. cerevisiae in fundamental and applied research is 
the availability of its entire sequenced genome (Mager and Winderickx, 2005) and methods for 
genetic manipulations thus facilitating functional genomic analysis.  Another advantage 
includes methods for manual manipulations with individual cells and spores using dissecting 
microscope. 
 
It was suggested in many studies that genes involved in regulation of ageing have a common 
evolutionary origin between unicellular S. cerevisiae and higher eukaryotes (Longo and 
Fabrizio, 2012).  For this reason S. cerevisiae can serve as an alternative, economical model 
complementing ageing research in higher eukaryotes and mammals.  Yeasts have also been very 
useful for cell cycle and checkpoint research and other fundamental cellular processes.  Yeast 
has additional advantages such as rapid growth, spore formation and simple transformation 
methods that could be employed in basic research.  It is easy to grow and can be manipulated 
under normal laboratory conditions.  S. cerevisiae have small genome with ~6,700 genes.  It can 
also exist in stable haploid or diploid state.  Yeasts have a short cell cycle i.e., approximately 90 
minutes as compared to other simple systems that are currently being utilised to study 
eukaryotic system like worms, fruit flies and rats.  In yeast, comparative analysis of the 
genomes and the predicted proteins have shown that ~40% of yeast proteins are conserved in 
eukaryotic evolution (Rubin et al., 2000) and 30% of known genes involved in human diseases 
have yeast homologues (Bassett et al., 1997).  This aspect presents it as an efficient model 
system and powerful tool to investigate different diseases and the therapeutic approaches to find 
solutions in combating human diseases.  
 
1.3.2. Yeast cell cycle and cell cycle checkpoint 
A cyclic array of organised events whereby cell grow, divide and bring about accurate DNA 
replication, duplication and segregation of all essential cell components into daughter cells is 
known as cell cycle (Elledge, 1996).  The cell cycle in yeast has been divided in four easily 
identifiable stages namely G1, S, G2M and M (Figure 1.13).  The G1 phase is characterised by 
un-budded cells.  Cells can be identified as an oval-shaped under the light microscope.  Growth 
and preparation of chromosomes for replication take place in this phase.  In the S phase (DNA 
synthesis phase) cells appear with small buds.  DNA and histone proteins (DNA proteins) 
synthesis, and chromatin assembly take place in this phase.  Centromere duplication also occurs 
in this phase.  The G2M phase is a transition phase between the S (DNA synthesis) and M 
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(division) phases.  The newly emerged bud grows and gets to the parental cell size.  The M 
phase (mitosis and nuclear division) is the final stage in the cell cycle in which nuclear division 
takes place.  The cells divided into two, remain still connected to each other but have their 
separate nuclei. 
 
There is another phase known as G0 or “quiescent” phase (Gray et al., 2004) when the cell 
leaves the cell cycle at the G1 phase either temporarily or permanently and enters in this G0 
phase/stationary phase.  The stationary phase has been characterised by cell cycle arrest and 
with a number of physiological, biochemical and morphological changes.  The cell wall gets 
thickened with the accumulation of reserve carbohydrates, and acquires the capability of 
thermotolerance (Werner-Washburne et al., 1993). 
 
Figure 1.13.  The different phases of yeast cell cycle. 
Life cycle of yeast shows different phases as they appear under the microscope.  Grey areas represent 
the nucleus, solid lines represent the mother cell and dotted lines show the newly emerging daughter 
cell (taken from Herskowitz, 1988). 
 
The genetically controlled surveillance and response mechanisms by which cell monitor and 
control cell cycle events to ensure genomic integrity are known as cell cycle checkpoints 
(Clerici et al., 2001, Mogila et al., 2006).  They include both intrinsic and extrinsic pathways.  
Intrinsic pathways regulate successive cell cycle events in an extremely organised sequence 
(Hartwell and Weinert, 1989).  Extrinsic checkpoints prevent cell cycle progression in response 
to DNA damage.  The gene products (checkpoint controls) are involved in monitoring cell cycle 
events such as chromosome replication, duplication and segregation.  The checkpoint controls 
and DNA damage response pathways and the genes involved to mediate are highly conserved 
(Gartner et al., 2000). 
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The cell cycle is under tight regulation of different checkpoint mechanisms which constantly 
monitor the integrity of genome and cell cycle progression e.g., the G1 checkpoint senses DNA 
damage before the cell enters S phase (transition point G1-S).  The G2 checkpoint monitors 
DNA damage after the S phase (G2-M) and stops progression of the cell cycle into the next 
phase until the damage is either repaired or, if not, cell self-destruction takes place through 
apoptosis (Hartwell and Weinert, 1989, Weinert, 1998).  The S-M checkpoint detects the error 
in DNA synthesis (S) such as interruption in DNA replication and delays the onset of mitosis 
(M) (Boddy and Russell, 2001).  The M phase checkpoint similarly senses spindle error.  The 
high order of organisation of cell cycle events is essential to keep the cell viable (Elledge, 
1996).  Genetic damage is unavoidable if the cell progresses to the next phase of cell cycle 
without completing the previous phase.  An example of an error is a non-disjunction of 
chromosomes during meiosis when chromosomes segregate in anaphase before the kinetochore 
of sister chromatid has attached to the microtubule.  As a result, daughter cells will either 
contain one extra or lack one chromosome (trisomy).  The normal feature of a eukaryotic cell is 
to follow one step after another in an accurate and organised way i.e., one round of replication 
should follow one round of mitosis as a rule to avoid an error to ensure viability.   
 
The cell is under constant threat of endogenous (cellular metabolites) or exogenous DNA 
damaging factor (Gospodinov and Herceg, 2013, Abbotts et al., 2014) which may lead to 
mutations, genomic instability (cancer) or cellular death (Sancar et al., 2004).   
DNA damage caused by telomere uncapping is controlled by different checkpoint genes (Table 
1.3) that activate an intricate network of protective mechanisms through intracellular signalling 
to DNA damage response proteins resulting in either arrest or apoptosis of the cell (Longhese et 
al., 1998).   
 
DNA damage checkpoints signalling pathways are activated in response to DNA insult under 
both intrinsic and extrinsic factors such as ultraviolet radiation (Sinha and Hader, 2002), 
ionizing radiations, chemotherapeutic drugs, replication error (HU, UV light), alkylating agents 
(MMS) (Ghosal and Chen, 2013) or reactive oxygen species (Zhang et al., 1993).  The DNA 
damage range from DSBs, SSBs (single strand breaks), stalled replication fork, modified bases 
and intra-strand crosslinking.  Eukaryotic cells respond to DNA perturbations by activating 
checkpoint signalling pathways and recognising damage at different phases of cell cycle e. g., 
G1-S transition, S phase or G2-M phase either alone or in specialised sub-complexes (cell cycle 
stage specific) and activate network of systems including DDR.  The checkpoint proteins have 
been described as sensors, transducers and effectors: sensors proteins detect replication blocks 
or DNA damage; transducers relay this signal; and effectors that act on targets of the checkpoint 
(Boddy and Russell, 2001).  DNA repair response could be HR, NHEJ, BER, NER, and MMR 
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(mismatch repair).  Alteration or mutation of checkpoint genes may result in the failure of 
checkpoint controls due to defective proteins and may lead cell to senescence or cancer.   
 
Table 1.3.  DNA damage checkpoint proteins. 
 Budding yeast Fission yeast Human 
PIKK Mec1  Rad3 ATR 
PIKK  Tel1 Tel1  ATM  
Adaptor Rad9  Crb2  53BP1, MDC1, BRCA1? 
Rfc1 homolog  Rad24 Rad17  Rad17 
9-1-1 clamp  Rad17 Rad9  Rad9  
Mec3  Hus1 Hus1 
Ddc1 Rad1  Rad1  
MRX complex  Mre11  Mre11  Mre11  
Rad50 Rad50 Rad50 
Xrs2 Nbs1 Nbs1 
BRCT domain adaptor?  Dpb11  Rad4/Cut5 TopBP1  
Signaling kinase  Rad53 Cds1 Chk2 
Signaling kinase  Chk1 Chk1 Chk1 
Polo kinase Cdc5 Cdc5 Plo1 Plk1 
Securin Pds1 Cut2  Securin 
Separase  Esp1  Cut1  Separase 
APC-targeting subunit Cdc20  Slp1  p55
CDC
 
(Taken from Harrison and Haber, 2006). 
 
In S. cerevisiae, DNA damages activate signal transduction pathways by protein kinases 
cascade along with non-kinase mediator proteins (Pfander and Diffley, 2011).  Different 
members of Rad proteins (Rad9, Rad17, Rad24 and Rad53) and Mec1 and Mec3 are required 
for efficient damage response machinery (Figure 1.14).  The mutants defective in or lacking any 
of these regulatory proteins delay cell cycle at G1-S or G2-M checkpoints.  In budding yeast, 
the sensor kinase, Mec1 (hATR) and the downstream kinase, Rad53 (hChk2) play essential 
roles in signal transduction pathways (Ohouo and Smolka, 2012).  Rad9 as an adaptor or 
mediator protein recruits Rad53 protein to site of DNA lesion in close proximity of Mec1 
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(Vialard et al., 1998, Blankley and Lydall, 2004).  Mec1 (hATR) and Tel1 (hATM), the sensor 
kinases initiate the activation of the downstream kinase effectors Rad53 and Chk2 in response 
to DNA damage and delay cell cycle and activate repair proteins (Branzei and Foiani, 2006).  
Mec1 and Rad53 are crucial for the integrity of genomic DNA as they regulate effector proteins 
involved in DNA replication, transcription and cell cycle control (Ohouo and Smolka, 2012).  
Rad53 and Mec3 are involved in S/M checkpoint activation which delays the onset of mitosis 
when blocked by the presence of replication problem such as stalled replication fork (Enomoto 
et al., 2002). 
 
In S. cerevisiae, Mec1-Ddc2 checkpoint protein kinase complex (human ATR-ATRIP) initiates 
a signal transduction pathway in response to DNA damage and replication stress to mediate cell 
cycle arrest (Navadgi-Patil and Burgers, 2008).  A non-kinase mediator protein Dpb11 activates 
the Mec1-Ddc2 checkpoint kinase complex (Mordes et al., 2008).  Yeast Dpb11 (hTop-BP1) 
binds to and activates checkpoint kinase Mec1 and phosphorylates downstream effector kinase 
Rad53 (hChk1/2) and RPA (Pfander and Diffley, 2011).  Dpb11 interacts directly with the yeast 
DNA damage checkpoint clamp Ddc1-Mec3-Rad17 (9-1-1: human hRad9-hHus1-hRad1), 
loaded around effector DNA, Mec1 (Mec1-Ddc2) and recruit Rad9 at sites of DNA damage 
(Puddu et al., 2008).  The ternary complex of Dpb11, Mec1 and Rad9 is required for efficient 
Rad9 phosphorylation/activation by Mec1.  The phosphorylation of Rad9 by Cdk generates 
binding site for Dpb11 protein while inactive Cdk during G1 phase does not induce checkpoint 
signalling (Pfander and Diffley, 2011).   
 
A number of other DNA repair proteins are activated including serine-threonine kinase, a 
nuclear protein Dun1 (DNA-damage uninducible) which is involved in post replicative DNA 
repair and transient arrest of cell cycle at G2-M (Zhou and Elledge, 1993) and proficient in 
induction of many other repair proteins.  Rad53 inhibits the activity of Swi4 and Swi6 
(switching deficient) proteins required entering cell in S phase, after damage in G1 phase.  
Similarly DNA replication factor C (RFC) recognises the damage in S phase and activate Rad53 
and deactivate enzyme DNA primase that prevent downstream DNA synthesis.  
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Figure 1.14.  A hypothetical model of the DNA damage checkpoint response in yeast S. cerevisiae. 
The first step in DNA damage checkpoint is the recognition of DNA damage.  In budding yeast, the 
products of RAD9, RAD17, RAD24, MEC3 and DDC1 genes are essential for an early recognition of 
damage.  The phosphorylation of Ddc1, Rad9 and Rad24 depends on Mec1, initiator of signal 
transduction.  The phosphorylated Rad9 interact with Rad53.  The DNA replication protein Pol ε and RFC 
5 (subunit of replication factor-C) sense replication block and damage of DNA synthesis.  RFC interact 
with Rad24 and the resulting complex load proliferating cell nuclear antigen (PCNA) like clamp (Mec3-
Ddc1-Rad17) on site of DNA damage and recruit DNA polymerase at the site of block.  Rad9 and Rad24 
belong to different epistasis groups and have different effect in addressing ssDNA accumulation at 
telomere.  The Mec3-Ddc1-Rad17 complex is a homologue of human hRad9-hMec3-hRad17 clamp.  
Pds1 (precocious dissociation of sisters) is essential for meiotic progression and mitotic cell cycle arrest. 
(Taken from Longhese et al., 1998). 
 
1.3.3. Yeast lifespan 
Under favourable environment and in the presence of rich nutrients wild-type cells of yeast in 
a liquid culture continue to grow.  Normally yeast cell completes a round of cell cycle in 
approximately 90 minutes (Blow, 1993).  Growth of yeast cultures is monitored by using a 
spectrophotometer by measuring optical density of the culture’s suspension at 600-660 nm 
which varies in different species and mutants.  In chronological lifespan study samples of 
ageing culture are measured taking its optical density as a function of time.  The data of 
pooled samples are used to construct the growth curve to measure the differences between 
wild type and the mutants.  Similar to bacteria, yeast cells grow through lag phase (slow 
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growth of cells to adjust in a new environment), log phase with rapid growth and reach to 
stationary phase (with a very slow rate of growth as nutrients decreased in medium) (Gray et 
al., 2004).  When the nutrients become scarce in a medium or in the environment, the cells 
shift from fermentation to respiratory metabolism with a slight lag (known as diauxic shift) in 
growth curve (Figure 1.15) to adjust to new environment and start utilising ethanol produced 
during fermentation.  When all nutrients sugar and ethanol (carbon sources present in the 
medium) are exhausted, the culture of cells enters in stationary phase with a significant 
number of cells exiting cell cycle and become quiescent (G0 phase), a dormant or resting state 
(Gray et al., 2004).  A number of molecular changes occur in this phase in cell structure; in 
cell wall and in cytosol along with the storage of sugar trehalose.  Functional changes 
accompany the structural modification.  In stationary phase different changes occur at 
transcription and translation levels (Werner-Washburne et al., 1993).  A cell remains in this 
stationary phase until the return of nutrients/carbon source and re-enter the cycle at the 
availability of the nutrients (medium) and starts dividing again. 
 
Figure 1.15.  A typical growth curve of the yeast culture. 
In rich medium (YEPD) containing glucose, yeast cells proliferate exponentially using fermentation.  The 
density of the culture (measured at 600 nm) increases logarithmically with time during log phase.  
Diauxic shift reaches when all glucose in medium is utilised (after ~ 1 day).  The cells shift from 
fermentation to respiration to use alternative carbon source in the medium with very slow proliferation.  
When carbon source are exhausted after ~5-7 days the culture reaches saturation state (non-
proliferating phase), and cells become quiescent.  (Adapted from Gray et al., 2004). 
 
Ageing in S. cerevisiae has been addressed from two aspects: chronological lifespan (CLS) and 
replicative lifespan (RLS) (Figure 1.16).  CLS is measured by the length of time a stationary 
phase cell remains viable in a non-dividing state and has been proposed as a model to study 
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post-mitotic cells in mammals (Fabrizio and Longo, 2003).  RLS is expressed as the number of 
daughter cells produced by the mother cell before senescence (Mortimer and Johnston, 1959, 
Kennedy et al., 1994).  These two aspects of ageing have been used in studies on dividing 
(mitotically active cells) and non-dividing cells (somatic cells) in higher organisms (Piper, 
2006).  In yeast, RLS studies have been carried out through micromanipulation by dissecting 
mother cells and separating new daughter cells.  It is a time-consuming and laborious technique 
but the only successful approach for the study of senescence in yeast at present. 
 
 
 
Figure 1.16.  Two lifespans of yeast: CLS and RLS  
(Adapted from Piper, 2006, Kaeberlein et al., 2007). 
 
The CLS of yeast is measured to find out comparative differences in survival time due to 
different mutations related to ageing.  In nature, yeast can survive and age in the stationary 
(under calorie restriction), or post-diauxic (high metabolic phase) or in a very low metabolic 
state (spore) (Gray et al., 2004, Herman, 2002).  Under adverse conditions, yeast cells become 
arrested in the G1 phase of the cell cycle as unbudded cells, which survive with low metabolism 
(Herskowitz, 1988).  It is not starvation that causes ageing and death as yeast cells can store 
glycogen and trehalose (reserve sugars) when nutrients are available and utilise these nutrients 
slowly when they not available (Fabrizio and Longo, 2003).  Under favourable environmental 
conditions with sufficient nutrients, cells resume their growth.  For chronological lifespan 
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measurement yeast cells are grown in a nutrient-rich medium e.g., glucose-containing yeast 
peptone dextrose (YEPD) or synthetic complete (SD/SC) media and are maintained either in the 
same media or in water under calorie restriction.  Calorie restrictions have been reported to 
increase the lifespan in many organisms including worms, flies and rodents (Masoro, 2005) and 
budding yeast (Lin et al., 2002).  In mammals calorie restriction is known to retard ageing in by 
causing a metabolic shift toward increased protein turnover and decreased macromolecular 
damage by reducing oxidative stress (Finkel and Holbrook, 2000).  Caloric restriction attenuates 
the degree of oxidative damage, reduces age-related increase in DNA damage (Hamilton et al., 
2001), decreases tissue lipid peroxidation (Zainal et al., 2000), increases resistance to oxidative 
stressors (Hall et al., 2000) and reduces mitochondrial ROS production (Pamplona and Barja, 
2006).   
 
In glucose-containing medium, yeast cells grow rapidly, a post-diauxic phase (high metabolism 
to growth phase) is followed by a stationary phase (low metabolism phase) until cells stop 
dividing or die.  Post-diauxic and stationary phase cells show resistance to cellular stress and 
accumulate reserve carbohydrates (Werner-Washburne et al., 1993).  In YEPD medium, yeast 
cells grow fast until saturation and stop growing when they pass through the diauxic shift, 
followed by a very slow growth rate, cell cycle arrest and stationary phase.  Cells enter into this 
stationary phase normally 3-6 days after the diauxic phase (Lillie and Pringle, 1980, Gray et al., 
2004).  Rich medium induces large fluctuations in viability over time due to regrowth of 
subgroup of the arrested cells which may use nutrients released from the dead cells and re-enter 
the cell cycle (Zambrano and Kolter, 1996).  Synthetic complete medium (SC) is used in high-
throughput studies instead of YEPD to overcome the problem of high viability fluctuations due 
to survivors.  Moreover, SC medium promotes a shorter lifespan (5-6 days) with high 
metabolism in the post-diauxic phase and yeast die rapidly after this phase whereas it may take 
3 months before cells start dying in YEPD medium (Fabrizio and Longo, 2003).  In CLS 
experiments with YEPD/SC medium, after the saturation stage, yeast cultures are switched to 
water that mimics severe caloric restriction.  In water, yeast cells enter stationary phase with 
reduced metabolism and survive much longer.  However, in both ways, mutations related to 
ageing or longevity show potential difference in viability over time (Fabrizio and Longo, 2007, 
Fabrizio and Longo, 2003).  
 
The principal discoveries associated with yeast ageing might contribute to understand the 
ageing process in mammals and finding out key pathways and genes involved in the regulation 
of the ageing process.  These pathways have many similarities between yeast and higher 
eukaryotes due to common evolutionary origins.  The knowledge obtained from the simple 
studies with short lived model organisms can be applied to human genetics and molecular 
biology, to understand the complicated process of ageing and senescence in higher organisms.   
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A number of genes/signalling pathways involved in lifespan regulation have been identified 
e.g., the nutrient/insulin/insulin-like growth factor (IGF)-I-like pathway in mammals, and the 
Ras/protein kinase A (PKA), TOR (target of rapamycin) kinases, and Sch9 (Serine/threonine-
protein kinase) pathways in yeast (Gray et al., 2004).  Recent investigation in yeast gerontology 
research have shown that TOR kinases mediate the cellular responses that are involved in 
cellular longevity with an increasing evidence that the molecular determinants of ageing are 
conserved in higher eukaryotes including mammals.  TOR has also been reported to act as 
coordinator with other nutrient-responsive kinases PKA and Sch9 and mediate the cellular 
response with changing nutrient levels with altered glucose and nitrogen levels (Pedruzzi et al., 
2003).  TOR and PKA kinases are activated in the presence of plenty of nutrients and increase 
ribosome biogenesis to activate protein synthesis machinery and suppress the stress response 
(Kaeberlein et al., 2007, Kaeberlein et al., 2005).  The activation of TOR and PKA (cyclic 
AMP-dependent protein kinase) repress features of quiescence.  Downregulation of these 
pathways under depletion of carbon source increases stress resistance, leading cell to G1 
progression and extends the CLS (Fabrizio and Longo, 2003).  Inactivation of the TOR causes 
activation of PKC pathway which promotes entry into quiescence cell state.  In yeast, SNF1 
protein kinase (a member of SNF1/AMPK family; SNF, Sucrose-non fermenting) is inhibited 
by the presence of fermentable carbon sources such as glucose but activated with the depletion 
of carbon in the medium and facilitate shift from fermentation to respiratory metabolism, 
required for entry into quiescence phase (Hedbacker and Carlson, 2008).   
 
Inhibition of TOR and deletion of Sch9 increases both replicative and chronological lifespan 
(Kaeberlein et al., 2005).  While deletion of small G proteins Ras1 and Ras2 that activate the 
PKA pathway have opposite effects on the chronological and replicative lifespans; deletion of 
RAS1 increases RLS with slight decrease in CLS, while deletion of RAS2 decreases RLS with 
dramatic extension in CLS (Sun et al., 1994).   
 
RLS is associated the accumulation of extrachromosomal ribosomal DNA circles (ERCs)which 
were thought to cause yeast replicative senescence (Sinclair and Guarente, 1997).  Several genes 
e.g., RTG2 (retrograde regulation), LAG1 (yeast longevity-assurance gene), and SIR2 involved 
in the regulation of lifespan have been reported (D'Mello N et al., 1994, Borghouts et al., 2004).  
A number of mutations have been identified that play a role in the extension of yeast lifespan by 
preventing ageing.  For example, semi-dominant mutation sir4-42 of the silencing gene SIR4 
extends lifespan by 30% (Kennedy et al., 1995).  It prevents Sir3 and Sir4 proteins recruitment 
to the telomere and increases their concentration at other chromosomal regions like nucleolus 
(Kennedy et al., 1997).  Mutation in SIR4 also enhances rDNA silencing (Smith et al., 1998, 
Smith and Boeke, 1997) possibly by preventing formation of extrachromosomal rDNA circles 
through homologous recombination.   
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After systematic sequencing of the S. cerevisiae genome, the next challenge is to reveal the 
function of new genes.  In genetics, the function of a gene is analysed by mutation analysis of a 
gene where mutant phenotypes are known.  Most commonly hybrid plasmids are employed to 
introduce the foreign gene fragment into the yeast host.  The limitation of this method is that 
host yeast sometime tends to lose or alter foreign plasmid or suffer instability.  It is challenging 
to construct and maintain stable recombinant plasmid and its expression in extended cultures.  
Alternatively, classical methods of gene cloning for the expression of recombinant proteins and 
gene silencing are employed for new gene’s expression both in vitro and in vivo studies.  
Another popular approach is PCR-mediated gene iteration in the chromosome DNA.   
 
Since the first report of a targeted gene modification, hundreds of yeast genes have been altered 
(deleted or modified) for their functional analysis (Scherer and Davis, 1979).  The one-step 
PCR-mediated technique is an easy, simple and rapid approach in the functional analysis of S. 
cerevisiae genes (Rothstein, 1991, Baudin et al., 1993, Lorenz et al., 1995).  Any desired gene 
can be iterated or deleted with the use of modulating plasmids/‘marker swap’ plasmids (Cross, 
1997) without a time-consuming cloning process (Longtine et al., 1998).  This process required 
the desired gene sequence and restriction map of the open reading frame (ORF).  A selectable 
marker (heterologous auxotrophic marker) is used to interrupt the target sequence.  The hybrid 
oligonucleotides that are used for PCR synthesis of the deletion fragment consist of two parts; 
one that allows the homologous/heterologous recombination at the desired locus (5’ 
end/deleting sequence), the second, which permits the PCR amplification of a selectable marker 
(3’ end).  A 5’ deleting sequence from the target region of gene could be 35-51 nucleotides 
(Baudin et al., 1993, Lorenz et al., 1995) followed by 17-20 nucleotides at the 3’ end, 
homologues to the selectable marker.  The PCR amplicon-containing marker gene surrounded 
by flanking sequences of the target gene is used to transform auxotrophic yeast by a standard 
method (Gietz et al., 1992) with the use of PEG or DMSO (Gietz et al., 1995, Soni et al., 1993) 
that increase yeast transformation efficiency.  Transformants are selected with complementation 
of the auxotrophic marker on appropriate dropout medium.  Further analysis of the gene for its 
modification or complete knockout is carried out by its phenotype or Southern blot 
hybridisation analysis, or with PCR amplification using diagnostic primers. 
 
The auxotrophic markers most commonly used in yeast include deficiencies in 4 syntheses 
adenine, glutamic acid, histidine, leucine, lysine and uracil (Mulleder et al., 2012).  Yeast 
shuttle vectors used for genetic manipulation of S. cerevisiae contain antibiotic resistance 
markers, which can be used in both S. cerevisiae and the bacterium Escherichia coli (Da Silva 
and Srikrishnan, 2012), and yeast selectable markers.  The latter could be a gene that confers 
resistance to antibiotic or antifungal toxins (van den Berg and Steensma, 1997) or biosynthetic 
genes which could complement auxotrophic markers e.g., HIS3, ADE2, URA3 and TRP1.  The 
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auxotrophic markers that complement the S. cerevisiae mutations should have sufficient 
nucleotide difference to avoid homologous recombination.  The use of synthetic markers is a 
preferred approach in transformation studies instead of using antibiotics that may have their 
lethal effect on cell survival.  Genes can be deleted or overexpressed under regulatable 
promoters.  For PCR-mediated deletion, heterologous marker modules have the advantage over 
homologous or marker-swap approaches (Wach et al., 1997).  Plasmids are available that make 
use of a selectable marker module with the heterologous his5
+
 gene (Schizosaccharomyces 
pombe) (Wach et al., 1997) or the S. cerevisiae TRP1 gene or Escherichia coli Kan
r
 gene 
(Hadfield et al., 1990).  These marker modules allow full or part of gene deletion/modifications 
with or without adding a tagging protein under regulatable promotors and are used for efficient 
analysis of gene functions.   
 
Telomere-binding capping proteins ensure linear chromosome maintenance by end-protection 
and extension of G-rich strands (Palm and de Lange, 2008).  Uncapped telomeres activate DNA 
damage checkpoint signalling pathways to regulate cellular proliferation.  Conditional telomere 
capping dysfunction leads to sister chromatids’ rearrangements and genetic instability (Mathieu 
et al., 2004).  However, the direct contribution of telomere uncapping to senescence and ageing 
is not clear due to the lack of appropriate models.  The asymmetrical cell division and 
availability of different mutants with particular phenotypes makes budding yeast a powerful tool 
in cellular and genetic studies.  The recent mutants lacking Cdc13 and Stn1, in the absence of 
EXO1 showed reduced G1 phase with a slow rate of growth due to senescence of large number 
of cells (Zubko and Lydall, 2006).  This slow growth seems to be under genetic control of 
RAD24 (an important checkpoint gene).  These preliminary observations open the prospect of 
extensive study of the above mentioned mutants that could link genetic instability, checkpoint 
control and cellular senescence in the integrated scenario of ageing.  Such a study will result in 
developing a novel approach to better understand the phenomenon of telomere uncapping in 
ageing by using yeast as a model. 
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1.4. Aims and Objectives 
1.4.1. Aims  
This work aims to develop a novel budding yeast model for investigating the impact of 
dysfunction in telomere capping on ageing and cellular responses.   
The main molecular part in addressing this aim was generating CDC13 deletion mutants in 
which the whole gene or its C- and N-termini are deleted by gene knock-outs using target 
oriented PCR mediated technique.  The biological part of the work included: 1) studying 
differences in chronological lifespan in the obtained mutants with telomere capping 
dysfunction; 2) analyses of telomere length and telomeric DNA patterns of the mutants; 3) 
studying cellular responses of the obtained mutants to oxidative and genotoxic stress. 
 
1.4.2. Objectives 
The following tasks were formulated as main objectives of the study.   
A. To carry out CDC13 disruption (full and partial) by one step PCR mediated technique. 
B. To perform genetic crosses to generate new combinations of the obtained mutations. 
C. To analyse the telomere length and telomeric DNA patterns in the obtained mutants 
lacking Stn1 and/or Cdc13 protein and in N- and C-terminus truncated Cdc13 mutants 
(Southern blot hybridisation). 
D. To investigate cellular responses of mutants with telomere capping dysfunctions to 
genotoxic agents (UV, MMS, HU, H2O2). 
E. To determine differences in chronological lifespans of mutants without essential telomere 
capping proteins Stn1 and Cdc13 or mutant strains with N- and C-terminal deletion variants of 
protein Cdc13-1. 
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Chapter 2 
Materials and Methods 
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2.1 Materials 
 Acetic acid (Fisher Scientific, UK) 
 Acrodisc® syringe filters 0.2 µm (Pall Life Sciences, UK) 
 Adenine (Amino purine) hemisulphate salt (Sigma-Aldrich, UK) 
 Agarose (Melford, UK)  
 Albumin from bovine serum (Sigma-Aldrich, UK) 
 Amersham gene images AlkPhos direct labelling and detection system with CDP-star 
(GE Healthcare Limited, UK)  
 Amersham Hybond membrane-N (GE Healthcare Limited, UK)  
 Ammonium acetate (Sigma-Aldrich, UK)  
 Autoradiography film, blue (UltraCruz™) (Santa Cruz Biotechnology, USA) 
 Bacteriological agar (Oxoid Limited, UK)  
 Bacteriological peptone (Oxoid Limited, UK) 
 BamH1-HF (New England Biolabs Limited, UK) 
 BD Falcon 125 ml Erlenmeyer Tissue Culture Flask, Flat Base (Scientific Laboratory 
Supplies, UK) 
 Bijoux container sterile, 7 ml (Scientific Laboratory Supplies, UK) 
 Blue/Orange Loading Dye, 6x (Promega Limited, UK) 
 Calcium chloride (Sigma-Aldrich, UK) 
 Chloroform-isoamyl alcohol mixture, 24:1 (Sigma-Aldrich, UK) 
 Chromatography paper, Whatman 3MM CHR (Whatman Instruments Limited, England)  
 Dextrose (D-glucose anhydrous) (Fisher Scientific, UK) 
 Dimethyl sulfoxide (DMSO) (Sigma-Aldrich, UK) 
 DNA ladders:  
 1 kb (Invitrogen™, Life Technologies, USA) 
 100 bp (Invitrogen™, Life Technologies, USA) 
 100 bp (New England Biolabs (NEB), UK) 
 EcoRI-HF® (New England Biolabs Limited, UK) 
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 Eppendorf tubes (Scientific Laboratory Supplies, UK) 
 Escherichia coli DH5 alpha cells were kindly donated by Dr Qiuyu Wang (Manchester 
Metropolitan University)  
 Escherichia coli K-12 strain NM522 (Manchester Metropolitan University, local stock) 
 Ethanol (Fisher Scientific, UK))  
 Ethidium bromide (Sigma-Aldrich, UK)  
 Ethylene diamine tetra acetic acid (EDTA) (Fisher Scientific, UK)  
 Glusulase (PerkinElmer, USA) 
 Glycerol (BDH, UK)  
 Glycine (Fisher Scientific, UK)  
 Go Taq green master mix 2x (Promega Limited, UK)  
 HindIII enzyme (New England Biolabs Limited, UK) 
 Hybond-N+ (GE Healthcare Limited, UK)  
 Hydrochloric acid (BDH, UK)  
 Hydrogen peroxide (H2O2) (Sigma-Aldrich, UK) 
 Hydroxyurea (HU) (Sigma-Aldrich, UK) 
 Isopropanol (Sigma-Aldrich, UK)  
 Lambda HindIII marker (Invitrogen Life Technologies, USA) 
 L-arginine (HCl) (Sigma-Aldrich, UK) 
 L-aspartic acid (Sigma-Aldrich, UK) 
 L-glutamic acid (monosodium salt) (Sigma-Aldrich, UK) 
 L-histidine (Sigma-Aldrich, UK) 
 L-Iysine (mono-HCl) (Sigma-Aldrich, UK) 
 L-leucine (Sigma-Aldrich, UK) 
 L-methionine (Sigma-Aldrich, UK) 
 L-phenylalanine (Sigma-Aldrich, UK)  
 L-serine (Sigma-Aldrich, UK) 
 L-threonine (Sigma-Aldrich, UK) 
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 L-tryptophan (Sigma-Aldrich, UK) 
 L-tyrosine(Sigma-Aldrich, UK) 
 L-valine (non-animal source) (Sigma-Aldrich, UK) 
 Magnesium chloride (Sigma-Aldrich, UK)  
 Mannitol (Sigma-Aldrich, UK)  
 2--Mercaptoethanol (Sigma-Aldrich, UK)  
 Methyl methanesulfonate (MMS) (Sigma-Aldrich, UK) 
 Methylglyoxal (Sigma-Aldrich, UK) 
 Methanol (Sigma-Aldrich, UK) 
 Microtitre plate flat bottom well sterile (Scientific Laboratory Supplies, UK) 
 Nuclease-free water (Sigma-Aldrich, UK)  
 Phosphate buffered saline (PBS), 20x (Santa Cruz Biotechnology, USA) 
 Phenol:Chloroform:Isoamyl Alcohol (25:24:1) (Sigma-Aldrich, UK) 
 Potassium acetate (Sigma-Aldrich, UK)  
 Primers (Invitrogen-Life Technologies, USA)  
 Q5®high-fidelity DNA polymerase (New England Biolabs, UK)  
 QIAprep spin miniprep Kit (50) (cat. no. 27104, Qiagen, USA) 
 QIAgen plasmid midi kit (25) (cat. no. 12143, Qiagen, USA) 
 QIAquick gel extraction kit(50) (cat. no. 28704, Qiagen, USA)  
 RNase A (Qiagen, USA)  
 Sodium chloride (Sigma-Aldrich, UK)  
 Sodium dodecyl sulphate (Sigma-Aldrich, UK)  
 Sodium hydroxide (BDH, UK)  
 Sodium phosphate (BDH, UK)  
 Spreader sterile (Scientific Laboratory Supplies, UK) 
 Sterile needles (BD Plastipak, UK)  
 TrackIt™ λ DNA/Hind III Fragments (Invitrogen-Life Technologies, USA) 
 Tris Base (Fisher Scientific, UK) 
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 Tris-Borate-EDTA buffer, 10x (Invitrogen-Life Technologies, USA)  
 Triton X-100 (Bio-Rad, USA) 
 Tryptone (Oxoid Limited, UK)  
 Tween-20, 10% (Bio-Rad, USA) 
 Universal sterile container, 30 ml (Scientific Laboratory Supplies, UK) 
 Uracil (Sigma-Aldrich, UK) 
 Urea (Sigma-Aldrich, UK) 
 96-well plates (Scientific Laboratory Supplies, UK)  
 Wizard SV gel and PCR clean-up system (Promega Limited, UK)  
 XhoI (New England Biolabs, UK)  
 Yeast extract (Oxoid Limited, UK)  
 Yeast Nitrogen Base without amino acids and ammonium sulfate (Sigma-Aldrich, UK) 
 Yeast plasmids (pDL 501, pDL 504, pDL 515, pDL 516 etc.) were kindly donated by 
Professor D. Lydall (Newcastle University)  
 Yeast species: Schizosacharomyces pombe (fission yeast) and Saccharomyces cerevisiae 
(budding yeast), Manchester Metropolitan University, local stock; DLY strains: 640, 641, 
1108, 1195, 1272, 1273, 1296, 1297, 2607, 2608, 2625, 2626, 2684, 2685, 3181, 3182, 
3345, 3343, genotypes of which are provided in Table 2.1 
 Zymolyase®-20T (AMS Biotechnology Limited, Europe)  
 Stock Solutions: 
 SDS solution (10 %, w/v): 10 g of SDS in 100 ml of sterile deionized water. 
 Sodium chloride (NaCl) 5 M, contained 58.44 g in 200 ml total volume of distilled H2O.  
 Sodium hydroxide (NaOH) 5 M, contained 20 g in total volume 100 ml of distilled H2O. 
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2.2 Equipment 
 AC power adapter (Transitronix, Taiwan)  
 Balance (Sartorius Machatronics Limited, UK)  
 Block heater SBH130DC (Bibby Scientific Limited, UK)  
 Centrifuge (J2-21) (Beckman Instruments INC., UK)  
 Centrifuge 5415 D (Eppendorf, Germany)  
 Confocal microscope (Leica DN 2500) (Leica Microsystems CMM, GBH, Germany)  
 Digital camera (Coolpix 4500) (Nikon, Tokyo, Japan)  
 Electrophoresis tank (Subcell® GT) (Bio-Rad, UK)  
 Gene flash bio Imaging (Syngene, UK)  
 Glass beads (0.5 mm, soda lime) (BioSpec Product, Inc., supplied by Thistle Scientific, 
UK) 
 Haemocytometer (Weber Scientific International, England)  
 Hybridisation Oven (Appligene, UK)  
 Ice machine (Scotsman AF 100) (Frimont, UK)  
 Incubator (compact)-model C330 (LEEC Limited, UK)  
 Incubator (cooled-model 1200) (LMS, UK)  
 Incubator (Swallow) (LTE Scientific Limited, UK)  
 Incubator IP30 (LTE Scientific Limited, UK)  
 Incubator shaker (Excella E25) (New Burnswick Scientific, USA)  
 Incubator shaker series-I26 (New Brunswick Scientific, USA)  
 Laboratory freezer Bio cold (Scientific Laboratory Supplies, UK)  
 Magnetic stirrer hot plate (Stuart Scientific Limited, UK)  
 Manipulator system (Singer Instruments Limited, UK)  
 Microcentrifuge (Sigma Micro 1-14 with 24 x 1.5 ml tube rotor) (Sigma-Aldrich, UK) 
 Microwave oven (Toshiba Corporation, UK)  
 Millipore water purification system, RiOs™ and ElixR (Millipore, France)  
 Nanodrop 2000/2000c (Thermo Fisher Scientific, UK) 
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 Orbital shaker R100 rotatest (Luckham Limited, England)  
 Paper towels (Scientific Laboratory Supplies, UK) 
 Parafilm (Scientific Laboratory Supplies, UK)  
 Peltier thermal cycler-200 (MJ Research INC., USA) 
 Petri plates 90 mm (Scientific Laboratory Supplies, UK) 
 pH/mV/temperature meter model AGB-75 (Scientific Laboratory Supplies, UK) 
 Portable autoclave vario 3028 (Dixons Surgical Instruments Limited, UK) 
 Power supply (James Electronics, UK) 
 Power supply PowerPac™ basic (Bio-Rad, USA)  
 Printer digital graphic (Sony Corporation, Japan)  
 Quantity one imaging system (Bio-Rad Laboratories INC., Italy) 
 Razor blades (Kratos Analytical, UK)  
 Refrigerator-Global 48CD (AS Catering Supplies Limited, UK) 
 Replica platter (Sigma-Aldrich, UK) 
 RunOne electrophoresis cell and multi-caster system, 230V (Embitec, USA)  
 Sigma 3-16K centrifuge refrigerated high capacity (Sigma-Aldrich, Germany)  
 Spectrophotometer (Jenway 6305) (Bibby Scientific Limited, UK)  
 Spectrophotometer (Ultrospec 2000 UV/visible) (Pharmacia Biotech, England)  
 Syngene G: Box bio imaging system (Syngene, UK)  
 Ultra-low temperature freezer, -80°C (NuAire, Japan)  
 Ultraviolet Transilluminator (Ultraviolet Products INC., USA)  
 Ultraviolet Translinker, (TL-2000) UVP® (Ultraviolet Products INC., USA)  
 Vortex mixer MV17 (Chiltern Scientific Instrumentation Limited, UK)  
 Water bath (Bibby Scientific, UK) 
 Water bath shaking-GLS 400 (Grant Instruments Limited, UK)  
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2.3 Methods and Work Programme 
This research project involves both molecular techniques and microbiological methods.  For 
simplicity I have divided the methodologies into two parts i.e. yeast methods and molecular 
biology methods.  
 
2.3.1 Yeast methods 
Yeast methodologies used in this work include cultivation of budding yeast, Saccharomyces 
cerevisiae (S. cerevisiae ) on different media, genotype confirmation by checking genetic 
markers, spot test assays, testing viability in glycerol, chronological lifespan studies, genetic 
crosses between different mutants and tetrad analysis of their progenies by using a 
micromanipulator. 
 
2.3.1.1 Preparation of media 
Nutrient-rich media YEPD (yeast extract, peptone and dextrose; Method S2.1), minimal media 
synthetically defined or synthetic dextrose minimal medium (SD; Method S2.2), synthetic 
complete (SC; Method S2.3) and dropout media lacking histidine (-H), tryptophan (-T), leucine 
(-L) and uracil (-U) were prepared as described by (Amberg et al., 2005). 
 
2.3.1.2 Growth of budding yeast on agar media 
The S. cerevisiae strains used in this study had genetic background W303 (two of background 
BY4741) and are listed in Table 2.1 with their essential genotypes.  These strains contain an 
ade2-1 mutation; therefore, growth medium YEPD used routinely for their cultivation, was 
supplemented with adenine sulphate at concentration of 50 mg/L. 
 
All strains were initially streaked out onto YEPD agar plates from -80°C glycerol stock or from 
old agar plates using sterile tooth picks or culture loops.  Media plates were incubated at 23°C 
for 5-7 days to attain well-separated single colonies.  Few colonies (4-5) were selected to grow 
on dropout solid media lacking histidine, leucine, tryptophan or uracil to confirm genotypic 
growth markers by testing for their auxotrophies.  Two strains were employed for each gene 
mutation including positive controls.  For example strains DLY 640 and 641 were utilised as 
positive control for CDC13.  While strains DLY 2607 and 2608 (cdc13∆::HIS exo1∆::LEU2) 
tryptophan and uracil auxotrophs were used as negative controls of CDC13. 
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Table 2.1.  Yeast strains S. cerevisiae used in this study and their essential genotype. 
 
 
 
2.3.1.3 Cultivation of yeast strains in liquid media 
Freshly grown, well-separated, same-size colonies (after 3-5 days’ incubation on YEPD agar at 
23°C), were picked to set starter cultures in YEPD broth in sterile containers (Method S2.1) 
under aseptic conditions.  The inoculated cultures were grown in a shaking incubator at 150 rpm 
at the desired temperature (23°C or 30°C) to obtain fresh cultures with most of the cells at the 
exponential phase, required for setting the experiment. 
 
 
 
DLY 
Strain  
Strain brief 
genotype 
Genetic 
background 
Strain essential genotype 
1.  640 WT W303 
MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3 GAL+ 
psi+ ssd1-d2 RAD5 
2.  641 WT W303 
MATalpha ade2-1 trp1-1 can1-100 leu2-3,112 his3-11, 15 ura3 
GAL+ psi+ ssd1-d2 RAD5 
3.  1108 cdc13-1 W303 
MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3 GAL+ 
psi+ ssd1-d2 RAD5 cdc13-1-int 
4.  1272 exo1∆ W303 
MATalpha ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3 GAL+ 
psi+ ssd1-d2 RAD5 exo1::LEU2 
5.  1273 exo1∆ W303 
MATalpha ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3 GAL+ 
psi+ ssd1-d2 RAD5 exo1::LEU2 
6.  1296 exo1∆ cdc13-1  W303 
MATa exo1::LEU2 cdc13-1-int ade2-1 trp1-1 can1-100 leu2-3, 112 
his3-11,15 ura3 GAL+ psi+ ssd1-d2 RAD5 
7.  1297 exo1∆ cdc13-1 W303 
MATalpha exo1::LEU2 cdc13-1-int ade2-1 trp1-1 can1-100 leu2-
3,112 his3-11,15 ura3 GAL+ psi+ ssd1-d2 RAD5 
8.  2605 exo1∆ cdc13-1 W303 
MATalpha exo1::LEU2 cdc13-1-int ade2-1 trp1-1 can1-100 leu2-3, 
112 his3-11,15 ura3 GAL+ psi+ ssd1-d2 RAD5, survivor at 36°C 
9.  2606 exo1∆ cdc13-1 W303 
MATalpha exo1::LEU2 cdc13-1-int  rad24::TRP1 ade2-1 trp1-1 
can1-100 leu2-3,112 his3-11,15 ura3 GAL+ psi+ ssd1-d2 RAD5 
survivor at 36°C 
10.  2607 exo1∆ cdc13∆ W303 MAT not known (initially alpha) cdc13::HIS exo1::LEU2 
11.  2608 exo1∆ cdc13∆ W303 
MATnot known (initially alpha) cdc13::HIS exo1::LEU2 ade2-1 
trp1-1 can1-100 leu2-3,112 his3-11,15 ura3 GAL+ psi+ ssd1-d2 
RAD5 
12.  2625 
cdc13-1 exo1∆ 
stn1∆ 
W303 
MATnot known (initially alpha) cdc13-1-int stn1::HIS exo1::LEU2 
ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3 GAL+ psi+ ssd1-
d2 RAD5 
13.  2626 
cdc13-1 exo1∆ 
stn1∆ 
W303 
MATnot known (initially alpha) stn1::HIS exo1::LEU2 ade2-1 trp1-1 
can1-100 leu2-3,112 his3-11,15 ura3 GAL+ psi+ ssd1-d2 RAD5 
14.  2684 
cdc13∆ exo1∆ 
stn1∆ rad24∆  
W303 
MATalpha cdc13::HIS stn1::HIS exo1::LEU2 rad24::TRP ade2-1 
trp1-1 can1-100 leu2-3,112 his3-11,15 ura3 GAL+ psi+ ssd1-d2 
RAD5? 
15.  2685 
cdc13∆ exo1∆ 
stn1∆ rad24∆  
W303 MATalpha cdc13::HIS stn1::HIS exo1::LEU2 rad24::TRP (TR) 
16.  3343 yku70∆ BY4741 MATa yku70::URA3 
17.  3345 yku70∆ BY4741 MATalpha yku70::URA3 
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2.3.1.4 Calculation of viability of yeast cells 
The viability of cells in stationary/G0 arrested cultures was determined using the traditional 
colony-forming units (CFUs) method (Fabrizio and Longo, 2007).  For this purpose, the 
stationary cultures were serially diluted to achieve a cell density between 1x10
3
 to 5x10
3
 
cells/ml.  Fifty microlitres of the final dilution were plated twice onto two halves of a YEPD 
agar plate and incubated at 30°C for 2-3 days.  The resulting colonies were counted manually. 
All the cultures were presumed to be 100% viable at their maximum value that was either on 
day 6 or day 9 after inoculum in synthetic defined (SD)/synthetic complete (SC) media (Method 
S2.2).  Subsequent CFU measurements until day 27-30 were normalised to the maximum CFUs 
value.  Averages and standards deviations for at least three to five replicates were calculated for 
each experiment and the data are presented graphically. 
 
2.3.1.5 Verification of auxotrophic marker by replica plating  
In yeast, the use of selectable marker genes is important for efficient detection and selection of 
transformed cells in gene modification studies.  Auxotrophy tests can also be used to counter 
select against revertants.  In genetic studies on yeast, nutritional marker genes offer an 
alternative to markers of resistance to antibiotics or other toxic compounds.  The examples of 
such genes are HIS3, LEU2, TRP1 and MET15 etc.  These are wild type alleles of yeast genes 
that encode key components of metabolic pathways such as L-histidine, L-leucine, L-tryptophan 
and L- methionine.  Nutrient-requiring auxotrophic yeast strains can be propagated only in 
media that contain appropriate growth factors.  It is an easy and low cost approach to 
manipulate auxotrophy-complementing genes. 
 
Experimental yeast strains were tested for genetic markers on different dropout media (Method 
S2.3) by the standard procedure of replica plating with velveteen (Lederberg and Lederberg, 
1952) at the beginning and the end of the all chronological lifespan experiments.  Auxotrophy 
complementation approach was also used for marker selection in gene knockout experiments.  
In genetic crosses of strains, the resulting progenies were selected on dropout media lacking one 
of the following components: uracil, histidine, leucine or tryptophan. 
 
Yeast cells (4-5 colonies) or cultures were streaked on YEPD agar plates as distinct non 
overlapping short lines and grown for 2-3 days at 23°C (less growth was encouraged).  These 
agar plates (master plates) carrying the initial cultures were inverted onto a square piece of 
sterilised velveteen that was firmly placed onto a replica platter (a cylindrical support of ~9 cm 
in diameter, with a metal flange to hold the fabric firmly).  The culture was transferred onto the 
velveteen with slight digital pressure from the initial (master) plate.  Cells imprinted onto the 
fabric provided the same pattern for replicating replica inocula to subsequent plates with 
nutrient requirement media.  Replica plates were grown at the desired temperature and the 
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results were documented either by recording data, or by taking a photograph after 3-5 days of 
growth. 
 
2.3.1.6 Chronological lifespan studies 
In yeast, the chronological lifespan (CLS) is a measure of the “length of time a population of 
yeast strain remains viable under non-dividing conditions in post-diauxic phase (ethanol rich SD 
medium) or in stationary phase (water) (Fabrizio and Longo, 2003).  Viability has been defined 
by the ability of a single cell to reproduce and form colony (CFUs) within 48 hours (Fabrizio et 
al., 2004).  To measure CLS, yeast cells are grown in glucose-containing rich medium (SD) and 
maintained in this medium in a post-diauxic phase (high metabolism to normal growth with 
short survival) or in water in a stationary phase (low metabolism growth, with longer survival) 
until they stop dividing, indicating cell cycle arrest. 
 
For CLS measurement, a modified method of (Murakami et al., 2008) was adopted (Protocol 
S2.1).  Yeast cells from experimental strains were streaked out on YEPD and incubated at 23°C 
for 3-5 days to obtain single colonies.  YEPD broth was inoculated in sterile glass tubes with 
fresh cells from morphologically similar colonies from YEPD plates for six experimental strains 
each with five replicas, resulting in a total of 30 cultures.  Overnight (o/n) cultures were diluted 
in 20 ml or 50 ml of SD medium in flasks with equal numbers of cells ~1-2 x 10
6
/ml based on 
OD660 with 1:5 cultures to flask volume ratio (Protocol S2.1).  Cultures were kept at 30°C with 
agitation (200 rpm) for the entire period of the experiment (~ 30 days) with pooling samples at 
every third day.  The cultures were checked for genetic markers at the beginning and end of 
ageing studies to ensure the maintenance of the genotype throughout the experiment.  
Microscopy was carried out at day 3, 6 and 30 to check for stationary phase cell arrest. 
For yeast survival, the first reading was taken after 3 days of culture dilution by diluting the 
ageing culture to approximately 1000 cells/ml in sterile distilled water and plating 50 µl of this 
dilution in duplicate onto both halves of YEPD plates.  Viable cell counts were measured in 50 
µl by counting colony forming units (CFU) on YEPD plates for each strain after 2-3 days’ 
incubation at 30°C.  Average viable counts/50 µl was taken into account to calculate the total 
viable cell number in 1 ml by multiplying it by the dilution factor.  Plates were incubated for an 
additional 1-2 days for the last few readings of the survival experiments as older cells re-enter 
the cell cycle slowly (Fabrizio and Longo, 2003).  Percentages of survivals were estimated after 
every three days until 27-30 days by adjusting the dilution factor according to decreasing 
viability trends.  The maximum number of CFUs at day 6 or 9 was considered to be initial 
survival point (100% survival) and was used to determine time-dependent % survival.  In 
addition CLS were also measured (Protocols S2.2-S2.4) for 30 days to 90 days under calorie 
restriction in water for different mutants and wild type strains. 
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2.3.1.7 Spot tests 
Yeast strains were grown at 23°C for 3-5 days for analysis.  The loops full of cells from freshly 
grown single colonies were inoculated into 2-3 ml of sterile water.  All samples were vortex 
mixed to get homogenous suspensions.  The cell densities were equalised on the basis of 
absorbance (~1) at 660 nm wavelength (OD660) using a spectrophotometer.  For each strain, 250 
µl of this suspension was carefully added into the wells of the first column of a 96-well sterile 
microtiter plate (one well for each sample).  To prepare serial dilutions, 200 µl of sterile water 
was added to the corresponding rows of each strain (starting from well numbers two to six (2-6).  
Five-fold serial dilutions were prepared by taking 50 µl of the sample from column 1 and re-
suspending it in the adjacent column for each strain using a multichannel pipette.  This step was 
repeated from well 2 to 6.  To keep an equal volume in each well from well 1-6, 50 µl of 
suspension was discarded from well 6.  A sterile 48-prong replica plating device (Sigma) was 
used to spot a drop of 3-5 µl on 2-3 day old YEPD plates to avoid cultures spreading.  The 
plates were allowed to dry and incubated at 23°C or the desired temperature for 3-5 days.  This 
method was used to determine not only the initial viability of different strains on agar media, 
but also to see the intensity of growth of different strains at defined temperatures, in the 
presence of different genotoxic agents. 
 
2.3.1.8 Testing viability of cells kept in glycerol  
Viability tests were performed to analyse the percentage viability (CFUs) in different mutants 
under the effects of preservation in 25% glycerol as compared to water at -80°C.  Cultures were 
grown either in YEPD broth (o/n) or on YEPD agar (2-3 days) at 23°C or 30°C.  From each 
plate a loop-full of pure cultures was used to make a suspension in sterile water.  Cells were 
washed three times by centrifugation at 73 x g (1,000 rpm) in a bench top microcentrifuge 
(Sigma Micro 1-14, Sigma-Aldrich, UK) for five minutes in sterile water.  The total cell number 
was estimated on the basis of OD660 in diluted cultures (Amberg et al., 2005).  Based on OD660, 
cells were equalised in all suspensions.  Total cell concentrations/ml was also measured by 
haemocytometer (Weber Scientific International, England) by counting cell number randomly in 
5, 9 or 13 small squares.  On the basis of the cell counts, cultures were serially diluted to get 
1000 cells/ml of final dilution.  For the final dilution, two sets were prepared: one in water and 
another in 25% glycerol with 4-5 aliquots of each.  Each set was preserved at -80°C for different 
time periods.  The samples (water/glycerol) were plated on YEPD agar in duplicates for zero 
time periods (0H), one hour (1H), one day (1D), three days (3D) and one week (1W).  Viability 
was calculated by counting colonies from plating of 50 µl of suspension on each half of a YEPD 
plate.  The average number of CFUs was taken to calculate % viability. 
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2.3.1.9 Mating haploids and sporulation of diploids 
Crossing between strains with opposite mating types is a convenient method to generate new 
combinations of different mutations.  Yeast crosses were carried out by mixing approximately 
equal numbers of cells from two haploid parental strains with opposite mating types, the MATa 
(a) and MAT alpha (α).  A thin smear of one haploid strain was made on YEPD plates followed 
by a second smear of the opposite strain onto the first strain using a sterile tooth pick.  The 
plates were incubated either at 23°C for 2-3 days or at 28°C overnight (minimum 6-8 hrs) for 
diploids to form and to grow after mating.  Mixed culture was picked up from the surface of the 
medium and was streaked out on fresh plates of selective medium [dropout media without 
histidine, leucine, tryptophan and uracil -4 (HLTU
-
) in this case] to select single colonies of 
diploid cells.  The selective plates were divided in three parts with presumptive diploids 
cultured in the middle, non-sporulated parental cells at the top on either side as controls, while 
the bottom part of the plate was used to purify diploids.  Haploid parents did not grow due to the 
lack of essential amino acids in the media, while a single purified colony was picked up to set a 
culture in 2 ml of YEPD broth and was grown at 28°C until saturation (for approximately 2 
days) in a shaking incubator at 150 rpm.  The cultures were examined under a microscope at a 
magnification of 400x to observe cell arrest.  From saturated cultures, an aliquot of 500 µl was 
washed twice with sterile water by spinning at 73 x g (1,000 rpm) for 3 minutes.  The washed 
cell pellets were re-suspended in 2 ml of 1% potassium acetate solution, supplemented with 
appropriate amino acids (all four in this case) and were grown at 28°C for 2-3 days for 
sporulation.  The culture was examined under a phase contrast microscope to see spores in asci.  
 
A sporulated culture was transferred to a 1.5 ml eppendorf tube and cells were pelleted by 
spinning at 12,470 x g (13,000 rpm) for 30 seconds in benchtop centrifuge.  After discarding the 
supernatant, the cell pellet was re-suspended in 1 ml of sterile water and washed twice at 
maximum speed for 30 second to 1 minute.  Finally, the pellet was re-suspended in 1 ml of 
sterile water and was either stored at 4°C for 1 week or used directly for tetrad analysis.  From 1 
ml of suspension 18 µl was transferred into a fresh tube and mixed with 2 µl of glusulase 
enzyme (PerkinElmer, USA) commercial product of snail juice.  The mixture was vortexed 
briefly and incubated at 30°C for approximately 5-8 minutes to dissolve the sac surrounding the 
tetrads.  The incubation time is dependent on genetic background of each strain.  Sac digestion 
was monitored by examining a loop-full of the digest under a phase contrast microscope.  When 
most of the asci appeared as discrete spheres, the sample was ready for dissection as tightly 
packed tetrahedral-shape spores cannot be resolved by micro-dissection.  The culture was 
transferred to ice to terminate digestion and 1 ml of sterile water was added to tube.  Cells were 
treated gently at this stage as extensive treatment can dissociate and disperse the four spores.  
After gentle rotation the tube, an aliquot of 8-10 µl of the suspension was plated along a line on 
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one side of the YEPD plate for tetrad dissection, and the plates were allowed to dry before 
performing tetrad analysis. 
 
2.3.1.10 Tetrad dissection and spore analysis 
Sporulated cultures consist of non-sporulated vegetative cells and four-spore asci.  Tetrad 
analysis is a traditional method to study an ascus containing four spores (the product of a single 
meiotic event). 
Micromanipulation was carried out on the surface of plates having digested asci under 100x 
magnifications.  Four-spore clusters were picked individually from agar surface by positioning a 
microneedle close to the ascus and transferring it to a new area away from the total population.  
These four spores were separated and arrayed, evenly spaced, on the agar surface and their 
positions were noted down to keep track of them.  In total, more than 100 tetrads were dissected 
and arranged on different nutrient-rich YEPD plates.  Petri dishes containing spores were 
incubated for 2-3 days at 23°C until the spore colonies produced.  The colonies grown from 
separated ascospores were replica-plated onto nutrient requirement synthetic/dropout media 
lacking essential amino acids like histidine, leucine, tryptophan and uracil to test the genotype.  
The growth patterns on selective media revealed the Mendelian segregation of markers, and the 
genotypes of resulting haploid colonies were assessed on the basis of marker combinations.  
Further confirmation of the genotypes was carried out by PCR analysis (for CDC13, cdc13-1 
and STN1 genes) 
 
2.3.1.11 Microscopy 
Yeast strains growing in culture or on agar media are prone to contamination.  Therefore, phase 
contrast microscopy was used to confirm the purity of yeast strains or suspected contaminations 
on the basis of typical cell size or cellular shape.  The culture slides were prepared by placing a 
drop of sterile water onto a slide and resuspending yeast cells in it.  A coverslip was placed onto 
the top of the suspension, and microscopical analysis was carried out.  Pictures were taken at a 
magnification of 400x under a Zeiss KF microscope fitted with Nikon Coolpix 4500 camera (4 
Mega pixels 4x optical Zoom) fitted with Zoom Nikkor 7.85-32 mm lens. 
 
2.3.1.12 Spectrophotometry  
Measuring OD was used to estimate cell densities in diluted cultures (Hartwell, 1970).  Optical 
densities were measured either against sterile water or media.  The spectrophotometer (Jenway 
6305, Bibby Scientific Limited, UK) was calibrated for optical density at 660 nm wavelength 
(OD660).  1 ml of water or medium was used as a blank (setting it as a reference).  The samples 
for OD measurements were prepared by mixing 0.2 ml of culture/suspension and 0.8 ml of 
sterile water followed by, thorough sample vortexing to obtain a homogenous cell suspension.  
1 ml of this suspension was transferred to a cuvette, and the cell density was measured at OD660.  
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Considering the OD660 value, the total cell number/ml was calculated for the diluted suspension.  
The spectrophotometry technique was used to equalise cells for further inoculum in CLS 
experiments and also for making suspensions for spot test assays. 
DNA concentrations were estimated using scanning spectrophotometry (nanodrop technology).  
A Nanodrop 2000, a highly sensitive spectrophotometer (Nanodrop 2000/2000c, Thermo Fisher 
Scientific, UK) was used to measure OD at 260 nm and 280 nm wavelengths. 
 
2.3.1.13 Cell count by using haemocytometer 
A haemocytometer (Weber Scientific International, England) counting chamber, was used 
routinely to determine the number of cells per unit of volume of a suspension.  An approximate 
cell concentration is required for a number of microbiological applications to start culture with 
specific number of cells, or equalising cell numbers for different cultures in CLS studies. 
To estimate total cell counts, homogenous cell suspensions at appropriate dilutions were 
prepared.  A small drop of a suspension was placed at the edge of the coverslip on a 
haemocytometer.  According to the cell density, an appropriate number of small squares within 
the central square (consisting of 25 small squares, each sub-divided into 16 tiny squares) were 
taken into account to count the cell number.  The total cell number/ml of the suspension was 
calculated by counting cells in 5, 9 or 13 small squares as below: 
 
Total cell number/ml = (number of cells counted/total volume in cubic mm
3
) x 1000 (cm
3
 or ml) 
Total volume (mm
3
) = depth of the chamber (mm) x surface area of squares counted (mm
2
) 
Where  
Depth of chamber = 0.1 mm 
Surface area (mm
2
) = number of small squares (any number out of 25) x 1/25 (0.04 mm
2
) 
or 
= number of tiny squares (any number out of 16) x 1/25 x 1/16 (0.0025 mm
2
) 
 
2.3.1.14 Glycerol preservation 
Yeast strains were stored at 4°C on YEPD agar medium for short time periods while for longer 
periods strains were stored in 15 % (v/v) glycerol at -80°C.  To prepare the glycerol stock, 
cultures were either grown in YEPD broth from purified colonies or from yeast cultured on 
YEPD plates.  From the plates, cells were scraped up with sterile tooth picks and re-suspended 
in 1 ml of 15% glycerol in 1.5 ml screw cap tubes under sterile conditions.  The vials were 
tightly closed, shaken to make homogenous suspensions and stored at -80°C.  The cultures were 
revived when required by transferring small portions of this frozen stock to YEPD plates and 
growing at 23°C. 
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2.3.1.15 Toxicity and genotoxicity assays  
In yeast genetics, toxicity tests are carried out to determine the destructive effect of a toxin, a 
hazardous chemical or radiation on genomic DNA, RNA or expression levels to elucidate the 
relative role of different genes involved in genome maintenance through cell damage repair 
pathways. 
 
Yeast cells from fresh colonies were grown overnight at 23°C in 5-10 ml of YEPD broth from 
test strains.  Cells from the log-phase of growth were harvested and washed three times with 
sterile water.  The washed pellets of cells were re-suspended in sterile water.  The OD of 
suspensions was determined by measuring absorbance at 660 nm wavelength to estimate the cell 
number.  The optical density of cultures was subsequently adjusted to ~1-1.5 to keep similar 
loads of cells.  Five-fold serial dilutions of this suspension were prepared in a 96-well plate for 
each strain as has been described in the spot test section (2.4.1.7) and spotted with a sterile 
replica plater on media plates prepared with different concentrations of genotoxic agents 
hydrogen peroxide (H2O2), methyl methanesulfonate (MMS) and hydroxyurea (HU) as 
described below. 
 
To test the sensitivity of mutant strains to ultraviolet (UV) radiation, on the yeast genome, the 
serial dilutions of cultures were spotted onto YEPD plates.  Two plates were used for each 
irradiation time point.  Each group of plates was labelled with their respective UV exposure 
time (control without UV exposure, 10, 15, 30 seconds and so on) before exposure.  Initially, a 
broad range of UV exposure times (from 10, 15, 20, 30, 40, 50, 60, 70, and 100 seconds) was 
tested to establish the most effective exposure time.  This range was narrowed down to doses 
obviously effecting the growth of cells.  The UV dose was expressed in J/M
2
 (1 mJ/cm
2
=10 
J/m
2
).  For example if sample was exposed to UV for 10 seconds, the exposure time was 
multiplied with the unit of system  and converted the resulted value to mJ/cm
2
 or
 
J/m
2
 i.e., 10 
second x100 μJ/cm2 =1000 μJ/cm2 or 1 mJ/cm2=10 J/m2.  The plates with sets of cultures were 
placed inside a UV cross-linker under the UV lamp (TL-2000 UVP
®
, Ultraviolet Products INC, 
USA).  The lid of the plate was removed and the cells were exposed to UV light (short wave 
254 nm) for different exposure times.  After UV exposure, the plates were cultivated for 3-5 
days at 23° and 30°C. 
 
To test cellular responses to intracellular oxidative stress in the presence of H2O2, YEPD 
medium was prepared according to a standard protocol.  Plates were poured with different 
concentrations of H2O2 by mixing stock solution (30% concentration) of H2O2 to the melted 
medium at a temperature of ~55°C.  Different deletion mutants, CDC13 and STN1 were initially 
tested on media with 2 to 8 mM H2O2.  The most effective doses of H2O2 were used in the final 
tests. 
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Similarly, toxic effects of MMS, a DNA alkylating agent, were studied on YEPD medium 
containing 0.010%-0.035% of MMS.  The sensitivity to HU was monitored on YEPD medium 
with initial doses of 10, 25 and 30 mM of HU.  Based on the responses, concentrations were 
further increased to 50 mM, 75 mM, and finally to 100 mM of HU.  All plates were dried before 
use. 
 
2.3.1.16 Transformation of yeast cells by lithium acetate method 
Competent yeast cells were prepared by inoculating a single colony of freshly grown culture 
into 10 ml of selective medium/dropout medium with (Gietz et al., 1995).  The culture was 
grown o/n in incubator shaker at 150 rpm at 23°C and 30°C for temperature-sensitive and 
temperature-resistant strains respectively.  The starter cultures were diluted with 100 ml of 
YEPD broth to OD ~ 0.2 at wavelength 660 nm.  The inoculated cultures were grown at the 
required temperature for 4-4.5 hours in an incubator shaker (Excella E25, New Burnswick 
Scientific, USA) at 200 rpm.  The cells were pelleted at 1,377 x g (3,000 rpm) for 5 minutes in a 
Beckman centrifuge (J2-21, Beckman Instruments INC, UK) and washed in 50 ml of sterile 
distilled water at the same speed.  The resulting pellet of cells was re-suspended in 1.5 ml of 
lithium acetate/Tris EDTA buffer (Li/TE) (see below for recipe).  The cell suspension was 
transferred to a sterile eppendorf tube.  The cells were centrifuged in a benchtop centrifuge for 1 
minute at maximum speed and re-suspended in 500 µl Li/TE buffer.  In a fresh tube, ~1 µg 
plasmid DNA was mixed with 160 µg (16 µl of 10 µg/µl stock) of single-stranded carrier DNA 
to enhance uptake of DNA fragment.  Freshly prepared 100 µl of yeast cell suspension, 10 µl of 
dimethyl sulfoxide (DMSO), and 600 µl of freshly prepared PEG/Li/TE (see below for recipe of 
PEG/Li/TE buffer) were also added to this vial and mixed gently.  The percentage of PEG is 
crucial in the yeast transformation buffer.  The new solution of PEG was used for each 
transformation to avoid the chances of evaporation.  This vial was incubated in a water bath at 
42°C for 15-20 minutes for the efficient transformation of yeast cells.  To overcome the 
resistance of cell wall, yeast are generally heat shocked for 15 to 45 minutes.  After incubation 
the mixture was centrifuged for 1 min at maximum speed, and the cell pellet was re-suspended 
in 1 ml of sterile distilled water.  From 1 ml mixture, 100 µl of the cells were plated onto 
appropriate selective media.  For example, tranrsformants with vector pFA6a containing a 
histidine marker was first selected on the medium without histidine.  However, yeast cells used 
for transformation were with the LEU
+
 marker so the medium used for the second round of 
selection was lacking both histidine and leucine. 
 
Lithium acetate /Tris EDTA buffer (3 ml): 
0.3 ml 10x LiAc (Lithium acetate) 
0.3 ml 10x TE (Tris EDTA) 
2.4 ml sterile distilled water (SDW) 
69 
 
PEG (Polyethylene glycol 4000)/LiAc/TE solution (3 ml): 
0.3 ml 10x LiAc 
0.3 ml 10x TE 
2.4 ml 50% PEG (sterile solution of PEG 4000 in water by mixing 200 g of PEG in 
400 ml of DW) 
 
PEG/Lithium Acetate solution for transformation (10 ml): made fresh just before use. 
50% PEG 4000 8 ml 
10x TE 1 ml 
10x LiAc 1 ml 
10x TE (1L, sterile): 
1M Tris-HCl pH 7.5 100 ml 
500 mM EDTA (pH 7.5) 20 ml 
 
10x Lithium Acetate (LiAc) (400 ml): 
Lithium acetate 40.8 g in the final volume of 400 ml.  Adjusted to pH 7.5 with diluted acetic 
acid (autoclaved). 
 
2.3.2 Molecular Biology Methods 
2.3.2.1 Preparation of competent E. coli cells for transformation 
This method was used to concentrate bacterial cells from diluted cultures from the mid 
exponential phase and to make cells capable of taking up foreign DNA (competent) with a high 
efficiency of transformation.  Foreign DNA, due to its hydrophilic nature, cannot normally pass 
through the cell membrane.  A high concentration of calcium chloride (CaCl2) was used to make 
small holes in the cell membrane and DNA was forced to enter the cells by heat shock. 
 
Glycerol stock of E. coli K-12 strain NM522 was removed from -80°C (15% glycerol), and a 
loop-full of cells was streaked on nutrient agar medium to get well-separated single colonies.  
The culture plate was incubated at 37°C overnight (o/n) for optimal growth.  A single colony 
from a freshly grown plate was picked up with a sterile tooth pick and transferred to 10 ml of 
nutrient broth to set the starter culture in incubator shaker at 37°C with vigorous shaking.  Five 
ml of o/n culture was inoculated into 500 ml of nutrient broth (1:100 dilution) in a 2.5 L flask 
and grown at 37°C at 200 rpm until the mid-exponential phase; this corresponds to OD 0.4 at 
600 nm (approximately 3 ½-4 hours).  At this stage, the culture was removed from the shaker 
incubator and transferred to 250 ml Beckmann tubes under sterile conditions.  The cells were 
harvested by centrifugation at 4°C at 15,302.9 x g (10,000 rpm) for 5 minutes in a Beckmann 
centrifuge (J2-21, Beckman Instruments INC., UK).  The supernatant was discarded, and the 
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pellet was re-suspended in 100 ml of ice-cold sterile 0.1M CaCl2 solution.  The suspension was 
again spun as before and, after discarding the supernatant, the pellet was re-suspended in 50 ml 
of ice-cold sterile 0.1M CaCl2, followed by centrifugation and finally re-suspending the pellet in 
15% glycerol (8.5 ml 0.1M CaCl2 solution and 1.5 ml glycerol) to adjust the final cell density to 
OD ~ 0.48 at 550 nm wavelength.  Competent cells were mixed gently by pipetting.  The 
suspended cells were aliquoted (200 µl) into 2 ml screw cap tubes and stored at -80°C freezer 
until further use. 
 
2.3.2.2 Transformation of E. coli with plasmid DNA 
Competent E. coli K-12 cells (strain NM522) were used for various plasmid transformations.  
Aliquots of competent cells were removed from -80°C and were thawed on ice for 10-15 
minutes.  Two µl of yeast plasmid (pDL501, pDL504, pDL515, pDL516 etc., Table 2.2) DNA 
(diluted 5 times from the original concentrated preparation, ~100 ng) were added to the vial 
containing 200 µl of competent cells and mixed by finger flicking.  After incubation on ice 
during 10 min, vials containing cells were subjected to heat shock at 42°C for 30-45 seconds 
(Sambrook and Russell, 2001).  800 µl of nutrient broth (rich nutrient medium) was added to the 
vial, and tubes were placed in an incubator shaker at 37°C for 30-60 min to recover the 
transformed cells after heat shock.  The cell mixture was then plated on nutrient agar media with 
antibiotic, ampicillin used at the final concentration of 100 µg/ml to select antibiotic resistant E. 
coli cells transformed with different yeast plasmids e.g., pFA6a-His3MX6 plasmid. 
 
Table 2.2.  Yeast plasmids used for CDC13 disruption with modulating marker DNA. 
 
 
(Longtine et al., 1998)  
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2.3.2.3 Plasmid DNA extraction  
Plasmid DNAs were extracted at small scale (<20 µg) using the QIAgen mini (QIAprep spin 
miniprep Kit, cat. no. 27104, Qiagen, USA) or at large scale (up to 100 µg) using midi plasmid 
kits (QIAgen plasmid midi kit, cat. no. 12143, Qiagen, USA) by following the instruction 
manual provided by the manufacturer. 
 
2.3.2.4 Confirmation of plasmid DNA size by digestion with restriction 
enzymes 
3-5 µl of purified plasmid DNA (~500 ng-1 µg) were digested with single or unique cutter 
(EcoRI, BamHI, PstI or HindIII restriction enzymes), chosen on the basis of the plasmid 
restriction map.  For example, single cutter EcoRI restriction enzyme was used with 20 units per 
reaction in a 20 µl reaction mixture to linearise vector pFA6a-HIS3MX6, and its double enzyme 
digestion was performed with two enzymes, EcoRI and BamHI for further size confirmation.  
The digestion mixture was incubated for 2-3 hours at 37°C.  Digestion was terminated by 
adding 1 µl of 0.5 M EDTA and was stored at -20°C until further analysis by agarose gel 
electrophoresis.  
 
2.3.2.5 Agarose gel electrophoresis  
Agarose gel electrophoresis was carried out to confirm the presence of plasmid and genomic 
DNA after extraction, to quantify purified PCR product/plasmid/genomic DNA in a known 
volume, to check linearised DNA size after restriction digestion and to confirm the desirable 
amplicons following PCR.  Purified uncut DNA (3-5 µl) and digested DNA (15-20 µl) were 
resolved on a 0.8% agarose gel with 0.25 µg/ml ethidium bromide (Sigma-Aldrich, UK) in 1x 
TBE running buffer to estimate the size, yield and purity of DNA.  DNA markers 1 kb ladder 
from Invitrogen™ (Life Technologies, USA) and 100 bp DNA ladder quantitative from 
NEB/Invitrogen™ (Life Technologies, USA) were included as reference standards on either 
side of the gel.  All DNA gels were photographed with a GeneFlash gel imaging system 
(Syngene) fitted with a PULNiX TM-300 CCD camera [8-48 mm f1.2 6x manual zoom lens 
(Computar H6Z0812) under UV illumination]. 
 
2.3.2.6 PCR amplification for CDC13 and cdc13-1 detection 
Polymerase chain reaction (PCR) amplification was carried out to detect CDC13 or cdc13-1 in 
cells of different yeast strains.  The primers N1 (forward primer) and N2 (reverse primer) were 
used to amplify CDC13 specific N-terminal fragments with an approximate size of 378 bp 
(from 953 to 1330 bp of the open reading frame (ORF).  The isolated colonies were picked from 
the media plate and denatured at 95°C for 15-20 minutes in 20-25 µl sterile water or 0.02 M 
NaOH.  Samples were centrifuged for 1-3 min to pellet down denatured cell debris.  The PCR 
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reaction was set up using 2 µl of clear supernatant as a template in 25 µl of reaction volume 
with 2x PCR master mix from Promega (3 mM MgCl2, 400 μM dNTPs, and 50 units/ml Taq 
polymerase).  Each PCR reaction contained 10 μl of nuclease-free water, 0.25 μl each of 
forward and reverse primers (stock 100 pM/μl), 2 μl template DNA, and 12.5 μl of Promega’s 
green master mix). 
 
PCR conditions were as below: 
 
1. 95° C for 15 min      (Denaturing step) 
2. 94° C for 25 sec (seconds)    (Denaturing step) 
3. 56° C for 30 sec   32 cycles (Primer annealing step) 
4. 72° C for 30 sec     (Extension step) 
5. 32 cycles from steps 2-4 
6. 72° C for 5 min 
 
Amplified fragments were resolved on 1.5 % agarose gel with 1x TBE buffer to confirm the 
presence of the fragments of the expected size. 
 
2.3.2.7 Post PCR amplified product restriction enzyme analysis 
After confirmation of PCR fragment size on the gel, 10-15 µl of amplified product was digested 
with 10-20 U of EcoR1 restriction enzyme to differentiate between wild type CDC13 and its 
mutant form, cdc13-1.  The cdc13-1 mutant have an additional EcoR1 site (sequence below) 
that replaced nucleotide ‘C’ (5’…TGAATCC…3’) with ‘T’ (5’…TGAATT C…3’) at sequence 
position 1111 of CDC13 ORF. 
 
EcoR1 site 
 
As a result of digestion, CDC13 showed a single band of ~378 bp corresponding to the 
sequence from 953 to 1330 bp of the ORF without EcoR1 site), and cdc13-1 generated two 
bands of sizes ~219 and ~159 bp (due to the EcoR1 cut) on 2.5 % agarose gel.  
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2.3.2.8 CDC13 modification by PCR and homologous recombination 
In gene functional analysis studies, the target gene replacement is a standard technique used to 
achieve gene replacement in “one step PCR-mediated gene modification, deletion and 
integration” at the target specific site (Longtine et al., 1998).  It is a quicker and cheaper 
alternative to time-consuming gene cloning technique. 
 
The first step in PCR based gene deletion and modification is the choice of yeast plasmids with 
selectable marker of interest.  A number of yeast plasmids are available that serve as template 
for PCR synthesis of DNA fragment for gene manipulation.  The hybrid primers are designed 
by selecting 5’-ends from the target gene nucleotide sequences and 3’-ends from modular 
marker sequence for the synthesis of disruption cassettes by PCR using plasmid DNA as 
template.  The amplified DNA fragment with flanking region of gene is transformed into host 
yeast.  Homologous recombinants that carry the deleted gene are identified on the basis of 
selectable marker and confirmed by diagnostic PCR for the deletion of gene and integration of 
marker module in yeast genome. 
 
2.3.2.8.1 Yeast plasmid for cdc13-1 full gene deletion 
The plasmid pFA6a-HIS3MX6 (pDL501) with a histidine marker module was chosen as a 
template for PCR synthesis of the sequence for CDC13 full gene deletion (Longtine et al., 1998, 
Wach et al., 1997) (Figure 2.1). 
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Figure 2.1.  Map of the yeast plasmid pFA6a-HIS3MX6 (3782 bp). 
(A)  Map of circular plasmid showing unique restriction sites (http://www.snapgene.com/). 
(B)  Map of linear plasmid showing the position of PCR primers (F1 and R1) used as the 3’ part of hybrid 
deletion primers. 
 
The HIS3MX6 DNA module contains a heterologous his5
+
 marker gene that complements S. 
cerevisiae his3 mutations.  The his5
+
 gene is basically a hybrid gene from Saccharomyces 
kluyveri and Schizosacchromyces pombe adapted for better transformation efficiency.  
Transformation of yeast S. cervisiae with the HIS3 gene of S. kluyveri under its native promoter 
could result in 5% more false positives as compared to Sz. pombe under the strong TEF gene 
B 
A 
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promoter and terminator (Wach et al., 1997).  The hybrid histidine gene is ~1.4 kb and encodes 
for imidazole glycerol-phosphate dehydratase required for histidine biosynthesis. 
 
2.3.2.8.2 Hybrid primers for CDC13 full gene deletion cassettes  
The chimeric primers have 100% homology with the target gene sequences as well as with the 
metabolic marker gene.  To delete cdc13-1, the 3’ends of forward (N-F1) and reverse (C-R3) 
hybrid primers were picked from the start and end of the HIS3MX6 marker module sequences 
corresponding to 20 nucleotides (nt) as shown by sequences F1 and R1 respectively on the 
circular and linear maps of plasmid pDL501 in Figure 2.1 and 2.2 (Longtine et al., 1998).  The 
5’ gene-specific targeting sequences corresponding to 46 and 40 nucleotides were immediately 
upstream (including start codon ATG and first three nucleotides from the start) and downstream 
of the CDC13 open reading frame to be deleted, as shown in Figure 2.3; (Table 2.3). 
 
The 3’ marker sequence of primers should hybridize with homologous HIS3 DNA of plasmid 
pDL501 in the PCR reaction to amplify the ~1409 bp deletion cassette, whereas the flanking 5’ 
guide sequences will recombine with target DNA in their normal chromosomal location during 
yeast transformation to disrupt cdc13-1 resulting in cdc13-1Δ::HIS3MX6 construct (Figure 2.4). 
 
 
Figure 2.2.  Histidine (HIS3) marker module: a PCR template to generate fragments for CDC13 gene 
deletion and modification. 
The plasmid pFA6a-HIS3MX6 uses the HIS3MX6 module that contains the Sz. pombe his5
+
gene, (Wach et 
al., 1997) with TEF promoter and terminator sequences from a filamentous fungus Ashbya gossypii.  The 
arrow within the box indicates the direction of transcription.  Outside arrows indicate forward (F1) and 
reverse (R1) PCR primers (arrows shown in black represent the 3’ part of hybrid primers corresponding 
to sequences on either side of the HIS3MX6 module whereas the red parts represent the 5’ end of the 
primers homologous to the yeast target sequences).  Gene-specific primer-length dictates the size of 
PCR product e.g., with 40-nucleotide homologous primers, the size of the amplicon is expected to be 
1403 bp (Adapted from (Wach et al., 1997). 
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Figure 2.3.  Designing of primers for cdc13-1 full gene deletion: selecting the 5’ ends of the hybrid 
primers. 
CDC13 ORF (1-2775) with upstream and downstream sequences with each being 200 nucleotides in 
length, accessed from Saccharomyces Genome Database (SGD) (http://www.yeastgenome.org/).  
Nucleotide sequences dark red in colour was selected as 5’ end of hybrid primers.  Diagnostic primers 
(N1 and N2) were used to detect the 378 bp fragment for CDC13 or cdc13-1. 
 
 
CDC13 sequence 
>YDL220C  Chr 4   from 62044 to 65218   
TGTGGATTATTTAATATGTACATGCAGCCTTGATTAACGTGATTATACTTTTTAAACCTT 
TGATATCCAAATTTTTCAACGTCATAAGAGACGCGAAGGCCTAGTGAGATGCGAAATGCT 
AATTCAAAATGGAAATTTAAGAATATATTCATATATGTTTCTCTTTGGATACGAATGACC 
GTGGAAACTATCGCCTAAAAATGGATACCTTAGAAGAGCCTGAGTGTCCTCCACATAAAA 
ATCGTATTTTTGTGAGCTCGAGTAAAGATTTTGAAGGCTATCCCAGCAAAGCAATAGTTC 
CCGTGCAATTCGTGGCGCTTTTAACCTCAATACACCTGACTGAAACAAAATGTTTGCTAG 
GCTTTTCTAATTTTGAGAGGCGAGGAGATCAATCCCAAGAAGATCAATATTTAATCAAAC 
TGAAGTTCAAAGATAGGGGCTCGGAGAGGTTAGCCCGGATCACTATTTCCTTACTTTGCC 
AATACTTTGATATTGAACTGCCAGATTTAGATTCTGACTCAGGCGCATCCCCAACAGTAA 
TACTGAGAGATATTCACCTTGAAAGGTTATGTTTTTCAAGTTGTAAAGCTTTATATGTAT 
CAAAACACGGGAACTATACTCTATTCTTAGAGGACATAAAACCGTTGGATTTGGTAAGTG 
TGATAAGCACCATATCTACAAAATCGACAAATAGCAGCAAGCATTCGTCATCAGAACTTA 
TTTCAGAATGTGATTTGAACAACTCACTTGTGGATATCTTCAACAATTTAATAGAAATGA 
ATAGAGACGAGAAAAACAGGTTTAAATTTGTAAAGTTGATTCACTACGATATAGAACTAA 
AAAAGTTCGTTCAAGACCAACAAAAGGTATTATCGCAGAAATCAAAAGCCGCAGCAATTA 
ATCCTTTCTTTGTGCCAAATAGACTAGGGATACCTTACATTGAATCCCAAAACGAATTCA 
ACTCGCAGCTTATGACGCTTAATGTAGATGAACCGACCACAGATATAAGCAACATGGGAG 
AGGAAATGCATGACAGCGCAGATCCCATTGAGGATTCAGATTCCTCAACTACCTCCTCTA 
CCGGGAAATATTTCAGCTCAAAATCCTACATCCAGTCACAGACACCTGAAAGGAAAACAA 
GCGTACCAAATAATTGGCACGATGATGATTCCGGAAGCAAGAGGAAGAGAAAGCTTTCTT 
TCCACAGTCCGAACGCGTCCTCAATCCGCAAAGCCATCAGTTATGAGCAACTTTCCCTAG 
CTAGTGTAGGCTCAGTTGAAAGGTTAGAGGGCAAAATTGTTGGCATGAATCCACCTCAAT 
TCGCCAGTATAAATGAGTTCAAATATTGCACATTGAAATTATATTTTACGCAGCTCTTAC 
CAAATGTCCCAGACAAGGTCCTGGTGCCAGGCGTCAATTGCATTGAGATCGTTATCCCGA 
CGAGAGAGCGAATCTGTGAGCTCTTCGGTGTTTTAAACTGTCAAAGCGACAAGATATCGG 
ATATTTTACTACTGGAAAAGCCTGATCGAATTTCCGTCGAAGTTGAAAGGATCCTGTGGG 
ACAATGACAAGACCGCCAGCCCAGGTATGGCAGTATGGAGTTTGAAGAACATTAGCACCG 
ACACGCAGGCGCAGGCGCAGGTGCAGGTGCCTGCGCAATCGTCGGCGTCAATCGATCCGT 
CTCGCACAAGGATGAGCAAAATGGCAAGGAAAGACCCCACCATCGAATTCTGTCAGTTGG 
GACTCGACACTTTTGAGACCAAATACATAACAATGTTTGGCATGCTAGTCTCCTGCTCGT 
TTGATAAACCTGCCTTTATATCTTTTGTCTTTAGCGATTTTACCAAGAACGATATCGTCC 
AAAACTATCTTTACGACAGATATCTAATAGATTACGAGAACAAGTTAGAGCTGAACGAGG 
GCTTCAAAGCCATCATGTACAAAAACCAATTCGAAACGTTTGACTCTAAGCTCAGAAAAA 
TATTCAACAACGGGCTAAGAGATCTACAGAACGGCCGCGATGAAAACCTTTCGCAATACG 
GCATAGTTTGTAAGATGAATATAAAAGTGAAAATGTACAACGGCAAATTGAATGCCATTG 
TGCGCGAATGTGAGCCGGTCCCGCATTCCCAAATAAGCAGCATCGCCTCGCCTTCACAGT 
GCGAACATTTAAGATTGTTCTACCAACGAGCGTTCAAGAGAATTGGCGAATCCGCAATTT 
CACGCTATTTCGAAGAGTACCGGAGGTTTTTCCCCATACATAGAAACGGTTCTCATCTCG 
CGAAACTGAGGTTCGATGAAGTAAAGCATGAACCAAAAAAATCACCCACTACACCAGCTC 
TCGCAGAACACATACCCGACCTGAATGCAGACGTGTCCTCCTTCGATGTAAAGTTCACAG 
ATATATCTTCTCTCTTGGACTCCTCGGCTCGCCTCCCGCGCCCACAGCAAACACACAAGA 
GCAACACATTATACAGTTGCGAGGGCCGTATCATCGCCATCGAGTACCACGCATCTGATC 
TCTGCTTCCATATCACGAATGAGCTCCCACTTTTACAAACCCGCGGCTTGGCCCCGGAGC 
GAGTGTTGCAACTACACATCATTACCTCCAAGAACTTTGCTTATTTTTTCAACCGCTCAA 
GCGCCTACTTACAGCGTCAGCCTCTTGAGGAAAAATATACGCAATTGGCACAATTTCTCG 
GCCATTCATTTAAATTCAATATAACCTCCTCGCTCACGCTGTTCCCTGACACTACCGTGG 
CACTCCAGATCTGGTGCCCAATTGAATGCACCTTTCGGGAATTGCAACAACAGCTGGCCC 
ATCCGAAGGTTGCAGCGGCTCCTGATTCAGGGAGTCTTGATTGCGCAATTAATGCTACCG 
TCAATCCTCTGCGACTTCTTGCCGCGCAAAATGGCGTCACCGTGAAAAAGGAGGAGGATA 
ATGACGATGACGCCGGAGCCGTTCCCACCTCGTAAGACATGATCCGCGCAGCCCAACGCG 
GCGGTGCCAAATTGCAGTGACGTCTCGGAGTAATATAAAAAAAAAAGACCAAATAACCAA 
ATTTAAGGGTGCTCTGAATATAAGGGAGTGGAACGTTTTCACACGAAGGAAAAGGGAAAG 
AGGGGAGTGGTAAGAAGCAAGAGTCAATGAAAGGTCTTCCTTCCTTCTTGATGCT 
‘C’ substituted by ‘T’ 
at position 1111 
resulting in for 
EcoR1 site (GAATTC) 
in cdc13-1 mutation 
N1 
Forward primer 
5’part (46 nt), 
sequence red in 
colour 
Reverse primer 
5’part (40 nt), 
sequence red in 
colour  
N2 
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Table 2.3.  Primer sequences used for the deletion of the CDC13 full gene or its N- and C-terminus 
truncation. 
 
 
 
 
 
 
 
Figure 2.4.  A diagrammatic representation of HIS3MX6-cdc13-1 full gene deletion construct. 
cdc13-1 deletion (cdc13-1Δ) with modulating plasmid pFA6a-HIS3MX6 (pDL501). 
 
2.3.2.8.3 Plasmid selection for cdc13-1 N-terminus deletions  
The ORF or coding sequence of CDC13 (1-2775 bp) was theoretically divided into two halves 
of 1386 and 1389 bp.  The first half of CDC13, that is N-terminus part of gene (1386 nt plus one 
ATG codon), was deleted with the yeast plasmid pFA6a-TRP1-PGAL1 (pDL515; 3962 bp) 
(Figure 2.5) containing the tryptophan marker (TRP1) module.  The S. cerevisiae TRP1 marker 
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gene produces the phosphoribosylanthranilate isomerase enzyme, required for tryptophan 
biosynthesis and is under the TRP1 promoter.  The integration of this marker in the yeast 
genome through homologous recombination will result in truncation of the CDC13 N-terminus, 
while the remaining C-terminal half of CDC13 will be expressed under the PGAL1 inducible 
promoter, regulated by Gal4 substrate.  The Gal4-dependent induction in turn is mediated by an 
upstream activating sequence (UAS) in modular DNA.  
 
 
 
 
Figure 2.5.  The map of yeast plasmid pFA6a-TRP1-PGAL1 (3962 bp) with unique restriction sites. 
The map of circular plasmid showing unique restriction sites, primer sites and the TRP1 marker for N-
terminus deletion (http://www.snapgene.com). 
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2.3.2.8.4 Hybrid primers for cdc13-1 N-terminal deletion cassettes 
The hybrid primers for the cdc13-1 N-terminus deletion (NTΔ) consist of a 50 and 48-mer 5’ 
gene-specific parts (Figure 2.6) and a 20-mer 3’ modulating DNA part selected from the yeast 
plasmids pFA6a-TRP1-pGAL1 (pDL515) (Figure 2.7; Table 2.3) or pFA6a-HIS3MX6-PGAL1 
(pDL516); both plasmids utilise common sequences, i.e.,‘F4’ and ‘R2’ for forward and reverse 
primers respectively for 3’ends (Longtine et al., 1998)., however, with amplicons of different 
size.  The forward primer (FT-N1) for NTΔ contains 50 nucleotides from just upstream of the 
CDC13 start codon whereas the reverse primer (RT-N1) consists of 48 nucleotides from the 
middle of CDC13 ORF and with one start codon (CAT) in the complementary strand to start 
transcription in the middle while preserving the remaining amino acid sequence/protein.  The 
resulting chimeric primers can be used with either plasmid template with a size-specific 
amplified cassette to delete the N-terminus with tryptophan or histidine marker. 
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Selection of the gene-specific guide sequence for 5’ ends of hybrid primers from the CDC13 sequence 
for NTΔ 
CDC13 sequence ORF 1-2775: >YDL220C  Chr 4   from 62044 to 65218    
 
 
Figure 2.6.  Primers design for cdc13-1 N-terminus deletion: selecting the 5’ ends of the hybrid primers.   
CDC13 ORF (1-2775) with upstream and downstream sequences with each being 200 nucleotides in 
length, accessed from Saccharomyces Genome Database (SGD) (http://www.yeastgenome.org/).  
Nucleotide sequences shown in red were selected to design 5’ targeting sequences for cdc13-1 N-
truncation. 
 
 
 
TGTGGATTATTTAATATGTACATGCAGCCTTGATTAACGTGATTATACTTTTTAAACCTT 
TGATATCCAAATTTTTCAACGTCATAAGAGACGCGAAGGCCTAGTGAGATGCGAAATGCT 
AATTCAAAATGGAAATTTAAGAATATATTCATATATGTTTCTCTTTGGATACGAATGACC 
GTGGAAACTATCGCCTAAAAATGGATACCTTAGAAGAGCCTGAGTGTCCTCCACAT 
AAAAATCGTATTTTTGTGAGCTCGAGTAAAGATTTTGAAGGCTATCCCAGCAAAGCAATA 
GTTCCCGTGCAATTCGTGGCGCTTTTAACCTCAATACACCTGACTGAAACAAAATGTTTG 
CTAGGCTTTTCTAATTTTGAGAGGCGAGGAGATCAATCCCAAGAAGATCAATATTTAATC 
AAACTGAAGTTCAAAGATAGGGGCTCGGAGAGGTTAGCCCGGATCACTATTTCCTTACTT 
TGCCAATACTTTGATATTGAACTGCCAGATTTAGATTCTGACTCAGGCGCATCCCCAACA 
GTAATACTGAGAGATATTCACCTTGAAAGGTTATGTTTTTCAAGTTGTAAAGCTTTATAT 
GTATCAAAACACGGGAACTATACTCTATTCTTAGAGGACATAAAACCGTTGGATTTGGTA 
AGTGTGATAAGCACCATATCTACAAAATCGACAAATAGCAGCAAGCATTCGTCATCAGAA 
CTTATTTCAGAATGTGATTTGAACAACTCACTTGTGGATATCTTCAACAATTTAATAGAA 
ATGAATAGAGACGAGAAAAACAGGTTTAAATTTGTAAAGTTGATTCACTACGATATAGAA 
CTAAAAAAGTTCGTTCAAGACCAACAAAAGGTATTATCGCAGAAATCAAAAGCCGCAGCA 
ATTAATCCTTTCTTTGTGCCAAATAGACTAGGGATACCTTACATTGAATCCCAAAACGAA 
TTCAACTCGCAGCTTATGACGCTTAATGTAGATGAACCGACCACAGATATAAGCAACATG 
GGAGAGGAAATGCATGACAGCGCAGATCCCATTGAGGATTCAGATTCCTCAACTACCTCC 
TCTACCGGGAAATATTTCAGCTCAAAATCCTACATCCAGTCACAGACACCTGAAAGGAAA 
ACAAGCGTACCAAATAATTGGCACGATGATGATTCCGGAAGCAAGAGGAAGAGAAAGCTT 
TCTTTCCACAGTCCGAACGCGTCCTCAATCCGCAAAGCCATCAGTTATGAGCAACTTTCC 
CTAGCTAGTGTAGGCTCAGTTGAAAGGTTAGAGGGCAAAATTGTTGGCATGAATCCACCT 
CAATTCGCCAGTATAAATGAGTTCAAATATTGCACATTGAAATTATATTTTACGCAGCTC 
TTACCAAATGTCCCAGACAAGGTCCTGGTGCCAGGCGTCAATTGCATTGAGATCGTTATC 
CCGACGAGAGAGCGAATCTGTGAGCTCTTCGGTGTTTTAAACTGTCAAAGCGACAAGATA 
TCGGATATTTTACTACTGGAAAAGCCTGATCGAATTTCCGTCGAAGTTGAAAGGATCCTG 
TGGGACAATGACAAGACCGCCAGCCCAGGTATGGCAGTATGGAGTTTGAAGAACATTAGC 
ACCGACACGCAGGCGCAGGCGCAGGTGCAGGTGCCTGCGCAATCGTCGGCGTCAATCGAT 
CCGTCTCGCACAAGGATGAGCAAAATGGCAAGGAAAGACCCCACCATCGAATTCTGTCAG 
TTGGGACTCGACACTTTTGAGACCAAATACATAACAATGTTTGGCATGCTAGTCTCCTGC 
TCGTTTGATAAACCTGCCTTTATATCTTTTGTCTTTAGCGATTTTACCAAGAACGATATC 
GTCCAAAACTATCTTTACGACAGATATCTAATAGATTACGAGAACAAGTTAGAGCTGAAC 
GAGGGCTTCAAAGCCATCATGTACAAAAACCAATTCGAAACGTTTGACTCTAAGCTCAGA 
AAAATATTCAACAACGGGCTAAGAGATCTACAGAACGGCCGCGATGAAAACCTTTCGCAA 
TACGGCATAGTTTGTAAGATGAATATAAAAGTGAAAATGTACAACGGCAAATTGAATGCC 
ATTGTGCGCGAATGTGAGCCGGTCCCGCATTCCCAAATAAGCAGCATCGCCTCGCCTTCA 
CAGTGCGAACATTTAAGATTGTTCTACCAACGAGCGTTCAAGAGAATTGGCGAATCCGCA 
ATTTCACGCTATTTCGAAGAGTACCGGAGGTTTTTCCCCATACATAGAAACGGTTCTCAT 
CTCGCGAAACTGAGGTTCGATGAAGTAAAGCATGAACCAAAAAAATCACCCACTACACCA 
GCTCTCGCAGAACACATACCCGACCTGAATGCAGACGTGTCCTCCTTCGATGTAAAGTTC 
ACAGATATATCTTCTCTCTTGGACTCCTCGGCTCGCCTCCCGCGCCCACAGCAAACACAC 
AAGAGCAACACATTATACAGTTGCGAGGGCCGTATCATCGCCATCGAGTACCACGCATCT 
GATCTCTGCTTCCATATCACGAATGAGCTCCCACTTTTACAAACCCGCGGCTTGGCCCCG 
GAGCGAGTGTTGCAACTACACATCATTACCTCCAAGAACTTTGCTTATTTTTTCAACCGC 
TCAAGCGCCTACTTACAGCGTCAGCCTCTTGAGGAAAAATATACGCAATTGGCACAATTT 
CTCGGCCATTCATTTAAATTCAATATAACCTCCTCGCTCACGCTGTTCCCTGACACTACC 
GTGGCACTCCAGATCTGGTGCCCAATTGAATGCACCTTTCGGGAATTGCAACAACAGCTG 
GCCCATCCGAAGGTTGCAGCGGCTCCTGATTCAGGGAGTCTTGATTGCGCAATTAATGCT 
ACCGTCAATCCTCTGCGACTTCTTGCCGCGCAAAATGGCGTCACCGTGAAAAAGGAGGAG 
GATAATGACGATGACGCCGGAGCCGTTCCCACCTCGTAAGACATGATCCGCGCAGCCCAA 
CGCGGCGGTGCCAAATTGCAGTGACGTCTCGGAGTAATATAAAAAAAAAAGACCAAATAA 
CCAAATTTAAGGGTGCTCTGAATATAAGGGAGTGGAACGTTTTCACACGAAGGAAAAGGG 
AAAGAGGGGAGTGGTAAGAAGCAAGAGTCAATGAAAGGTCTTCCTTCCTTCTTGATGCT 
5’ part of reverse primer (48), 
sequence red in colour  
5’ part of forward primer 
(50), sequence red in colour  
C1 
C2 
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Figure 2.7.  Map of yeast plasmid pFA6a-TRP1-PGAL1 (3962 bp) showing positions of F4 and R2 primers 
and inducible promoter. 
(A)  Map of the circular plasmid (http://www.snapgene.com/).  
(B)  Map of the linear plasmid.  
Plasmid map shows TRP1 marker under TRP1 promoter and the location of F4 and R2 primers used for 
truncating N-terminus of CDC13 without adding any tags (Longtine et al., 1998). 
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The expected PCR product with 40 nucleotide gene-specific hybrid primers has been reported to 
be 1.558 kb with the TRP1-PGAL1 marker (Longtine et al., 1998), however, considering the 
size of the guide sequence as 50 and 48 nt for forward and reverse primers, the size of the PCR 
amplicon (deletion cassette) was estimated to be ~1.576 kb for NTΔ. 
 
The marker cassette containing TRP1-PGAL1 or HIS3MX6-PGAL1 will replace the first 1389 
nt of Cdc13 ORF sequence resulting in NTΔ::TRP1-PGAL1 (Figure 2.8) or NTΔ::HIS3MX6-
PGAL1 depending upon the template plasmid used.  
 
 
 
 
Figure 2.8.  Diagrammatic representation of cdc13-1 N-terminus truncation (NTΔ) using TRP1-PGAL1 
deletion cassette. 
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2.3.2.8.5 Plasmid selection for cdc13-1 C-terminus deletions  
To delete the C-terminus, the second half of the cdc13-1 yeast plasmid pFA6a-GFP(S65T)-
HIS3MX6 (4698 bp) was utilised .  The HIS3MX6 DNA module is similar to the marker 
module of plasmid pFA6a-HIS3MX6 (Figure 2.9) used for the full gene deletion construct with 
the heterologous his5
+
 marker gene of S. pombe and Saccharomyces kluyveri origin.  However, 
it also contains the ADH1 terminator to stop the replication of truncated transcripts of gene of 
interest e g., cdc13-1 C-terminus truncated construct in this case. 
The HIS3MX6 produces imidazoleglycerol-phosphate dehydratase, required for histidine 
biosynthesis.  This marker gene is controlled by a strong promoter and terminator from the TEF 
gene of filamentous fungus A. gossypii.  The marker module is provided with ADH1 terminator 
to terminate the expression of the N-terminus half of the CDC13 gene. 
 
 
 
Figure 2.9.  The map of yeast plasmid pFA6a-GFP(S65T)-HIS3MX6 (4698 bp) with unique restriction sites. 
The map of circular plasmid DNA shows primer sites and the HIS marker for C-terminus deletion with or 
without GFP tag (accessed from www.snapgene.com) under TEF promoter. 
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2.3.2.8.6 Hybrid primers for cdc13-1 C-terminal deletion cassettes 
The hybrid primers for cdc13-1 C-terminus deletion (CTΔ) consist of a 50/51-mer 5’ gene-
specific part and a 20-mer 3’ modulating DNA part from plasmid pFA6a-GFP(S65T)-ADH1-
HIS3MX6 (pDL504).  The forward primer (FT-C2) for CTΔ contains 50 nucleotides from the 
middle of cdc13-1 including one stop codon ‘TGA’ at the end to terminate transcription after 
the N-terminus half of the Cdc13-1 protein whereas the reverse primer (RT-C2) consists of 51 
nucleotides from the end of CDC13 ORF sequence, just downstream of the stop codon ‘TAA’ 
as shown in Figure 2.10. 
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Selection of the gene-specific guide sequence for 5’ ends of hybrid primers from 
the CDC13 sequence for CTΔ 
CDC13 sequence: >YDL220C  Chr 4   from 62044 to 65218   
 
 
Figure 2.10.  Primers design for cdc13-1 C-terminus deletion: selecting the 5’ part of the hybrid primers. 
CDC13 ORF (1-2775) with upstream and downstream sequences with each being 200 nucleotides in 
length, accessed from Saccharomyces Genome Database (SGD) (http://www.yeastgenome.org/).  
Nucleotide sequences shown in blue were selected to design 5’ end of hybrid primers for cdc13-1 C-
truncation. 
 
 
 
 
TGTGGATTATTTAATATGTACATGCAGCCTTGATTAACGTGATTATACTTTTTAAACCTT 
TGATATCCAAATTTTTCAACGTCATAAGAGACGCGAAGGCCTAGTGAGATGCGAAATGCT 
AATTCAAAATGGAAATTTAAGAATATATTCATATATGTTTCTCTTTGGATACGAATGACC 
GTGGAAACTATCGCCTAAAAATGGATACCTTAGAAGAGCCTGAGTGTCCTCCACATAAAA 
ATCGTATTTTTGTGAGCTCGAGTAAAGATTTTGAAGGCTATCCCAGCAAAGCAATAGTTC 
CCGTGCAATTCGTGGCGCTTTTAACCTCAATACACCTGACTGAAACAAAATGTTTGCTAG 
GCTTTTCTAATTTTGAGAGGCGAGGAGATCAATCCCAAGAAGATCAATATTTAATCAAAC 
TGAAGTTCAAAGATAGGGGCTCGGAGAGGTTAGCCCGGATCACTATTTCCTTACTTTGCC 
AATACTTTGATATTGAACTGCCAGATTTAGATTCTGACTCAGGCGCATCCCCAACAGTAA 
TACTGAGAGATATTCACCTTGAAAGGTTATGTTTTTCAAGTTGTAAAGCTTTATATGTAT 
CAAAACACGGGAACTATACTCTATTCTTAGAGGACATAAAACCGTTGGATTTGGTAAGTG 
TGATAAGCACCATATCTACAAAATCGACAAATAGCAGCAAGCATTCGTCATCAGAACTTA 
TTTCAGAATGTGATTTGAACAACTCACTTGTGGATATCTTCAACAATTTAATAGAAATGA 
ATAGAGACGAGAAAAACAGGTTTAAATTTGTAAAGTTGATTCACTACGATATAGAACTAA 
AAAAGTTCGTTCAAGACCAACAAAAGGTATTATCGCAGAAATCAAAAGCCGCAGCAATTA 
ATCCTTTCTTTGTGCCAAATAGACTAGGGATACCTTACATTGAATCCCAAAACGAATTCA 
ACTCGCAGCTTATGACGCTTAATGTAGATGAACCGACCACAGATATAAGCAACATGGGAG 
AGGAAATGCATGACAGCGCAGATCCCATTGAGGATTCAGATTCCTCAACTACCTCCTCTA 
CCGGGAAATATTTCAGCTCAAAATCCTACATCCAGTCACAGACACCTGAAAGGAAAACAA 
GCGTACCAAATAATTGGCACGATGATGATTCCGGAAGCAAGAGGAAGAGAAAGCTTTCTT 
TCCACAGTCCGAACGCGTCCTCAATCCGCAAAGCCATCAGTTATGAGCAACTTTCCCTAG 
CTAGTGTAGGCTCAGTTGAAAGGTTAGAGGGCAAAATTGTTGGCATGAATCCACCTCAAT 
TCGCCAGTATAAATGAGTTCAAATATTGCACATTGAAATTATATTTTACGCAGCTCTTAC 
CAAATGTCCCAGACAAGGTCCTGGTGCCAGGCGTCAATTGCATTGAGATCGTTATCCCGA 
CGAGAGAGCGAATCTGTGAGCTCTTCGGTGTTTTAAACTGTCAAAGCGACAAGATATCGG 
ATATTTTACTACTGGAAAAGCCTGATCGAATTTCCGTCGAAGTTGAAAGGATCCTGTGGG 
ACAATGACAAGACCGCCAGCCCAGGTATGGCAGTATGGAGTTTGAAGAACATTAGCACCG 
ACACGCAGGCGCAGGCGCAGGTGCAGGTGCCTGCGCAATCGTCGGCGTCAATCGATCCGT 
CTCGCACAAGGATGAGCAAAATGGCAAGGAAAGACCCCACCATCGAATTCTGTCAGTTGG 
GACTCGACACTTTTGAGACCAAATACATAACAATGTTTGGCATGCTAGTCTCCTGCTCGT 
TTGATAAACCTGCCTTTATATCTTTTGTCTTTAGCGATTTTACCAAGAACGATATCGTCC 
AAAACTATCTTTACGACAGATATCTAATAGATTACGAGAACAAGTTAGAGCTGAACGAGG 
GCTTCAAAGCCATCATGTACAAAAACCAATTCGAAACGTTTGACTCTAAGCTCAGAAAAA 
TATTCAACAACGGGCTAAGAGATCTACAGAACGGCCGCGATGAAAACCTTTCGCAATACG 
GCATAGTTTGTAAGATGAATATAAAAGTGAAAATGTACAACGGCAAATTGAATGCCATTG 
TGCGCGAATGTGAGCCGGTCCCGCATTCCCAAATAAGCAGCATCGCCTCGCCTTCACAGT 
GCGAACATTTAAGATTGTTCTACCAACGAGCGTTCAAGAGAATTGGCGAATCCGCAATTT 
CACGCTATTTCGAAGAGTACCGGAGGTTTTTCCCCATACATAGAAACGGTTCTCATCTCG 
CGAAACTGAGGTTCGATGAAGTAAAGCATGAACCAAAAAAATCACCCACTACACCAGCTC 
TCGCAGAACACATACCCGACCTGAATGCAGACGTGTCCTCCTTCGATGTAAAGTTCACAG 
ATATATCTTCTCTCTTGGACTCCTCGGCTCGCCTCCCGCGCCCACAGCAAACACACAAGA 
GCAACACATTATACAGTTGCGAGGGCCGTATCATCGCCATCGAGTACCACGCATCTGATC 
TCTGCTTCCATATCACGAATGAGCTCCCACTTTTACAAACCCGCGGCTTGGCCCCGGAGC 
GAGTGTTGCAACTACACATCATTACCTCCAAGAACTTTGCTTATTTTTTCAACCGCTCAA 
GCGCCTACTTACAGCGTCAGCCTCTTGAGGAAAAATATACGCAATTGGCACAATTTCTCG 
GCCATTCATTTAAATTCAATATAACCTCCTCGCTCACGCTGTTCCCTGACACTACCGTGG 
CACTCCAGATCTGGTGCCCAATTGAATGCACCTTTCGGGAATTGCAACAACAGCTGGCCC 
ATCCGAAGGTTGCAGCGGCTCCTGATTCAGGGAGTCTTGATTGCGCAATTAATGCTACCG 
TCAATCCTCTGCGACTTCTTGCCGCGCAAAATGGCGTCACCGTGAAAAAGGAGGAGGATA 
ATGACGATGACGCCGGAGCCGTTCCCACCTCGTAAGACATGATCCGCGCAGCCCAACGCG 
GCGGTGCCAAATTGCAGTGACGTCTCGGAGTAATATAAAAAAAAAAGACCAAATAACCAA 
ATTTAAGGGTGCTCTGAATATAAGGGAGTGGAACGTTTTCACACGAAGGAAAAGGGAAAG 
AGGGGAGTGGTAAGAAGCAAGAGTCAATGAAAGGTCTTCCTTCCTTCTTGATGCT 
5’ part of forward primer, 
sequence blue in colour 
(50 nt). 
5’ part of reverse primer 
sequence blue in colour 
(51 nt)  
N1 
N2 
‘C’ substituted by ‘T’ at 
position 1111 resulting in 
EcoR1 site (GAATTC) in 
cdc13-1 mutation. 
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2.3.2.8.6.1 Selection of sequence for 3’ part of hybrid primers from the modulating 
plasmid sequence for CTΔ  
The 3’ part of hybrid primers ‘F3’ and ‘R1’ sequences for forward and reverse primers were 
picked from the ADH1-HIS3MX6 marker module as shown in Figure 2.11 and Table 2.3 
(Longtine et al., 1998). 
 
 
 
Figure 2.11.  Map of yeast plasmid pFA6a-GFP(S65T)-HIS3MX6 (4698 bp) showing positions of F3 and R1 
sequences and HIS3MX6 marker. 
(A)  Map of the circular plasmid (http://www.snapgene.com/)  
(B)  Map of the linear plasmid.  
Plasmid map shows the HIS3MX6 module, a yeast heterologous HIS3 marker (corresponding to S. 
cerevisiae HIS3 gene), ADH1 terminator and F3 and R1 sequences used as 3’ ends of hybrid primers to 
amplify the CDC13-C-terminus deletion cassette without adding a C-terminal GFP tag. 
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The expected PCR product with 40 nucleotide gene-specific hybrid primers with the GFP tag 
has been reported to be 2.348 kb (Longtine et al., 1998).  However, considering the size of the 
GFP fragment ~710 bp or 713 bp (Chalfie et al., 1994) the size of the PCR amplicon (deletion 
cassette) for CTΔ was estimated to be ~1.680 kb without the GFP tag. 
 
As shown in Figure 2.12, the PCR-amplified marker cassette HIS3MX6 will replace 1389 nt of 
the ORF of cdc13-1 (from 1387 to 2775 nt) in homologous recombinants resulting in cdc13-1 
CTΔ::ADH1-HIS3MX6 construct. 
 
 
 
Figure 2.12.  Diagrammatic representation of cdc13-1 C-terminus truncation (CTΔ) using HIS3MX6 
deletion cassette of modulating plasmid pFA6a-GFP(S65T)-HIS3MX6).  
 
2.3.2.9 PCR amplification for transforming modules 
To amplify the CDC13 full gene deletion, N-terminus and C-terminus truncation cassettes, yeast 
plasmids pDL501, pDL515/516 and pDL504 DNA were used as PCR templates with forward 
and reverse primers (Table 2.3).  Plasmid DNA were diluted 10 times to a final concentration of 
~0.050 µg/µl in TE buffer or water and used as a template in PCR reaction (~100 ng).  The 
reaction mixture contained 0.5 µl of each forward and reverse hybrid primer from 100 µM 
stocks, 25 µl 2x PCR master mixes (GoTag Green master mix, Promega #7112) and with ~100 
ng of template plasmid in a final volume of 50 µl. 
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Thermocycler programming carried out as follows: 
 
For full cdc13-1 deletion cassette with primers N-F1 (C03) and C-R3 (C08): 
 
1. 95°C for 5 min (minutes)    (Denaturing step) 
2. 94°C for 1 min      (Denaturing step) 
3. 58°C for 1 min    30 cycles (Primer annealing step) 
4. 70°C for 1 min and 20 sec    (Extension step) 
5. 30 cycles from step 2 to step 4 
6. 72°C for 10 min 
7. 4°C for ∞ 
For cdc13-1 N-terminus deletion cassette with primers FT-N1 (D09) and RT-N1 (D10): 
1. 95°C for 5 min     (Denaturing step) 
2. 94°C for 1 min      (Denaturing step) 
3. 58°C for 1 min   30 cycles (Primer annealing step) 
4. 70°C for 1 min and 30 sec    (Extension step) 
5. 30 cycles from step 2 to step 4 
6. 72°C for 10 min 
7. 4°C for ∞ 
 
For cdc13-1 C-terminus deletion cassette with primers FT-C2 (D11) and RT-C2 (D12):  
1. 95°C for 5min      (Denaturing step) 
2. 94°C for 1 min      (Denaturing step) 
3. 55°C for 1 min   30 cycles (Primer annealing step) 
4. 68°C for 1min and 40 sec    (Extension step) 
5. 30 cycles from step 2 to step 4 
6. 72°C for 10 min 
7. 4°C for ∞ 
 
The amplified fragments (5 µl) were analysed on 0.8% agarose gel to confirm the desired 
fragment size.  PCR amplification generated a HIS3-containing deletion amplicon of ~1.4 kb for 
the full gene deletion with CDC13-specific flanking guided sequences.  PCR amplicons 
generated for N-truncation with HIS3 marker and TRP1 marker were ~1.9 kb and ~1.5 kb 
respectively.  For C-truncation, the deletion amplicon with the HIS3 marker was ~1.6 kb.  These 
deletion amplicon DNAs were used to transform yeast to integrate the marker in the yeast 
genome through a recombination process resulting in full cdc13-1 gene knockout, N- and C-
terminus deletion.   
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2.3.2.10 Purification of PCR amplicons 
For yeast transformation, amplified DNA was purified as follows: 
 
2.3.2.10.1 Sodium acetate and isopropanol precipitation 
In the first attempt the PCR product from seven individual reactions was combined (~350 µl) 
and mixed with 35 µl of 3 M sodium acetate buffer (1/10 volume of combined reactions).  An 
equal volume of isopropanol was added, mixed immediately and centrifuged to precipitate the 
DNA pellet at 12,470 x g (13,000 rpm) for 25 minutes.  Isopropanol was carefully decanted and 
pellet was washed with 70% ethanol to remove salts at 12,470 x g (13,000 rpm) for 5-10 min in 
a bench top centrifuge.  The pellet was air dried and re-suspended in an appropriate volume of 
sterile water or 1x TE buffer.  Purified DNA was stored at -20°C until further use. 
 
2.3.2.10.2 DNA purification by using gel extraction method 
DNA was excised from the gel and purified following the QIAquick (#28704) protocol. 
 
2.3.2.10.3 DNA purification by phenol-chloroform method 
The amplified DNA was resolved on agarose gel.  The right size DNA band was excised and 
melted at 37
o
C in a sterile eppendorf tube.  An equal volume of phenol:chloroform:isoamyl 
alcohol mixture (25:24:1) was added to the DNA, and contents of the tube was mixed 
thoroughly by vortexing.  The turbid mixture was centrifuged at room temperature at 7,378 x g 
(10,000 rpm) for 5 minutes.  The clear upper phase was removed carefully and precipitated with 
a 1/10 volume of 3 M sodium acetate and 2.5 volume of ethanol, followed by washing in 70% 
ethanol.  The pellet of DNA was re-suspended in the required volume of sterile water or 1x TE 
buffer and used in transformation experiments. 
 
2.3.2.11 Transformation of yeast competent cells with the deletion modules  
A standard technique of lithium acetate transformation (Gietz et al., 1995) was used to 
transform yeast strains DLY 1272, 1296 and 1297 (haploid) with the purified amplified DNA 
fragments.  The strains 1296-TR and 1297-TR include the cdc13-1 mutant allele while strain 
1272 contains CDC13 gene.  However all three strains contain leucine marker (exo1::LEU).  
The transformants were initially selected on medium lacking leucine and histidine for cdc13-1 
full gene deletion or its C-terminus truncated mutants.  For the second round of selection, 
transformants were replica plated on dropout medium supplemented with tryptophan and uracil 
and without histidine and leucine nutrients for double markers selection.  For N-terminal 
deletion, the transformants were selected on dropout medium lacking leucine and tryptophan to 
detect recombinants with N-terminus truncated Cdc13-1 mutants.  The histidine/tryptophan 
positive colonies that appeared after 5-7 days of incubation at 30°C, were assumed to be the 
clones with cdc13-1 knockout/disruption after successful integration of the marker. 
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2.3.2.11.1 PCR analysis of transformants  
Putative clones were examined for the confirmation of gene disruption and integration of 
marker within genome.  Selected clones were screened using PCR approach for the deletion of 
N-or C-terminal sequence of cdc13-1 and for the presence of respective marker module. 
 
2.3.2.11.2 Diagnostic PCR for CDC13 region and marker modules 
Two set of primers were designed based on the ORF of CDC13 to confirm the N- and C-
terminal sequence of gene.  Figure 2.13 shows the position of the diagnostic primers and the 
length of the final PCR product within the coding sequence of CDC13 (between the ‘ATG’ start 
and ‘TAA’, stop codons). 
Diagnostic primers N1 and N2 [D04/D05] and C1 and C2 (D06/D11) were used to amplify 
CDC13 N-terminus (~378 bp) and C-terminus specific fragments (~276 bp) respectively to 
detect full gene knockout or its N- and C-truncation as a result of recombination (Table 2.4) and 
integration of the HIS and TRP1 markers in the yeast genome.  After confirming the cdc13-1 
gene specific sequence PCR was performed to confirm marker genes, HIS or TRP1 in positive 
transformants.  The H1 and H2 primer pair was used to amplify ~1.6 kb ADH1-HIS3MX6 
modular DNA, whereas T1 and T2 primers pairs were used to amplify1.9 kb HIS3MX6-PGAL1 
and 1.5 kb TRP1-PGAL1 modular DNA in cdc13-1 CTΔ and NTΔ constructs (Table 2.5). 
For PCR screening, single colonies were picked up from the second round of selection and 
denatured at 95°C for 15-20 minutes.  Two µl of clear supernatant was used as a template to set 
up the PCR reaction in 25 µl of reaction volume using respective forward and reverse primers.  
Amplified fragments, uncut (N- and C-terminus) and cut (N-terminus amplicon with EcoR1 
enzyme) were analysed on 2.5% agarose gel for size analysis. 
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Figure 2.13.  Diagnostic primers for the detection of CDC13 N- and C-terminus.   
The primer sequence for N- and C-terminus detection are highlighted in orange and aqua within the ORF 
sequence (1-2775) of CDC13 to amplify 378 bp and 276 bp from the N- and C-terminus respectively. 
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Table 2.4.  Diagnostic primers for N- and C-terminus detection of CDC13 gene. 
 
 
 
Table 2.5.  Diagnostic primers to detect integration of modular DNA in yeast genome. 
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2.3.2.12 DNA sequencing 
DNA sequencing was used to determine the exact sequence of nucleotides in modified DNA 
samples (PCR amplified fragments) used in this study and to identify the regions of possible 
variations and mismatches as a result of PCR amplification and homologous recombination. 
To verify the sequence of Cdc13 N- and C-terminus deletion mutants (in 24 genomic clones), 
mutated DNAs were analysed for their nucleotide sequences at the modified region between 200 
nt upstream and 200 nt downstream of CDC13 in strains 1296-TR and 1297-TR.  The DNA 
sequencing comprised genomic DNA isolation, primer designing for sequencing and PCR 
amplification of ~3 kb fragment that includes ORF sequence from N- and C-truncated cdc13-1 
clones, purification of the amplified fragment, concentration estimations through gel 
electrophoresis and spectrophotometry, and sequencing by using GATC-biotech facilities (the 
ABI Model 3730XL, machine 18127-012 Model 730). 
 
2.3.2.12.1 Designing of primers for sequencing of DNA from N- and C-truncated 
cdc13-1 mutants 
For single read sequencing four primers, F1, R1, R2 and R3 (Figure 2.14) were designed for N-
terminus truncated cdc13-1 mutants by taking into consideration the primer conditions e.g. 
melting temperature (TM, between 52°C-58°C), primer length (18-20 bp), and GC content (40-
60%) etc.  Computer programmes Primer3 (http://bioinfo.ut.ee/primer3-0.4.0/) and NCBI/ 
Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast) were used to design and 
analyse primers.  F1 is the forward primer selected from the upstream sequence of CDC13, 
while R1 is the reverse primer selected from the tryptophan marker module DNA.  The R2 
primer was selected from the C-terminus half of CDC13 ORF sequence while the R3 primer 
was from the downstream region of CDC13. 
 
Similarly, primers F1, F2, F3 and R3 (Figure 2.15) were designed to sequence C-terminus 
truncated cdc13-1 constructs.  The sequencing primers, F1 (forward) and R3 (reverse) were 
selected from upstream and downstream sequence of CDC13 ORF.  The F2 primer was from 
the N-terminus half of CDC13 gene while F3 primer was selected from the histidine marker 
module DNA.  
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Figure 2.14.  Sequencing primers for cdc13-1-N truncation. 
Sequencing primers F1, R1, R2 and R3 were used to sequence cdc13-1 NTΔ (TRP1-GAL1) ~3 kb template 
from N-terminus deletion mutants in strains 1296-TR and 1297-TR. 
 
 
 
Figure 2.15.  Sequencing primers for cdc13-1-C truncation. 
Sequencing primers F1, F2, F3 and R3 were used to sequence cdc13-1 CTΔ (His3MX6) ~3 kb template 
from C-terminus deletion mutants in strains 1296-TR and 1297-TR. 
 
 
95 
 
Primers F1, N1, N2 and R3 were used to sequence the open reading frame of cdc13-1 (Figure 
2.16) including upstream and downstream regions from survivor strains 1296-TR and 1297-TR, 
original strains used for cdc13-1 N- and C-terminus modification.  All these primers used for 
sequencing were sent in a concentration of 10 pM/µl (10 µM) in 100 µl volume to GATC-
Biotech. 
 
 
Figure 2.16.  Sequencing primers for cdc13-1. 
Sequencing primers F1, N1, N2 and R3 were used to sequence cdc13-1 containing template from strains 
1296-TR and 1297-TR. 
 
2.3.2.12.2 PCR amplification and purification of sequencing templates 
For automated sequencing, the template DNA is required to be free of impurities like proteins, 
RNA, polysaccharides and genomic DNA that might interfere in nucleotide reading.  This was 
achieved by sequencing the PCR product directly rather than cloning it first.  For PCR template 
yeast genomic DNAs were extracted following the “Yale quick method” for DNA preparation 
(Adams et al., 1998).  Un cut DNAs (1-2 µl) were analysed by agarose gels (0.7-0.8 % w/v) 
electrophoresis in 1x TBE buffer to estimate the quality and quantity of DNA.  Genomic DNA 
was diluted 1:100 for each sample to be used as a template in PCR amplification mixture. 
 
PCR was performed in 50 µl of reaction volume using 1 unit of Q5 enzyme (0.5 µl), Q5 reaction 
buffer (10 µl of 5x enhancer and reaction buffer), 200 µM of dNTPs (1 µl) and 0.5 µM of 
forward [F1 (22 nt’s) 5’ACATGCAGCCTTGATTAACGTG3’] and reverse [R3 (22 nt’s) 
5’GGTCTTCCTTCCTTCTTGATGC3’] primers with 2 µl of diluted template DNA.  The 
resulting ~3 kb amplicon (Figure 2.17) consisted of either cdc13-1 in the case of survivor 
1296/1297-TR or N- and C-truncated cdc13-1 with a gene disrupting modular marker in 
truncated mutants.  The following thermo cycling conditions were used for amplifying the 
desired PCR product. 
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PCR conditions: 
1. 98° C for 50 sec     (Initial Denaturation) 
2. 98° C for 10 sec     (Denaturation) 
3. 60° C for 30 sec   32 cycles (Primer annealing) 
4. 72° C for 90 sec     (Extension, 20 sec to 1 min/kb) 
5. 32 cycles from steps 2 to step 4 
6. 72° C for 2 min     (Final Extension) 
 
 
 
Figure 2.17.  PCR to generate template for sequencing cdc13-1 mutants. 
Primers F1 and R3 were used to amplify ~3 kb template containing either fullgene or, N- /C-terminus 
deleted version of cdc13-1 from strains 1296-TR and 1297-TR. 
 
Following PCR amplification, agarose gel electrophoresis (0.7% agarose) using 1x TBE buffer 
was performed to confirm the presence of the desired fragments and also for an estimation of 
qualitative concentration.  More precisely, the concentration of purified amplicons was 
estimated by spectrophotometer, Nanodrop 2000. 
 
2.3.2.12.3 DNA quantification 
DNA samples were prepared as per the “GATC” DNA sequencing facility's recommendation 
for purity and concentration.  Amplicons were purified by the Promega’s spin columns method 
by following the user manual and by phenol-chloroform method.  In phenol/chloroform 
extraction PCR-amplified 3 kb fragments were cleaned up of unwanted PCR products by the 
phenol/chloroform mixture.  An equal volume of amplified products was extracted once with 
phenol/chloroform/isoamyl alcohol (25:24:1) mixture followed by chloroform/isoamyl alcohol 
(24:1) extraction.  Purified DNA was precipitated with ethanol after addition of 1/10 volume of 
3 M potassium acetate buffer followed by washing with 70% ethanol to remove salts.  Purified 
DNA was eluted in sterile water.  DNA concentration and purity of the final purified PCR 
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products was calculated by both gel electrophoresis (see section 2.4.2.5) and spectrophotometric 
analysis at 260 and 280 nm in 1 µl volume using the Nanodrop 2000 ).  For DNA quantitation 
by gel electrophoresis the known volume of purified DNA were run along with known masses 
of quantitative marker.  Using ladder bands as a reference the intensity of band of interest was 
compared to reference standard that was similar to band in question and calculated after 
correction in for the difference in volume.  Typical DNA concentrations were estimated to be 
between 15 and 42 ng/μl.  All 26 samples (50 µl for each mutant) were prepared in similar 
manner and sequenced in GATC-Biotech (platform Sanger ABI 3730xl). 
 
2.3.2.12.4 Sequencing data analysis from text data and chromatograms 
Purified amplicons (10-50 ng) and 10 pM/µl of each primer were sent to the GATC-Biotech 
sequencing service.  The Applied Biosystems 3730xl DNA analyser was used for automated 
sequencing.  DNA sequencing data was evaluated by the Phred20 system using the Basecaller 
KB 1.4.1.8.  Sequencing results (electronic files) were obtained in the form of text files 
(nucleotide sequences) and chromatograms.  Four chromatograms were obtained for each 
sample DNA in accordance with each of the four primers used for sequencing PCR products.  
The expected nucleotide sequences for ~3 kb PCR product containing either cdc13-1 or as a 
result of marker module integration cdc13-1 NTΔ-TRP1-GAL1 or cdc13-1 CTΔ-HIS3MX6 
were constructed using free online resources for yeast CDC13 gene 
(http://www.yeastgenome.org) and for yeast plasmids 
(https://www.snapgene.com/resources/plasmid_files/yeast_plasmids/) and were used as a 
reference sequences for the analysis of N-and C-truncated mutants’s sequenced DNA.   
 
Due to design of primers, the automated sequencing of each mutant (N- or C-truncated) resulted 
in four overlapping chromatograms and text data files (sequence data).  Using online software 
for DNA sequence analysis and alignments such as NCBI's BLAST engine 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi ), each text file was compared and aligned with the 
reference sequence (theoretical construct) to map fragments and to find any mismatches.  
Multiple nucleotide sequence alignment was conducted using online tool MUSCLE (MUltiple 
Sequence Comparison by Log-Expectation; http://www.ebi.ac.uk/Tools/msa/muscle/).  All 
mismatches, especially possible errors near the end and beginning of each run were manually 
double-checked and further verified against the sequence chromatogram of that text data file.  
The position of all mismatches or mutations, i.e., insertion, deletion or point mutation were 
mapped on the related construct sequence and determined for each of 24 mutants and also for 
cdc13-1 for the original strains used for N- and C-truncation.  Finally, the coding sequence of 
each construct was analysed for the amino acid sequence through translation by using online 
resources (http://bio.biomedicine.gu.se/edu/translat.html) and any mutations found in the 
protein sequence were documented. 
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2.3.2.13 Total DNA isolation of yeast 
“Yale quick method” was adopted for the extraction of total DNA (Adams et al., 1998) from S. 
cerevisiae strains.  Different strains of S. cerevisiae including wild type, cdc13-1 N- and C-
truncated mutants and CDC13 and STN1 single and double deletion mutants were grown on 
YEPD agar media at 23°C, 30°C and 37°C for three days.  Two independent mutants of each 
genotype were used.  A loop-full of cells was collected for each sample and transferred in 2 ml 
eppendorf tubes.  Cells were re-suspended in 250 μl of lysis buffer A [containing 0.1 M EDTA 
(pH 7.5) and 14 mM β-mercaptoethanol and ~1 mg/ml of zymolyase].  The resulting cell 
suspension was incubated at 37°C with intermittent vortex mixing to facilitate cell wall 
digestion and rendering the cells to spheroplasts.  After incubation of approximately 45-60 
minutes, 100 μl of buffer B [containing 0.25 M EDTA (pH 8.5), 0.5 M Tris base and 2.5% (w/v) 
SDS] was added to each tube.  Cells were mixed by inversion and the mixture was incubated 
further at 65°C for 30 minutes for lysis.  Following the lysis, 100 μl of neutralising buffer (5 M 
potassium acetate) was added to each sample.  After quick mixing by inversion, cell lysates 
were incubated on ice for 30 minutes to precipitate the denatured proteins.  Precipitated cell 
debris was collected by spinning tubes at 16,162 x g (14,800 rpm) for at least 20 minutes.  The 
supernatant was transferred to new tubes containing 720 μl of 100% ethanol and mixed by 
inversion.  The precipitated DNA was spun out by centrifugation at maximum speed for 5 
minutes.  Supernatant was discarded by decanting tubes thoroughly and un-dried DNA pellets 
were mixed with 200 μl of TE buffer (containing 100 mM Tris-HCl pH 7.5 and 10 mM EDTA) 
and 1 mg/ml of RNAase A.  DNA was re-suspended slowly by incubating tubes at 37°C for 35 
minutes with occasional vortex mixing.  Total DNA was re-precipitated with 200 μl of 
isopropanol through bench top centrifugation for 10 minutes at maximum speed.  The 
supernatant was discarded and DNA pellets were washed with 150 μl of 70 % ethanol to remove 
salts through centrifugation.  Finally, DNA pellets were air-dried and dissolved in an 
appropriate volume of TE buffer (50-100 µl) by incubating the tube at 37°C followed by 4°C 
incubation o/n.  For each sample, 2 µl of DNA (mixed with 2 µl of 5x DNA dye and 6 µl of 1x 
TE buffer) was examined on 0.7% agarose gel to roughly estimate the quantity and quality of 
DNA.  The resulting preparation was diluted to a desired concentration, or used directly for 
downstream applications such as PCR reactions and for Xho1 digestion for Southern blot 
hybridisation analysis. 
 
2.3.2.14 Southern blot hybridisation analysis of telomeric DNA 
Southern blot hybridisation was performed to find if there are any differences in telomeric DNA 
patterns and telomere length in the presence or absence of essential telomere capping proteins 
Cdc13 and Stn1.  Southern blot hybridisation analysis comprised the digestion of genomic 
DNA, its separation on the gel, transfer onto membrane and finally detection of terminal 
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restriction fragments of telomeric DNA by an enzyme labelled probe hybridising with Y’+TG 
telomeric regions.  This probe was used to hybridise and detect telomere length patterns. 
 
2.3.2.14.1 Digestion of total DNA and agarose gel resolution 
Total DNA extracted from different yeast cells was digested with the Xho1 enzyme using 1 µl 
(20 U) of restriction enzyme, 2.5 µl of 10x reaction buffer and 0.25 µl of 100x BSA in 25 µl of 
reaction volume at 37°C overnight (16-18 hrs).  The digested DNA (8-12 µl with 1x DNA dye) 
was resolved by electrophoresis on 0.8 % agarose gel at low voltage (40 volts) overnight in 1x 
TBE buffer containing 0.5 µg/ml ethidium bromide in gel.  The gel with well-separated DNA 
restriction fragments was photographed and further processed for blotting DNA fragments on 
Hybond-N
+
 positively charged nylon membrane. 
 
2.3.2.14.2 Blotting of separated DNA fragments onto membrane 
Acid depurination: The agarose gel containing resolved DNA fragments was rinsed briefly in 
deionised water.  The gel was soaked three times for 10 minutes in diluted acid (0.25 M HCl 
solution) with gentle shaking.  The acid treatment depurinates the DNA resulting in the partial 
dehydrolysis of the DNA.  The covalent bond between a purine base and deoxyribose sugar in 
DNA is more sensitive to HCl than the bond between sugar and pyrimidine base, the treatment 
of gel with acid will remove purines from DNA to make transfer of large pieces of DNA easy.  
At the end of acid treatment the fragile gel was rinsed quickly and carefully in deionised water. 
 
Alkali denaturation: The DNA in gel was denatured further by soaking the gel twice for 20 
minutes in alkaline solution containing 1.5 M NaCl and 0.5 M NaOH.  The alkali treatment 
rendered DNA single stranded to facilitate its binding with the membrane and eventually with 
the complementary probe sequence.  The gel was rinsed again briefly in deionised water. 
 
Neutralisation: Finally, the gel was soaked twice for 20 minutes in 1 M ammonium acetate 
(NH4CH3CO2) solution to neutralise DNA.  The size of the gel was measured.  Two pieces of 3 
MM Whatman paper and one piece of Hybond N
+
 membrane were cut to the size of the gel.  
The membrane was labelled on one side for orientation and soaked in NH4CH3CO2 solution.  
One piece of the 3 MM paper was also soaked in NH4CH3CO2 solution.  Figure 2.18 depicts the 
setup for DNA transfer from agarose gel to the membrane over a weekend (one to two 
overnights).  After DNA transfer, this set up was disassembled, and the side of membrane in 
contact with DNA was marked.  The membrane with blotted DNA was washed briefly with 2x 
SSC buffer.  The wet membrane was exposed to the UV cross-linker (with DNA side towards 
UV) to bind DNA permanently onto membrane.  The membrane was stored at 4°C until 
hybridisation. 
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Figure 2.18.  Southern blot setup for the transfer of DNA from gel to Hybond N
+
 membrane. 
 
2.3.2.14.3 Preparation of the labelled probe 
The plasmid 987 that contains Y’+TG fragment of ~1 kb was kindly donated by Professor 
David Lydall from the University of Newcastle.  Plasmid DNA (2 µl) was used for 
transformation of E. coli (K-12 strain NM522) competent cells.  Ampicillin-resistant colonies 
were selected on nutrient agar medium with 100 µg/ml of ampicillin.  The plasmid DNA was 
extracted from ~16 hours grown culture of E. coli with a QIAgen kit following the 
manufacturer’s instructions and was re-suspended in 200 µl of sterile 1x TE buffer (10 mm Tris-
Cl, pH 8.0; 1 mM EDTA).  The purified DNA was digested at 37°C overnight with restriction 
enzymes BamHI and XhoI to release the 1 kb Y’+TG fragment.  The digestion was performed in 
165 µl of total reaction volume with 140 µl plasmid DNA, 3 µl (60 units) each of XhoI and 
BamHI enzymes with 16.5 µl of 10x buffer and 1.5 µl of 100x BSA.  The digested DNA was 
resolved on 0.8% agarose gel.  The fragment of ~1 kb was excised from the gel and the DNA 
was extracted using QIAgen kit (#28704) by following the user manual. 
 
The approximate concentration of purified fragment was estimated to be ~10-15 ng/µl.  The 
amount of the probe DNA required for hybridisation was estimated according to the size of the 
filter (equivalent to 0.125 ml/cm
2 
to 0.25 ml/cm
2
).  The DNA was labelled with the Amersham 
Gene Images AlkPhos direct labelling and detection system with CDP-star (RPN 3690, GE 
Healthcare) with the thermostable alkaline phosphatase enzyme.  The DNA was denatured for 
10 minutes in a boiling water bath.  Denatured probe DNA was cooled immediately on ice for 
10-15 minutes and centrifuged briefly to collect the contents at the bottom of the tube.  20 µl of 
reaction buffer, 4 µl of labelling reagent and 20 µl of the diluted cross linker were added to 20 
µl of denatured DNA (~200 ng).  The contents of the tube were mixed thoroughly and spun to 
bring the contents to the bottom.  The reaction was incubated at 37°C for 30 minutes.  The 
freshly labelled probe was kept on ice and used within half an hour. 
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2.3.2.14.4 Hybridisation and detection of probed DNA 
The hybridisation buffer (Amersham’s AlkPhos direct labelling and detection system) was 
prepared with the addition of salt, NaCl and blocking reagent as recommended in the manual.  
The required volume of pre-hybridisation/hybridisation buffer was preheated to 56°C.  The 
membrane with DNA was placed inside the hybridisation tube with pre-warmed buffer and pre-
hybridised for 15-30 minutes in the hybridisation oven.  The labelled Y’+TG telomeric probe 
was added in the tube at a concentration of ~5-10 ng/ml of buffer and left overnight at 56°C in 
the hybridisation oven.  Next morning, the membrane was washed with the primary wash buffer 
[2 M urea, 0.1% (w/v) SDS, 50 mM sodium phosphate buffer pH 7, 150 mM NaCl, 1 mM 
MgCl2 and 0.2% (w/v) blocking reagent] twice at 55°C for 10 minutes, with excess of buffer 
and gentle shaking followed by a secondary wash with 1x wash buffer (0.05 M Tris base and 
0.1 M NaCl, pH 10) twice for 5 minutes at room temperature to remove excess non-specific 
bound probe. 
 
Chemiluminescent detection was carried out with CDP-star solution.  Excess of the wash buffer 
was drained without drying the membrane.  Detection reagent (~50 µl/ml) was pipetted onto the 
blot and left for 5 minutes.  Excess of detection reagent was drained off by touching the blot 
onto a non-absorbent surface.  The blot with DNA side up (wrapped in saran wrap) was placed 
in the film cassettes, exposed and developed on a sheet of autoradiograph film following the 
user manual for an appropriate length of time (15 minutes, 3 hrs, one night and 3 days). 
 
2.3.2.15 Statistical analysis 
Colony count data were statistically analysed using Microsoft office Excel 2010, version, 
14.0.7151 5001 (32 bit), part of Microsoft office professional plus 2010 (Microsoft Corporation, 
USA) to calculate mean, standard deviation (SD), standard error of the mean (SEM) and 
viability % etc.  One way ANOVA was applied to test the significance of difference between 
control and test groups.  The resulting values were considered significant if the p-values were 
below 0.05.  Data were presented as mean SEM from three independent experiments unless 
stated otherwise. 
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Chapter 3 
Cdc13 disruption in yeast Saccharomyces 
cerevisiae 
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3.1. Introduction 
In yeast, the availability of full deletion collections (comprising thousands of individual gene 
deletions) and complete genome sequencing (Winzeler et al., 1999, Kastenmayer et al., 2006) 
has made it possible to detect the unknown functions of genes in cellular processes.  Out of 
numerous approaches available nowadays, gene disruption analysis using modular plasmids, 
PCR techniques and yeast transformation are economical, time saving and easy studies to 
conduct as compared to the traditional in vitro creation of constructs through multiple cloning 
steps (Wach et al., 1997, Longtine et al., 1998).  The elaborate one step PCR technique 
followed by guided homologous recombination directly modifies targeted DNA within the 
genome with the added advantage of a genetically linked auxotrophic marker for an easy 
selection of transformants.  This approach is utilised not only to identify the role of a particular 
gene, but also to investigate the significance of truncated and mutated genes in cellular 
processes. 
 
Cdc13 is a multifunctional protein that plays key roles in cellular processes, mainly telomere 
replication, length-maintenance, end-protection and telomerase regulation (Qi and Zakian, 2000, 
Sun et al., 2011).  Cdc13 binds the single-stranded telomere DNA at TG1-3 repeats (~300-350 
repeats in S. cerevisiae) of telomere G-tails (Nugent et al., 1996).  Cdc13 plays an important 
role to prevent the chromosome ends from nuclease degradation and to elongate the DNA after 
its replication by recruiting telomerase enzyme to telomere.  For its capping function, Cdc13 
physically binds to long single-stranded telomere ends during late S to G2 phases of the cell 
cycle.  There are several lines of evidence that Cdc13 interacts with its regulatory partners Stn1 
and Ten1 and collectively forms a CST protective cap (Wellinger, 2009).  This assembly 
provides a loading platform for other proteins and telomerase to regulate telomere length and 
genomic stability. 
 
For its protective activity, Cdc13p interacts with various other capping proteins through its N- 
and C-terminal regions, conferring their crucial roles in telomere protection and length 
regulation (Hsu et al., 2004).  The Cdc13 N-terminus is composed of the telomerase activation 
domain, required for telomerase recruitment.  Furthermore, Cdc13 protein dimerisation, 
required to bind the telomere, is also facilitated through its N-terminus.  Conversely, the C-
terminus supports the Stn1-Ten1 interaction and consists of a DNA binding domain that is 
utilised to bind single-stranded telomeres with high affinity and specificity to cap the 
chromosome throughout the cell cycle (Mason and Skordalakes, 2010).  Lack of Cdc13 causes 
single-stranded DNA accumulation at the telomere that leads to cell cycle arrest and cell death 
(Nugent et al., 1996). 
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In the first part of the Cdc13 disruption studies, a one-step PCR-mediated technique was 
employed to construct a cdc13-1 full gene deletion module through genetic transformation and 
recombination to enable its functional analysis.  In the second part, partial cdc13-1 deletion 
mutants were generated with cdc13-1 N- and C-terminus truncations to provide molecular 
dissection of their function. 
 
3.2. Aims and objectives 
The main aim of this part of the study was to construct cdc13-1 full ORF deletion and partial 
deletion mutants (Cdc13 with N-and C-terminus truncations) in temperature-resistant survivors 
of cdc13-1 exo1Δ mutants.  This aim included the following objectives: 
 
 To identify appropriate yeast plasmids and design hybrid primers for CDC13 full gene 
deletion, CDC13 N- or C-half deletion cassettes. 
 To integrate the deletion cassettes into genome of cdc13-1 exo1Δ mutants by genetic 
transformation. 
 To confirm cdc13-1 knock-out by performing diagnostic PCR. 
 To perform genetic crosses to obtain new combinations of deletion.  
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3.3. Results 
The first part of the results is devoted to CDC13 full gene deletion.  In the next sections, N- and 
C-terminus truncations are described in detail.   
 
3.3.1. CDC13 full gene deletion 
CDC13 is located at chromosome IV.  The open reading frame of CDC13 gene consists of 1-
2775 nucleotides (nt) that encodes a protein of 924 amino acids with a molecular weight of 
~104895.2 Da (Wu and Zakian, 2011).  A single nucleotide change in the coding sequence 
results in mutant cdc13-1 that is sensitive to enhanced temperature and shows phenotypic 
growth retardation.  The full deletion of CDC13 results in immediate cell cycle arrest and cell 
death (Weinert and Hartwell, 1993).  The mutant cdc13-1 cannot grow at higher temperatures.  
Nevertheless cdc13-1 conditional mutants in the absence of EXO1 gene form rare survivors able 
to grow at high temperatures (up to 36°C).  It was decided to delete the full coding sequence of 
cdc13-1 in exo1Δ mutants (Figure 3.1). 
 
 
Figure 3.1.  Deletion of cdc13-1 full ORF (1-2775 bp). 
 
A simple scheme describing the cdc13-1 disruption module is shown in Figure 3.2 and Figure 
3.3.  The process of disruption includes the choice of a yeast plasmid, chimeric primer design 
based on the selected plasmid and target gene sequences (Figure 3.2A), PCR amplification of 
the marker module with a flanking sequence of the target gene (deleting sequence for 
homologous recombination, Figure 3.2B), transformation of the host yeast strain and 
confirmation of transformants on the basis of marker integration and diagnostic PCR for the 
gene sequence (Figure 3.2C). 
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Figure 3.2.  Diagrammatic scheme for transformation of S. cerevisiae strain with the PCR product 
carrying HIS3 disruption module with guided sequences to delete cdc13-1 (adapted from (Wach et al., 
1997). 
(A) Selection of hybrid primers for deletion of cdc13-1 ORF specific sequence.   
(B) Synthesis of disruption cassettes by PCR using HIS3MX6 marker DNA (Longtine et al., 1998) as a 
template. 
(C) The identification of replaced ORF of cdc13-1 with diagnostic  primers from the middle of the cdc13-1  
gene spanning between 953 and 1330 nucleotides whereas nucleotide ‘C’ at position 1111 has been 
replaced with ‘T’ that creates an EcoRI site in the cdc13-1 mutant strain. 
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Figure 3.3.  In silico manipulation of CDC13 ORF sequence at specific nucleotide positions.  Arrow 
showing the position of flanking sequences homologous to target sequences. 
(A) CDC13 ORF with 1-2775 bp sequence, divided in two halves (N- and C-terminus). 
(B) CDC13, full gene deletion (7-2775 bp). 
(C) CDC13, N-terminus deletion (1-1389 bp). 
(D) CDC13, C-terminus deletion (1387-2775 bp). 
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3.3.1.1. Plasmid DNA extraction and DNA size evaluation via digestion with 
restriction enzymes 
For CDC13 full gene deletion, plasmid pFA6a (with the histidine marker gene) was used 
(Longtine et al., 1998).  The plasmid DNA was transformed in E. coli using a standard protocol 
and resulting transformants were selected on nutrient agar plates with 100 µg/ml of ampicillin 
as it has been described for E. coli transformation.  Plasmid DNA was extracted using a QIAgen 
kit by following the manufacturer‘s instruction manual. 
 
It was decided to conduct CDC13 full gene (ORF 2775 bp) deletion in the yeast strain DLY 
1296 (Table 2.1) in temperature resistant/survivors (TR) and to compare the transformation 
efficiency of 1296-ts (temperature sensitive) cells with its TR survivors.  The method for “TR 
and ts cell preparation and genotype selection for auxotrophies requirement” has already been 
mentioned in the Yeast Methods section.   
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Agarose (0.8%) gel analysis of plasmid (pFA6a-HIS3MX6; pDL501) DNA extracted from 
transformed E. coli NM522 from four independent preparations presents purified uncut DNA, 
linearised plasmid and double-digested plasmid (Figure 3.4).  Purified DNA exhibits multimeric 
forms of plasmid with supercoiled DNA at the front (owing to its smallest size) being ~3 and 4 
kb in size (Figure 3.4, lanes 1-4).  The single digestion with restriction enzyme EcoRI (unique 
cut at position 1360 on plasmid map) resulted in a linearised DNA fragment with a size of 
approximately ~4 kb (3.782 kb; Figures 3.8 and 3.9A, lanes 5, 6, 7, 8).  Conversely, double 
enzyme digestion with EcoRI and BamH1 resulted in two fragments, approximately 2.465 kb 
and 1.317 kb in size, corresponding to their sites on the DNA map at positions 1360 and 43 
respectively (Figures 3.8 and 3.9A, lanes 9-12).  In silico analysis of plasmid pFA6a-HIS3MX6 
DNA with EcoRI and BamH1 also confirms the sizes of the linear DNA and fragments 
generated through double digestion of plasmid on a simulative gel (Figure 3.5B).  However, the 
concentration of plasmid DNA varied in all four preparations that is consistent with uncut and 
digested DNA samples.  The purified plasmid DNA was diluted in a ratio of 1:5 and 1:10 and 
used as a DNA template to produce PCR amplified modules for CDC13 gene disruption in 
transformation experiments. 
 
 
Figure 3.4.  Plasmid (pFA6a-HIS3MX6) DNA isolation and size estimation through restriction enzyme 
analysis.  Agarose gel electrophoresis of digested plasmid DNA was carried in 1 x TBE buffer.  Uncut 
(3 µl) and digested DNA (5 µl) were analysed on 0.8% (w/v) agarose gel with ethidium bromide dye 
at a concentration of 0.25 µg /ml. 
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Figure 3.5.  In silico size analysis of yeast plasmids pFA6a-HIS3MX6 (pDL501). 
(A) Circular map of plasmid DNA showing EcoR1 and BamH1 sites utilised for digestion with restriction 
enzymes.  
(B) Simulative gel showing fragments after single(lanes 6-8) and double digestion (lanes 9-11) with the 
above enzymes (www.snapgene.com/resources) 
 
3.3.1.2. PCR amplification for CDC13 full gene (ORF) deletion cassettes 
The plasmid pFA6a-HIS3MX6 contains a histidine marker module that was used as a PCR 
template to generate amplified transforming fragments of 1403 bp for CDC13 gene 
manipulation.  This selectable marker module contains the Shizosaccharomyces pombe his5+ 
gene (Wach et al., 1997), which complements S. cerevisiae his3 mutations, with TEF strong 
promoter and terminator sequences from a filamentous fungus Ashbya gossypii (A. gossypii). 
A 
B 
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After evaluating the yield, purity and size of yeast plasmid (pFA6a-HIS3MX6), purified DNA 
was diluted (1:10) and used as a template to produce a PCR-amplified linear module for 
CDC13/cdc13-1 deletion using hybrid primers N-F1 (forward) and C-R3 (reverse) in a 50 µl 
reaction volume.  The 0.9% agarose gel analysis revealed the presence of the desired amplified 
fragments in all seven individual reactions analysed through electrophoresis (Figure 3.6, lanes 
3-9).  The size of the amplified fragments was estimated to be ~ 1.403 kb as expected.  The 
amplified products were pooled from individual reactions (50 µl/reaction) and purified using 
either a QIAquick PCR purification kit or the phenol chloroform extraction method or absolute 
ethanol precipitation with 3 M potassium acetate buffer followed by washing with 70% ethanol. 
 
 
 
Figure 3.6.  PCR amplification for CDC13 full gene deletion amplicon using the pFA6a-HIS3MX6 marker 
module.  PCR was performed in a 50 µl reaction volume with forward primer (N-F1; 5’C TCT TTG GAT 
ACG AAT GAC CGT GGA AAC TAT CGC CTA AAA ATG GAT cggatccccgggttaattaa 3’ and reverse primers (C-
R3; 5’GCA ATT TGG CAC CGC CGC GTT GGG CTG CGC GGA TCA TGT C gaattcgagctcgtttaaac 3’) resulting in 
a ~1.403 kb gene disruption module fragment.  Lanes 1 and 2 represent non-template negative controls 
without DNA.  Lanes 3-9 present PCR amplicons from independent reactions. All samples were checked 
in a 5 µl volume.  Lane ‘M1’ represents 1 kb DNA marker (Invitrogen), loaded as 500 ng per 10 µl 
volume. 
 
3.3.1.2.1. Estimation of concentration of purified amplicon 
The purified DNA was estimated to be ~100 ng per 3 µl as compared to the quantitative marker 
on 0.8% agarose gel (Figure 3.7, lanes 1-3).  This precipitated, amplified DNA was used to 
transform temperature-resistant survivo rs of yeast strains DLY 1296 and DLY 2605 possessing 
cdc13-1 mutation. 
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Figure 3.7.  Estimation of concentration of purified DNA. 
Amplified DNA was precipitated with 1/10 volume of 3 M potassium acetate buffer and ethanol, and 
washed in 70% ethanol.  M1 and M2 represent DNA ladders; 1kb DNA marker (Invitrogen) and 100 bp 
DNA markers (NEB), were loaded 10 and 5 µl each per lane respectively.  3 µl of purified DNA was 
analysed by gel electrophoresis. 
 
3.3.1.3. Generation and analysis of temperature-resistant (TR) survivors 
Temperature-resistant survivors were selected as rare colonies produced at high temperature 
(36°C) by three temperature-sensitive (ts) cdc13-1 mutant strains DLY 2605, DLY 1296 and 
DLY 1108 after 5-7 days of growth on YEPD medium followed by 2-3 passages at 30°C.  To 
test the possibility of the emergence of spontaneous revertants due to gene conversion or 
recombination, ts mutants of cdc13-1; DLY 2605, DLY 1296 and DLY 1108 and their TR 
survivors were initially examined for nutritional markers by replica plating, and finally 
genotyped for the presence of mutation cdc13-1 by using PCR.  Amplified products were 
further investigated for the presence of cdc13-1 or CDC13 by restriction enzyme analysis. 
 
3.3.1.3.1. Confirmation of genetic markers in survivors by replica plating 
Genetic marker analysis by replica plating at 23°C and 30°C (with four colonies A-D for each 
strain) on four dropout media each lacking one of the essential components (-H, -L, -T, -U) 
confirmed the presence of leucine markers in survivor cells from strains 2605-TR and 1296-TR 
(Figure 3.8).  Strains 1296-ts (3) and TR (6 and 7), 2605-TR (8 and 9) showed growth only on 
YEPD (replicas 1 and 2) and dropout media lacking amino acid leucine (replicas 4) at 23°C 
indicating the presence of the LEU2 marker gene for de novo synthesis of l-leucine.  
Conversely, control strains 1108-ts (4) and 1108-TR (5) grew only on rich nutrient medium 
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YEPD (replica 1 and 2 at 23°C).  Lack of growth of ts or TR cells of strain 1180 (control) at 
23°C and 36°C respectively on any of the dropout media corroborated the absence of the above 
four auxotrophic markers in this strain. 
 
Figure 3.8.  Auxotrophic marker analysis through replica plating on YEPD and dropout media at (23°C) 
and (36°C). 
Experimental strains from ts mutants of cdc13-1; DLY 1296-ts (3), DLY 1108-ts (4) and DLY 2605-ts and 
their TR survivors 1296-TR (6 and 7) and 2605-TR (8 and 9) were grown on YEPD.  For each strain, four 
random colonies A-D with approximately same sizes were streaked on a master plate (YEPD) as distinct 
short lines and were cultivated at 23°C for ~24-36 hours to attain less growth of cultures.  These initial 
cultures were replica plated on two sets of nutrient requiring dropout media (replica 3-6 at 23°C and 2-5 
at 36°C) each lacking one essential metabolic component (-H, -L, -T or -U and on YEPD medium (replica 1 
and 2 at 23°C and replica 1 at 36°C control).  Wild type strains 640 (1), 641 (2) (WT), and cdc13-1 mutant 
strain 1108-ts (4) and TR (5) lacking four genetic markers were used as experimental controls.  Replica 
plates were grown at 23°C and 36°C for 3 days before photography.  Photographs were taken using a gel 
documentation system. 
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Strains 1296-ts (3) and 1108-ts (4) did not grow at 36°C on YEPD medium (replica 1) as 
expected exhibiting sensitivity to high temperature due to cdc13-1 mutation.  At 36°C strains 
1296-TR (6 and 7) and 2605-TR (8 and 9) showed growth only on (YEPD, replica 1) and 
dropout medium in the absence of amino acid leucine (replica 3) indicating the presence of the 
LEU2 marker gene.  Strains 640 (1) and 641 (2) (wild type) were used as controls and their 
growth on YEPD medium only indicates the absence of four genetic markers. 
 
3.3.1.3.2. Confirmation of cdc13-1 mutation in survivors by PCR 
The cdc13-1 mutation has an additional EcoRI restriction site “GAATTC” where ‘C’ is replaced 
with ‘T’ at position 1111 of the CDC13 ORF (Figure 3.9).  This EcoRI site was used to 
differentiate between CDC13 and cdc13-1 mutants by analysing cells from ts strains, 2605, 
1296 and 1108 and their TR survivors by PCR amplification using N1 and N2 primers and 
restriction enzyme analysis of amplified product. 
 
 
Figure 3.9.  PCR amplicon contains EcoRI restriction site within the ORF sequence (953-1330 
nucleotides) of cdc13-1. 
The amplified fragment between nucleotides 953 and 1330, with diagnostic primers N1 and N2 was 
subjected to EcoR1 restriction digestion that released two fragments, ~219 bp and ~159 bp with cdc13-
1, and a single, intact fragment of 378 bp in the case of wild type CDC13. 
 
Restriction analysis of PCR products verified the presence of the cdc13-1 mutation in cells from 
survivors.  Agarose gel analysis of undigested PCR amplicons revealed a single fragment of 
approximately 378 bp (Figure 3.10A) in mutant cells analysed corresponding to CDC13 ORF 
sequence from 953-1330 nucleotides.  However, as shown in Figure 3.10B, EcoRI restriction 
digestion generated two fragments of ~159 bp (ORF from nucleotides 953-1111) and ~219 bp 
(ORF from nucleotides 1112-1330) confirming the presence of cdc13-1 in the mutant strain 
2605-TR (lanes 3 and 4), strain 1296-TR and -ts (lanes 5, 6 and 8) and strain 1108-TR and -ts 
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(lanes 7 and 9).  The single intact fragment of ~378 bp corroborates CDC13 in wild type strains 
640 and 641 used as controls (Figure 3.10B (lanes 10 and 11). 
After confirmation of cdc13-1 mutation, the survivors from strains 1296 and 2605 were utilised 
in transformation experiments for CDC13 knockout. 
 
 
 
Figure 3.10.  Confirmation of survivors: verification of genotypical mutation cdc13-1 by PCR 
amplification and EcoRI restriction analysis of amplified fragment in ts strains and their TR survivors. 
 
Lanes M1: 1kb ladder, 500 ng (Invitrogen); 1-2:-ve control [Non template control (NTC) without cells or 
DNA]; 3-4: Strain 2605-TR (cdc13-1 mutant cultivated at 36°C); 5-6: Strain 1296-TR (cdc13-1 mutant 
cultivated at 36°C); 7: Strain 1108-TR (cdc13-1 mutant cultivated at 36°C); 8: Strain 1296-ts (cdc13-1 
mutant cultivated at 23°C); 9: Strain 1108-ts (cdc13-1 mutant cultivated at 23°C); 10: Strain 640 WT 
(control, cultivated at 23°C); 11: Strain 641 WT (control, cultivated at 23°C); M2: 100 bp ladder, 500 ng 
(NEB). 
Temperature-sensitive (ts) strains and their survivors (TR) were cultivated at 23°C and 36°C respectively 
for 2-3 days.  The cells from freshly grown cultures were denatured at 95°C for 10 minutes.  PCR was 
carried out in a 25 µl reaction volume with primers N1 and N2. 
(A) Agarose gel analysis of uncut PCR amplicons (5µl) from individual reactions. 
Gel electrophoresis presents a distinct fragment of ~378 bp (CDC13/cdc13-1) from ts and TR cells of 
strains 1108, 1296 and 2605 which were digested and analysed on 2% agarose gel for the verification of 
cdc13-1 mutation. 
(B) 
(A) 
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(B) Electrophoretic analysis of EcoRI digested PCR products to verify the genotypic mutation cdc13-1 in ts 
and TR survivors.  Gel electrophoresis of EcoRI digested PCR product showed a single fragment of ~378 
bp in strains 640 and 641 (WT) (lanes 10 and 11) with respect to nucleotides sequenced from 953-1330 
of the ORF while two fragments of ~159 bp (from nucleotides 953-1111) and ~219 bp (from nucleotides 
1112-1330) were released with strains 1108-TR and -ts (lanes 7 and 9), 1296-TR and -ts (lanes 5, 6 and 8) 
and strain 2605-TR (lanes 3 and 4) after EcoRI digestion.  Digestion was performed in 30 µl of total 
reaction with 15 µl of amplified product at 37°C for 2 hours.  Digested products in 15 µl was analysed on 
2% agarose gel. 
 
3.3.1.4. Transformation of cdc13-1 survivors with CDC13 disruption module 
In order to transform cdc13-1 survivors (strains 1296 and 2605) ~1.3 µg of potassium acetate 
precipitated amplified module DNA was used.  Transformation of survivors was carried out 
with freshly prepared 100 µl competent cells with a viable count of ~7.6 x 10
7
 cells/ml.  As it 
has been demonstrated in Figure 3.11, the transformants were initially selected on dropout 
medium lacking histidine for strains 1296-TR (plates no. 3 and 4) and 2605-TR cells (plates no. 
7 and 8).  For positive controls, the competent cells were plated on dropout medium without 
leucine (plates no. 2 and 6), and for negative controls, cells were plated on media lacking 
histidine (plates no. 1 and 5).  Three his
+
 transformants were obtained with strain 1296-TR as 
compared to two clones with strain 2605-TR after 5-7 days of incubation at 30°C. 
Transformation efficiency (homologous recombination) was estimated to be one cell out of 
2.53x10
6
 cells for 1296-survivors and one transformant out of 3.8x10
6
 cells for 2605-survivors 
with 15 minutes incubation at 42°C (heat shock).  The colony shape in strain 1296-
transformants was rough with wavy margins as compared to circular colonies with smooth 
margins observed in strain 2605-transformants.  In the following experiment, transformation 
efficiency through homologous recombination was increased to one transformant out of 
2.14x10
5
 cells (28 his
+
 transformants) with 1.6 µg of modular DNA after 35 minutes of 
incubation at 42°C (data not shown), that was almost 12 times higher as compared to the initial 
efficiency. 
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Figure 3.11.  Transformation of cells from strains 1296-TR and 2605-TR with CDC13 PCR deletion module 
(HIS3MX6). Plates 1 and 5 with medium lacking histidine were used as negative controls for cells of 
strain 1296-TR and 2605-TR.  Plates 2 and 6 with medium lacking leucine were positive controls for cells 
of strain 1296-TR and 2605-TR.  Plates 3, 4 and 7, 8 show transformants in cells from strain 1296-TR and 
2605-TR respectively on medium lacking histidine. 
 
3.3.1.4.1. Confirmation of CDC13 knockout in his+ transformants by diagnostic PCR 
The six histidine-positive transformants were analysed by PCR for cdc13-1 deletion in strain 
1296 and 2605 survivors after a second round of selection on medium lacking histidine.  Gel 
analysis manifested a fragment of ~378 bp in positive controls only (Figure 3.12, lanes 9-12).  
However, no amplification was observed in transformants analysed (lanes 3-8) indicating 
deletion of the cdc13-1 gene by target-guided homologous recombination.  Strains 2607 and 
2608 with cdc13 deletion were used as negative controls (lanes 1 and 2). 
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Figure 3.12.  PCR screening for confirmation of cdc13-1 deletion in his3
+
 transformants of strains 1296 
and 2605. 
Lane M2: 100 bp ladder 500 ng (NEB); 1: Strain 2607 cells (CDC13Δ), negative control; 
2: Strain 2608 cells (CDC13Δ), negative control; 3-8: 1296-TR, transformant #1-#6 cells; 
9: 1296-TR cells (cdc13-1 mutant) positive control; 10: 2605-TR cells (cdc13-1 mutant) positive control; 
11: Strain 640 (wild type) cells, positive control; M1: 1kb ladder 500 ng (Invitrogen); 12: Strain 641 (wild 
type cells, positive control. 
PCR was performed in a 25 µl reaction volume with GoTaq green master mix from Promega.  Uncut PCR 
product (5µl) was analysed electrophoretically on a 1.6% agarose gel. 
 
3.3.1.5. Comparative analysis of cdc13-1 disruption efficiency in 
temperature-sensitive strain and its temperature-resistant survivors  
In this experiment, the temperature-sensitive cdc13-1 strain 1296-ts (23°C) and its temperature-
resistant survivor 1296-TR (36°C) were used for CDC13 deletion.  The competent cells were 
prepared following the standard protocol as described in the methods section.  Transformation 
was carried out using a purified PCR DNA module (~1 µg) with flanking guided 
oligonucleotide from upstream and downstream of CDC13 and freshly prepared cells (100 µl) 
with a viable count of 9.66x10
8
 cells/ml for temperature-sensitive strain 1296-ts and 8.35x10
8
 
cells/ml for its survivor 1296-TR.  Transformants (his
+
) were selected initially on dropout 
medium lacking histidine (Figure 3.13, plates no.1-2 and 5-6) followed by a second round of 
selection on dropout medium lacking both histidine and leucine (Figure 3.13, plates no. 3 and 
4).  Transformation efficiency of 1296-TR cells was estimated to be one cell out of 2.4x10
6
 cells 
with 30 minutes’ incubation at 42°C (heat shock).  Conversely, 1296-ts cells showed 
transformation efficiency (homologous recombination) of one cell out of 9.66x10
6 
cells (~four 
times less as compared to 1296-TR cells) under the same experimental conditions. 
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Transformation of 1296-TR and 1296-ts cells using the CDC13 disruption module  
 
Figure 3.13.  Transformation of cdc13-1 temperature-sensitive strain 1296-ts and its temperature-
resistant survivor with PCR-based CDC13 disruption module.  Modular DNA with guided sequences was 
purified from gel using a Qiaquick PCR purification kit.  Approximately 1 µg of DNA was used to 
transform suspension (100 µl) of competent cells.  In strain 1296-ts, 10 his
+
 transformants were 
obtained as compared to 35 transformants for the survivor (1296-TR). 
 
3.3.1.5.1. Confirmation of the histidine marker in transformants by replica plating 
The HIS
+
 putative clones obtained after transformation of cells of strain 1296-TR and -ts were 
further analysed through marker analysis and diagnostic PCR for the confirmation of cdc13-1 
deletion and the integration of the histidine marker.  Ten transformants (#1-#10) each for both 
1296-ts and its TR survivors were systematically tested for the genotypic markers by replica 
plating to confirm prototrophy for histidine and leucine markers (Figure 3.14). 
Figure 3.14A-B (streak 1) demonstrates that the parental strains 1296-ts and 1296-TR 
respectively did not grow on dropout media lacking histidine, tryptophan or uracil (replica 2, 4 
and 5) but exhibited growth on nutrient-rich medium YEPD (replica 1) and medium without 
leucine (replica 3) confirming its prototrophy (the presence of LEU2 marker gene for the de 
novo synthesis of l-leucine).  All 1296-ts and TR transformants examined contained histidine 
marker (replica 2) owing to their growth on medium without histidine.  However, further 
analysis of transformants for CDC13 gene deletion by PCR is required for the final 
confirmation of its knockout. 
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Figure 3.14.  Analysis of metabolic markers in ts and TR transformants by replica plating. 
Ten transformants from ts (1296-ts) and TR survivors (1296-TR) of strain 1296 were randomly picked for 
marker analysis.  The strains 1296-ts and 1296-TR (1) did not grow on dropout media lacking histidine, 
tryptophan or uracil (replica 2, 4 and 5, lane 1) indicating its auxotrophies for these markers but grew 
only on dropout medium lacking leucine (A and B respectively, replica 3).  All 1296-ts and -TR 
transformants (#1-#10) exhibited prototrophy to histidine and leucine markers owing to their growth on 
A 
B 
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the plate lacking these markers (A and B, replica 2 and 3).  Replica plates were grown at 23°C and 30°C 
for 3 days before photography.  Pictures were taken using a gel documentation system (Syngene). 
3.3.1.5.2. Confirmation of cdc13-1 deletion in his+ transformants by diagnostic PCR 
3.3.1.5.2.1. Agarose gel analysis of PCR products in uncut and EcoR1 digested 
amplicons 
Further analyses of clones for CDC13 gene knockout were carried out by diagnostic PCR.  Ten 
his
+ 
transformants (#1-#10) were screened by PCR for cdc13-1 deletion in strain 1296-ts and its 
survivor (1296-TR).  The PCR amplification results are shown in Figure 3.15 (A, undigested 
PCR fragments) and (B, EcoR1 digested PCR fragments) confirming cdc13-1 knockout in 
1296-TR-transformants #1-#10.  Gel analyses revealed a fragment of ~378 bp (Figure 3.15A, 
lanes 20-29) and two smaller fragments of 219 bp and 159 bp (Figure 3.15B, lanes 20-29) in all 
temperature-sensitive transformants examined (1296-ts) with varying intensity.  However, none 
of the fragments were observed in 1296-TR transformants (Figure 3.15A, lanes 10-19).  Wild 
type strains 640 and 641 (CDC13) were used as controls (lanes 5-6 respectively) along with the 
strains 1296-TR and -ts and 2605-TR cells (lanes 7-9 respectively), originally used for 
transformation. 
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Figure 3.15.  Confirmation of cdc13-1 deletion through PCR screening: analysis of uncut and 
EcoR1digested amplicons. 
Lanes M1: 1kb ladder, 500 ng (Invitrogen); 1-2: NTC-1, -ve controls; 3-4: Strain 2607 and 2608 (cdc13Δ), -
ve controls; 5-6: Strain 640 and 641 (wild type, CDC13), +ve control; 7-9: Strain 1296-TR, 1296-ts 
and2605-TR respectively (cdc13-1 mutant), +ve controls; 10-19: 1296-TR transformant #1-# 10; 20-29: 
1296-ts transformant #1-# 10; 30-31: cdc13-1 deletion clone (1296-TR) #1-#2, (control); 32: cdc13-1 
deletion clone (2605-TR) #1, (control); 33: cdc13-1 deletion clone (1296-TR) #1, (control); M2: 100 bp 
ladder (NEB). 
(A) Agarose gel electrophoresis of uncut amplicons. 
(B) Agarose gel electrophoresis of EcoR1 digested amplicons. 
Gel analysis revealed a fragment of 378 bp in all HIS
+
 ts-transformants (putative) analysed (A, lanes 20-
29). However, TR survivors-transformants did not show any fragment (A, lanes 10-19).  PCR was 
performed in a 25 µl reaction volume with GoTaq Green master mix from Promega.  PCR amplified 
uncut product (5 µl) and digest (10 µl) was analysed on 2% agarose gel.  
A 
B 
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Table 3.1 shows the comparative analysis of HIS
+ 
transformants with 1296 temperature 
sensitive strain and its temperature-resistant survivors. 
 
Table 3.1.  Comparison of cdc13-1 gene knockout, by PCR mediated homologous recombination in 
temperature-sensitive cdc13-1 strain and its temperature-resistant survivor. 
 
Strain (DLY) 1296-TR 1296-ts 
Growth temperature 30°C 23°C 
Marker module DNA 100 µl (1µg) 100 µl (1µg) 
Incubation temperature 
and time period for yeast 
transformation 
42°C for 30 minutes 42°C for 30 minutes 
Transformants obtained 35 10 
Transformation efficiency 1 out of 2.4x10
6
 
4 times > than ts cells 
1 out of 9.66x10
6
 
 
Clones tested for genetic 
makers 
Transformants #1-#10 
histidine and leucine positive 
Transformants #1-#10 
histidine and leucine positive 
Diagnostic PCR for cdc13-1 
disruption 
Transformants #1-#10; No 
amplification, 
cdc13-1 knockout in all 
clones tested 
Transformants #1-#10;  
amplification with varying 
intensity,  
cdc13-1 present in genome in 
all clones tested 
 
On the basis of these results it could be concluded that appropriate mutants were successfully 
generated using the above mentioned protocols.  Yeast cells can survive without CDC13 in 
survivor strain 1296-TR in the absence of EXO1.  Growth of these temperature-resistant 
survivors without Cdc13 indicates that CDC13 might be dispensable in temperature-resistant 
survivors. However it was not possible to disrupt cdc13-1 in temperature-sensitive cells, 
presumingly owing to the essential function of the Cdc13 protein at low temperature.  It can be 
hypothesised that at higher temperatures Cdc13 capping is not necessary for telomere function 
and that an alternative mechanism exists to maintain telomeres and ensure genomic stability.  
These results are in agreement with a recent report (Ngo and Lydall, 2010) illustrating that the 
absence of Cdc13 can allow cell division with the inactivation of three DNA damage proteins 
(Sgs1, Exo1 and Rad9).  It would be interesting, in future studies, to investigate the mechanism 
that exists in temperature-resistant cells that maintain telomeres in the absence of Cdc13 and 
makes cell survival possible.   
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3.4. cdc13-1 N- and C-terminus deletion 
3.4.1. cdc13-1 N-terminal deletion (NTΔ) 
The sequence for open reading frame of CDC13 or cdc13-1 (1-2775) was divided into two 
halves, termed N- and C-terminus (see part 1 of this chapter; Figure 3.3).  The first half, or N-
terminus, consists of 1386 nt with respect to the N-terminus of Cdc13, and the second half from 
the C-terminus half of the protein composed of 1389 nt (Figure 3.3, A, C and D).  CDC13 
modification for N- and C-terminus deletion was carried out in cdc13-1 EXO1 deletion (strains 
1296-TR and 1297-TR) and CDC13 EXO1 deletion (1272) mutants. 
The PCR-based homologous recombination strategy that was used for full gene deletion 
(Figures 3.2 and 3.3), was also adopted to generate C- and N-terminus deletions of CDC13.  
However, the yeast plasmids and gene-specific target sequence for the hybrid primers were 
different. 
 
3.4.1.1. Modulating DNA template preparation for N-terminal truncation 
The plasmid pFA6a-TRP1-PGAL1 (pDL515) (Chapter 2, Figure 2.5) with a tryptophan marker 
module was used as a template for PCR synthesis of the fragment for CDC13 N-terminal 
deletion (Wach et al., 1997, Longtine et al., 1998). 
 
The TRP1-PGAL1 DNA module is provided with an inducible promoter PGAL1 (~569 bp, S. 
cerevisiae origin), regulated by Gal4 for the transcription of the C-terminus half of protein after 
the deletion of its N-terminus with target-specific primers.  In the marker module another 
upstream activating sequence (UAS) (~118 nt) mediates Gal4-dependent induction.  The yeast 
TRP1 marker encodes a protein of 24 kDa required for the biosynthesis of the tryptophan 
marker. 
 
3.4.1.1.1. Plasmid DNA extraction and size evaluation  
3.4.1.1.1.1. Transformation of bacterial cells with yeast plasmid DNA 
Three yeast plasmids pDL504 (pFA6a-GFP(S65T)-His3MX6) for CTΔ, pDL515 (pFA6a-
TRP1-PGAL1) and pDL516 (pFA6a-His3MX6-PGAL1) for NTΔ were transformed to E. coli 
K-12 (NM522) (Figure 3.16).  A single, well-isolated colony was used to set culture in nutrient 
broth (NB) for plasmid DNA extraction.  DNA of three plasmids was extracted from host E. 
coli NM522 and dissolved in 200 µl sterile distilled water.  The purified DNA (5 µl) was 
digested in total volume 20 µl with 20 units of a restriction enzyme. 
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Figure 3.16.  Transformation of host bacterial cells with yeast plasmids DNA. 
Transformation was carried out with E. coli K-12 (strain NM522), chemically competent cells (200 µl) 
with ~200 ng of plasmid DNA (pDL 504, 515 and 516).  Transformants were selected on nutrient agar 
(NA) medium containing 100 µg/ml of ampicillin (3-5).  For positive control, untransformed NM 522 cells 
were grown on NA medium without ampicillin (1), while for the negative control, untransformed E. coli 
cells were grown on NA plates containing ampicillin (2).  Transformation was carried with 45 second 
heat shock at 42°C.  The transformed mixtures, 100 µl of each, were plated and incubated at 37°C 
overnight. 
 
3.4.1.1.1.2. Plasmid DNA extraction and size estimation 
Figure 3.17 represents agarose gel (0.8%) electrophoresis of extracted plasmids DNA pDL504 
(4.698 kb), pDL515 (3.962 kb) and pDL516 (4.298 kb), respectively (lanes 1-3) with their 
approximate sizes.  Purified DNA band patterns exhibited multimeric forms of plasmids with 
supercoiled DNA running at the front because of its smallest size.  Relative size analysis shows 
that the plasmid in lane 1 (pDL504, 4.698 kb), is comparatively larger in size as compared to 
DNA in lane 2 and 3 (pDL515, 3.962 kb and pDL516, 4.298 kb respectively).  However, it was 
difficult to estimate the exact size of the plasmids from undigested samples.  
 
Plasmid DNA size estimation was carried out by digesting DNA with a single cut restriction 
enzyme, EcoRI, that resulted in linearised DNA fragments (lanes 4, 5 and 6), between 4 and 5 
kb in size.  Restriction enzyme digestion of the plasmids with EcoRI and/or Pst1 resulted in two 
to three fragments.  Digestion of the plasmid pDL504 with Pst1 (lane 7) resulted in three 
fragments 3.086 kb, 1.165 kb and 447 bp in size corresponding to three restriction sites at 35, 
1200 and 1647 on the map (Figure 3.18A).  The double digestion of plasmid pDL515 with 
EcoR1 and Pst1 (lane 8) resulted in 2.457 kb and 1.505 kb fragments corresponding to sites 
1540 for EcoR1 and 35 for Pst1 (Figures 3.17, 3.18A).  The plasmid pDL516 produced three 
fragments of 3.086 kb, 796 bp and 447 bp that correspond to three sites of Pst1 at 35, 831 and 
1278.  The 447 bp fragments from plasmids pDL504 and pDL516 are not visible on the gel.   
The simulative gel (Figure 3.18B) with single- and double-digested plasmids also confirms the 
same restriction fragment pattern.  
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Figure 3.17.  Isolation of yeast plasmid DNA and analysis of its size after digestion with restriction 
enzymes. 
Lanes M1: 1 kb DNA marker, 500 ng (Invitrogen); 1-3: undigested plasmid DNA (pDL504, pDL515, 
pDL516 respectively); 4-6: EcoRI digested (linearised) DNA, pDL504 (4.698 kb), pDL515 (3.962 kb) and 
pDL516 (4.329 kb) respectively; 7: Pst1 digested plasmid pDL504 DNA, with two fragments of 
approximately 3.086 kb and 1.165 kb and one fragment of 447 bp (not visible); 8: Pst1 and EcoRI double 
digested plasmid DNA pDL515, with two fragments of approximately 2.457 kb and 1.505 kb; 9: Pst1 
digested plasmid pDL516 with two fragments of approximately 3.086 kb, 796 bp and 447 bp (not 
visible); M1: 1 kb DNA marker, 500 ng (Invitrogen). 
Agarose gel electrophoresis presents uncut DNA (lanes 1-3), linearised DNA (lanes 4, 5 and 6) and 
double digested DNA (lanes 7, 8 and 9) for plasmid DNA pDL504 (pFA6a-His3MX6, 4.698 kb), pDL515 
(pFA6a-TRP1-GAL1, 3.962 kb) and pDL516 (pFA6a-His3MX6-GAL1, 4.329 kb) respectively.  Estimation of 
approximate size was carried out by comparing DNA with reference markers.  Uncut DNA (2 µl) and 
digested DNA (3 µl) from each sample was analysed on 0.8% agarose gel. 
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Figure 3.18.  In silico size analysis of yeast plasmids used for N- and C-truncation. 
(A)  Maps of yeast circular plasmid DNAs showing EcoR1 and Pst1 sites utilised for digestion with 
restriction enzyme. 
(B)  Simulative gel showing fragments after single and double digestions. 
 
After confirming sizes of plasmids, the diluted DNAs were diluted use as a DNA template to 
produce the PCR amplified module for CDC13 gene disruption (N- and C-terminus deletion). 
 
3.4.1.1.2. PCR synthesis of HIS3MX6-PGAL1 and TRP1-PGAL1 modulating DNA 
for cdc13-1-NTΔ 
After electrophoresis analysis of extracted DNA, the purified plasmid DNAs were diluted in a 
ratio of 1:10 and used as DNA templates in PCR reactions.  PCR was performed to produce 
DNA module possessing HIS3MX6-GAL1 and TRP1-GAL1 deletion cassettes for NTΔ (Figure 
3.19).  The sizes of the amplified fragments were examined on an analytic gel and were 
estimated to be ~1.9 kb for HIS3MX6-PGAL1 module (lanes 2-7) and ~1.5 kb for TRP1-
PGAL1 deletion amplicons (lanes 9-14) as expected. 
 
A 
B 
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Figure 3.19.  PCR amplification of HIS3MX6-PGAL1 and TRP1-PGAL1 DNA modules for cdc13-1 NTΔ. 
The N-terminal deletion modules were amplified using yeast vector pFA6a-HIS3MX6-PGAL1 (pDL516) 
and pFA6a-TRP1-PGAL1 (pDL515) as a template in a 50 µl reaction volume with FT-N1 and RT-N1 hybrid 
primers.  For each sample 5 µl of PCR reaction mixture was examined on 0.8% agarose gel to confirm the 
presence of expected fragments.   
Lanes M1: 1 kb DNA marker, 500 ng (Invitrogen); 2-7: Amplified fragments with the plasmid template 
pDL516 (pFA6a-HIS3MX6-PGAL1); 9-14: Amplified fragments with the plasmid template pDL515 (pFA6a-
TRP1-PGAL1); 15-16: Negative controls (NTC without cell or DNA); M2: 100 bp DNA marker, 500 ng 
(Invitrogen). 
 
Amplified fragments were extracted by the phenol-chloroform method.  Gel electrophoresis 
(Figure 3.20) shows PCR products unpurified fragments (lanes 1 and 5) and the phenol-
chloroform extracted, ethanol precipitated purified fragments, each for HIS3MX6-PGAL1 
(lanes 2 and 3) and TRP1-PGAL1 (lanes 6 and 7) modulating DNA respectively.  The 
approximate concentrations of purified PCR products for both fragments were estimated to be 
~40-50 ng/µl with approximately 90-95% recovery (Figure 3.20, lanes 2-3 and 6-7 
respectively), based on intensities of marker bands on the analytic gel.  The purified PCR 
products ~1-3 µg of DNA was used to transform yeast cells (cdc13-1 mutant strains) for NTΔ. 
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Figure 3.20.  Purification and estimation of concentration of PCR amplicons for cdc13-1 N-terminus 
deletion cassettes. 
Lanes M1: 1 kb DNA marker, 500 ng (Invitrogen); 1: PCR product with TRP1-PGAL1 containing plasmid 
DNA (not purified); 2-3: PCR product for NTΔ (purified); 4: Blank; 5: PCR products for HISMX6-PGAL1 for 
NTΔ (not purified); 6-7: PCR products for HIS3MX6-PGAL1 marker for NTΔ (purified); M2: 100 bp DNA 
marker, 500 ng (Invitrogen). 2 µl each for HIS3MX6-PGAL1 and TRP1-PGAL1 (lanes 6 and 7) modulating 
DNA respectively were analysed on the analytical gel.  The PCR products 2 µl were examined on 0.8% 
agarose gel. 
The purified linear DNA with target-specific oligonucleotides (5’ ends of hybrid primers) were 
used to transform yeast strains 1296-TR (cdc13-1), 1297-TR (cdc13-1) temperature resistant 
survivors and 1272 (CDC13) to disrupt CDC13 N-terminus in its normal chromosomal location. 
 
3.4.1.1.3. Generation and analysis of temperature resistant survivors 
Temperature-resistant survivors were generated at high temperature (36°C) from two 
temperature-sensitive cdc13-1 mutant strains DLY 1296 and DLY 1297.  Strain DLY 1272 with 
wild type CDC13 was also grown at 36°C (Figure 3.21A).  The survivors from 1296-TR and 
1297-TR produced heterogeneously sized (minute and large irregularly shaped colonies with 
rough edges (Figure 3.21A, 1 and 2), that could be genetically unstable cells.  In contrast, strain 
1272 generated homogenous, uniform size colonies with smooth edges, (Figure 3.21A, 3). 
At 23°C, strains 1296 (cdc13-1), 1297 (cdc13-1) and 1272 (CDC13) exhibited growth in all 
three suspensions including one concentrated and two diluted suspensions tested [(Figure 3.21B, 
plate (p) 1, 2 and 3, non-diluted culture (a), 10
-2 
dilution (b) and 10
-4
 dilution (c)], while at 36°C 
strains 1296 and 1297 showed growth in only non-diluted concentrated suspension (p 4 and 5, 
dilution a) that is remarkably low as compared to growth at 23°C.  However,  strain 1272 
containing intact CDC13 gene,  presented more or less similar growth patterns at both 23°C (29 
cells per 50 µl) and 36°C (16 cells per 50 µl) (p 3 and 6). 
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Figure 3.21.  Generation of survivors at high temperature (36°C). 
(A) Yeast strains 1296 and 1297 (cdc13-1 exo1Δ) produced TR colonies (plates 1-2 respectively).  Strain 
1272 (CDC13 exo1Δ) grows at high temperature but does not show survivors (plate 3).  Strains 1296 and 
1297 (cdc13-1 exo1Δ, 1 and 2) showed rough edges and non-uniform sizes of colonies while strain 1272 
(CDC13 exo1Δ, 3) at high (36°C) temperature shows colonies with smooth edges and uniform size with 
no growth retardation. 
(B) The freshly grown cells from strains, 1296-TR, 1297-TR and 1272 were serially diluted.  The cells from 
concentrated suspension (a) and two different dilutions, 10
-2
 (b) and 10
-4 
(c), were plated on YEPD 
medium.  Plates were cultivated for five days at 23°C and 36°C.  Each section ( a, b, or c) of the plate 
showed the comparable growth of cells from 50 µl of the suspension at 23°C or 36°C. 
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3.4.1.1.4. Selection of temperature-resistant survivors to prepare competent cells 
TR cells from strains 1296 and 1297 (cdc13-1 exo1Δ), and 1272 (CDC13 exo1Δ) were further 
analysed for the incidence of spontaneous revertants and for the presence of metabolic markers 
by replica plating.  Ten colonies each from strains 1296-TR and 1297-TR cells (previously 
selected at 36°C) were randomly picked and were replica plated at two different temperatures, 
30°C and 37°C (Figure 3.22 and 3.28 respectively).  Strains 1296-TR and 1297-TR (colonies 1-
10) showed growth only on YEPD and leucine-deficient media (replica 1 and 3) confirming 
their auxotrophy for histidine, tryptophan and uracil.  However, a few colonies from both strains 
grew on tryptophan- and uracil-deficient media.  Strain 1296-TR displayed tryptophan 
revertants, not very obvious at 30°C (Figure 3.22, replica 4) but prominent at 37°C represented 
by replica 4 (streak 1B, 3C, 4A, 4D and 8D) and uracil revertants, by replica 5, (colony number 
7 in streaks C) at 37°C as shown in Figure 3.22.  Strain 1297-TR also produced tryptophan 
revertants observed at 30°C (Figure 3.23, replica 4, colony number 3B and 7D), and at 37°C 
(replica 4, colony number 1D, 4A, 4B, and 7B-7D), and uracil revertants observed at 37°C 
(replica 5, colony number 10, in B-D streaks). 
On the basis of revertant analysis, the colony numbers ‘3A’ and ‘2A’ were selected for strain 
1296 and strain 1297 respectively to set overnight cultures to prepare competent cells avoiding 
revertants. 
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Figure 3.22.  Confirmation of genetic markers in survivors strain 1296-TR cells by replica plating on YEPD 
and dropout media by exposing cells at 30°C and 37°C. 
For strain 1296-TR, 10 colonies, each with four streaks (A-D) were analysed by replica plating (1-5) for 
metabolic markers and revertants.  All tested colonies (1-10) showed growth at YEPD (replica 1) and 
medium lacking leucine (replica 3).  However, a few colonies (revertants) grew on tryptophan deficient 
(replica 4) and uracil lacking (replica 5) media. 
The cells from streak ‘3A’ (replica 3) were used to set overnight culture for preparation of competent 
cells. 
Replica plates were incubated at 30°C and 37°C for 5 days before photography.  Pictures were taken 
using a Syngene gel documentation system. 
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Figure 3.23.  Confirmation of genetic markers in survivors strain 1297-TR cells by replica plating on YEPD 
and dropout media by exposing cells at 30°C and 37°C. 
For strain 1297-TR, 10 colonies, each with four streaks (A-D) were analysed by replica plating (1-5) to 
examine metabolic markers and revertants.  All tested colonies (1-10) showed growth at YEPD (replica 1) 
and medium lacking leucine (replica 3).  Few colonies (revertants) also emerged on medium lacking 
tryptophan (replica 4) at both 30°C and 37°C.  Few cells from streak ‘2A’ (replica 3) were used to set 
overnight culture for preparation of competent cells. 
Replica plates were incubated at 30°C and 37°C for 5 days before photography.  Pictures were taken 
using gel documentation system (Syngene). 
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3.4.1.1.5. Checking genetic markers in competent cells  
To verify further that no revertants grew in the cells selected to set cultures for the preparation 
of competent cells, the overnight starter cultures grown for competent cells were initially 
analysed for the incidence of revertants in 5 µl of the suspension.  As presented in Figure 3.24, 
all three strains showed growth on YEPD (1) and leucine-deficient media (3) indicating the 
presence of LEU2 marker.  However, scarce revertants were emerged on T
–
 medium (4).  The 
total number of tryptophan revertants was counted in 5 µl of suspension (x8 streaks in total) 
with 10 colonies in strain 1272, 5 colonies in 1296-TR and 6 in strain 1297-TR.  However, only 
one histidine revertant (Plate 2, 3A) was observed in strain 1296-TR. 
 
 
Figure 3.24.  Analysis of recovery of revertants from strains 1272, 1296-TR and 1297-TR cells on dropout 
media.  
Cells from the overnight cultures of strains 1272, 1296-TR and 1297-TR were streaked (5 µl per streak) 
on YEPD (1) and dropout media (2-5).  The plates were incubated at 30°C for 5 days before photography.  
Pictures were taken using a gel documentation system (Syngene). 
 
The frequency of revertants was further estimated in 50 µl volume of the competent cell 
suspension (Figure 3.25) by comparing it with the total viable count and is presented in Table 
3.2.  All three strains exhibited revertants for the tryptophan markers.  However, no obvious 
revertants were observed for the histidine marker for strain 1297-TR. 
 
It appears from the above observations that the tryptophan marker could generate an 
unavoidable background of spontaneous revertants (as a result of gene conversion or other 
recombinations) that might result in false positives in gene disruption by homologous 
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recombination.  The 100 µl of freshly prepared competent cell suspension for each sample were 
used to transform with yeast modulating DNA for CDC13 disruption. 
 
 
Figure 3.25.  Analysis of competent cells for spontaneous revertants in population of 1272, 1296-TR and 
1297-TR by testing cells for the incidence of prototrophies on dropout media.  
Competent cells from strains 1272, 1296- and 1297-TR showed abundant growth on YEPD and medium 
lacking leucine (–L) confirming their genetic markers (plating 3).  However, a few colonies appeared on 
tryptophan- and uracil-deficient media (plating 4 and 5 respectively).  The total numbers of revertants in 
50 µl of cell suspension were 92, 75 and 39 colonies for tryptophan and 2 colonies each for uracil in 
strains 1272, 1296-TR and 1297-TR respectively. 
Plates with suspension were incubated at 30°C for 5 days before photography.  Pictures were taken 
using gel documentation system (Syngene). 
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Table 3.2.  Frequency of revertants in strains 1296-TR, 1297-TR and 1272 grown at 30°C. 
 
  Strains 
(DLY) 
No of 
Revertants/50 
µl 
(on medium 
lacking T*)  
No of 
Revertants/50 
µl 
(on medium 
lacking H) 
Total 
viable 
count/50 
µl 
Frequency of 
revertant in TR 
cells 
(revertants/viable 
count) 
1 1272 
(36°C) (L
+
) 
92 0 colony 110.5x10
6
 0.83x10
-6
 
2 1296-TR 
(L
+
) 
75 1 26x10
6
 2.88x10
-6
 
3 1297-TR 
(L
+
) 
39 0 84x10
6
 0.46x10
-6
 
 
*Multiple number of tryptophan revertants appeared on medium deficient in T in all three strains 
tested, in contrast to other media (L
–
 and U
–
), where no revertants were observed. 
 
3.4.1.1.6. Analysis of survivors for genotypic CDC13 status 
Finally, survivors were analysed for the presence of cdc13-1 and CDC13 through PCR in order 
to exclude clones with CDC13 alleles resulted from possible reversions of cdc13-1 to CDC13.  
Figure 3.26 confirmed the presence of 378 bp fragments in cells of ts strains and TR survivors.  
 
 
Figure 3.26.  PCR analysis of cells grown at 30°C for the presence of cdc13-1 and CDC13. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: strains 2607, 2608 (cdc13Δ),-ve 
controls; 5: strain 640 (WT), +ve control; 6-7: strains 2625 and 2626 (cdc13-1 mutant) +ve controls; 8-9: 
strains 2605-ts and 1108-ts (cdc13-1 mutant) +ve controls; 10-11: strains 2605-TR and 1108-TR (cdc13-1 
mutant) +ve controls; 12-14: strains 1272 (CDC13), 1296 and 1297 (cdc13-1) 23°C; 15-17: strains 1272 
(CDC13), 1296 and 1297 (cdc13-1) 30°C; M2: 100 bp ladder, 500 ng (NEB). 
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The strains used for transformation were analysed by PCR from colonies treated by heat (95°C).  For 
PCR, temperature-sensitive strains 1296 and 1297 and their temperature-resistant survivors, and 
strain1272 were cultivated on YEPD medium at 23°C and 30°C for three days.  A loopful of cells from a 
pure culture were denatured at 95°C for 15 minutes prior to PCR.  PCR products from these strains 
exhibited a single fragment of ~378 bp size (lanes 12-17) with diagnostic primers (N1 and N2) for the N-
terminus. 
Wild type strain 640 (CDC13) as well as mutant strains 2625, 2626, 2605 and 1108 (ts and TR) with 
cdc13-1 were used as positive controls (lanes 5-11).  Uncut PCR products (5µl) were analysed on a 1.5% 
agarose gel. 
 
3.4.1.2. Transformation of yeast cells with amplified CDC13 N-terminus 
disruption modules  
Tranformations of cells from three strains 1296-TR, 1297-TR and 1272 were carried out 
according to the standard protocol (Materials and Methods).  Freshly prepared competent cells 
(100 µl each) were transformed with ~1.5 µg of purified PCR product for N-terminus truncation 
with TRP1-PGAL1 and HIS3MX6-PGAL1 deletion modules. 
 
3.4.1.2.1. Transformation with TRP1-PGAL1 marker module for CDC13 N-terminus 
deletion  
The transformants with TRP1-PGAL1 deletion cassettes were selected on T
–
L
–
 dropout medium 
(Figures 3.27, 3.28 and 3.29; 1a-5a) for strains 1296-TR, 1297-TR and 1272 respectively with 
appropriate negative (non-transformed cells on T–L– medium) and positive controls (non-
transformed cells on L
–
 dropout medium).  There was moderate growth of revertants in the 
negative controls for all three strains as compared to abundant growth for positive controls. 
To purify transformants from background growth, colonies were replica-plated for a second 
round of selection (Figures 3.31, 3.32 and 3.33; 1b-5b).  From the second selection, 24 T
+
L
+
 
colonies each from strains 1296 and 1297 and 16 transformants from strain 1272 were screened 
for N-terminal deletion using a diagnostic PCR assay.  The rapid screening assay involved PCR 
amplification for the N- and C-terminus specific DNA sequences directly from colonies and 
detection of amplicons on the basis of their molecular sizes by agarose gel electrophoresis. 
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Figure 3.27.  Transformation of 1296-TR cells for NTΔ and selection of trp
+
 transformants (1-5) through 
the first (1a-5a) and second (1b-5b) round of selection on T
–
L
–
 medium.  Approximately 685 T
+
L
+
 colonies 
per 100 µl of competent cells grew after five to seven days of incubation at 30°C.  These were replica-
plated at 30°C for a repeated selection.  Negative control shows approximately 39 colonies grown after 
plating 20 µl of competent cells.  They could be spontaneous revertants. 
 
 
 
Figure 3.28.  Transformation of 1297-TR cells for NTΔ and selection of trp
+
 transformants (1-5) through 
first (1a-5a) and second (1b-5b) rounds of selection on T
–
L
–
 medium.  Approximately 550 T
+
L
+
 colonies 
per 100 µl competent cells grew after five to seven days of incubation at 30°C.  These were replica 
plated at 30°C for a repeated selection.  Negative control shows approximately 25 colonies per 20 µl of 
competent cell suspension.  They could be spontaneous revertants. 
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Figure 3.29.  Transformation of 1272 cells for NTΔ and selection of trp
+
 transformants (1-5) through first 
(1a-5a) round of selection on T
–
L
–
 dropout medium.  
Numerous T
+
L
+
 colonies (from plating 100 µl of competent cells) grew after five to seven days of 
incubation at 30°C.  They were replica-plated at 30°C for the second of selection.  Negative control also 
shows approximately 25 colonies (spontaneous revertants) resulted from plating 20 µl of competent 
cells.  Sixteen well separated colonies were picked randomly for PCR screening for NTΔ and were 
analysed through PCR. 
 
3.4.1.2.2. Transformation with HIS3MX6-PGAL1 marker module for CDC13 N-
terminus deletion  
Tranformation of three strains (1296-TR, 1297-TR and 1272) were carried out with deletion 
cassettes containing the HIS3MX6-PGAL1 module marker according to the protocol adopted 
for NTΔ.  The transformants were selected on dropout medium lacking histidine and leucine.  
There was no growth on H
–
L
–
 dropout plates used as negative controls.  However, positive 
controls (the plates with L
–
 medium) showed abundant growth for all of these three strains. 
 
3.4.1.3. Screening for CDC13 disruption and marker module integration 
through analytical PCR 
All three initial strains 1296-TR, 1297-TR and 1272 were auxotrophs for tryptophan and 
histidine markers.  The selection of transformants for NTΔ on tryptophan-deficient medium (in 
case of the TRP1-PGAL1 deletion module) and histidine-deficient medium (HIS3MX6-PGAL1 
deletion module) indicates the presence of the respective markers.  However, to confirm 
whether these markers had replaced the N-terminus of CDC13, further analysis of these 
transformants was required to confirm the integration of these markers and deletion of the 
desired sequence from CDC13.  Analytical PCR for the detection of N-terminus (using N1 and 
140 
 
N2 primer pair) and C-terminus (C1 and C2 primer pair) of CDC13 were performed.  Analysis 
of the transformants was carried out with diagnostic PCR to detect TRP1-PGAL1 and 
HIS3MX6-PGAL1 (using T1 and T2 primer pair), and HIS3MX6 (using H1 and H2 primers) to 
verify the integration of the tryptophan or histidine marker module into the genome.  Amplicon 
were determined for their molecular size by electrophoretic separation of PCR reaction products 
on agarose gel. 
 
3.4.1.3.1. Diagnostic PCR for the confirmation of CDC13 region  
To check the primers’ specificities, diagnostic PCR was performed with cells from strains 1296-
TR, 1297-TR (cdc13-1 mutants) and wild type strain 640.  Electrophoresis analysis (Figure 
3.30) manifested a single fragment of 378 bp for the N-terminus of cdc13-1 or CDC13 (lanes 1-
4) and 276 bp for the C-terminus (lanes 5-8) in all four samples examined with almost the same 
intensity, confirming the presence of both halves of CDC13 in chromosomal DNA of the tested 
cells.   
 
 
 
Figure 3.30.  Diagnostic PCR to detect CDC13 (N- and C-terminus): analysis of PCR products on agarose 
gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen; 1-2: PCR products with cells from strains 1296-TR and 1297-
TR (cdc13-1 mutants); 3-4: PCR product with cells from strain 640 x2 (WT, CDC13), +ve control; 5-6: PCR 
products with cells from strain 1296-TR and 1297-TR (cdc13-1 mutants); 7-8: PCR products with cells 
from strain 640 x2 (WT, CDC13), +ve control; 9-10: NTC, -ve control; M2: 100 bp ladder, 500 ng 
(Invitrogen). 
Two set of PCR were carried out with freshly grown yeast cells (phenotypically pure culture).  Cells from 
the subculture of single colony were re-suspended in sterile water (20 µl), denatured in a heat block for 
15 minutes.  The supernatant was separated by centrifugation and used as a template source for PCR.  
The PCR was carried out in 25 µl volume with 2 µl supernatant of heated cells (genomic DNA) with 1x 
master mix (Promega’s GoTaq Green master mix) and 2 µM of primers.  PCR amplified products (7 µl) 
were examined on 1.5% agarose gels.  Agarose gel analysis of PCR products for CDC13 N- (N1 and N2 
primer pair) and C-terminus (C1 and C2 primer pair) shows discrete bands of DNA fragments from 
different strains. 
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3.4.1.3.2. Diagnostic PCR for the detection of marker-specific fragment to confirm 
marker integration 
Diagnostic primers for the confirmation of marker modules were selected from the reported 
sequence (Longtine et al., 1998).  DNA of plasmids pDL504, pDL516 and pDL515, were 
analysed using primer pairs H1-H2 and T1-T2 to check for their specificity.  H1 and H2 primers 
allowed amplifying a fragment of ~1.6 kb (1.579 kb) specifically from plasmid DNA pDL504 
possessing the HIS3MX6 marker module only (Figure 3.31, lane 2).  Conversely, T1 and T2 
primers allowed amplification of ~1.8 kb (1.845 kb) and ~1.5 kb (1.481 kb) fragments of the 
HIS3MX6-PGAL1 (lane 6) and TRP1-PGAL1 (lane 7) marker module from plasmids pDL516 
and pDL515 (DNA) respectively.  However, H1 and H2 primers produced a faint band of ~1.6 
kb in plasmid pDL516 (lane 3) and using T1 and T2 primers resulted in a faint band of ~1.8 kb 
in plasmid pDL504 with HIS3MX6 (lane 5).  There was no amplification for the TRP1-PGAL1 
module (with template DNA of plasmid pDL515, lane 4) using the H1 and H2 primer pair, 
confirming their specificity for the pDL504 template only.  As the screenings of mutants by 
diagnostic PCR were performed with heated cells rather than DNA this further reduced the 
intensity of non-specific faint bands.  Considering primer specificity, the H1 and H2 primers 
could only be utilised to screen C-terminus truncated mutants with the histidine marker whereas 
primers T1 and T2 could be used to screen N-terminus truncated mutants with either HIS3MX6-
PGAL1 or TRP1-PGAL1 module with resulting in size-specific PCR products. 
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Figure 3.31.  Diagnostic PCR to detect integrated modulating DNA sequences (HIS3MX6 and TRP-PGAL1): 
analysis of PCR products on agarose gel. 
 
Agarose gel analysis of PCR products of HIS3MX6 (H1-H2 primer pairs) and TRP1-GAL1 (T1-T2 primer 
pairs) DNA shows primers’ specificities for template DNA. 
Lanes M1: 1 kb DNA marker, 500 ng (Invitrogen); 1: negative control (NTC); 2: H1-H2-PCR products with 
template DNA pDL504 (pFA6a-GFP(S65T)-HIS3MX6); 3: H1-H2-PCR reaction product with template DNA 
pDL516 (pFA6a-HIS3MX6-PGAL1; 4: H1-H2-PCR reaction product with template DNA pDL515 (pFA6a-
TRP1-PGAL1); 5: T1-T2-PCR amplified fragment with template pDL504 (pFA6a-GFP(S65T)-HIS3MX6); 6: 
T1-T2-PCR amplified fragment with template pDL516 (pFA6a-HIS3MX6-PGAL1; 7: T1-T2-PCR amplified 
fragment with template pDL515 (pFA6a-TRP1-PGAL1); M2: 100 bp DNA marker, 500 ng (Invitrogen). 
DNA of plasmids pDL504, pDL516 and pDL515, were analysed using primer pairs H1-H2 and T1-T2 to 
check for their specificity. 
PCR was performed in 25 µl reaction volume using 1x master mix (Promega’s GoTaq Green master mix) 
and 2 µM of forward and reverse primers with ~100 ng of plasmid DNA template.  Amplified products 
(7µl) were analysed on a 0.8% agarose gel. 
 
3.4.1.3.3. Genotypic analysis of transformed cells  
To verify disruption of cdc13-1 or CDC13 with marker cassettes TRP1-PGAL1 and HIS3MX6-
PGAL1 for NTΔ, the T+L+and H+L+ transformants were screened by diagnostic PCR for N-
terminus with appropriate controls. 
 
3.4.1.3.4. Diagnostic PCR for the confirmation of cdc13-1 NTΔ in TRP1+ 
transformants  
After the second round of selection, T+L+
 
transformants from strains 1296-TR, 1297-TR and 
1272 were analysed by diagnostic PCR to verify N-terminus disruption and integration of the 
marker.  In total, 24 transformants (each from strains 1296-TR and 1297-TR and 16 
transformants from strain 1272) were analysed systematically for the detection of the N-
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terminus (PCR with N1-N2 primers), TRP1-PGAL1 marker module (PCR with T1-T2 primers) 
and finally for the C-terminus (PCR with C1-C2 primer pair, data not shown).  
 
3.4.1.3.5. Screening of cdc13-1 NTΔ::(TRP1-PGAL1) in mutants of strain 1296-TR  
3.4.1.3.5.1. Analytical PCR for the N-terminus 
The 24 tryptophan-positive transformants were analysed by diagnostic PCR for cdc13-1 NTΔ in 
survivor strains 1296.  Gel analysis revealed a fragment of ~378 bp in 18 transformants #N1, N3 
and N8-N14 (Figure 3.32, lanes 9, 11 and 16-22 respectively) and transformants #N15-N20 and 
#N22-N24 (Figure 3.34, lanes 9-14 and 16-18 respectively) in consonance with controls cdc13-
1 (Figures 3.32 and 3.34, lanes 5-6) and CDC13 (Figures 3.32 and 3.34, lanes 7-8) indicating 
the presence of cdc13-1 or CDC13, however no amplification was observed in other 
transformants analysed (Figure 3.32, lanes 10 and 12-15; Figure 3.34, lane 15) confirming 
successful deletion of cdc13-1 gene by target guided homologous recombination.  As the N-
terminus fragment of cdc13-1 should be replaced by a marker cassette of TRP1-PGAL1 
resulting in cdc13-1-NTΔ::TRP1-PGAL1, the correct integration of TRP1-PGAL1 was 
confirmed by second analytical PCR with the marker specific primers T1 and T2.  
 
3.4.1.3.5.2. Analytical PCR for the TRP1-PGAL1 modular marker 
In parallel to diagnostic PCR, the same supernatant from heated cells was examined for the 
tryptophan marker module with the T1 and T2 primer pair.  The presence of the tryptophan 
marker module was confirmed in six mutants out of a total of 24 examined for NTΔ (Figure 
3.33, lanes 8 and 10-13; Figure 3.35, lane 13).  The all six T
+
L
+
 transformants (#N2, N4-N7 
corresponding to lanes 8 and 10-13 in Figure 3.33, and #N21 in Figure 3.35, lane 13) 
respectively, displayed discrete marker-specific bands of the TRP1-PGAL1 module with 
varying intensity and did not amplify the gene-specific N-terminus fragment, confirming the 
replacement of the N-terminus with the TRP1 marker module.  Conversely, all other TRP1+ 
transformants that did not amplify the marker but showed cdc13-1-N-terminus fragment, could 
be spontaneous revertants, (rather than recombinants) emerging as a result of gene conversion. 
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Figure 3.32.  PCR screening (1-14) for cdc13-1 N-terminus deletion (NTΔ::TRP1) in the strain 1296-TR: 
agarose gel electrophoresis of PCR products (N1-N2 primer pair). 
The putative, cdc13-1 NTΔ transformants (#N1-N14) were screened by PCR for cdc13-1 N-terminus.  The 
PCR was carried out with N1-N2 diagnostic primers in 25 µl reaction volume with 2 µl of denatured 
genomic DNA from cells.  The PCR products (10 µl) were examined on a 1.5% agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strain 
2607 and 2608 respectively (cdc13Δ); 5-6: PCR products from cells of strains 1296-TR, 1297-TR 
respectively (cdc13-1); 7-8: PCR products from cells of strain 640 X2 (WT, CDC13) cells; 9-22: PCR 
products from cells of transformants #N1-N14 in strain 1296-TR (anticipated cdc13-1-NTΔ mutants). 
Gel analysis showed fragments of sizes ~378 bp in nine transformants #N1, N3 and N8-N14 (lanes 9, 11 
and 16-22), all other NTΔ mutants examined, #N2, N4-N7 (lanes 10, 12-15) exhibited no fragment 
indicating the absence of the N-terminus. 
 
 
Figure 3.33.  PCR confirmation for TRP1-GAL1 marker module in cdc13-1-NTΔ mutants (1-14) in strain 
1296-TR: electrophoretic analysis of PCR products (T1-T2 primer pair). 
The putative cdc13-1 NTΔ transformants (#N1-14) were screened by diagnostic PCR for the TRP1-PGAL1 
marker module.  The PCR was carried out with T1-T2 diagnostic primers in 25 µl reaction volume with 2 
µl of denatured genomic DNA from cells.  The PCR products (10 µl) were examined on a 0.8% agarose 
gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strains 
1296-TR, 1297-TR (cdc13-1 mutants), control; 5-6: PCR products with plasmid DNA (pDL515 containing 
TRP1-PGAL1) +ve control; 7-20: PCR products from cells of transformants #N1-N14 in strain 1296-TR 
(anticipated cdc13-1-NTΔ mutants). 
Gel analysis showed the fragments of ~1.481 kb in five NTΔ transformants out of a total 14 examined 
(N2, N4-N7, lanes 8, 10-13 respectively), indicating the replacement of the N-terminus by the 
tryptophan marker integrated by homologous recombination. 
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Figure 3.34.  PCR screening (15-24) for cdc13-1 N-terminus deletion (NTΔ) in the strain 1296-TR: agarose 
gel electrophoresis of PCR products (N1-N2 primer pair). 
The putative, cdc13-1 NTΔ transformants (#N15-#N24) were screened by PCR for cdc13-1 N-terminus. 
The PCR was carried out with the N1-N2 diagnostic primers in 25 µl reaction volume with 2 µl of 
denatured genomic DNA from cells.  The PCR products (10 µl) were examined on a 1.5% agarose gel.   
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strains 
2607 and 2608 (cdc13Δ) respectively; 5-6: PCR products from cells of strains 1296-TR, 1297-TR (cdc13-1) 
respectively; 7-8: PCR products from cells of strain 640 X2 (WT, CDC13); 9-18: PCR products from cells of 
transformants #N15-N24 in strain 1296-TR (anticipated cdc13-1-NTΔ mutants). 
Gel analysis showed discrete DNA band of ~378 bp in nine transformants #N15-N20 and N22-N24 (lanes 
9-14, and 16-18), whereas one NTΔ mutant (N21, lane 15) exhibited no N-terminus-specific fragment. 
 
 
 
Figure 3.35.  PCR confirmation for TRP1-PGAL1 marker module in cdc13-1-NTΔ mutants (15-24) in strain 
1296-TR: the electrophoretic analysis of the PCR products (T1-T2 primers). 
The putative, cdc13-1 NTΔ transformants (#N15-24) were screened by diagnostic PCR for the TRP1-
PGAL1 marker module.  The PCR was carried out with the T1-T2 diagnostic primer pair in a 25 µl reaction 
volume with 2 µl of denatured genomic DNA from cells.  The PCR amplified products (10 µl) were 
examined on a 0.8% agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strains 
1296-T, 1297-TR (cdc13-1 mutants), control; 5-6: PCR products with plasmid DNA (pDL515 possessing 
TRP1-PGAL1) +ve control; 7-16: PCR products from cells of transformants #N15-N24 in strain 1296-TR 
(anticipated cdc13-1-NTΔ mutants). 
Gel analysis presented a fragment of ~1.481 kb in one NTΔ transformant (N21, lanes 13), indicating 
replacement of the N-terminus by the tryptophan marker. 
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3.4.1.3.6. Screening of cdc13-1 NTΔ::(TRP1-PGAl1) in mutants of strain 1297-TR  
3.4.1.3.6.1. Analytical PCR for N-terminus 
The tryptophan-positive transformants (24) were analysed by diagnostic PCR for cdc13-1 NTΔ 
in strain 1297 survivors.  Gel analysis revealed a fragment of ~378 bp in 15 transformants #N2-
3, N6, N9-10, and N12-13 (Figure 3.36, lanes 10-11, 14, 17-18, 20 and 21 respectively) and 
transformants #N15, N17-N21 and N23-N24 (Figure 3.38, lanes 9, 11-15, 17-18 respectively), 
in consonance with cdc13-1 (Figures 3.36 and 3.38, lanes 5-6) and CDC13-specific bands 
(Figures 3.36 and 3.38, lanes 7-8) indicating the presence of cdc13-1 or CDC13.  However, no 
amplification was observed in other transformants analysed (Figure 3.36, lanes 9, 12-13, 15-16, 
19, 22 and Figure 3.38, lanes 10 and 16) confirming successful deletion of the cdc13-1 gene by 
target guided homologous recombination.  As the N-terminus fragment of cdc13-1 should be 
replaced by a marker cassette of TRP1-PGAL1 resulting in cdc13-1-NTΔ::TRP1-PGAL1, the 
correct integration of TRP1-PGAL1 was confirmed by a second analytic PCR with marker-
specific primers T1 and T2. 
 
3.4.1.3.6.2. Analytical PCR for TRP1-PGAL1 modular marker 
In parallel diagnostic PCR, the same denatured supernatants were examined for the tryptophan 
marker module using the T1 and T2 primer pair.  The presence of the tryptophan marker module 
was confirmed in nine mutants out of a total of 24 examined for NTΔ (Figure 3.37, lanes 9, 12-
13, 15-16, 19 and 22; Figure 3.39, lanes 10 and 16).  All nine T
+
L
+
 transformants showing 
discrete marker-specific bands with varying intensity for the NTΔ::TRP1-PGAL1 construct, did 
not amplify the gene specific N-terminus fragment, confirming the replacement of the N-
terminus with the TRP1 marker module.  Conversely, all other TRP1
+
 transformants that did not 
amplify the marker and showed the N-terminus fragment could be spontaneous revertants. 
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Figure 3.36.  PCR screening (1-14) for cdc13-1 N-terminus deletion (NTΔ) in strain 1297-TR: agarose gel 
electrophoresis of the PCR products (N1-N2 primers). 
The putative, cdc13-1 NTΔ transformants (#N1-N14) were screened by PCR for cdc13-1 N-terminus.  The 
PCR was carried out with the N1-N2 diagnostic primers in a 25 µl reaction volume with, 2 µl of 
denatured genomic DNA from cells.  The PCR amplified products (10 µl) were examined on a 1.5% 
agarose gel.  
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strains 
2607 and 2608 (cdc13Δ); 5-6: PCR products from cells of strains 1296-TR, 1297-TR (cdc13-1); 7-8: PCR 
products from cells of strain 640 X2 (WT, CDC13); 9-22: PCR products from cells of transformants #N1-
N14 in strain 1297-TR (anticipated cdc13-1-NTΔ mutants). 
Gel analysis showed the N-terminus specific fragments ~378 bp in seven transformants #N2, N3, N6, N9, 
N10, N12 and N13 (lanes 10-11, 14, 17-18 and 20-21).  All other NTΔ mutants #N1, N4, N5, N7, N8, N11 
and N14 (lanes 9, 12-13, 15, 16, 19 and 22) exhibited no fragment indicating the absence of the cdc13-1-
N-terminus. 
 
 
 
Figure 3.37.  PCR confirmation (1-14) for the TRP1-GAL1 marker module in cdc13-1-NTΔ mutants in 
strain 1297-TR: the electrophoretic analysis of amplified products (T1-T2 primers pair). 
The putative, cdc13-1 NTΔ transformants (#N1-N14) were screened by diagnostic PCR for the TRP1-GAL1 
marker module.  The PCR was carried out using the T1-T2 diagnostic primers in a 25 µl reaction volume 
with 2 µl of denatured genomic DNA from cells.  The PCR amplified products (10 µl) were examined on a 
0.8% agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-5: PCR products from cells of strains 
1296-TR, 1297-TR X2 (cdc13-1 mutant), control; 6: PCR products from cells of strain 1272 cells (CDC13) 
control; 7-8: PCR products with plasmid DNA (pDL515 with TRP1-GAL1), +ve control; 9-22: PCR products 
from cells of transformants #N1-N14 in strain 1297-TR (anticipated cdc13-1-NTΔ mutants). 
Gel analysis showed a fragment of ~1.481 kb in seven NTΔ transformants (N1, N4, N5, N7, N8, N11 and 
N14, lanes 9, 12-13, 15-16, 19 and 22) out of the fourteen examined, indicating replacement of the N-
terminus by the tryptophan marker. 
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Figure 3.38.  PCR screening (15-24) for cdc13-1 N-terminus deletion (NTΔ) in strain 1297-TR: agarose gel 
electrophoresis of amplified products with the N1 and N2 primer pair. 
The putative, cdc13-1 NTΔ transformants (#N15-N24) were screened by PCR for cdc13-1 N-terminus.  
The PCR was carried out using the N1-N2 diagnostic primers in a 25 µl reaction volume with 2 µl 
denatured genomic DNA from cells.  The PCR amplified products (10 µl) were examined on a 1.5% 
agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strains 
2607 and 2608 cells (cdc13Δ); 5-6: PCR products from cells of strains 1296-TR, 1297-TR (cdc13-1); 7-8: 
PCR products from cells of strains 640 X 2 (WT, CDC13); 9-18: PCR products from cells of transformants 
#N15-N24 in strain 1297-TR (anticipated cdc13-1-NTΔ mutants). 
Gel analysis showed fragments of ~378 bp in eight transformants (lanes 9, 11-15 and 17-18).  The other 
two mutants examined exhibited no fragment (lanes 10 and 16) indicating the absence of the N-
terminus (NTΔ). 
 
 
Figure 3.39.  PCR confirmation for the TRP1-PGAL1 marker module in cdc13-1-NTΔ mutants (15-24) in 
the strain 1297-TR: electrophoretic analysis of PCR products (using T1 and T2 primer pair). 
The putative, cdc13-1 NTΔ transformants (#N15-24) were screened by diagnostic PCR for the TRP1-
PGAL1 marker module. The PCR was carried out with the T1-T2 diagnostic primers in a 25 µl reaction 
volume with 2 µl denatured genomic DNA.  The PCR amplified products (10 µl) were examined on a 0.8% 
agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-5: PCR products from cells of strains 
1296-TR, 1297-TR X2 (cdc13-1 mutant), controls; 6: PCR products from cells of strain 1272 (CDC13); 7-8: 
PCR products with plasmid DNA (pDL515 with TRP1-GAL1) +ve control; 9-18: PCR products from cells of 
transformants #N15-N24 in strain 1297-TR (anticipated cdc13-1-NTΔ mutants). 
Gel analysis showed the fragments of ~1.481 kb in only NTΔ transformants which were negative for the 
cdc13-1-N-terminus (N16 and N22, lanes 10 and 16), indicating replacement of the N-terminus by the 
tryptophan marker by homologous genomic integration.  The PCR amplified products (10 µl) were 
examined on a 0.8% agarose gel. 
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3.4.1.3.7. Screening of CDC13 NTΔ::(TRP1-PGAL1) in mutants of strain 1272  
3.4.1.3.7.1. Analytic PCR for the N-terminus 
The 16 tryptophan-positive putative transformants (N1-N16) were analysed by diagnostic PCR 
for CDC13-NTΔ in strains 1272.  Gel analysis manifested amplified fragments of ~378 bp with 
the N-terminus-specific primers in all of the clones examined (Figure 3.40, lanes 7-22), 
indicating the presence of the intact CDC13 gene. 
As the N-terminus fragment of cdc13-1 was targeted to be replaced by a marker cassette of the 
TRP1-PGAL1 through homologous recombination, the integration of TRP1 module was 
verified by analytic PCR with marker-specific primers, T1 and T2. 
 
3.4.1.3.7.2. Analytic PCR for the TRP1-PGAL1 modular marker 
Further analysis of the above tryptophan-positive putative transformants with the marker-
specific primers T1 and T2 revealed that the marker cassette of TRP1-PGAL1 did not integrate 
within the chromosomal DNA of any of the selected transformants tested to replace the N-
terminus of CDC13.  Figure 3.41 (lanes 8-22), confirmed the absence of the tryptophan marker 
module in all transformants examined for NTΔ.  The tested tryptophan+ transformants 
(putative), however, could be the result of spontaneous gene conversion (not by homologous 
recombination) without integration of the TRP1 marker within the genome. 
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Figure 3.40.  PCR screening for CDC13 N-terminus deletion (NTΔ) mutants (1-16) in the strain 1272: 
agarose gel electrophoresis of PCR products (N1and N2 primers). 
The putative cdc13-1 NTΔ transformants (#N1-N16) were screened by PCR for CDC13 N-terminus 
specific fragment.  The PCR was carried out using the N1and N2 diagnostic primers in a 25 µl reaction 
volume with 2 µl of denatured genomic DNA from cells.  The PCR products (10 µl) were examined on a 
1.5% agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strains 
2607 and 2608 (cdc13Δ); 5-6: PCR products from cells of strains 1272 and 640 (WT, CDC13); 7-22: PCR 
products from cells of transformants #N1-N16 in strain 1272 (anticipated CDC13-NTΔ mutants). 
Gel analysis showed fragment of ~378 bp in all 16 transformants examined (lanes, 7-22). 
 
 
 
Figure 3.41.  PCR for the TRP1-PGAL1 marker module in anticipated CDC13-NTΔ mutants (1-16) in the 
strain 1272: electrophoretic analysis of PCR products (T1-T2 primer pair). 
The putative CDC13-NTΔ transformants (#N1-16) were screened by diagnostic PCR for the TRP1-PGAL1 
marker module.  The PCR was carried out using diagnostic primers in a 25 µl reaction volume with 2 µl of 
denatured genomic DNA from cells.  The PCR products (10 µl) were examined on a 0.8% agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3: PCR products from cells of strain 
1272 (CDC13), control; 4: PCR products from cells of strains 1296-TR, (cdc13-1 mutant), control; 5-6: PCR 
products with plasmid DNA (pDL515 with TRP1-PGAL1), +ve control; 7-22: PCR products from cells of 
transformants #N1-N16 in strain 1272 (anticipated CDC13-NTΔ mutants). 
The gel analysis showed the absence of fragments ~1.481 kb in all trp1
+
 transformants examined (N1-
N16 with respect to lanes 7-22), indicating no replacement of the N-terminus by the tryptophan marker 
through homologous recombination. 
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Overall results for cdc13-1 N-terminus deletion with the TRP1-PGAL1 marker module and 
PCR analysis to confirm the correct mutants (NTΔ::TRP1-PGAL1) has been summarised in 
Table 3.3 that presents the comparative number of mutants generated in all three strains, 1296-
TR, 1297-TR and 1272. 
 
Table 3.3.  Analysis of tryptophan-positive transformants for cdc13-1 N-terminus truncation with TRP1-
PGAL1 module by homologous recombination 
 
 
Strains DLY 
(selected clones) 
1296-TR 
(cdc13-1) 
1297-TR 
(cdc13-1) 
1272 
(CDC13) 
1 
T
+
L
+ 
transformants 
analysed for NTΔ 
24 24 16 
2 
PCR
+
 for N-terminus 
(N1-N2, 378 bp) 
18 15 16 
3 
PCR
+
 for TRP1-PGAL1 
(T1-T2, 1.845 kb) 
6 9 0 
4 
True mutants 
NTΔ::TRP1-PGAL1 
construct 
6/24  
(25%) 
9/24  
(37.5%) 
0/16 
0% 
5 
False positive 
(T
+
L
+ 
revertants) 
18/24 
(75%) 
15/24 
(62.5%) 
16/16  
(100%) 
6 
Target-specific 
homologous 
recombination (HR) 
6/24 (25%) 
9/24 
(37.5%) 
0% 
7 
Non homologous 
recombination (NHR) 
0% 0% 0% 
8 
Name of the construct 
generated  
 
N2, N4, N5, 
N6, N7, 
N21 
N1, N4, N5, 
N7, N8, 
N11, N14, 
N16, N22 
- 
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3.4.1.3.8. PCR screening of H+L+ transformants for cdc13-1 N-terminus deletion 
(cdc13-1 NTΔ::HIS3MX6-PGAL1)To verify disruption of cdc13-1 or CDC13 with the marker 
cassette HIS3MX6-PGAL1 for NTΔ, the H
+
L
+
 transformants were screened by diagnostic PCR 
for the cdc13-1 N-terminus and His marker module with appropriate controls.  After a second 
round of selection, H
+
L
+
 transformants from strains 1296-TR, 1297-TR and 1272 were analysed 
by diagnostic PCR for the verification of N-terminus disruption and integration of the marker.  
In total, 30 transformants each from 1296-TR and 1297-TR (data shown only for 15) and 10 
transformants from strain 1272 were analysed systematically for the detection of the N-terminus 
(PCR with N1-N2 primers), HIS3MX6 marker module (PCR with H1-H2 primers) and finally 
for the C-terminus (PCR with the C1-C2 primer pair, data not shown). 
 
3.4.1.3.8.1. Screening of cdc13-1 NTΔ::HIS3MX6-PGAL1 mutants of strain 1296-TR 
3.4.1.3.8.1.1. Analytical PCR for the N-terminus 
A PCR was performed with the N1 and N2 primer pair to detect the cdc13-1 N-terminus in 15 
histidine-positive transformants in strain 1296.  Gel analysis revealed a fragment of ~378 bp in 
all tested transformants #N1-N15 (Figure 3.42, lanes 8-22 respectively) in agreement with 
controls cdc13-1 (lanes 5-6) and CDC13 (lane 7), indicating the presence of intact cdc13-1 or 
CDC13 without disruption. 
The genomic integration of the marker cassette HIS3MX6-PGAL1 was diagnosed by a second 
analytical PCR with marker-specific primers to test whether these his
+
 transformants were 
revertants or non-homologous recombinants. 
 
3.4.1.3.8.1.2. Analytical PCR for the HIS3MX6-PGAL1 module  
In parallel PCR, the same putative his
+
 transformants were also examined for the histidine 
marker module with the H1 and H2 primer pair.  No marker-specific band (~1.6 kb) was 
detected in all transformants examined for NTΔ (Figure 3.43, lanes 8-22).  As a result, there was 
no replacement of the N-terminus with the histidine marker module (HIS3MX6-pGAL1).  All 
histidine
+
 transformants which were PCR-positive for the N-terminus fragment but did not 
amplify the marker could be spontaneous revertants, (not non-homologous recombinants) 
emerging as a result of gene conversion. 
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Figure 3.42.  PCR screening for cdc13-1 N-terminus deletion (NTΔ::HIS3MX6-PGAL1) mutants (1-15) of 
strain 1296-TR: agarose gel electrophoresis of PCR products (N1-N2 primers). 
The putative, cdc13-1 NTΔ transformants (#N1-N15) were screened by PCR for the cdc13-1 N-terminus.  
The PCR was carried out with N1 and N2 diagnostic primers in a 25 µl reaction volume with 2 µl of 
denatured genomic DNA from cells.  The PCR products (10 µl) were examined on a 1.5 % agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strains 
2607 and 2608 (cdc13Δ mutants); 5-6: PCR products from cells of strains 1296-TR, 1297-TR (cdc13-1 
mutants); 7: PCR products from cells of strain 640 (WT, CDC13); 8-22: PCR products from cells of 
transformants # N1-N15 in strain 1296-TR (expected cdc13-1-NTΔ mutants). 
Gel analysis showed fragments of ~378 bp in all transformants (lanes 8-22).  Wild type strains 640 
(positive for CDC13) and 1296-TR and 1297-TR strains positive for cdc13-1 showed a single fragment of 
378 bp (lanes 5-7 respectively) with almost the same intensity.   
 
 
 
Figure 3.43.  PCR to detect HIS3MX6-GAL1 marker module in anticipated cdc13-1-NTΔ mutants (1-15) in 
strain 1296-TR: electrophoretic analysis of PCR products (H1 and H2 primers). 
The fifteen (#N1-15) histidine positive putative cdc13-1 NTΔ transformants were screened by diagnostic 
PCR for the HIS3MX6-PGAL1 marker module.  The PCR was carried out with the H1-H2 diagnostic 
primers in a 25 µl reaction volume, with 2 µl of denatured genomic DNA.  The PCR amplified products 
(10 µl) were examined on a 0.8 % agarose gel. 
Lanes M1:  1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strains 
1296-TR, 1297-TR (cdc13-1 mutant), -ve control; 5-6: PCR products with DNA of plasmid (pDL504 with 
HIS3MX6) +ve control; 7: PCR products from cells of mutant cdc13-1-CTΔ::HIS3MX6 in strain 1297-TR, 
+ve control; 8-22: PCR products from cells of transformants # N1-N15 in strain 1296-TR. 
Gel analysis did not show any fragment of ~1.680 kb for any of the his
+
 transformants (lanes 8-22), 
indicating an absence of marker integration in genome. 
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3.4.1.3.8.2. Screening of cdc13-1 NTΔ::HIS3MX6-PGAL1 mutants of strain 1297-TR  
3.4.1.3.8.2.1. Analytical PCR for the N-terminus 
The 15 histidine positive transformants were analysed for strain 1297 survivors.  Gels analysis 
exhibited the faint bands of ~378 bp in all transformants with varying intensity (Figure 3.44, 
lanes 8-22) with similar size in positive controls, cdc13-1 (lanes 5-6) and CDC13 (lane 7) 
indicating the presence of intact cdc13-1 or CDC13 in chromosomal DNA.  To test whether his
+
 
transformants were revertants or non-homologous recombinants with integrated marker 
(HIS3MX6-PGAL1) second analytical PCR with marker-specific primers was performed.  
 
3.4.1.3.8.2.2. Analytical PCR for the HIS3MX6-PGAL1 modular  
The results of diagnostic PCR performed to detect the histidine marker with the H1 and H2 
primer pair, did not confirm the presence of a marker-specific band (~1.6 kb) in any of the 
mutants examined (Figure 3.45, lanes 8-22).   
This indicates that, there was no replacement of the N-terminus with the HIS3MX6-PGAL1 
module.  All histidine
+
 transformants (which did not amplify the marker but showed the N-
terminus fragment) could be spontaneous revertants, (not non-homologous recombinants) 
emerging as a result of gene conversion. 
 
3.4.1.3.8.3. Screening of cdc13-1 NTΔ::HIS3MX6-PGAL1 mutants of strain 1272  
3.4.1.3.8.3.1. Analytical PCR for the N-terminus 
The 10 histidine-positive transformants were analysed for strain 1272.  Gel analysis exhibited 
N-terminus-specific bands of ~378 bp in all examined transformants with varying intensity 
(Figure 3.46, lanes 10-19) along with positive controls, cdc13-1 (lane 5) and CDC13 (lanes 6-7) 
indicating the presence of non-disrupted CDC13. 
 
3.4.1.3.8.3.2. Analytical PCR for HIS3MX6-PGAL1 module marker 
To test whether the his
+
 transformants were revertants or non-homologous recombinants, a 
second analytical PCR was performed for the HIS3MX6-PGAL1 marker module using H1 and 
H2 primers.  The results did not confirm the presence of the marker-specific band (~1.6 kb) in 
any of the transformants examined (Figure 3.47, lanes 8-17). 
It could be concluded from the above results that there was no replacement of the N-terminus 
with the marker module in the analysed transformants.  All histidine
+
 transformants which did 
not amplify the marker and showed the N-terminus fragment could be spontaneous revertants 
(not non-homologous recombinants) emerging as a result of gene conversion. 
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Figure 3.44.  PCR screening for cdc13-1 N-terminus deletion (NTΔ::HIS3MX6-PGAL1) mutants (1-15) of 
strain 1297-TR: agarose gel electrophoresis of PCR products (N1-N2 primers). 
The putative cdc13-1 NTΔ transformants (#N1-N15) were screened by PCR for the cdc13-1 N-terminus 
specific fragment.  The PCR was carried out with diagnostic primers in a 25 µl reaction volume, with 2 µl 
of denatured genomic DNA from cells.  The PCR products (10 µl) were examined on a 1.5 % agarose gel. 
Lanes M1:  1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve controls; 3-4: PCR products from cells of 
strains 2607 and 2608 respectively (cdc13Δ); 5-6: PCR products from cells of strains 1296-TR, 1297-TR 
respectively (cdc13-1); 7: PCR products from cells of strain 640, (WT, CDC13); 8-22: PCR products from 
cells of his
+
 transformants # N1-N15 in strain 1297-TR (expected cdc13-1-NTΔ mutants). 
Gel analysis showed fragments of ~378 bp in all examined transformants (lanes 8-22) indicating intact 
cdc13-1 without disruption. 
 
 
 
Figure 3.45.  PCR to detect HIS3MX6-GAL1 modulular DNA in anticipated cdc13-1-NTΔ mutants (1-15) in 
strain 1297-TR: electrophoretic analysis of PCR products (H1-H2 primers). 
The potential, cdc13-1-NTΔ transformants (#N1-15) were screened by diagnostic PCR for the HIS3MX6-
PGAL1 module.  The PCR was carried out using H1-H2 diagnostic primers in a 25 µl reaction volume with 
2 µl of denatured genomic DNA from cells.  The PCR amplified products (10 µl) were examined on a 0.8 
% agarose gel. 
Lanes M1:  1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strains 
1296-TR, 1297-TR (cdc13-1 mutant)s; 5-6: PCR products with DNA of plasmid (pDL504 with HIS3MX6), 
+ve controls; 7: PCR products from cells of mutant cdc13-1-CTΔ::HIS3MX6 in strain 1297-TR, +ve control; 
8-22: PCR products from cells of transformants # N1-N15 in strain 1297-TR (expected cdc13-1-NTΔ 
mutants). 
Gel analysis did not show any fragments of ~1.680 kb for any of his
+
 transformants (lanes 8-22), 
indicating an intact gene without disruption. 
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Figure 3.46.  PCR screening for CDC13 N-terminus deletion (NTΔ::HIS3MX6-PGAL1) mutants (1-10) of 
strain 1272: agarose gel electrophoresis of PCR products (N1-N2 primers). 
The putative, CDC13 NTΔ transformants (#N1-N10) were screened by PCR for the CDC13 N-terminus 
specific fragment.  The PCR was carried out using N1-N2 diagnostic primers in a 25 µl reaction volume 
with 2 µl of denatured genomic DNA from cells.  The PCR products (10 µl) were examined on a 1.5 % 
agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strains 
2607 and 2608 (cdc13Δ); 5: PCR products from cells of strain 1296-TR (cdc13-1); 6-7: PCR products from 
cells of strain 1272 (CDC13); 8-9: PCR products from cells of strain 640, (WT, CDC13) cells; 10-19: PCR 
products from cells of transformants # N1-N10 in strain 1272 (expected CDC13-NTΔ mutants). 
Gel analysis showed fragments of sizes ~378 bp in all examined transformants (lanes 10-19) indicating 
intact CDC13 without disruption.   
 
 
 
Figure 3.47.  PCR to detect HIS3MX6 marker module in anticipated CDC13-NTΔ mutants (1-10) in the 
strain 1272: electrophoretic analysis of PCR products (H1-H2 primers). 
The putative, CDC13 NTΔ transformants (#N1-10) were screened by diagnostic PCR for the HIS3MX6 
marker module.  The PCR was carried out with H1-H2 diagnostic primers in a 25 µl reaction volume with 
2 µl of denatured genomic DNA from cells.  The PCR products (10 µl) were examined on a 0.8 % agarose 
gel. 
Lanes M1:  1 kb ladder, 500 ng (Invitrogen); 1: NTC, -ve control; 2-3: PCR products from cells of strains 
1296-TR, (cdc13-1 mutant) and 1272 (CDC13) respectively, -ve controls; 4-5: PCR products with DNA of 
plasmid (pDL504 with HIS3MX6), +ve control; 6-7: PCR products from cells of mutants cdc13-1-
CTΔ::HIS3MX6 in strains 1297-TR, +ve control; 8-17: PCR products from cells of transformants # N1-N10 
in strain 1272 (expected cdc13-1-NTΔ mutants). 
Gel analysis did not show any fragments of ~1.680 kb for any of his
+
 transformants (lanes 8-17), 
indicating the intact CDC13 gene without disruption.   
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3.4.1.3.8.4. Summary on transformation experiments and PCR screening for NTΔ  
Table 3.4 presents the number of transformants generated as a result of transformation and 
homologous recombination with the histidine and tryptophan markers cassettes used for the 
disruption of the N-terminus.  The strains 1296, 1297 and 1272 showed different number of 
revertants on T
–
L
–
 media (negative control) in transformation experiments.  Analysis of T
+
L
+
 
transformants also revealed a varying number of tryptophan revertants with strain 1296 and 
1297 survivors, whereas the transformants (H
+
L
+
 and T
+
L
+) analysed for NTΔ in strain 1272, 
were all proved through PCR to be revertants. 
 
Table 3.4.  The comparative analysis of H
+
L
+
 transformant (HIS3MX6-pGAL1 modular DNA; pDL516) and 
T
+
L
+
 transformant (TRP1-pGAL1 DNA; pDL515) for N-terminal truncation. 
 
 Strains 1296-TR 
(cdc13-
1) 
1297-TR 
(cdc13-1) 
1272 
(CDC13) 
H
+
L
+
 
transformants 
Total H
+
L
+
 transformants 
obtained in 100 µl 
144 63 10 
H
+
L
+ 
transformants 
analysed for NTΔ 
30 30 10 
H
+
L
+
revertants on H
–
L
–
 
media 
0 0 0 
T
+
L
+
 
transformants 
T
+
L
+ 
transformants 
obtained in 100 µl 
685 550 TMTC* 
T
+
L
+ 
transformants 
analysed for NTΔ 
24 24 16 
True mutant with 
NTΔ::TRP1-PGAL1 
construct 
6 9 0 
T
+
L
+ 
revertants on T
–
L
–
 
media per 100 µl 
195 125 220 
Viable count of TR cells in 
100 µl 
168x10
6
 52x10
6
 221x10
6
 
Frequency of T
+
L
+ 
revertants 
7.5x10
-6
 1.488x10
-6
 0.995x10
-6
 
 
TMTC* (too many to count) 
Frequency = no of revertants/viable count 
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3.5.1. cdc13-1 C-terminal deletion (CTΔ) 
The second half of the cdc13-1/ CDC13 open reading frame sequence between nucleotides 1387 
and 2775 (~1389 nt) with respect to the C-terminus half of CDC13 gene (Figure 3.3D) was 
targeted for disruption with homologous recombination with the histidine marker module. 
 
3.5.1.1. Modulating DNA template preparation for C-terminal truncation 
The plasmid pFA6a-GFP(S65T)-HIS3MX6 (pDL504) with the histidine marker module was 
used as a template for PCR amplification (synthesis) of the fragment for cdc13-1 C-terminal 
deletion (Wach et al., 1997, Longtine et al., 1998) (Figures 2.9, 2.11 in Methods; Figure 3.17). 
 
3.5.1.1.1. Plasmid DNA extraction and size evaluation  
The yeast plasmid pDL504 (pFA6a-GFP(S65T)-His3MX6) for CTΔ was transformed into 
bacterial cells (E.coli NM522 strain K-12) (Figure 3.16).  DNA was extracted and evaluated on 
the basis of molecular size as was explained in the N-terminus deletion section (Figure 3.17 and 
Figure 3.18, lanes 1, 4 and 7). 
 
3.5.1.1.2. PCR synthesis of HIS3MX6 (cdc13-1 CTΔ) and HIS3MX6-PGAL1 (cdc13-1 
NTΔ) modulating DNA  
3.5.1.1.2.1. Cross check of the homology of deletion primers for the his marker with 
and without PGAL1 promoter  
To verify the specificities of hybrid primers for their respective yeast plasmid, two sets of PCR 
were performed to amplify the N- and C-terminus deletion cassettes of cdc13-1 with the 
histidine marker using opposite primers.  Figure 3.48 presents the analysis of the resulting PCR 
reaction products.  The expected disruption cassette for the N-truncation (linear DNA of 1.9 kb) 
was amplified with the specific primers (FT-N1 and RT-N1) and template DNA of plasmid 
pFA6a-His3MX6-PGAL1 (lanes 3 and 4).  For C-truncation DNA fragment of ~1.6 kb was 
amplified using primers (FT-C2 and RT-C2) and the plasmid pFA6a-His3MX6 peculiar for that 
cassette (lanes 10 and 11).  However, faint bands of the correct size were amplified with 
opposite primers (second pairs of primers) from both plasmids.  This demonstrated some 
homology of these histidine plasmids to both set of primers (lanes 5 and 6; 12 and 13). 
 
 
159 
 
 
 
 
Figure 3.48.  PCR amplification using template plasmid pDL504 and pDL516 to cross check hybrid primer 
specificities: agarose gel electrophoresis of PCR products. 
In the first set of PCR hybrid primers, FT-N1 and RT-N1 specific for cdc13-1 N-terminus deletion modules 
were used with yeast vectors pDL516 (pFA6a-HIS3MX6-PGAL1) and pDL504 (pFA6a-HIS3MX6) 
respectively.  In the second set of PCR hybrid primers, FT-C2 and RT-C2 specific for cdc13-1 C-terminus 
deletion modules were used with yeast vectors pDL504 (pFA6a-HIS3MX6) and pDL516 (pFA6a-HIS3MX6-
PGAL1) respectively.  For each sample, 10 µl of amplicon was examined on a 0.9% agarose gel. 
Lanes M1: 1 kb DNA marker, 500 ng (Invitrogen); 1-2: negative control (NTC without cells or DNA); 
3-4: PCR products using plasmid pDL516 (pFA6a-His3MX6-PGAL1); 5-6: PCR products using plasmid 
pDL504 (pFA6a-His3MX6);  
7: M2 100 bp quantitative DNA marker, 500 ng (NEB); 8-9: negative control (NTC without cells or DNA); 
10-11: PCR products using plasmid pDL 504 (pFA6a-His3MX6); 12-13: PCR products using plasmid 
pDL516 (pFA6a-His3MX6-PGAL1; M2: 100 bp DNA marker, 500 ng (NEB). 
The N-terminus primers resulted in ~1.943 kb amplicons with the pDL516 template (lanes 3 and 4) and 
C-terminus primers resulted in ~1.579 kb amplicon with the plasmid template pDL504 (lanes 10 and 11).  
However, there is a slight amplification with the opposite primers (lanes 5-6, 12 and 13). 
 
3.5.1.1.2.2. PCR amplification of HIS3MX6 modulating DNA for cdc13-1 C-truncation 
Using yeast plasmid DNA pFA6a-HIS3MX6 as a template and hybrid primers (FT-C2 and RT-
C2), PCR was performed to amplify the HIS3MX6 marker module with ADH1 terminator to 
delete the second half of cdc13-1 (1387-2775 nt).  Figure 3.49 represents the result of 
electrophoresis analysis of amplified products and confirms the amplification of the required 
size fragments of approximately 1.6 kb for C-terminus truncation (lanes 3-7). 
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Figure 3.49.  PCR amplification for ADH1-HIS3MX6 modulating DNA for cdc13-1 C-terminus deletion: 
agarose electrophoretic analysis of PCR reaction products. 
cdc13-1 C-terminus deletion modules were amplified using the yeast vector pFA6a-GFP(S65T)-His3MX6 
(pDL504) as a template with hybrid primers FT-C2and RT-C2 and 1x green PCR master mix (Promega) in 
100 µl of reaction volume.  Amplified PCR products (3 µl) from each reaction were analysed on a 0.9% 
agarose gel. 
Lanes M1 and M2: 1 kb DNA marker, (Invitrogen) and 100 bp DNA marker quantitative (NEB), 500 ng 
respectively; 1-2: negative control (NTC) without cells or DNA; 3-7: the C-terminal ADH1-HIS3MX6 
deletion fragment of ~1.6 kb (1.680 kb without the GFP tag) as expected. 
 
3.5.1.1.2.3. Purification of HIS3MX6 modulating DNA for cdc13-1 C-terminus 
truncation 
For purification, the PCR products were extracted with phenol-chloroform followed by ethanol 
precipitation.  The agarose gel analysis of purified and non-purified product is shown in Figure 
3.50.  Lane 1 represents non-purified PCR product whereas lanes 2 exhibits extracted amplicon 
of C-terminus deletion cassettes (ADH1-HIS3MX6 DNA fragment with flanking target 
sequences).  The intensity of the linear DNA product was compared to that of the DNA masses 
of the reference standard (M2) to estimate the yield.  The approximate concentration of purified 
fragment was estimated to be ~30-50 ng/µl according to the quantitative marker (NEB 100 bp 
ladder). 
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Figure 3.50.  Agarose gel analysis of purified PCR amplified products for the cdc13-1 C-terminus deletion 
module (ADH1-HIS3MX6 DNA). 
PCR amplified product (350 µl) was purified by phenol-chloroform extraction and ethanol precipitation.  
The purified and non-purified (3 µl) amplicons were examined on a 0.8% agarose gel. 
Lanes M1 and M2: 1 kb DNA ladder, (Invitrogen) and 100 bp DNA marker quantitative (NEB), 500 ng 
respectively; 1: un-purified DNA from PCR reaction; 2: phenol-chloroform extracted DNA fragment). 
The purified fragment, 3 µl (lane 2) was analysed on a gel along with 3 µl un-purified amplicons (lane 1). 
The approximate concentration of purified fragment was estimated to be ~30-50 ng/µl according to the 
quantitative marker (NEB 100 bp ladder). 
 
3.5.1.2. Preparation of competent cells for transformation 
3.5.1.2.1. Generation and analysis of temperature-resistant (TR) survivors 
Temperature-resistant survivors were generated at high temperature (36°C) as explained earlier 
from cdc13-1 mutant strains DLY 1296 and DLY 1297 (Figures 3.21-3.26.  The strain DLY 
1272 with CDC13 (grown at 36°C) was also used in transformation experiments including 
above mentioned survivors strains. 
The competent cells prepared from these strains were tested for their viability.  Figure 3.51 
shows an example of viability counts in a 50 µl suspension for each strain.  The competent cells 
were also checked for the frequency of spontaneous revertants at 30°C on dropout media 
lacking histidine and tryptophan (for H
+
 and T
+ 
revertants).  The histidine marker did not show 
revertants on medium lacking histidine (data not shown). 
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Figure 3.51.  Viability count of the yeast competent cells. 
The concentrated competent cells from strains (1296-TR, 1297-TR and 1272) were diluted and 50 µl (of 
the three dilutions 10
-6
, 10
-7
 and 10
-8
) were plated on each half of a YEPD plate to estimate the viable 
count.  Cells were cultivated for 5 days at 23°C to get well spaced colonies for counting.  The total 
number of cells in one millilitre was calculated on the basis of colony numbers from 50 µl of 
suspensions.  Strain 1297 showed the highest viable cell number in one millilitre, i.e., 673.66x10
6
 cells 
while the viable cell count in strain 1272 was 497.5x10
6
 cells.  The strain 1296 exhibited the lowest 
viable count i.e., 142.33x10
6
 cells/ml. 
 
3.5.1.2.2. Transformation of cdc13-1 C-terminus deletion module into strain 1296-
TR, 1297-TR and 1272 competent cells 
Transformations of S. cerevisiae strains 1296-TR, 1297-TR and 1272 were carried out 
according to the standard protocol (Materials and Methods).  Freshly prepared competent cells 
previously analysed for viability, marker analysis (Figures 3.21-3.25) and PCR genotyping for 
CDC13 (Figure 3.26) were transformed with purified PCR product specific for C-terminus 
truncation.  Transformation was carried out with ~1.5 µg DNA (40 µl) and 10 µl single stranded 
carrier DNA (sperm DNA) in 100 µl suspension of yeast cells. 
For C-terminus deletion, the putative transformants were selected on histidine- and leucine-
deficient dropout medium for strain 1296-TR (Figure 3.52, 3a and 4a), 1297-TR (3b and 4b) 
and 1272 cells (3c and 4c).  The non-transformed cells from three strains 1296-TR, 1297-TR 
and 1272 were also plated on medium lacking histidine and leucine (H
–
L
–
 medium; as negative 
controls; 1a, 1b and 1c) and on L
–
 medium (as positive controls; 2a, 2b and 2c).  As expected, 
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there was no growth on H
–
L
–
 dropout plates used as a negative control.  However, in case of 
positive control the plates with L
–
 medium showed abundant growth for all these three strains. 
From the first round of selection after transformation, a few colonies grown on H
–
L
–
 medium 
were picked randomly and diluted suspension of these was plated on H
–
L
–
 dropout medium for 
a second round of selection to get the purified colonies.  The media plates with cell suspension 
were incubated for 5-7 days at 30°C.  Figure 3.53 demonstrates the growth shown by his
+
 
transformants with colonies which were picked randomly to screen analytically by PCR to 
verify gene disruption with the integration of the histidine marker module in the genome of the 
relevant strain.  
 
 
 
Figure 3.52.  Transformation of competent cells from strains 1296-TR, 1297-TR and 1272 with cdc13-1 C-
terminus truncation module. 
Freshly prepared competent cells were transformed with purified PCR fragments.  Transformation was 
carried out with ~1.5 µg amplified DNA (40 µl) and 10 µl single stranded carrier DNA (sperm DNA) in 100 
µl suspension of yeast cells.  Transformants were selected on HL-deficient medium in the first rounds of 
selection. Abundant colonies grew after five to seven days of incubation at 30°C.  A few cells were 
picked randomly from different places of plate, diluted in 10 µl of sterile water and spread over the HL-
deficient medium for a second round selection.  
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Figure 3.53.  Selection of H
+
L
+
 transformant colonies for PCR analysis for C-terminus truncation. 
From the first selection, a few cells were picked randomly from different places of plate, diluted in 10 µl 
of sterile water and spread over the HL-deficient media for a second round selection.  
From the second selection, 25 colonies were picked randomly for strain 1272 transformants, and 15 
transformants each for strains 1296-TR and 1297-TR.  Selected colonies were analysed for C-terminus 
deletion and for the genomic integration of the histidine marker with diagnostic PCR directly from 
denatured cells. 
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3.5.2. Confirmation of cdc13-1 disruption and marker module 
integration through analytical PCR 
After a second round of selection, H
+
L
+
 transformants from strains 1296-TR, 1297-TR and 1272 
were analysed by diagnostic PCR for the verification of C-terminus deletion and integration of 
the marker in chromosomal DNA.  In total, 15 transformants each from strains 1296-TR and 
1297-TR and 40 transformants from strain 1272 were analysed for the detection of the C-
terminus (PCR with C1-C2 primers), HIS3MX6 marker module (PCR with H1-H2 primers) and 
finally for the N-terminus (PCR with the N1-N2 primer pair).  
 
3.5.2.1. Screening of cdc13-1 CTΔ::(HIS3MX6) mutants in strain 1296-TR  
3.5.2.1.1. Analytical PCR for the C-terminus 
The 15 histidine-positive transformants (#C1-C15) were analysed by diagnostic PCR for cdc13-
1 CTΔ in strain 1296 survivors.  Gel electrophoresis revealed a fragment of ~276 bp in two 
transformants #C2 and #C8 (Figure 3.54, lanes 9 and 15 respectively) in consonance with 
cdc13-1 (lanes 5-6) or CDC13 (lane 7) indicating the presence of intact cdc13-1 or CDC13.  
However, no amplified products were observed in the other transformants analysed (lanes 8, 10-
14 and 16-22) confirming successful deletion of the cdc13-1 gene by target-guided homologous 
recombination.  As the C-terminus fragment of cdc13-1 should be replaced by a histidine 
cassette resulting in the cdc13-1-CTΔ::ADH1-HIS3MX6 construct, the correct integration of 
HIS3MX6 was confirmed by analytical PCR with marker-specific primers H1 and H2.  
 
3.5.2.1.2. Analytical PCR for HIS3MX6 modular marker 
Figure 3.55 confirmed the presence of the histidine marker module in mutants examined 
for CTΔ (lanes 8, 10-14 and 16-22).  The H+L+ transformant #C2 (lane 9), showing 
discrete gene specific band for the C-terminus did not amplify the marker (spontaneous 
revertant), whereas transformant #C8 (lane 15) with discrete marker specific fragment 
confirmed the integration of the marker without deleting the C-terminus, indicating its 
non-homologous recombination. 
 
3.5.2.1.3. Analytical PCR for the N-terminus 
In cdc13-1-CTΔ::ADH1-HIS3MX6 mutants, the presence of the intact N-terminus was 
confirmed by a second PCR with N1 and N2 gene-specific primers for the N-terminal half.  
Analytical gel shows the presence of ~378 bp fragments in the 15 tested transformants (Figure 
3.56A, lanes 7-21).  The EcoR1 digestion of amplified N-terminus fragments produced two 
discrete fragments (Figure 3.56B, lanes 7-21) of ~219 bp and ~159 bp corroborating the N-
terminus half of the cdc13-1 mutant in CTΔ::ADH1-HIS3MX6 construct of strain 1296-TR.  
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Figure 3.54.  PCR screening (1-15) for cdc13-1 C-terminus deletion (CTΔ) in strain 1296-TR: agarose gel 
electrophoresis of PCR products (C1 and C2 primer pair). 
The putative, cdc13-1 CTΔ transformants (#C1-15) were screened by PCR for the cdc13-1 C-terminus.  
The PCR was carried out with C1 and C2 diagnostic primers in a 25 µl volume with 2-3 µl of denatured 
genomic DNA from cells.  The PCR products (10 µl) were examined on a 1.5 % agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strain 
2607 and 2608 (cdc13Δ) respectively; 5-7: PCR products from cells of strains 1296-TR, 1297-TR (cdc13-1) 
and 640 (WT, CDC13); 8-22: PCR products from cells of transformants #C1-C15 in strain 1296-TR 
(expected cdc13-1-CTΔ mutants); M2: 100 bp ladder, 500 ng (Invitrogen). 
Gel analysis showed fragment of ~276 bp in two clones C2 and C8 (lanes 9 and 15).  All other CTΔ 
mutants examined, lanes 8, 10-14 and 16-22) exhibited no fragments indicating the absence of the C-
terminus. 
 
 
Figure 3.55.  PCR confirmation of HIS3MX6 marker module in cdc13-1-CTΔ mutants (1-15) in strain 1296-
TR: agarose gel electrophoretic analysis of PCR products (H1 and H2 primer pair). 
The putative, cdc13-1 CTΔ transformants (#C1-15) were screened by PCR for the HIS3MX6 marker 
module.  The PCR was carried out with H1 and H2 primers in a 25 µl volume with 2 µl of denatured 
genomic DNA from cells.  The PCR products (10 µl) were examined on a 0.8 % agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 2: NTC, -ve control; 3-4: PCR products from cells of strains 
1296-TR, 1297-TR (cdc13-1 mutant), control; 5-7: PCR products with plasmid DNA (pDL504 with 
HIS3MX6) +ve control; 8-22: PCR products from cells of transformants #C1-C15 in strain 1296-TR 
(anticipated cdc13-1-CTΔ mutants); M2: 100 bp ladder, 500 ng (Invitrogen). 
Gel analysis showed fragments of ~1.579 kb in all tested clones except one (#C2, lane 9), indicating the 
replacement of the C-terminus by the histidine marker integrated by homologous recombination.  
However, clone #C8 (lane 15) exhibited a fragment of 1.5 kb (HIS3MX6) indicating its non-homologous 
genomic integration without CTΔ. 
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Figure 3.56.  PCR confirmation of cdc13-1 N-terminus in cdc13-1-CTΔ mutants (1-15) of strain 1296-TR: 
electrophoretic analysis of uncut and cut PCR products (amplified using N1 and N2 primer pair). 
The cdc13-1 CTΔ clones (#C1-15) were screened by diagnostic PCR using CDC13 N-terminus-specific 
primers (N1 and N2).  The PCR products, uncut and digested (7 µl) were examined on a 1.5 % agarose 
gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strains 
2607 and 2608 (cdc13Δ), -ve control; 5-6: PCR products from cells of strains 1296-TR (cdc13-1) and 640 
(WT, CDC13) respectively; 7-21: PCR products from cells of transformants #C1-C15 with strains 1296-TR 
(expected cdc13-1-CTΔ mutants); 22:  mistake load; M2: 100 bp ladder, 500 ng (Invitrogen). 
Gel electrophoresis showed the ~378 bp fragment in all clones examined (#C1-C15, lanes 7-21 
respectively), confirming the presence of the intact N-terminus in CTΔ mutants. 
(A) Analytical gel showing uncut PCR fragment from N-terminus (amplified using N1 and N2 primers).  
(B) Analytical gel showing EcoR1 digested N-terminus specific PCR products. 
 
 
 
 
 
 
 
 
 
 
 
 
 
168 
 
 
3.5.2.1.4. Screening of cdc13-1 CTΔ::(HIS3MX6) mutants in strain 1297-TR  
3.5.2.1.4.1. Analytical PCR for the C-terminus 
The 15 histidine-positive transformants were analysed by diagnostic PCR for cdc13-1 CTΔ in 
strain 1297 survivors.  Gel analysis did not detect any fragments of ~276 bp in any of the clones 
examined (Figure 3.57, lanes 8-22 with respect to clones #C1-C15) indicating deletion of the 
cdc13-1 gene by target-guided homologous recombination.  As the C-terminus fragment of 
cdc13-1 is expected to be replaced by a marker cassette of HIS3MX6 in the cdc13-1-
CTΔ::ADH1-HIS3MX6 construct, the correct integration of HIS3MX6 was verified by 
analytical PCR with the marker-specific H1 and H2 primers.  
 
3.5.2.1.4.2. Analytical PCR for the HIS3MX6 modular marker 
Figure 3.58 confirmed the presence of the histidine marker module in all transformants 
examined for CTΔ (lanes 8-22).  The H+L+ transformants #C1-C15 manifested discrete bands of 
1.5 kb marker module with varying intensity, proving the integration of the marker in 
chromosomal DNA replacing the C-terminus, by homologous recombination. 
 
3.5.2.1.4.3. Analytical PCR for the N-terminus 
In cdc13-1-CTΔ::HIS3MX6 mutants, the presence of the intact N-terminus was confirmed by 
diagnostic PCR using N1 and N2 gene-specific primers from the N-terminal half.  Analytical 
gel shows the presence of ~378 bp fragments in all clones examined (Figure 3.59A, lanes 7-21).  
The restriction analysis of the N-terminus amplified fragments with EcoR1 enzyme produced 
two distinct fragments (Figure 3.59B, lanes 7-21) of ~219 bp and ~159 bp corroborating the N-
terminus specific fragment of the cdc13-1 mutant in CTΔ::HIS3MX6 construct of strain 1297-
TR.  
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Figure 3.57.  PCR screening (1-15) of cdc13-1 C-terminus deletion (CTΔ) in strain 1297-TR: agarose gel 
electrophoresis of C1 and C2 amplified PCR products. 
The putative, cdc13-1 CTΔ transformants (#C1-15) were screened by PCR for the cdc13-1 C-terminus 
with appropriate positive (lanes 5-7) and negative controls (lanes 1-4).  The PCR products (10 µl) were 
examined on a 1.5 % agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strain 
2607 and 2608 (cdc13Δ); 5-7: PCR products from cells of strain 1296-TR, 1297-TR (cdc13-1) and 640 (WT, 
CDC13); 8-22: PCR products from cells of transformants #C1-C15 in strain 1297-TR (expected cdc13-1-
CTΔ mutants); M2: 100 bp ladder, 500 ng (Invitrogen). 
The analytical gel did not show any fragments of ~276 bp in any of the clones examined (#C1-C15 with 
respect to lanes 8-22) indicating the deletion of the C-terminus. 
 
 
 
Figure 3.58.  PCR confirmation of the HIS3MX6 marker module in cdc13-1-CTΔ mutants (1-15) in strain 
1297-TR: electrophoretic analysis of PCR products (amplified using H1 and H2 primer pair). 
The presumptive, cdc13-1 CTΔ transformants (#C1-15) were screened by diagnostic PCR for the 
HIS3MX6 marker module.  The PCR products (10 µl) were examined on a 0.8 % agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve controls; 3-4: PCR products from cells of strains 
1296-TR, 1297-TR (cdc13-1 mutant), controls; 5-6: PCR products with plasmid DNA (pDL504 with 
HIS3MX6), +ve control; 7: blank; 8-22: PCR products from cells of transformants #C1-C15 in strain 1296-
TR (expected cdc13-1-CTΔ mutants); M2: 100 bp ladder, 500 ng (Invitrogen). 
Gel electrophoresis confirmed the presence of ~1.579 kb fragments (the histidine marker) in all 
examined clones (C1-C15 with respect to lanes 8-22), indicating the deletion of the C-terminus.  The PCR 
products (10 µl) were examined on a 0.8 % agarose gel.  
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Figure 3.59.  PCR confirmation of cdc13-1 N-terminus in cdc13-1-CTΔ mutants (1-15) in strain 1297-TR: 
electrophoretic analysis of uncut and cut PCR products (amplified using N1 and N2 primer pair). 
The cdc13-1 CTΔ clones (#C1-15) were screened by diagnostic PCR using CDC13 N-terminus-specific 
primers.  The PCR products, uncut and EcoR1 digested (7 µl), were examined on a 1.5 % agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strains 
2607 and 2608 (cdc13Δ); 5-6: PCR products from cells of strains 1297-TR, (cdc13-1) and 640 (WT, CDC13) 
respectively; 7-21: PCR products from cells of transformants #C1-C15 in strain 1297-TR (confirmed 
cdc13-1-CTΔ clones); M2: 100 bp ladder, 500 ng (Invitrogen). 
Gel electrophoresis confirmed fragments of ~378 bp in all clones examined #C1-C15 (lanes 7-21 
respectively), indicating the presence of the intact N-terminus with EcoR1 site in CTΔ::ADH1-HIS3MX6 
constructs. 
(A) Analytical gel showing uncut PCR fragment from N-terminus (amplified using N1 and N2 primers).  
(B) Analytical gel showing EcoR1 digested N-terminus specific PCR products. 
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3.5.2.2. Screening of CDC13 CTΔ::(HIS3MX6) in mutants of strain 1272  
3.5.2.2.1. Analytical PCR for the C-terminus 
In total, 77 histidine-positive transformants were analysed by diagnostic PCR for CDC13-CTΔ 
in strains 1272 (data are shown for 40 transformants, #C1-C40).  The gel analysis confirmed 
amplified fragments of ~276 bp with the C-terminus-specific primers in all of the examined 
transformants (Figures 3.60, 3.63 and 3.66, lanes 10-19, 8-22 and 8-22 with respect to 
transformants #C1-C10, C11-C25 and C26-C40 respectively) indicating the presence of the 
intact CDC13 gene. 
The genomic integration of the HIS3MX6 marker module was diagnosed by analytical PCR, 
using marker-specific primers. 
 
3.5.2.2.2. Analytical PCR for the HIS3MX6 modular marker 
Further analysis of the histidine-positive transformants with marker-specific primers H1 and H2 
revealed that the marker cassette of HIS3MX6, did not replaced the C-terminus of CDC13 
although it integrated within genome of a few of the transformants.  Figure 3.61 (lanes 10-13 
and 15), Figure 3.64 (faint bands in lanes 8, 11, 13-14, and 17-20), and Figure 3.67 (lane 19) 
showed the size-specific band of~ 1.5 kb with different intensity and confirmed the presence of 
the histidine marker module in a few transformants examined for CTΔ.  However, further 
analysis of these transformants for the CDC13 N-terminus could determine the nature of these 
H
+
L
+
 transformants, i.e., whether the result of spontaneous gene conversion or non-homologous 
recombination of the HIS3MX6 marker within genome.   
 
3.5.2.2.3. Analytical PCR for the N-terminus 
In histidine-positive mutants, the presence of the intact N-terminus was confirmed by diagnostic 
PCR with N1 and N2 gene-specific primers for the N-terminal half of CDC13.  Analytical gel 
(Figure 3.62 (lanes 9-18) and Figure 3.65 (lanes 8-22) confirmed the presence of ~378 bp 
fragments in transformants C1-C25 examined.  The restriction analysis of N-terminus amplified 
fragments with EcoR1 enzyme did not cut the ~378 bp fragment (Figure 3.62B, lanes 9-18) 
corroborating the N-terminus specific fragment of CDC13 (not cdc13-1 mutant) in H
+
L
+
 
transformants of strain 1272.  The conformation of the full CDC13 indicates the generation of 
the tested transformants by non-homologous recombination rather than gene conversion.  
Overall, the results of PCR analysis of forty histidine
+
 transformants in strain 1272 did not 
confirm any CTΔ mutant. 
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Figure 3.60.  PCR screening (1-10) for CDC13 C-terminus deletion (CTΔ) in strain 1272: agarose gel 
electrophoresis of C1-C2 amplified PCR products. 
The putative, CDC13-CTΔ transformants (#C1-10) were screened by PCR for the CDC13 C-terminus with 
appropriate positive (lanes 5-9) and negative controls (lanes 1-4).  The PCR amplified products (10 µl) 
were examined on a 1.5 % agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strain 
2607 and 2608 respectively (cdc13Δ); 5-6: PCR products from cells of strain 1296-TR and 1297-TR 
respectively (cdc13-1); 7-9: PCR products from cells of strain 1272 and 640 (WTx2) respectively (CDC13); 
10-19: PCR products from H
+
L
+
 cells of transformants #C1-C10 in strain 1272; 20: sample #C10 repeated; 
M2: 100 bp ladder, 500 ng (Invitrogen). 
The analytical gel shows amplified fragments of ~276 bp in all of the transformants examined (#C1-C10 
with respect to lanes 10-19) indicating the presence of C-terminus.   
 
 
 
Figure 3.61.  PCR confirmation of the HIS3MX6 marker module in CDC13-CTΔ mutants (1-10) in strain 
1272: electrophoretic analysis of PCR products (amplified using H1and H2 primers). 
The H
+
L
+
 CDC13-CTΔ transformants (#C1-10) were screened by diagnostic PCR for the HIS3MX6 marker 
module.  The PCR products (10 µl) were examined on a 0.8 % agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strains 
1296-TR, 1297-TR (cdc13-1 mutant), -ve control; 5: PCR products from cells of strains 1272 (CDC13), -ve 
control; 6-7: PCR products with DNA of plasmid (pDL504 with HIS3MX6), +ve control; 8-9: blank; 10-19: 
PCR products from H
+
L
+
 cells of transformants #C1-C10 in strain 1272 (expected CDC13-CTΔ mutants); 
M2: 100 bp ladder, 500 ng (Invitrogen). 
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Gel analysis confirmed the presence of ~1.579 kb fragment in five out of the 10 clones examined (#C1-
C4 and C6 with respect to lanes 10-13, and 15).  However, this does not indicate the deletion of the C-
terminus by the histidine marker. 
 
 
 
Figure 3.62.  PCR confirmation of the CDC13 N-terminus mutants (1-10) in histidine
+
 transformants in 
strain 1272: electrophoretic analysis of uncut and cut PCR products (amplified using N1-N2 primers). 
The putative CDC13-CTΔ, H
+
L
+
 transformants (#C1-C10) were screened by diagnostic PCR for N-terminus 
specific fragment.  The PCR products of uncut and digested products (7 µl) were examined on 1.5 % 
agarose gels. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strains 
2607 and 2608 (cdc13Δ) respectively; 5-6: PCR products from cells of strains 1272, (CDC13) and 640 (WT, 
CDC13) respectively; 7-8: PCR products from cells of strains 1296-TR, (cdc13-1) and 1297-TR (cdc13-1) 
respectively; 9-18: PCR products from cells of H
+
L
+
 transformants #C1-C10 in strain 1272 (cdc13-1-C-
terminus); M2: 100 bp ladder, 500 ng (Invitrogen). 
Gel analysis confirmed fragment of ~378 bp in all clones examined (#C1-C10, lanes 9-18 respectively), 
indicating the presence of the intact N-terminus in the tested H
+
L
+
 transformants. 
(A) Analytical gel showing uncut PCR amplified fragmens from N-terminus (amplified using N1 and N2 
primers). 
(B) Analytical gel showing EcoR1 digested PCR products of the N-terminus. 
 
 
 
 
174 
 
 
 
 
Figure 3.63.  PCR screening (11-25) for CDC13 C-terminus deletion (CTΔ) in strain 1272: agarose gel 
electrophoresis of PCR products (C1 and C2-specific primers). 
The putative, CDC13-CTΔ transformants (#C11-C25) were screened by PCR for the CDC13 C-terminus 
with appropriate positive (lanes 5-7) and negative controls (lanes 1-4).  The PCR products (10 µl) were 
resolved on a 1.5 % agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strain 
2607 and 2608 (cdc13Δ) respectively; 5: PCR products from cells of strain 1296-TR (cdc13-1); 6-7: PCR 
products from cells of strain 1272 and 640 (WT) CDC13, respectively; 8-22: PCR products from cells of 
transformants #C11-C25 in strain 1272; M2: 100 bp ladder, 500 ng (Invitrogen). 
Analytical gel shows fragments of ~276 bp in all of the H
+
L
+
 transformants examined (C11-C25 with 
respect to lanes 8-22) indicating the intact C-terminus. 
 
 
 
Figure 3.64.  PCR confirmation of the HIS3MX6 marker module in CDC13-CTΔ mutants (11-25) in the 
strain 1272: electrophoretic analysis of PCR products (amplified using H1 and H2 primers). 
The H
+
L
+
 putative CDC13-CTΔ transformants (#C11-C25) were screened by PCR for the HIS3MX6 marker 
module.  The PCR products (10 µl) were resolved on a 0.8 % agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strains 
1296-TR, 1297-TR (cdc13-1 mutant) respectively; 5: PCR products from cells of strain 1272, (CDC13); 6-7: 
PCR products from DNA of plasmid (pDL504 with HIS3MX6) +ve control; 8-22: PCR products from cells of 
transformants #C11-C25 in strain 1272 (expected CDC13-CTΔ mutants); M2: 100 bp ladder, 500 ng 
(Invitrogen). 
Gel analysis showed the presence of a ~1.579 kb fragment (faint bands) in eight out of the 15 clones 
examined (C11, C14, C16-17 and C20-C23 with respect to lanes 8, 11, 13, 14 and 17-20) indicating its 
non-homologous genomic integration without CTΔ. 
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Figure 3.65.  PCR confirmation of CDC13 N-terminus in histidine
+
 transformants (11-25) in strain 1272: 
electrophoretic analysis of uncut products (amplified with N1 and N2 primers). 
The CDC13-CTΔ transformants (#C11-C25) were screened by diagnostic PCR for the CDC13 N-terminus.  
The PCR products uncut (7 µl) were resolved on 1.5 % agarose gels. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve controls; 3-4: PCR products from cells of strains 
2607 and 2608 (cdc13Δ), respectively; 5: PCR products from cells of strains 1296-TR, (cdc13-1) ; 6-7: PCR 
products from cells of strains 1272, (CDC13) and 640 (WT, CDC13) respectively; 8-22: PCR products from 
cells of transformants #C11-C25 of the strain 1272 (confirmed cdc13-1-C-terminus); M2: 1 kb ladder, 
500 ng (Invitrogen). 
Gel analysis confirmed the presence of ~378 bp fragment in all 15 transformants examined (#C11-C25, 
lanes 8-22 respectively), indicating the presence of the intact N-terminus in his
+
 transformants. 
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Figure 3.66.  PCR screening for CDC13 C-terminus deletion (CTΔ) transformants (26-40) in strain 1272: 
agarose gel electrophoresis of PCR products (amplified with C1 and C2 primers). 
The presumptive his
+
 CDC13-CTΔ transformants (15) were screened by PCR for the CDC13 C-terminus 
deletion using appropriate positive (lanes 5-7) and negative controls (lanes 1-4).  The PCR products (10 
µl) were examined on a 1.5 % agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve control; 3-4: PCR products from cells of strain 
2607 and 2608 (cdc13Δ), respectively; 5: PCR products from cells of strain 1296-TR (cdc13-1); 6-7: PCR 
products from cells of strain 1272 and 640 (WT, CDC13), respectively; 8-22: PCR products from cells of 
transformants #C26-C40 of strain 1272; M2: 1 kb ladder, 500 ng (Invitrogen). 
The analytical gel confirmed amplified fragments of ~276 bp in all of the transformants examined (C26-
C40 with respect to lanes 8-22) indicating the presence of the intact C-terminus.   
 
 
 
Figure 3.67.  PCR confirmation of the HIS3MX6 marker module in CDC13-CTΔ mutants (26-40) in strain 
1272: electrophoretic analysis of PCR products (amplified with the H1-H2 primer pair). 
 
The presumptive CDC13-CTΔ transformants (#C26-#40) were screened by diagnostic PCR for the 
HIS3MX6 marker module.  The PCR products (10 µl) were examined on a 0.8 % agarose gel. 
Lanes M1: 1 kb ladder, 500 ng (Invitrogen); 1-2: NTC, -ve controls; 3-4: PCR products from cells of strains 
1296-TR, 1297-TR (cdc 13-1 mutant) respectively, -ve controls; 5: PCR products from cells of strains 
1272, cells (CDC13), -ve control; 6-7: PCR products with DNA of plasmid (pDL504 with HIS3MX6), +ve 
control; 8-22: PCR products from cells of transformants #C26-C40 in strain 1272 (expected CDC13-CTΔ 
mutants); M2: 1 kb ladder, 500 ng (Invitrogen). 
Gel analysis confirmed the presence of ~1.579 kb fragments in one (C37 with respect to lane 19) out of 
15 tested his
+
 transformants.  However, the presence of histidine fragment does not indicate the 
deletion of the C-terminus (PCR
+
 for C-terminus). 
177 
 
 
3.5.3. Summary of C-terminus truncation results 
The results on cdc13-1 C-terminus deletion with the HIS3MX6 marker module and PCR 
analysis to confirm the correct mutants (CTΔ::HIS3MX6) are summarised in Table 3.5.  The 
data below present numbers of clones generated in all three strains, 1296-TR, 1297-TR and 
1272 as a result of homologous recombination with gene-specific guide oligonucletides. 
 
Table 3.5.  Comparative analysis of histidine-positive transformants for C-terminus deletion for cdc13-1 
and CDC13 strains. 
 
Analysis of C-terminus truncation with ADH1-HIS3MX6 module (pDL504) 
 
Selected clones in DLY 
strains 
1296-TR 
(cdc13-1) 
1297-TR 
(cdc13-1) 
1272 
(CDC13) 
1 H
+
L
+
 transformants 
analysed for CTΔ 
15 15 77 
2 PCR
+
 for C-terminus 
(C1-C2 primer pair) 
2 0 77 
3 PCR
+
 for HIS3MX6 
(H1-H2 primer pair) 
14 15 14 
4 True mutant/ 
CTΔ::HIS3 construct 
13 (86.67%) 15 (100%) 0 % 
5 False positive 
H
+
L
+
 revertants) 
2 (13.33%) 0 % 77 (100%) 
6 Target specific 
homologous 
recombination (HR) 
13 (86.67%) 15 (100%) 0% 
7 Non homologous 
recombination (NHR) 
1 (6.67%) 
 
0 % 14 (18.18%) 
(C1-4, 
C6,C11,C14, 
C16, C17, C20-
C23, C37*) 
8 Name of the 
constructs 
generated  
C1,C3-C7, C9-
C15 
C1-C15 - 
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3.6. Genetic crosses 
In the past, genetic crosses were performed mainly to map different genes on chromosomes and 
to estimate the genetic distance between the mapped genes.  At present, genetic crosses in yeast 
are carried out to generate new combinations of known mutations arising as a consequence of 
meiotic recombination.  Analysis of newly derived deletion mutants can provide insights into 
gene function.  In order to monopolise on this technology, two classical techniques were 
selected for the following studies; genetic crossing and the separation of spores by 
micromanipulation, to yield new deletion mutants.  
 
3.6.1. Haploid strain crosses and micromanipulation 
A number of crosses were performed in this study in an attempt to generate new combinations 
of mutations of capping proteins from the obtained mutations.  A representative example has 
been shown here to show the generation and analysis of diploids and haploids.  Yku70 is 
another important telomere capping protein beside Cdc13 and Stn1.  In order to study the 
impact of Yku70 in the STN1 deletion mutants, crosses were performed to obtain deletion 
combinations, stn1::HIS exo1::LEU2 yku70::URA3 (H
+
L
+
U
+
).  Other desired deletion 
combinations was stn1::HIS exo1::LEU2 (H
+
L
+
). 
 
Two crosses were carried out by mixing a loopful of culture from MATa (strain 3345; MATa 
yku70::URA3) and MATα (strain 2684/2685; MATα cdc13::HIS stn1::HIS exo1::LEU2 
rad24::TRP) (Figure 3.68A) on nutrient rich medium YEPD plates and incubated at 28°C for a 
minimum of 8 hours (Figure 3.68B).  The resulting diploid cells were selected on dropout media 
without complemented for four auxotrophies.  Parental strains were used as controls (Figure 
3.68A and C).  Only diploid cells grew on dropout medium through complementation by 
compensating nutrients, an indicative of a successful cross.  Diploid cells were purified through 
2-3 passages (Figure 3.68C), single colonies were selected, grown for sporulation and for 
micromanipulation analysis. 
 
Diploids cells were analysed by sporulating, saturated cultures for tetrad formation in potassium 
acetate medium (Figure 3.69A and B).  In total, 82 tetrads were analysed by dissecting four-
spore tetrads and isolating individual cells by micromanipulation.  Germination of 31 spores out 
of 328 cells isolated, revealed low viability of micromanipulated cells (~9%).  Further analysis 
of the 31 viable spores by replica plating for genotypic markers segregated all spores into 6 
groups with the gene combinations presented in Table 3.6 
 in correlation with Figure 3.70. 
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Figure 3.68.  Crosses between haploid strains 3345 and 2684/2685 and purification of diploid cells by 
sub culturing. 
(A) Growth of parental strains on YEPD medium. 
(B) Crosses of S. cerevisiae strain DLY 3345, Ura
+
 (MATa yku70::URA3) with DLY strains 2684 or 2685, 
HIS
+
, LEU
+
 and TRP
+
 (MATα cdc13::HIS stn1::HIS exo1::LEU2 rad24::TRP), on YEPD plates to generate 
diploid cells. 
(C) Selection of diploids cells on dropout medium lacking histidine, leucine, tryptophan and uracil.  The 
parental cells did not grow on this selective medium.  The selected diploids cells were further purified by 
sub culturing on dropout medium without four essential nutrients. 
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Figure 3.69.  Sporulation of diploid culture (NS-C2, 3345 x 2685). 
(A) Saturated cultures with G1-arrested ovoid cells, sporulation in 1% potassium acetate buffer. 
(B) Tetrads with four spores as examined with a phase contrast microscope. 
Diploid cultures were grown to saturation at 28°C in YEPD broth (approximately two days).  Saturated 
cultures were sporulated in 1% potassium acetate buffer.  Tetrads with four cells were examined with a 
phase contrast microscope.  Sporulated cells (asci) were treated with glusulase enzyme to digest sac 
surrounding tetrads at 30°C for 8 to 10 minutes.  Micromanipulation was carried out to separate spores 
(ascospores) from digested tetrads for genotype analysis by using a dissecting microscope with a 
micromanipulator attached (Singers).  The pictures were taken with Zeis KF microscope at a 
magnification of 400x fitted with a Nikon Coolpix 4500 camera (4 megapixels 4x optical zoom).  
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Genotype assessment on the basis of growth on dropout media 
Marker 
combinatio
n 
Growth patterns on dropout media Spore number ID 
-
Histidi
ne 
 
-Leucine 
 
-
Tryptopha
n 
 
-Uracil 
 
1.  HLT
U 
+/+++
+ 
+/++++ +/++++ +/+++
+ 
1, 2, 3, 5, 11, 12, 15, 16, 17, 
18, 19, 20, 23, 24, 29, 30, 31 
2.  HT +/+++
+ 
- +/++++ - 4, 6, 7, 8 
3.  T - - +/++++ - 9, 10, 25, 28 
4.  LT - +/++++ +/++++ - 13 
5.  LTU - +/++++ +/++++ +/+++
+ 
26, 27 
6.  HLT +/+++
+ 
+/++++ +/++++ - 14, 21, 22 
 
Figure 3.70.  Replica plating on YEPD and dropout media for random spore genetic analysis revealed six 
groups of genetic combinations. 
In total, 82 tetrads were dissected from sporulated cultures.  The cells separated by micromanipulation, 
showed low viability (31 cells germinated out of 328 showing ~9% viability).  Viable spores were replica 
plated on dropout media for marker analysis.  Genotypes were assessed on the basis of marker 
combination.  These combinations (1-6) were further analysed for haploid or diploid cell status on 
sporulating medium: 0.3-0.5% anhydrous sodium acetate with 1.5 % agar (Fowell, 1952). 
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Table 3.6.  Assessment of genetic combinations on the basis of auxotrophic markers. 
 Marker 
combin
ation 
Genotype assessed Sp
or
es 
Frequ
ency  
(%) 
1.  HLTU cdc13::HIS and/or stn1::HIS exo1::LEU2 
rad24::TRP yku70::URA3 
17 55 
2.  HT cdc13::HIS &/ stn1::HIS rad24::TRP 4 13 
3.  T rad24::TRP 4 13 
4.  LT exo1::LEU2 rad24::TRP 1 3 
5.  LTU exo1::LEU2 rad24::TRP yku70::URA3 2 6 
6. 6 HLT cdc13::HIS and/ stn1::HIS exo1::LEU2 
rad24::TRP 
3 ~10 
 
The first group incorporated the gene combination (cdc13::HIS and/ stn1::HIS exo1::LEU2 
rad24::TRP yku70::URA3) and contained the maximum number of spores (17 out of 31).  The 
other groups include one to four spores, representing less frequent gene combinations.  All 
groups were further investigated for haploid or diploid cell status on sporulating media.  
Microscopic examination revealed the nature of all cells in first group diploid rather than 
haploid by the formation of tetrads typical of diploids on sporulating medium. 
 
All spores from group 2 and group 6 were analysed for the presence or absence of CDC13 and 
STN1 genes.  The haploids cells were purified by sub-culturing on dropout medium.  The 
freshly grown cells were analysed by two parallel PCR to detect CDC13 (N-terminus) and STN1 
(full gene).  Two haploids (H
+
L
+
T
+
) #14 and #21 confirmed the presence of wild type CDC13 
with the deletion of the STN1 gene.  These haploids with resulting genotype CDC13 stn1::HIS 
exo1::LEU2 rad24::TRP1 were examined for their chronological life span and growth 
sensitivity to different genotoxic agents. 
 
However no required combination of yku70 with H
+
L
+
U
+
 (stn1::HIS exo1::LEU2 
yku70::URA3) was obtained in these crosses.  Further crosses are required to achieve the full 
complement of required gene combinations by increasing the viability of isolated spores.   
A number of crosses were carried out to obtain the required combinations of genes (CDC13 
stn1::HIS exo1::LEU2) in the absence of rad24, and quite a few tetrads were dissected to 
analyse the resulting haploids (~100 tetrads with ~400 spores).  The viable hybrids were 
obtained by selection on minimal medium.  However, the putative hybrids could not be 
achieved (either not propagated or occur with very low frequency).   
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In addition haploid cells from strain 1296 (mating type a) harbouring cdc13-1 N-truncated 
mutation were also crossed to cells from strain 1297 (mating type α) containing cdc13-1 C-
truncated mutation.  The resulting diploids were analysed for marker analysis and also for 
CDC13 by detecting N- and C-terminals through PCR.  Diploids grown for sporulation (three 
times), however, failed to sporulate or to form tetrads.  These diploids were further studied for 
their sensitivity to genotoxic agents.  
 
3.6.2. Conclusions: 
The study reveals: 
  potential of the PCR based approach to generate DNA cassette and to detect its integration 
diagnostically in chromosomal DNA directly from cells; 
 the ease of utilisation of PCR-based approach and genetic transformation to generate 
CDC13 full gene deletion mutants using cdc13-1 exo1Δ mutants of yeast S. cerevisiae; 
 disruption of CDC13 N-terminus by PCR generated PGAL1-TRP1 deletion module and its 
confirmation by diagnostic PCR in cdc13-1 exo1Δ mutants; 
 CDC13 C-terminus truncation by ADH1-HIS3MX6 deletion cassette (amplified fragment 
with target oriented flanking regions) and confirmation of its integration into chromosomal 
DNA of cdc13-1 exo1Δ mutants by performing diagnostic PCR; 
 usability of traditional genetic crosses in obtaining new combination of deletions from the 
existing mutations/deletions through tetrad analysis using micromanipulation e.g., 
generation of STN1 deletion mutants (H
+
L
+
T
+
, stn1Δ exo1Δ rad24Δ with CDC13, #14 and 
#21 haploid in this study)  
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Chapter 4 
Sequencing and Telomere length studies 
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4.1. Introduction 
Essential capping proteins, Cdc13 and Stn1 help to maintain genomic integrity by capping 
chromosome at ends in budding yeast.  It makes them indispensable components of telomeres.  
In the absence of Cdc13, uncapped telomeres accumulate excessive single-stranded DNA, arrest 
cell division and die (Garvik et al., 1995).  However, capping proteins Cdc13 and Stn1 are 
dispensable in the absence of exonuclease activities on uncapped telomeres in exo1Δ mutants 
(Zubko and Lydall, 2006) indicating existence of alternative mechanism of telomere capping. 
In yeast, telomeric DNA consists of multiple repeats of nucleotide sequence (TG1-3)n, which 
varies in length in different chromosomes and strains with an average length of about 300-350 
bp (Louis, 1995, Teng and Zakian, 1999).  There are two other sub-telomeric structure or repeat 
elements, Y’ and X (Louis and Haber, 1990).  Adjacent to the telomere, the Y’ elements are 
present in single or in repeats of two to four copies while X elements vary from 300 bp to 3 kb 
in length and are present in almost all telomeres.  In yeast, the length of the telomere is 
maintained by the telomerase enzyme, and in its absence, or in telomerase-defective cells, the 
telomeres are maintained by a Rad52-dependent recombination and Pol32-dependent break-
induced replication mechanisms (Lydeard et al., 2007, Lundblad and Blackburn, 1993).  Two 
examples of such cells are human senescent cells lacking active telomerase, and telomerase 
independent survivor cells in budding yeast.  Both could maintain telomeres by homologous 
recombination by amplifying telomeric and sub-telomeric structures (Teng and Zakian, 1999).   
The telomeric patterns are characterised on the basis of copy number, location and restriction 
site differences of Y’ elements (Louis and Haber, 1990).  In yeast, telomeric repeat lengths are 
determined by digesting genomic DNA with Xho1, which generates ~1.3 kb conserved terminal 
restriction fragments (TRFs) detectable by Southern blot hybridisation (Parenteau and 
Wellinger, 1999).  In budding yeast, two types of telomeric DNA patterns have been found in 
cells that survive under condition of telomere dysfunctions (survivors).  For example telomerase 
deficient tlcΔ cells (Teng and Zakian, 1999), telomerase deficient human somatic cells or fast 
rate growing colonies in sgs1Δ exo1Δ rad9Δ cdc13Δ yeast cells.  These cells shows growth 
crisis, shortened telomere and post senescence survivors’ accumulation, and maintain their 
telomere using recombination dependent mechanism (Ngo and Lydall, 2010). 
In type I survivors (the more common of the two), subtelomeric Y’ elements are amplified 
followed by very short tracts of terminal TG DNA at the end of chromosomes.  In type II 
survivors, terminal TG1-3 telomeric repeats are amplified and are shown as very long and 
heterogeneous in length with 12 kb or more of TG repeats at the ends of chromosomes (Teng 
and Zakian, 1999, Signon et al., 2001, Chen et al., 2001).  Type I telomeric patterns can be 
converted to type II that can return to wild type length upon the reintroduction of telomerase.  
The yeast type II survivors resemble human ALT cells as both contain long, heterogenous 
 186 
 
telomeric repeats (Bryan et al., 1997, Teng and Zakian, 1999).  Both type II and human ALT 
cells amplify their telomeric DNA through recombination dependent DNA replication that 
might involve extrachromosomal circular DNA containing telomeric repeat elements (Henson et 
al., 2009, McEachern and Haber, 2006).  In yeast, the type II telomeric DNA mimics immortal 
or cancerous cells of humans that also maintain telomeric DNA in the absence of telomerase.  
The Exo1 exonuclease is considered to be an initiator of the recombination process in type I and 
type II survivors and generates the substrate for the recombination process in the absence of 
telomerase (Maringele and Lydall, 2004).  In yeast, the Southern blot hybridisation pattern with 
restriction endonuclease-digested genomic DNA is used to determine telomeric DNA patterns, 
either of type I or Type II, on the basis of fragment sizes.  In this study to characterise telomeric 
DNA in different deletion mutants, genomic DNA was extracted, digested with XhoI restriction 
enzyme (recognition site within the Y’ fragment) and was subjected to Southern blot analysis 
with the Y’+TG probe to examine telomere and Y’ lengths. 
 
4.2. Aims and objectives 
This part of the study is devoted to determine the sequence of deletion constructs, analysing the 
telomere length and telomeric DNA patterns in mutants lacking Cdc13 and Stn1 proteins and 
also in N- and C-terminus truncated variants of Cdc13 mutants using Southern blot 
hybridisation. This aim involves the following objectives:  
 
 To sequence the integrated N- and C-terminus deletion constructs. 
 To study the telomere length patterns in the CDC13 and STN1 deletion mutants in the 
presence of EXO1 deletion by using Southern blot hybridisation. 
 To compare the length of telomeres and their DNA patterns in N- and C-terminus 
truncated Cdc13 conditional mutants. 
 To investigate the effects of temperature on the telomere lengths and telomeric DNA 
patterns in N- and C-terminus truncated mutants. 
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4.3. Results 
Yeast strains used in this study are listed in Table 4.1.  The STN1 deletion mutants in the 
presence of EXO1 and RAD24 deletions were generated by crosses followed by tetrad analysis 
using micromanipulation.  The cdc13-1 N- and C-terminus truncated mutants were generated by 
knock-out PCR techniques using survivor strains 1296-TR and 1297-TR.  The truncated 
mutants of cdc13-1 were sequenced to determine their DNA.  
 
Table 4.1.  Yeast strains and mutants used in telomere length experiments. 
 Specification DLY strains Essential genotype 
1.  WT 640 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3 
GAL+ psi+ ssd1-d2 RAD5 
2.  WT 641 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3 
GAL+ psi+ ssd1-d2 RAD5 
3.  cdc13-1 survivor at 36°C 1296-TR MATa exo1::LEU2 cdc13-1 
4.  cdc13-1 N-terminus deletion 
mutants in strain 1296-TR: #2, 
#4, #5, #6, #7, #21 
1296 NTΔ (TRP1) cdc13-1 NTΔ::TRP1 exo1::LEU2 
5.  cdc13-1 C-terminus deletion 
mutants in strain 1296-TR: #3, 
#4, #6, #7,#9, #10 
1296 CTΔ (HIS3) cdc13-1 CTΔ::HIS3MX6 exo1::LEU2 
6.  cdc13-1 survivor at 36°C 1297-TR MATa exo1::LEU2 cdc13-1 
7.  cdc13-1 N-terminus deletion 
mutants in strain 1297-TR: #1, 
#7, #8, #11, #14, #22 
1297 NTΔ (TRP1) cdc13-1 NTΔ::TRP1 exo1::LEU2 
8.  cdc13-1 C-terminus deletion 
mutants in strain 1297-TR: #3, 
#4,#7, #8, #11, #12 
1297 CTΔ (HIS3) cdc13-1 CTΔ:: HIS3MX6 exo1::LEU2 
9.  EXO1 deletion mutant 1272 MATalpha exo1::LEU2 RAD5 
10.  EXO1 deletion mutant 1273 MATalpha exo1::LEU2 RAD5 
11.  STN1 deletion mutant  #14 (haploid) CDC13 stn1::HIS exo1::LEU2 rad24::TRP1 
12.  STN1 deletion mutant  #21 (haploid) CDC13 stn1::HIS exo1::LEU2 rad24::TRP1 
13.  CDC13 deletion mutant 2607 MAT? (initially alpha) cdc13::HIS exo1::LEU2 
14.  CDC13 deletion mutant 2608 MAT? (initially alpha) cdc13::HIS exo1::LEU2 ade2-1 trp1-1 
can1-100 leu2-3,112 his3-11,15 ura3 GAL+ psi+ ssd1-d2 
RAD5 
15.  CDC13 STN1 RAD24 EXO1 
deletion mutant 
2684 MATalpha cdc13::HIS stn1::HIS exo1::LEU2 rad24::TRP 
ade2-1 trp1-1 can1-100 leu2-3,112 his3-11, 15 ura3 GAL+ 
psi+ ssd1-d2 RAD5? 
16.  CDC13 STN1, RAD24 EXO1 
deletion mutant 
2685 MATalpha cdc13::HIS stn1::HIS exo1::LEU2 rad24::TRP  
 
(N- and C-truncated mutants shown in bold were used in CLS studies) 
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4.3.1. DNA sequencing of CDC13 N- and C-terminus deletion 
constructs 
cdc13-1 N- and C-truncated mutants generated using survivor strains 1296-TR and 1297-TR 
were selected by their phenotypic auxotrophies and were confirmed by PCR for cdc13-1 N- and 
C-termini modification and linked markers (as has been described Chapter 3).  In order to 
determine the correct DNA sequence of the constructs for functional studies, six N- and C-
truncated cdc13-1 constructs each for strains 1296 and 1297 were sequenced (twenty four 
clones in total with twelve each for N- and C-terminus deletion). 
 
The rapid and elaborate PCR technique was utilised to prepare sequencing templates from 
genomic DNA of different constructs using the high fidelity Q5 DNA polymerase enzyme 
(NEB).  To overcome the greater error rate of in vitro misincorporation of bases, this 
polymerase enzyme has an associated 3′ → 5′ exonuclease that confers a proofreading function 
by removing errors. 
 
As only the coding region of cdc13-1 gene was modified, two primers flanking the CDC13 were 
designed from upstream and downstream of the gene to amplify an approximately 3 kb 
fragment that contains cdc13-1 sequence (in the case of parental strains 1296- and 1297-TR) or 
the integrated marker linked with the N- and C-truncated part of cdc13-1 in the case of 
constructs.  The 3 kb amplified fragments were subjected to sequencing to determine any 
mutations. 
 
The part is related to sequence N- and C-terminal truncated constructs to confirm the 
nucleotide sequence of truncated Cdc13 (N- or C-terminus) and related markers (TRP1 or 
HIS3) and to analyse the coding sequence of the construct for any amino acid changes. 
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4.3.1.1. Primers design for sequencing cdc13-1 and gene disrupting modular 
DNA 
Three sets of primers were used to sequence ~3 kb region of cdc13-1-NTΔ::TRP1, cdc13-1-
CTΔ::HIS3MX6 constructs and cdc13-1 full gene, from mutants strain 1296-TR and 1297-TR.  
The details of the sequencing primers are shown in Table 4.2. 
Table 4.2.  Sequencing primers used for cdc13-1, N- and C-terminus deletion mutants. 
Primer name 
Construct 
sequenced 
Primer 
length  
(nt) 
Primer sequence  
 
Location of primer 
F1 (for)* CTΔ and NTΔ 22 5’ ACATGCAGCCTTGATTAACGTG 3’ CDC13 upstream region 
F2 (for) CTΔ  20 5’ CAACTCGCAGCTTATGACGC 3’ CDC13 N-terminus 
F3 (F3-HIS3)  
(for) 
CTΔ 20 5’ TGAGGCGCGCCACTTCTAAA 3’ 
HIS3MX6 modular plasmid 
(at the start of ADH1 
terminator) 
R1 (R2-TRP1) 
(rev)* 
NTΔ 20 5 ’CATTTTGAGATCCGGGTTTT 3’ 
TRP1-PGAL1 modular plasmid 
(at the end of GAL1 promoter) 
R2 (rev) NTΔ 22 5’ TTCTGCGAGAGCTGGTGTAGTG 3’ CDC13 C-terminus 
R3 (rev) CTΔ and NTΔ 22 5’ GCATCAAGAAGGAAGGAAGACC 3’ CDC13 downstream region 
N1 (for) cdc13-1 20 5’ ATTGGCACGATGATGATTCC 3’ 
Forward primer from CDC13 N-
terminus half 
N2 (rev) cdc13-1 20 5’ TTCGATCAGGCTTTTCCAGT 3’ 
Reverse primer from CDC13 N-
terminus half 
 
*Forward (for) and reverse (rev) primers 
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4.3.1.1.1. Primers to sequence cdc13-1 amplicons  
The four primers F1, N1, N2 and R3 were selected to sequence cdc13-1 DNA from strain 1296-
TR and 1297-TR.  Figure 4.1 shows the relevant position of each primer within the coding 
sequence and 200 nt upstream and downstream of the cdc13-1.  F1 and N1 are forward primers 
whereas N2 and R3 are reverse primers. 
 
cdc13-1 ORF sequence including the upstream and downstream non-coding region
 
Figure 4.1.  Selection of primers to sequence 3 kb PCR fragment containing cdc13-1 ORF (a reference 
sequence). 
CDC13 ORF (1-2775) with upstream and downstream sequences with each being 200 nucleotides in 
length, accessed from Saccharomyces Genome Database (SGD) (http://www.yeastgenome.org/) and 
primers used to sequence ~3 kb (3175-20=3155) PCR fragment from cdc13-1 mutants (control sequence 
from strains 1296-TR and 1297-TR).  The ATG and TAA represent the start and stop codons of cdc13-1 
replication.  The primers (highlighted sequence) include F1 (22) 5’ACATGCAGCCTTGATTAACGTG 3’, N1 
(20) 5’ATTGGCACGATGATGATTCC 3’, N2 (20) 5’TTCGATCAGGCTTTTCCAGT 3’ (reverse complement of 
ACTGGAAAAGCCTGATCGAA) and R3 (22) 5’ GCATCAAGAAGGAAGGAAGACC 3’ (reverse complement of 
GGTCTTCCTTCCTTCTTGATGC). 
 
 
     SQ   Sequence 3175 BP; 
     TGTGGATTAT TTAATATGTA CATGCAGCCT TGATTAACGT GATTATACTT TTTAAACCTT        60 
     TGATATCCAA ATTTTTCAAC GTCATAAGAG ACGCGAAGGC CTAGTGAGAT GCGAAATGCT       120 
     AATTCAAAAT GGAAATTTAA GAATATATTC ATATATGTTT CTCTTTGGAT ACGAATGACC       180 
     GTGGAAACTA TCGCCTAAAA ATGGATACCT TAGAAGAGCC TGAGTGTCCT CCACATAAAA       240 
     ATCGTATTTT TGTGAGCTCG AGTAAAGATT TTGAAGGCTA TCCCAGCAAA GCAATAGTTC       300 
     CCGTGCAATT CGTGGCGCTT TTAACCTCAA TACACCTGAC TGAAACAAAA TGTTTGCTAG       360 
     GCTTTTCTAA TTTTGAGAGG CGAGGAGATC AATCCCAAGA AGATCAATAT TTAATCAAAC       420 
     TGAAGTTCAA AGATAGGGGC TCGGAGAGGT TAGCCCGGAT CACTATTTCC TTACTTTGCC       480 
     AATACTTTGA TATTGAACTG CCAGATTTAG ATTCTGACTC AGGCGCATCC CCAACAGTAA       540 
     TACTGAGAGA TATTCACCTT GAAAGGTTAT GTTTTTCAAG TTGTAAAGCT TTATATGTAT       600 
     CAAAACACGG GAACTATACT CTATTCTTAG AGGACATAAA ACCGTTGGAT TTGGTAAGTG       660 
     TGATAAGCAC CATATCTACA AAATCGACAA ATAGCAGCAA GCATTCGTCA TCAGAACTTA       720 
     TTTCAGAATG TGATTTGAAC AACTCACTTG TGGATATCTT CAACAATTTA ATAGAAATGA       780 
     ATAGAGACGA GAAAAACAGG TTTAAATTTG TAAAGTTGAT TCACTACGAT ATAGAACTAA       840 
     AAAAGTTCGT TCAAGACCAA CAAAAGGTAT TATCGCAGAA ATCAAAAGCC GCAGCAATTA       900 
     ATCCTTTCTT TGTGCCAAAT AGACTAGGGA TACCTTACAT TGAATCCCAA AACGAATTCA       960 
     ACTCGCAGCT TATGACGCTT AATGTAGATG AACCGACCAC AGATATAAGC AACATGGGAG      1020 
     AGGAAATGCA TGACAGCGCA GATCCCATTG AGGATTCAGA TTCCTCAACT ACCTCCTCTA      1080 
     CCGGGAAATA TTTCAGCTCA AAATCCTACA TCCAGTCACA GACACCTGAA AGGAAAACAA      1140 
     GCGTACCAAA TAATTGGCAC GATGATGATT CCGGAAGCAA GAGGAAGAGA AAGCTTTCTT      1200 
     TCCACAGTCC GAACGCGTCC TCAATCCGCA AAGCCATCAG TTATGAGCAA CTTTCCCTAG      1260 
     CTAGTGTAGG CTCAGTTGAA AGGTTAGAGG GCAAAATTGT TGGCATGAAT TCACCTCAAT      1320 
     TCGCCAGTAT AAATGAGTTC AAATATTGCA CATTGAAATT ATATTTTACG CAGCTCTTAC      1380 
     CAAATGTCCC AGACAAGGTC CTGGTGCCAG GCGTCAATTG CATTGAGATC GTTATCCCGA      1440 
     CGAGAGAGCG AATCTGTGAG CTCTTCGGTG TTTTAAACTG TCAAAGCGAC AAGATATCGG      1500 
     ATATTTTACT ACTGGAAAAG CCTGATCGAA TTTCCGTCGA AGTTGAAAGG ATCCTGTGGG      1560 
     ACAATGACAA GACCGCCAGC CCAGGTATGG CAGTATGGAG TTTGAAGAAC ATTAGCACCG      1620 
     ACACGCAGGC GCAGGCGCAG GTGCAGGTGC CTGCGCAATC GTCGGCGTCA ATCGATCCGT      1680 
     CTCGCACAAG GATGAGCAAA ATGGCAAGGA AAGACCCCAC CATCGAATTC TGTCAGTTGG      1740 
     GACTCGACAC TTTTGAGACC AAATACATAA CAATGTTTGG CATGCTAGTC TCCTGCTCGT      1800 
     TTGATAAACC TGCCTTTATA TCTTTTGTCT TTAGCGATTT TACCAAGAAC GATATCGTCC      1860 
     AAAACTATCT TTACGACAGA TATCTAATAG ATTACGAGAA CAAGTTAGAG CTGAACGAGG      1920 
     GCTTCAAAGC CATCATGTAC AAAAACCAAT TCGAAACGTT TGACTCTAAG CTCAGAAAAA      1980 
     TATTCAACAA CGGGCTAAGA GATCTACAGA ACGGCCGCGA TGAAAACCTT TCGCAATACG      2040 
     GCATAGTTTG TAAGATGAAT ATAAAAGTGA AAATGTACAA CGGCAAATTG AATGCCATTG      2100 
     TGCGCGAATG TGAGCCGGTC CCGCATTCCC AAATAAGCAG CATCGCCTCG CCTTCACAGT      2160 
     GCGAACATTT AAGATTGTTC TACCAACGAG CGTTCAAGAG AATTGGCGAA TCCGCAATTT      2220 
     CACGCTATTT CGAAGAGTAC CGGAGGTTTT TCCCCATACA TAGAAACGGT TCTCATCTCG      2280 
     CGAAACTGAG GTTCGATGAA GTAAAGCATG AACCAAAAAA ATCACCCACT ACACCAGCTC      2340 
     TCGCAGAACA CATACCCGAC CTGAATGCAG ACGTGTCCTC CTTCGATGTA AAGTTCACAG      2400 
     ATATATCTTC TCTCTTGGAC TCCTCGGCTC GCCTCCCGCG CCCACAGCAA ACACACAAGA      2460 
     GCAACACATT ATACAGTTGC GAGGGCCGTA TCATCGCCAT CGAGTACCAC GCATCTGATC      2520 
     TCTGCTTCCA TATCACGAAT GAGCTCCCAC TTTTACAAAC CCGCGGCTTG GCCCCGGAGC      2580 
     GAGTGTTGCA ACTACACATC ATTACCTCCA AGAACTTTGC TTATTTTTTC AACCGCTCAA      2640 
     GCGCCTACTT ACAGCGTCAG CCTCTTGAGG AAAAATATAC GCAATTGGCA CAATTTCTCG      2700 
     GCCATTCATT TAAATTCAAT ATAACCTCCT CGCTCACGCT GTTCCCTGAC ACTACCGTGG      2760 
     CACTCCAGAT CTGGTGCCCA ATTGAATGCA CCTTTCGGGA ATTGCAACAA CAGCTGGCCC      2820 
     ATCCGAAGGT TGCAGCGGCT CCTGATTCAG GGAGTCTTGA TTGCGCAATT AATGCTACCG      2880 
     TCAATCCTCT GCGACTTCTT GCCGCGCAAA ATGGCGTCAC CGTGAAAAAG GAGGAGGATA      2940 
     ATGACGATGA CGCCGGAGCC GTTCCCACCT CGTAAGACAT GATCCGCGCA GCCCAACGCG      3000 
     GCGGTGCCAA ATTGCAGTGA CGTCTCGGAG TAATATAAAA AAAAAAGACC AAATAACCAA      3060 
     ATTTAAGGGT GCTCTGAATA TAAGGGAGTG GAACGTTTTC ACACGAAGGA AAAGGGAAAG      3120 
     AGGGGAGTGG TAAGAAGCAA GAGTCAATGA AAGGTCTTCC TTCCTTCTTG ATGCT           3175 
// 
N1 
N2 
EcoR1 site  
in cdc13-1 
R3 
F1 
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4.3.1.1.2. Primers to sequence the NTΔ amplicon  
Similarly, the primers F1, R1, R2 and R3 were used to sequence the cdc13-1-N-truncated 
construct (NTΔ amplicon, 3 kb).  Figure 4.2 shows the relevant position of each primer within 
200 nt upstream and downstream of the cdc13-1-NTΔ::GAL1-TRP1 region (grey colour 
sequences).  F1 is a forward primer whereas R1, R2 and R3 are reverse primers. 
 
 
 
Figure 4.2.  Selection of primers used to sequence the cdc13-1-N-truncated construct (NTΔ 
amplicon~3267 bp). 
The sequence shows the position of the primers used for sequencing.  The highlighted codons ‘ATG’ and 
‘TAA’ represent start and stop codons for the cdc13-1 C-terminus half replication after N-truncation.  The 
primers include F1 (22) 5’ ACATGCAGCCTTGATTAACGTG 3’, R1 (20) 5’CATTTTGAGATCCGGGTTTT 3’ 
(reverse complement of AAAACCCGGATCTCAAAATG), R2 (22) 5’TTCTGCGAGAGCTGGTGTAGTG 3’ (reverse 
complement of CACTACACCAGCTCTCGCAGAA) and R3 (22) 5’ GCATCAAGAAGGAAGGAAGACC 3’ (reverse 
complement of GGTCTTCCTTCCTTCTTGATGC). 
 
 
     TGTGGATTAT TTAATATGTA CATGCAGCCT TGATTAACGT GATTATACTT TTTAAACCTT        60 
     TGATATCCAA ATTTTTCAAC GTCATAAGAG ACGCGAAGGC CTAGTGAGAT GCGAAATGCT       120 
     AATTCAAAAT GGAAATTTAA GAATATATTC ATATATGTTT CTCTTTGGAT ACGAATGACC       180 
     GTGGAAACTA TCGCCTAAAA GAATTCGAGC TCGTTTAAAC CTCCTTACGC ATCTGTGCGG       240 
     TATTTCACAC CGCAGGCAAG TGCACAAACA ATACTTAAAT AAATACTACT CAGTAATAAC       300 
     CTATTTCTTA GCATTTTTGA CGAAATTTGC TATTTTGTTA GAGTCTTTTA CACCATTTGT       360 
     CTCCACACCT CCGCTTACAT CAACACCAAT AACGCCATTT AATCTAAGCG CATCACCAAC       420 
     ATTTTCTGGC GTCAGTCCAC CAGCTAACAT AAAATGTAAG CTTTCGGGGC TCTCTTGCCT       480 
     TCCAACCCAG TCAGAAATCG AGTTCCAATC CAAAAGTTCA CCTGTCCCAC CTGCTTCTGA       540 
     ATCAAACAAG GGAATAAACG AATGAGGTTT CTGTGAAGCT GCACTGAGTA GTATGTTGCA       600 
     GTCTTTTGGA AATACGAGTC TTTTAATAAC TGGCAAACCG AGGAACTCTT GGTATTCTTG       660 
     CCACGACTCA TCTCCATGCA GTTGGACGAT ATCAATGCCG TAATCATTGA CCAGAGCCAA       720 
     AACATCCTCC TTAGGTTGAT TACGAAACAC GCCAACCAAG TATTTCGGAG TGCCTGAACT       780 
     ATTTTTATAT GCTTTTACAA GACTTGAAAT TTTCCTTGCA ATAACCGGGT CAATTGTTCT       840 
     CTTTCTATTG GGCACACATA TAATACCCAG CAAGTCAGCA TCGGAATCTA GAGCACATTC       900 
     TGCGGCCTCT GTGCTCTGCA AGCCGCAAAC TTTCACCAAT GGACCAGAAC TACCTGTGAA       960 
     ATTAATAACA GACATACTCC AAGCTGCCTT TGTGTGCTTA ATCACGTATA CTCACGTGCT      1020 
     CAATAGTCAC CAATGCCCTC CCTCTTGGCC CTCTCCTTTT CTTTTTTCGA CCGAATTAAT      1080 
     TCTTAATCGG CAAAAAAAGA AAAGCTCCGG ATCAAGATTG TACAGATCTG TAAAGAGCCC      1140 
     CATTATCTTA GCCTAAAAAA ACCTTCTCTT TGGAACTTTC AGTAATACGC TTAACTGCTC      1200 
     ATTGCTATAT TGAAGTACGG ATTAGAAGCC GCCGAGCGGG TGACAGCCCT CCGAAGGAAG      1260 
     ACTCTCCTCC GTGCGTCCTC GTCTTCACCG GTCGCGTTCC TGAAACGCAG ATGTGCCTCG      1320 
     CGCCGCACTG CTCCGAACAA TAAAGATTCT ACAATACTAG CTTTTATGGT TATGAAGAGG      1380 
     AAAAATTGGC AGTAACCTGG CCCCACAAAC CTTCAAATGA ACGAATCAAA TTAACAACCA      1440 
     TAGGATGATA ATGCGATTAG TTTTTTAGCC TTATTTCTGG GGTAATTAAT CAGCGAAGCG      1500 
     ATGATTTTTG ATCTATTAAC AGATATATAA ATGCAAAAAC TGCATAACCA CTTTAACTAA      1560 
     TACTTTCAAC ATTTTCGGTT TGTATTACTT CTTATTCAAA TGTAATAAAA GTATCAACAA      1620 
     AAAATTGTTA ATATACCTCT ATACTTTAAC GTCAAGGAGA AAAAACCCGG ATCTCAAAAT      1680 
     GGCAGTATGG AGTTTGAAGA ACATTAGCAC CGACACGCAG GCGCAGGCGC AGGTGCAGGT      1740 
     GCCTGCGCAA TCGTCGGCGT CAATCGATCC GTCTCGCACA AGGATGAGCA AAATGGCAAG      1800 
     GAAAGACCCC ACCATCGAAT TCTGTCAGTT GGGACTCGAC ACTTTTGAGA CCAAATACAT      1860 
     AACAATGTTT GGCATGCTAG TCTCCTGCTC GTTTGATAAA CCTGCCTTTA TATCTTTTGT      1920 
     CTTTAGCGAT TTTACCAAGA ACGATATCGT CCAAAACTAT CTTTACGACA GATATCTAAT      1980 
     AGATTACGAG AACAAGTTAG AGCTGAACGA GGGCTTCAAA GCCATCATGT ACAAAAACCA      2040 
     ATTCGAAACG TTTGACTCTA AGCTCAGAAA AATATTCAAC AACGGGCTAA GAGATCTACA      2100 
     GAACGGCCGC GATGAAAACC TTTCGCAATA CGGCATAGTT TGTAAGATGA ATATAAAAGT      2160 
     GAAAATGTAC AACGGCAAAT TGAATGCCAT TGTGCGCGAA TGTGAGCCGG TCCCGCATTC      2220 
     CCAAATAAGC AGCATCGCCT CGCCTTCACA GTGCGAACAT TTAAGATTGT TCTACCAACG      2280 
     AGCGTTCAAG AGAATTGGCG AATCCGCAAT TTCACGCTAT TTCGAAGAGT ACCGGAGGTT      2340 
     TTTCCCCATA CATAGAAACG GTTCTCATCT CGCGAAACTG AGGTTCGATG AAGTAAAGCA      2400 
     TGAACCAAAA AAATCACCCA CTACACCAGC TCTCGCAGAA CACATACCCG ACCTGAATGC      2460 
     AGACGTGTCC TCCTTCGATG TAAAGTTCAC AGATATATCT TCTCTCTTGG ACTCCTCGGC      2520 
     TCGCCTCCCG CGCCCACAGC AAACACACAA GAGCAACACA TTATACAGTT GCGAGGGCCG      2580 
     TATCATCGCC ATCGAGTACC ACGCATCTGA TCTCTGCTTC CATATCACGA ATGAGCTCCC      2640 
     ACTTTTACAA ACCCGCGGCT TGGCCCCGGA GCGAGTGTTG CAACTACACA TCATTACCTC      2700 
     CAAGAACTTT GCTTATTTTT TCAACCGCTC AAGCGCCTAC TTACAGCGTC AGCCTCTTGA      2760 
     GGAAAAATAT ACGCAATTGG CACAATTTCT CGGCCATTCA TTTAAATTCA ATATAACCTC      2820 
     CTCGCTCACG CTGTTCCCTG ACACTACCGT GGCACTCCAG ATCTGGTGCC CAATTGAATG      2880 
     CACCTTTCGG GAATTGCAAC AACAGCTGGC CCATCCGAAG GTTGCAGCGG CTCCTGATTC      2940 
     AGGGAGTCTT GATTGCGCAA TTAATGCTAC CGTCAATCCT CTGCGACTTC TTGCCGCGCA      3000 
     AAATGGCGTC ACCGTGAAAA AGGAGGAGGA TAATGACGAT GACGCCGGAG CCGTTCCCAC      3060 
     CTCGTAAGAC ATGATCCGCG CAGCCCAACG CGGCGGTGCC AAATTGCAGT GACGTCTCGG      3120 
     AGTAATATAA AAAAAAAAGA CCAAATAACC AAATTTAAGG GTGCTCTGAA TATAAGGGAG      3180 
     TGGAACGTTT TCACACGAAG GAAAAGGGAA AGAGGGGAGT GGTAAGAAGC AAGAGTCAAT      3240 
     GAAAGGTCTT CCTTCCTTCT TGATGCT                                          3267 
 
F1 
R1 
R2 
R3 
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4.3.1.1.3. Primers to sequence the CTΔ amplicon 
Finally, the primers F1, F2, F3 and R3 were used to sequence the cdc13-1-C truncated construct 
(CTΔ amplicon).  Figure 4.3 shows the relevant position of each primer within 200 nt upstream 
and downstream of the cdc13-1-CTΔ::ADH1-HIS3MX6 construct region.  The F1, F2 and F3 
are forward primers whereas R3 is reverse primer. 
 
Figure 4.3.  Selection of primers used to sequence the cdc13-1 CTΔ-HIS3MX6 construct (CTΔ 
amplicon~3365 bp). 
The sequence shows the position of primers used for sequencing within the theoretical sequence as 
accessed from database and online resources.  The highlighted codons ‘ATG’ and ‘TAA’ represent start 
and stop codons for the cdc13-1 N-terminus half replication after C-truncation and for the histidine 
marker respectively.  The primers are F1 (22) 5’ACATGCAGCCTTGATTAACGTG 3’, F2 (20) 
5’CAACTCGCAGCTTATGACGC 3’, F3 (20) 5’TGAGGCGCGCCACTTCTAAA3’and R3 (22) 5’ 
GCATCAAGAAGGAAGGAAGACC 3’ (reverse complement of GGTCTTCCTTCCTTCTTGATGC). 
 
SQ   Sequence 3365 BP; 
 
     TGTGGATTAT TTAATATGTA CATGCAGCCT TGATTAACGT GATTATACTT TTTAAACCTT        60 
     TGATATCCAA ATTTTTCAAC GTCATAAGAG ACGCGAAGGC CTAGTGAGAT GCGAAATGCT       120 
     AATTCAAAAT GGAAATTTAA GAATATATTC ATATATGTTT CTCTTTGGAT ACGAATGACC       180 
     GTGGAAACTA TCGCCTAAAA ATGGATACCT TAGAAGAGCC TGAGTGTCCT CCACATAAAA       240 
     ATCGTATTTT TGTGAGCTCG AGTAAAGATT TTGAAGGCTA TCCCAGCAAA GCAATAGTTC       300 
     CCGTGCAATT CGTGGCGCTT TTAACCTCAA TACACCTGAC TGAAACAAAA TGTTTGCTAG       360 
     GCTTTTCTAA TTTTGAGAGG CGAGGAGATC AATCCCAAGA AGATCAATAT TTAATCAAAC       420 
     TGAAGTTCAA AGATAGGGGC TCGGAGAGGT TAGCCCGGAT CACTATTTCC TTACTTTGCC       480 
     AATACTTTGA TATTGAACTG CCAGATTTAG ATTCTGACTC AGGCGCATCC CCAACAGTAA       540 
     TACTGAGAGA TATTCACCTT GAAAGGTTAT GTTTTTCAAG TTGTAAAGCT TTATATGTAT       600 
     CAAAACACGG GAACTATACT CTATTCTTAG AGGACATAAA ACCGTTGGAT TTGGTAAGTG       660 
     TGATAAGCAC CATATCTACA AAATCGACAA ATAGCAGCAA GCATTCGTCA TCAGAACTTA       720 
     TTTCAGAATG TGATTTGAAC AACTCACTTG TGGATATCTT CAACAATTTA ATAGAAATGA       780 
     ATAGAGACGA GAAAAACAGG TTTAAATTTG TAAAGTTGAT TCACTACGAT ATAGAACTAA       840 
     AAAAGTTCGT TCAAGACCAA CAAAAGGTAT TATCGCAGAA ATCAAAAGCC GCAGCAATTA       900 
     ATCCTTTCTT TGTGCCAAAT AGACTAGGGA TACCTTACAT TGAATCCCAA AACGAATTCA       960 
     ACTCGCAGCT TATGACGCTT AATGTAGATG AACCGACCAC AGATATAAGC AACATGGGAG      1020 
     AGGAAATGCA TGACAGCGCA GATCCCATTG AGGATTCAGA TTCCTCAACT ACCTCCTCTA      1080 
     CCGGGAAATA TTTCAGCTCA AAATCCTACA TCCAGTCACA GACACCTGAA AGGAAAACAA      1140 
     GCGTACCAAA TAATTGGCAC GATGATGATT CCGGAAGCAA GAGGAAGAGA AAGCTTTCTT      1200 
     TCCACAGTCC GAACGCGTCC TCAATCCGCA AAGCCATCAG TTATGAGCAA CTTTCCCTAG      1260 
     CTAGTGTAGG CTCAGTTGAA AGGTTAGAGG GCAAAATTGT TGGCATGAAT TCACCTCAAT      1320 
     TCGCCAGTAT AAATGAGTTC AAATATTGCA CATTGAAATT ATATTTTACG CAGCTCTTAC      1380 
     CAAATGTCCC AGACAAGGTC CTGGTGCCAG GCGTCAATTG CATTGAGATC GTTATCCCGA      1440 
     CGAGAGAGCG AATCTGTGAG CTCTTCGGTG TTTTAAACTG TCAAAGCGAC AAGATATCGG      1500 
     ATATTTTACT ACTGGAAAAG CCTGATCGAA TTTCCGTCGA AGTTGAAAGG ATCCTGTGGG      1560 
     ACAATGACAA GACCGCCAGC CCAGGTTGAG GCGCGCCACT TCTAAATAAG CGAATTTCTT      1620 
     ATGATTTATG ATTTTTATTA TTAAATAAGT TATAAAAAAA ATAAGTGTAT ACAAATTTTA      1680 
     AAGTGACTCT TAGGTTTTAA AACGAAAATT CTTATTCTTG AGTAACTCTT TCCTGTAGGT      1740 
     CAGGTTGCTT TCTCAGGTAT AGCATGAGGT CGCTCTTATT GACCACACCT CTACCGGCAG      1800 
     ATCCGCTAGG GATAACAGGG TAATATAGAT CTGTTTAGCT TGCCTCGTCC CCGCCGGGTC      1860 
     ACCCGGCCAG CGACATGGAG GCCCAGAATA CCCTCCTTGA CAGTCTTGAC GTGCGCAGCT      1920 
     CAGGGGCATG ATGTGACTGT CGCCCGTACA TTTAGCCCAT ACATCCCCAT GTATAATCAT      1980 
     TTGCATCCAT ACATTTTGAT GGCCGCACGG CGCGAAGCAA AAATTACGGC TCCTCGCTGC      2040 
     AGACCTGCGA GCAGGGAAAC GCTCCCCTCA CAGACGCGTT GAATTGTCCC CACGCCGCGC      2100 
     CCCTGTAGAG AAATATAAAA GGTTAGGATT TGCCACTGAG GTTCTTCTTT CATATACTTC      2160 
     CTTTTAAAAT CTTGCTAGGA TACAGTTCTC ACATCACATC CGAACATAAA CAACCATGGC      2220 
     AGAACCAGCC CAAAAAAAGC AAAAACAAAC TGTTCAGGAG CGCAAGGCGT TTATCTCCCG      2280 
     TATCACTAAT GAAACTAAAA TTCAAATCGC TATTTCGCTG AATGGTGGTT ATATTCAAAT      2340 
     AAAAGATTCG ATTCTTCCTG CAAAGAAGGA TGACGATGTA GCTTCCCAAG CTACTCAGTC      2400 
     ACAGGTCATC GATATTCACA CAGGTGTTGG CTTTTTGGAT CATATGATCC ATGCGTTGGC      2460 
     AAAACACTCT GGTTGGTCTC TTATTGTTGA ATGTATTGGT GACCTGCACA TTGACGATCA      2520 
     CCATACTACC GAAGATTGCG GTATCGCATT AGGGCAAGCG TTCAAAGAAG CAATGGGTGC      2580 
     TGTCCGTGGT GTAAAAAGAT TCGGTACTGG GTTCGCACCA TTGGATGAGG CGCTATCACG      2640 
     TGCCGTAGTC GATTTATCTA GTAGACCATT TGCTGTAATC GACCTTGGAT TGAAGAGAGA      2700 
     GATGATTGGT GATTTATCCA CTGAAATGAT TCCACACTTT TTGGAAAGTT TCGCGGAGGC      2760 
     GGCCAGAATT ACTTTGCATG TTGATTGTCT GAGAGGTTTC AACGATCACC ACAGAAGTGA      2820 
     GAGTGCGTTC AAGGCTTTGG CTGTTGCCAT AAGAGAAGCT ATTTCTAGCA ATGGCACCAA      2880 
     TGACGTTCCC TCAACCAAAG GTGTTTTGAT GTGAAGTACT GACAATAAAA AGATTCTTGT      2940 
     TTTCAAGAAC TTGTCATTTG TATAGTTTTT TTATATTGTA GTTGTTCTAT TTTAATCAAA      3000 
     TGTTAGCGTG ATTTATATTT TTTTTCGCCT CGACATCATC TGCCCAGATG CGAAGTTAAG      3060 
     TGCGCAGAAA GTAATATCAT GCGTCAATCG TATGTGAATG CTGGTCGCTA TACTGCTGTC      3120 
     GATTCGATAC TAACGCCGCC ATCCAGTTTA AACGAGCTCG AATTCGACAT GATCCGCGCA      3180 
     GCCCAACGCG GCGGTGCCAA ATTGCAGTGA CGTCTCGGAG TAATATAAAA AAAAAAGACC      3240 
     AAATAACCAA ATTTAAGGGT GCTCTGAATA TAAGGGAGTG GAACGTTTTC ACACGAAGGA      3300 
     AAAGGGAAAG AGGGGAGTGG TAAGAAGCAA GAGTCAATGA AAGGTCTTCC TTCCTTCTTG      3360 
     ATGCT                                                                  3365 
// 
F1 
F2 
F3 
R3 
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Additional details of the sequence of the constructs cdc13-1 NTΔ-TRP1 (3267 bp) and cdc13-1 
CTΔ-HIS3MX6 are presented in Table 4.3 and 4.4 respectively. 
Table 4.3.  The sequence details of the cdc13-1 NTΔ-TRP1 construct (3267 bp). 
 
Nucleotide 
sequence 
Name of sequence 
(cdc13-1 NTΔ-TRP1 construct) 
Total 
length 
(bp) 
1 1-200 CDC13 upstream sequence (200) 
2 151-200 NTΔ: forward deletion primer (NF1) 5’ part (50) 
3 201-220 NTΔ: forward deletion primer’s (NF1) 3’ part (F4 primer from 
TRP1 modulating DNA) 
(20) 
4 221-300 Blank sequence (80) 
5 301-975 TRP1 marker coding sequence (end to start) (675) 
6 976-1123 TRP1 promoter (148) 
7 1124-1217 Blank sequence (94) 
8 1218-1335 UAC (upstream activating sequence) (118) 
9 1218-1659 GAL1 promoter (442) 
10 1662-1681 NTΔ: reverse deletion primer’s (NR1) 3’ part (R2 primer from 
TRP1 modulating DNA) 
(20) 
11 1682-1729 NTΔ: reverse deletion primer (NR1)’s 5’ part (48) 
12 1679-3067 CDC13-C-terminus (1389) 
13 3068-3267 CDC13 downstream sequence (200) 
 
Table 4.4.  The sequence details of the cdc13-1 CTΔ-ADH1-HIS3MX6 construct (3365 bp). 
 
Nucleotide 
sequence 
Name of sequence 
(cdc13-1 CTΔ-HIS3MX6 construct) 
Total 
length 
(bp) 
1 1-200 CDC13 upstream sequence (200) 
2 201-1589 CDC13-N-terminus (1389) 
3 
1537-1586 
C-terminus forward deletion primer (CF2)’s 5’ end: gene 
sequence 
(50) 
4 
1587-1606 
C-terminus forward deletion primer (CF2)’s 3’ end: F3 
modulating primer from HIS3MX6 DNA, used as F3 sequencing 
primer  
(20) 
5 1607-1609 Blank sequence (3) 
6 1610-1797 ADH1 terminator (188) 
7 1798-1871 Blank sequence including 30 nucleotide insertion: (74) 
8 1872-2214 TEF promoter (343) 
9 2215 Blank sequence (1) 
10 2216-2914 HIS3MX6 marker coding sequence (start to end) (699) 
11 2915-2917 Blank sequence (3) 
12 2918-3115 TEF terminator (198) 
13 3116-3145 Blank sequence (30) 
14 
3146-3165 
C-terminus reverse deletion primer (CR2) ’s 3’ end: (R1 
modulating primer from HIS3MX6 marker DNA) 
(20) 
15 
3166-3216 
C-terminus reverse deletion primer (CR2)’s 5’ end: gene 
sequence  
(51) 
16 3166-3365 CDC13 downstream sequence (200) 
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4.3.1.2. Sequencing template preparation 
4.3.1.2.1. Total DNA extraction  
Total DNA was prepared from 24 constructs and two controls.  Figure 4.4 presents the results of 
gel electrophoresis of genomic DNA extracted from 12 N-truncated (A) and 12 C-truncated (B) 
constructs of cdc13-1.  Cells were selected on dropout medium and single colonies cultivated 
onto YEPD plates for three days at 30°C.  DNA was isolated from N- and C-truncated cdc13-1 
clones, re-suspended in 100 µl 1x TE buffer at 4°C overnight (o/n).  DNA from 6 independent 
mutants with N-terminus deletion (Figure 4.4A) and C-terminus deletion (Figure 4.4B) were 
analysed electrophoretically for strain 1296 (lanes 1-6) and 1297 (lanes 7-12).  The genomic 
DNA from original strains 1296-TR and 1297-TR (cdc13-1) are shown in lanes 13 and 14 (B).  
All DNA bands exhibit an almost identical intensity, with a yield on average of 1-2 µg/µl.  The 
genomic DNAs were diluted (1:100 or 1:200) and used to amplify the 3 kb sequencing 
templates.  
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Figure 4.4.  Total DNA analysis of cdc13-1 N-terminus (cdc13-1-NTΔ::TRP1-PGAL1) and C-terminus 
(cdc13-1-CTΔ::HIS3MX6) deletion mutants generated in strain 1296-TR and 1297-TR survivors. 
For each sample, 2 µl of uncut DNA (mixed with 2 µl of 5x DNA dye and 6 µl of 1x TE buffer) was 
examined on a 0.7 % agarose gel.  M1 represents a 1 kb size marker (Invitrogen) used at a concentration 
of 1 µg (0.1µg/µl). 
 
(A) Agarose gel electrophoresis of genomic DNA from N-terminus truncated clones. 
Lanes 1-6: total DNA from NTΔ constructs (cdc13-1-NTΔ::TRP1-PGAL1) #2, #4, #5, #6, #7 and #21 in 
strain 1296-TR; 7-12: total DNA from NTΔ constructs (cdc13-1-NTΔ::TRP1-PGAL1) #1, #7, #8, #11, #14 
and #22 in strain 1297-TR. 
(B) Agarose gel electrophoresis of genomic DNA from C-terminus truncated clones. 
Lanes 1-6: total DNA from NTΔ constructs (cdc13-1-CTΔ::HIS3MX6) #3, #4, #6, #7, #9, #10 in strain 1296-
TR; 7-12: total DNA from NTΔ constructs (cdc13-1-CTΔ::HIS3MX6) #3, #4, #7, #8, #11, #12 in strain 1297-
TR; 13 and 14: total DNA from strain 1296-TR and strain 1297-TR respectively; M1: 1 kb marker 
(Invitrogen) 1 µg (0.1µg/µl). 
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4.3.1.2.1.1. PCR amplification of 3 kb specific fragments using CDC13 upstream and 
downstream primers  
PCR product of ~3 kb was amplified from genomic DNA with Q5 polymerase (NEB) using 
primers F1 and R3 with an initial denaturation during 50 seconds at 98°C followed by 32 cycles 
of 10 seconds of denaturation at 98°C, 30 seconds of annealing at 60°C and 90 seconds of 
extension at 72°C.  The final extension at 72°C was carried out for 2 minutes.  PCR conditions 
were adapted with the supplementation of enhancer (Figure 4.5A) or MgCl2 (Figure 4.5B).  The 
results of agarose gel electrophoresis of the PCR products show amplification of the desired 
band of ~3 kb with both concentrated and diluted template DNA (1:100 and 1:200) with more 
consistent and specific bands with almost similar intensity with MgCl2 (Figure 4.5). 
 
 
 
Figure 4.5.  PCR amplification of the 3 kb product in the presence of enhancer or MgCl2. 
Genomic DNA concentrated and diluted (1:100 and 1:200) from the construct cdc13-1-NTΔ/CTΔ 
in strain 1296-TR were used as a template.  PCR was performed in a 50 µl reaction volume with 1 
unit of Q5 enzyme in the presence of 1x enhancer/2 mM MgCl2 using forward F1 (5’ 
ACATGCAGCCTTGATTAACGTG 3’) and reverse R3 primer (5’ GCATCAAGAAGGAAGGAAGACC 3’).  
Gel electrophoresis shows amplified products with concentrated and diluted DNA templates.  2 µl 
of PCR products with 2 µl of 5x DNA dye and 6 µl 1x TE buffer were examined on a 0.7% agarose 
gel for all the samples. 
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(A) Gel electrophoresis of PCR products, amplified in the presence of enhancer. 
Lanes M3: lambda DNA Hind III fragments (Invitrogen), 1 µg (0.1 µg/µl); 1: -ve control (Non template 
control, without DNA); 2 and 3: PCR amplicons with concentrated template; 4 and 5: PCR products with 
diluted (1:200) template (genomic DNA from construct cdc13-1-NTΔ #4). 
(B) Gel electrophoresis of PCR products, amplified in the presence of 2 mM MgCl2. 
Lanes M1: 1 kb size marker (Invitrogen) used in a concentration of 1 µg (0.1µg/µl); 1 and 2: -ve controls 
(Non template control, without DNA); 3-5: PCR fragment amplified with 1/100 (lane 3) and 1/200 (lanes 
4 and 5) diluted DNA template from construct cdc13-1-NTΔ #2 of strain 1296-TR; 6 and 7: PCR fragment 
amplified with 1/100 (lane 6) and 1/200 (lane 7) diluted DNA template from construct cdc13-1-CTΔ #3 of 
strain 1296-TR; M3: lambda DNA Hind III fragments (Invitrogen), 1 µg (0.1 µg/µl). 
 
 
 
 
4.3.1.2.1.2. PCR amplification for the 3 kb fragment from genomic DNA of cdc13-1-N- 
and C-truncated mutants (1296-TR and 1297-TR). 
Sequencing templates were generated through PCR amplification from genomic DNA of N- and 
C-truncated cdc13-1 clones.  12 clones were selected for each modification, from strain 1296 
and 1297.  The genomic DNA used as a template was diluted to 1:200.  PCR was performed in a 
50 µl reaction volume with 1 unit of Q5 enzyme in the presence of 2 mM MgCl2 with forward, 
F1 (5-’ACATGCAGCCTTGATTAACGTG-3’) and reverse primer, R3 (5’-
GCATCAAGAAGGAAGGAAGACC-3’).  Figure 4.6 shows PCR fragments amplified from 
DNA isolated from six independent mutants with N-terminus deletion (A) and C-terminus 
deletion (B) of strains 1296- (lanes 3-8) and 1297-TR (lanes 10-15).  For each sample, 2 µl of 
PCR product was examined on a 0.7 % agarose gel.  The resulting amplified fragments (~3 kb) 
consisted of truncated cdc13-1 and a TRP1/HIS3MX6 marker DNA. 
 
For the control sequencing template, the 3 kb target region containing cdc13-1 coding region 
plus 200 nt upstream and downstream sequences were amplified using the F1 and R3 primers 
supplemented with 2 mM MgCl2 and genomic DNA template from original strains 1296-TR and 
1297-TR.  Agarose gel electrophoresis of the PCR products confirmed the presence of the 
required DNA fragments (~3 kb) from all tested deletion constructs and controls. 
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Figure 4.6.  Electrophoretic separation of PCR products following amplification with Q5 polymerase from 
cdc13-1 N-terminus (cdc13-1-NTΔ::TRP1-PGAL1) and C-terminus (cdc13-1-CTΔ::HIS3MX6) deletion 
mutants. 
For each sample, 2 µl of PCR product was examined on a 0.7 % agarose gel.  M3 represents lambda DNA 
Hind III fragments (Invitrogen), 1 µg (0.1 µg/µl).  Lanes 1 and 2 represent -ve controls (Non template 
control, without DNA). 
(A) Gel electrophoresis of PCR products from 12 N-terminus truncated clones (cdc13-1-NTΔ::TRP1-
PGAL1). 
Lanes: 3-8: PCR products (~3 kb) from N-terminus deletion constructs, #2, #4, #5, #6, #7 and #21 
respectively in strain 1296-TR; 10-15: PCR products (~3 kb) from N terminus deletion constructs, #1, #7, 
#8, #11, #14 and #22 respectively in strain 1297-TR. 
(B) Gel electrophoresis of PCR products from 12 C-terminus truncated clones (cdc13-1-CTΔ::ADH1-
HIS3MX6). 
Lanes 3-8: PCR products (~3 kb) from C-terminus deletion constructs #3, #4, #6, #7, #9, #10 respectively 
in strain 1296-TR; 10-15: PCR products (~3 kb) from C-terminus deletion constructs #3, #4, #7, #8, #11, 
#12 respectively strain 1297-TR. 
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4.3.1.2.1.3. Purification of 3 kb PCR fragments sequencing template  
For automated sequencing, the purification of amplified DNA templates was performed using a 
commercially available kit (Wizard® PCR preps DNA purification system, Promega).  The 
column purified DNA eluted in sterile water was ready for sequencing.  The quality and 
quantity of purified DNA was first estimated by measuring absorbance using a 
spectrophotometer (Nanodrop 2000; Table 4.5) and then separating the DNA by agarose gels 
electrophoresis (Figure 4.7) for N- (A) and C-truncated (B) PCR fragments.  The analytical gels 
showed the quantity of DNA ~30-50 ng/µl on average.  The purified DNA fragments from 26 
samples (24 clones and 2 controls) were sent for sequencing at a concentration of approximately 
30-50 ng/µl along with sequencing primers (at a concentration of 10 pmol/µl).  The automated 
sequencing was performed at GATC-Biotech facilities (Germany) on a ABI 3730xl DNA 
analyser (Applied Biosystems), which is high throughput, capillary electrophoresis systems and 
used for analysing fluorescently labelled DNA fragments.  . Data was evaluated by the Phred20 
system using the Base caller KB 1.4.1.8.   
 
The column purified DNA was successfully sequenced with a read length of 700 to 1000 nt 
sequences.  However, another set of amplified sequencing templates for N- and C-terminus ~3 
kb DNA (Figure 4.8A and B respectively), extracted with phenol-chloroform method followed 
by ethanol precipitation (Figure 4.9 for N- (A) and C-truncated (B) constructs failed in 
sequencing indicating the non-suitability of phenol extracted template for sequencing although 
it looked similar on analytical gels.  It also indicates that the purity of DNA is a crucial factor 
for successful sequencing.  
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Figure 4.7.  Electrophoretic separation of PCR products following purification of amplified products from 
cdc13-1 N-terminus (cdc13-1-NTΔ::TRP1-PGAL1) and C-terminus (cdc13-1-CTΔ::HIS3MX6) deletion 
mutants. 
PCR-amplified 3 kb fragments from 26 samples were cleaned up of unwanted PCR products (PCR 
primers and remaining dNTPs etc.).  Promega’s DNA purification columns were used to purify amplified 
products according to the manufacturer’s instruction.  Purified DNA was eluted in sterile water and 
analysed for concentration using a spectrophotometer (Nanodrop 2000).  For each sample, 2 µl of the 
purified DNA was examined on a 0.7 % gel. 
(A) Gel electrophoresis of purified PCR products from 12 clones with cdc13-1-N-truncation. 
Lanes 1-6: column purified ~ 3 kb PCR fragments from 6 clones, #2, #4, #5, #6, #7 and #21 respectively in 
strain 1296-TR; 7-12: column purified PCR fragments from 6 clones, #1, #7, #8, #11, #14 and #22 
respectively in strain 1297-TR; 14-15:  column purified PCR fragments from original strain 1296-TR and 
1297-TR (cdc13-1). 
(B) Gel electrophoresis of purified PCR products from 12 clones with cdc13-1-C-truncation. 
Lanes 1-6:  column purified PCR fragments (~3 kb) from 6 clones, #3, #4, #6, #7, #9, #10 respectively in 
strain 1296-TR; 8-13: column purified PCR fragments (3 kb) from 6 constructs, #3, #4, #7, #8, #11, #12 
respectively in strain 1297-TR. 
M1 represents 1 kb size marker (Invitrogen) used at a concentration of 1 µg (0.1µg/µl). 
M3 represents lambda DNA Hind III fragments (Invitrogen), 1 µg (0.1 µg/µl). 
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Table 4.5.  The estimation of concentration of column purified DNA by spectrophotometry. 
 
# Sample ID Nucleic acid 
conc. 
ng/µl 
Absorbance 
260/230 
Absorbance 
260/280 
     
1.  1296-N*#2 15.3 0.64 1.91 
2.  1296-N #4 42.1 1.54 1.83 
3.  1296-N #5 21.7 1.66 1.77 
4.  1296-N #6 21.5 1.62 1.78 
5.  1296-N #7 19 1.7 1.8 
6.  1296-N #21 18.6 1.08 1.84 
7.  1297-N #1 17.5 1.56 1.95 
8.  1297-N #7 21.7 1.72 1.8 
9.  1297-N #8 12.8 0.95 1.88 
10.  1297-N #11 18.1 1.43 1.94 
11.  1297-N #12 15.5 1.73 1.81 
12.  1297-N #22 19.1 0.8 1.87 
13.  1296-C*#3 23.5 2.33 1.95 
14.  1296-C #4 18.6 2.47 2.01 
15.  1296-C #6 16.8 0.86 2.04 
16.  1296-C #7 18.6 1.77 1.98 
17.  1296-C #9 25.8 0.64 1.84 
18.  1296-C #10 21.5 2.1 1.93 
19.  1297-C #3 16.5 1.77 1.98 
20.  1297-C #4 21.7 2.25 1.89 
21.  1297-C #7 24.3 2.06 1.83 
22.  1297-C #8 27.6 2.02 1.8 
23.  1297-C #11 27.3 2.09 1.91 
24.  1297-C #12 21.7 1.87 1.84 
25.  1296 #25 22 1.6 1.81 
26.  1297 #26 19.8 1.71 1.83 
 
*N denotes N-terminus deletion (NTΔ) mutant. 
*C denotes C-terminus deletion (CTΔ) mutant. 
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Figure 4.8.  Electrophoretic separation of PCR products following amplification with Q5 polymerase from 
cdc13-1 N-terminus and C-terminus deletion mutants generated from 1296-TR and 1297-TR survivors. 
PCR was performed as explained earlier with Q5 polymerase enzyme in 50 µl volume.  For each sample, 
2 µl of PCR product was examined on a 0.7 % agarose gel. 
(A) Gel electrophoresis of PCR amplified products from 12 N-terminus truncated clones. 
Lanes 3-8: PCR fragments (~3 kb) from strain 1296-TR N-terminus deletion constructs (cdc13-1-
NTΔ::TRP1-PGAL1) #2, #4, #5, #6, #7 and #21 respectively; 9-14: PCR products (3 kb) from strain 1297-TR 
N-terminus deletion constructs (cdc13-1-NTΔ::TRP1-PGAL1) #1, #7, #8, #11, #14 and #22 respectively. 
(B) Gel electrophoresis of PCR amplified products from 12 C-terminus truncated clones. 
Lanes 3-8: PCR fragments from strain 1296-TR C-terminus deletion constructs (cdc13-1-CTΔ::HIS3MX6) 
#3, #4, #6, #7, #9, #10 respectively; 9-14: PCR fragments from strain 1297-TR C-terminus deletion 
constructs (cdc13-1-CTΔ: HIS3MX6) #3, #4, #7, #8, #11, #12 respectively; 15-16: PCR fragments from 
control original strains 1296- and 1297-TR with cdc13-1. 
M1 represents 1 kb size marker (Invitrogen) used at a concentration of 1 µg (0.1µg/µl). M3 represents 
lambda DNA Hind III fragments (Invitrogen), 1 µg (0.1 µg/µl). Lanes 1 and 2 represent -ve controls (Non 
template control, without DNA). 
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Figure 4.9.  Electrophoretic analysis of PCR products following phenol extraction of amplified products 
from cdc13-1 N-terminus (cdc13-1-NTΔ::TRP1-PGAL1) and C-terminus (cdc13-1-CTΔ::HIS3MX6) deletion 
mutants. 
PCR-amplified 3 kb fragments were cleaned up of unwanted PCR products by the phenol/chloroform 
extraction method.  The clean DNA was examined as 2 µl of each sample on a 0.7 % gel.   
M1 represents 1 kb size marker (Invitrogen) used at a concentration of 1 µg (0.1µg/µl). M3 represents 
lambda DNA Hind III fragments (Invitrogen), 1 µg (0.1 µg/µl). 
(A) Gel electrophoresis of purified PCR products from 12 clones with cdc13-1-N-terminus truncation.  
Lanes 1-6: purified PCR products from 6 clones from strain 1296-TR (cdc13-1-NTΔ::TRP1-PGAL1) #2, #4, 
#5, #6, #7 and #21 respectively; 7-12: purified PCR products  from 6 clones from strain 1297-TR (cdc13-
1-NTΔ::TRP1-PGAL1) #1, #7, #8, #11, #14 and #22 respectively. 
 
(B) Gel electrophoresis of purified PCR products from 12 clones with cdc13-1-C-terminus truncation. 
Lanes 1-6: purified fragments (3 kb) from strain 1296-TR C- terminus deletion constructs (cdc13-1-
CTΔ::HIS3MX6) #3, #4, #6, #7, #9, #10 respectively; 7-12: purified fragments from strain 1297-TR C- 
terminus deletion constructs (cdc13-1-CTΔ::HIS3MX6) #3, #4, #7, #8, #11, #12 respectively; 13-14: 
purified PCR products  from control 1296- and 1297-TR with cdc13-1; 15-16: column-purified PCR 
fragments from cdc13-1-N-terminus-truncated (NTΔ#2) and C-terminus-truncated (CTΔ#3)-1296-TR 
clones. 
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4.3.1.3. Analysis of the sequencing data. 
Results of automated DNA sequencing were in the form of a four-colour-chromatogram and a 
text file of primary sequence data as interpreted by computer program (Phred-Phrap).  Four 
nucleotide sequence-reads (forward- and reverse-reads in accordance with 4 primers) were 
generated for each sample, mutants (24x4) and controls (2x4).  The text sequence of DNA was 
aligned with its relevant theoretical (reference) sequence, mentioned earlier for cdc13-1 (3175 
nt; Figure 4.1), NTΔ- (3267 nt; Figure 4.2) and CTΔ-constructs (3365 nt; Figure 4.3) to find any 
mismatches.  The cdc13-1 C-terminus, N-terminus in constructs and histidine marker were 
orientated from 5’ to 3’ (left to right) on top strand, while the tryptophan marker was in an 
opposite orientation from right to left. 
All miscalled bases and errors at the beginning and end of each sequence reads were manually 
double-checked by overlapping text data and the chromatogram analysis.  On the basis of 
homology analysis and sequencing results, real sequences were constructed for the individual 
mutants.  The resulting mutations, deletions, insertions and substitution were mapped and were 
further analysed for the predicted protein sequences (Cdc13-1-N- or C-terminus and linked 
tryptophan or histidine marker proteins) through translational analysis to see whether it could 
shift the frame or not.  Finally, all the identified (ascertained) modifications were summarised in 
Tables 4.6, 4.7 and 4.8 for cdc13-1 controls and N- and C-terminus-truncated constructs 
respectively.   
Table 4.6.  Analysis of modifications in cdc13-1 DNA sequence* in strains 1296-TR and 1297-TR mutants. 
 
DNA 
ID 
 (#) 
Name of 
Mutant/ 
construct  
Location of 
nucleotide 
Nature of DNA mutations  
 
Position of mutation 
(within coding region of cdc13-1, 
or non-coding 
upstream/downstream 
sequence) 
Modifi
cation 
of 
amino 
acid 
  
Protein 
Frame shift: 
(marker or 
Cdc13-1 
protein) 
   Deletio
n  
Insertio
n 
substituti
on 
   
25 
cdc13-1 exo1Δ 
(strain 1296-
TR) 
69, 78/79 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of resolution in 
the beginning of the sequence 
read, nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
 NO 
26 
cdc13-1 exo1Δ 
(strain 1297-
TR) 
69, 78/79 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of resolution in 
the beginning of the sequence 
read, nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
 NO 
 
*cdc13-1 ORF including 200 nt up- and downstream sequence. 
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Table 4.7.  Analysis of modifications in cdc13-1-N-terminus-truncated::TRP1-PGAL1 DNA from strains 
1296-TR and 1297-TR mutants. 
 
DNA 
ID 
(#) 
Name of  
the construct: 
(cdc13-1-NTΔ-
TRP1-PGAL1) 
Location of 
nucleotide 
Nature of DNA mutations  
 
Position of mutation 
(cdc13-1 coding region, 
upstream/downstream non-
coding sequence, TRP1 marker 
or promoter of modular DNA) 
Amino 
acid 
modificati
on 
Protein 
Frame shift: 
(marker or 
truncated 
Cdc13-1 
protein) 
   Deletion  Insertion substituti
on 
   
1 1296-NTΔ #2 78/79 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of resolution in 
the beginning of the sequence 
read, nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
 No 
  219   A→C Within F4 primer of TRP1 marker 
of modular DNA, downstream 
region of TRP1 marker 
 No 
  254  TAGATC  Within modular DNA, 46 
nucleotides outside the end 
(stop) codon of TRP1 marker 
 No 
  1706 A?   cdc13 C-half, mutation located 
within deletion primer 
 Yes/cdc13-1-
C-terminus 
2 1296-NTΔ #4  69, 78/79 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of resolution in 
the beginning of the sequence 
read, nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
 No 
  254  TAGATC  Within modular DNA, 46 
nucleotides outside the end 
(stop) codon of TRP1 marker 
 No  
3 1296-NTΔ #5  78/79 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of resolution in 
the beginning of the sequence 
read, nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
 No 
  254  TAGATC  Within  modular DNA, 46  
nucleotides outside the end 
(stop) codon of TRP1 marker 
 No  
4 1296-NTΔ #6  69, 78/79 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of resolution in 
the beginning of the sequence 
read, nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
 No 
  254  TAGATC  within modular DNA, 46 
nucleotides outside the end 
(stop) codon of TRP1 marker 
 No  
5 1296-NTΔ #7  69, 78/79 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of resolution in 
the beginning of the sequence 
read, nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
 No 
  254  TAGATC  Within modular DNA, 46 
nucleotides outside the end 
(stop) codon of TRP1 marker 
 No  
  457   T→C In TRP1 marker of modular DNA 
codon 173 changed from TTA to 
TTG, both stand for Leucine 
No change 
in AA 
No 
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DNA 
ID 
(#) 
Name of  
the construct: 
(cdc13-1-NTΔ-
TRP1-PGAL1) 
Location of 
nucleotide 
Nature of DNA mutations  
 
Position of mutation 
(cdc13-1 coding region, 
upstream/downstream non-
coding sequence, TRP1 marker 
or promoter of modular DNA) 
Amino 
acid 
modificati
on 
Protein 
Frame shift: 
(marker or 
truncated 
Cdc13-1 
protein) 
   Deletion  Insertion substituti
on 
   
6 1296-NTΔ #21  69, 78/79 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of resolution in 
the beginning of the sequence 
read, nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
 No 
  254  TAGATC  Within modular DNA, 46 
nucleotides outside the end 
(stop) codon of TRP1 marker 
 No  
  462   T→C Within coding sequence of TRP1 
marker of modular DNA, codon 
172 changed from AGC (Ser) to 
GGC (Gly) 
Change in 
AA-172 
from Ser 
to Gly 
No  
  1457   T→C Within GAL1 promoter of 
modular DNA (doubly confirmed) 
  
7 1297-NTΔ #1  78/79 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of resolution in 
the beginning of the sequence 
read, nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
  
  254  TAGATC  Within modular DNA, 46 
nucleotides outside the end 
(stop) codon of TRP1 marker 
 No 
  879   C→T Within coding sequence of TRP1 
marker of modular DNA, codon 
33 changed from GCT (Ala) to 
ACT (Thr) 
Change in 
AA-33 
from Ala 
to Thr 
No  
8 1297-NTΔ #7  78/79 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of resolution in 
the beginning of the sequence 
read, nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
  
  254  TAGATC  Within modular DNA, 46 
nucleotides outside the end 
(stop) codon of TRP1 marker 
 No 
  676   A→G Within coding sequence of TRP1 
marker of modular DNA, codon 
100 changed from CAT (His to 
CAC (His) (double confirmed) 
Change in 
codon-100 
of TRP1 
marker 
but not AA 
 
  2107   C→A Within C-terminus coding region 
of N-truncated cdc13-1, 
codon 143 changed from GGC 
(Gly) to GGA (Gly) in C-terminus 
half 
No change 
in protein, 
AA 
remains 
the same 
 
9 1297-NTΔ #8  69, 78/79 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of resolution in 
the beginning of the sequence 
read, nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
  
  254  TAGATC  Within modular DNA, 46 
nucleotides outside the end 
(stop) codon of TRP1 marker 
 No 
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DNA 
ID 
(#) 
Name of  
the construct: 
(cdc13-1-NTΔ-
TRP1-PGAL1) 
Location of 
nucleotide 
Nature of DNA mutations  
 
Position of mutation 
(cdc13-1 coding region, 
upstream/downstream non-
coding sequence, TRP1 marker 
or promoter of modular DNA) 
Amino 
acid 
modificati
on 
Protein 
Frame shift: 
(marker or 
truncated 
Cdc13-1 
protein) 
   Deletion  Insertion substituti
on 
   
  1092 A?   Within TRP1 promoter region, 
not reliable 
 no 
  1681 G?   cdc13 C- half, mutation located 
within deletion primer (reverse), 
not reliable 
 Yes/cdc13-CT 
10 1297-NTΔ #11  69, 78/79 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of resolution in 
the beginning of the sequence 
read, nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
  
  254  TAGATC  Within modular DNA, 46 
nucleotides outside the end 
(stop) codon of TRP1 marker 
 No 
  821   A→G Within coding sequence of TRP1 
marker of modular DNA, codon 
52 changed from ATT (Iso) to ACT 
(Thr) (double confirmed) 
Change in 
codon/AA-
52 of TRP1 
marker 
from Ile to 
Thr 
No 
11 1297-NTΔ #12  69, 78/79 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of resolution in 
the beginning of the sequence 
read, nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
  
  254  TAGATC  Within modular DNA, 46 
nucleotides outside the end 
(stop) codon of TRP1 marker 
 No 
12 1297-NTΔ #22  69, 78/79 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of resolution in 
the beginning of the sequence 
read, nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
  
  254  TAGATC  Within modular DNA, 46 
nucleotides outside the end 
(stop) codon of TRP1 marker 
 No 
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Table 4.8.  Analysis of modifications in cdc13-1-C-truncated::ADH1-HIS3MX6 DNA from strains 1296-TR 
and 1297-TR mutants. 
DNA ID 
(#) 
Name of  
the construct: 
(cdc13-1-CTΔ-
ADH1-
HIS3MX6) 
Location of 
nucleotide 
Nature of DNA mutations  
 
Position of mutation 
(cdc13-1 coding region, 
upstream/downstream non-
coding sequence, HIS3MX6 
marker DNA or its promoter 
or ADH1 terminator) 
Amino acid 
modification 
Protein 
Frame 
shift: 
(marker or 
truncated 
Cdc13-1 
protein) 
   Deletio
n 
Insertio
n 
substitutio
n 
   
13 1296-CTΔ #3 78/79 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of 
resolution in the beginning of 
the sequence read, 
nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
 NO 
  1763   C→T 
(Doubly 
confirmed) 
Mutation within ADH1 
terminator sequence at the 
start of HIS3MX6 modular 
DNA 
 NO 
 
  2213   A→G 
(Doubly 
confirmed) 
Mutation within TEF 
promoter before S. pombe 
his5 gene of HIS3MX6 
modular DNA 
 NO 
 
14 1296-CTΔ #4 78 
upstream 
A?   CDC13 upstream (miscounted 
peaks due to limit of 
resolution in the beginning of 
the sequence read, 
nucleotide ‘A’ in fact be two 
A’s, not accurate error) 
 NO 
  1763   C→T Mutation within ADH1 
terminator sequence at the 
start of HIS3MX6 modular 
DNA 
 NO 
 
  2213   A→G Mutation within TEF 
promoter before S. pombe 
his5 gene of HIS3MX6 
modular DNA 
 NO 
 
15 1296-CTΔ #6 1763   C→T Mutation within ADH1 
terminator sequence at the 
start of HIS3MX6 modular 
DNA 
 NO 
 
  3115   G→A Mutation within TEF 
terminator, the end part of 
HIS3MX6 modular DNA (This 
mutation is also present in 
few other mutants) 
  
16 1296-CTΔ #7  1763   C→T Mutation within ADH1 
terminator sequence at the 
start of HIS3MX6 modular 
DNA 
 NO 
 
  3115   G→A Mutation within TEF 
terminator, the end part of 
HIS3MX6 modular DNA (This 
mutation is also present in 
few other mutants) 
 No 
17 1296-CTΔ #9  1763   C→T Mutation within ADH1 
terminator sequence at the 
start of HIS3MX6 modular 
DNA 
 NO 
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DNA ID 
(#) 
Name of  
the construct: 
(cdc13-1-CTΔ-
ADH1-
HIS3MX6) 
Location of 
nucleotide 
Nature of DNA mutations  
 
Position of mutation 
(cdc13-1 coding region, 
upstream/downstream non-
coding sequence, HIS3MX6 
marker DNA or its promoter 
or ADH1 terminator) 
Amino acid 
modification 
Protein 
Frame 
shift: 
(marker or 
truncated 
Cdc13-1 
protein) 
   Deletio
n 
Insertio
n 
substitutio
n 
   
  3115   G→A Mutation within TEF 
terminator, the end part of 
HIS3MX6 modular DNA (This 
mutation is also present in a 
few other mutants) 
 NO 
 
  3306? 
Miscalled 
nucleotide 
at the start 
of sequence 
run? 
  G→A? CDC13 downstream sequence 
beyond deletion primer (This 
mutation is towards the start 
of sequence run, not very 
reliable) or modification 
could be in strain 1296-TR 
 NO 
 
18 1296-CTΔ #10  1763   C→T Mutation within ADH1 
terminator sequence at the 
start of HIS3MX6 modular 
DNA 
 NO 
 
  3115   G→A Mutation within TEF 
terminator, the end part of 
HIS3MX6 modular DNA (This 
mutation is also present in a 
few other mutants) 
 NO 
 
19 1297-CTΔ #3 
(cdc13-1 CTΔ) 
1763   C→T Mutation within ADH1 
terminator sequence at the 
start of HIS3MX6 modular 
DNA 
 NO 
 
  3306? 
Miscalled 
nucleotide 
at the start 
of R3-
sequence 
runs? 
  G→A? CDC13 downstream sequence 
beyond deletion primer (This 
mutation is towards the start 
of sequence run, not very 
reliable) or modification 
could be in strain 1296-TR 
 NO 
 
20 1297-CTΔ #4  1763   C→T Mutation within ADH1 
terminator sequence at the 
start of HIS3MX6 modular 
DNA 
 NO 
 
  3306? 
Miscalled 
nucleotide 
at the start 
of R3-
sequence 
runs? 
  G→A? CDC13 downstream sequence 
beyond deletion primer (This 
mutation is towards the start 
of sequence, not very 
reliable) or modification 
could be in strain 1296-TR 
 NO 
 
  1763   C→T Mutation within ADH1 
terminator sequence at the 
start of HIS3MX6 modular 
DNA 
 NO 
 
21 1297-CTΔ #7  1763   C→T Mutation within ADH1 
terminator sequence at the 
start of HIS3MX6 modular 
DNA 
 NO 
 
  3306? 
Miscalled 
nucleotide 
at the start 
  G→A? CDC13 downstream sequence 
beyond deletion primer (This 
mutation is towards the start 
of sequence, not very 
 NO 
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DNA ID 
(#) 
Name of  
the construct: 
(cdc13-1-CTΔ-
ADH1-
HIS3MX6) 
Location of 
nucleotide 
Nature of DNA mutations  
 
Position of mutation 
(cdc13-1 coding region, 
upstream/downstream non-
coding sequence, HIS3MX6 
marker DNA or its promoter 
or ADH1 terminator) 
Amino acid 
modification 
Protein 
Frame 
shift: 
(marker or 
truncated 
Cdc13-1 
protein) 
   Deletio
n 
Insertio
n 
substitutio
n 
   
of R3-
sequence 
runs? 
reliable) or modification 
could be in strain 1296-TR 
22 1297-CTΔ #8  1763   C→T Mutation within ADH1 
terminator sequence at the 
start of HIS3MX6 modular 
DNA 
 NO 
 
  3306? 
Miscalled 
nucleotide 
at the start 
of R3-
sequence 
runs? 
  G→A? CDC13 downstream sequence 
beyond deletion primer (This 
mutation is towards the start 
of sequence, not very 
reliable) or modification 
could be in strain 1296-TR 
 NO 
 
23 1297-CTΔ #11  1763   C→T Mutation within ADH1 
terminator sequence at the 
start of HIS3MX6 modular 
DNA 
 NO 
 
24 1297-CTΔ #12  1763   C→T Mutation within ADH1 
terminator sequence at the 
start of HIS3MX6 modular 
DNA 
 NO 
 
 
The EcoR1 site was confirmed in the parent strains at position 1311 (Figure 4.10).  No sequence 
modifications were found in the cdc13-1 coding region in either parent strain 1296 or 1297.  
However, a few mutations were encountered in N-truncated and C-truncated constructs.  These 
mutations were mainly substitution (occurrence 0-2 per read) with very few (0-1) deletion 
mutations.  Insertion of six nucleotide sequence (TAGATC) was confirmed in every N-
terminus-truncated mutant (100% of read) (Figure 4.11).  This sequence lies within the modular 
DNA of marker cassette, 46 nucleotides outside the stop codon of the TRP1 marker at position 
254.  The cdc13-1-NTΔ mutants (in strain 1296-TR) #4, #5 and #6 did not show any mutations 
(Figure 4.12).  Out of 8 substitution mutations identified in rest of the mutants (Figure 4.12 and 
4.13), 5 lay within the coding region of the TRP1 marker (Figures 4.14-4.18), one outside the 
TRP1 marker within the 3’ part of the deletion primer (not very reliable) (Figure 4.19) and one 
lay within the GAL1 promoter region (Figure 4.20).  Only one substitution mutation was 
positioned within the C-terminus half of the cdc13-1 gene (mutant #7 in strain 1297-TR) 
(Figure 4.21).  However, it does not change the amino acid (codon 143 changes from 
GGC→GGA, but both encode glycine, a silent mutation) (Figure 4.21B).  Only one nucleotide 
mismatch (deletion mutation?) was identified in NTΔ mutants #2 located within the deletion 
primer at the start of the C-terminus and might possibly shift the translational frame (however 
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not very reliable, seems sequencing error rather than a valid mutation from R2 chromatogram 
analysis) (Figure 4.22).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10.  Confirmation of EcoR1 site in cdc13-1 ORF sequence through sequencing of PCR fragment.  
Alignment of N1-sequence read (query) with that of reference sequence (subject) and N1-
chromatogram shows EcoR1 site (GAATTC) at position 1311 in 3 kb amplified DNA from genomic DNA of 
parent strain 1296-TR (A) and 1297-TR (B). 
 
 
Figure 4.11.  Confirmation of TAGATC sequence insertion in N-terminus truncated mutants at position 
254 of the reference sequence. 
Analysis of F1 sequence reads by DNA alignment with the reference sequence of NTΔ manifests TAGATC 
six nucleotide sequence in all tested mutants.  F1 sequences (1-12) were generated by automated 
sequencing of PCR fragments from genomic DNA of cdc13-1 N-truncated mutants of strain 1296-TR (A) 
and 1297-TR (B).  Whereas NTΔ reference sequence was constructed from cdc13-1 C-terminus ORF 
sequence and modular DNA sequence from yeast plasmid, pFA6a-TRP1-PGAL1 as accessed from online 
resources. 
1_F1_1007       CGCATAGATC GGCAAGTGCA CAAACAATAC TTAAATAAAT ACTACTCAGT NTΔ#2(1296) 
2_F1_1030       CGCATAGATC GGCAAGTGCA CAAACAATAC TTAAATAAAT ACTACTCAGT NTΔ#4(1296) 
3_F1_1051       CGCATAGATC GGCAAGTGCA CAAACAATAC TTAAATAAAT ACTACTCAGT NTΔ#5(1296) 
4_F1_1019       CGCATAGATC GGCAAGTGCA CAAACAATAC TTAAATAAAT ACTACTCAGT NTΔ#6(1296) 
5_F1_1041       CGCATAGATC GGCAAGTGCA CAAACAATAC TTAAATAAAT ACTACTCAGT NTΔ#7(1296) 
6_F1_1087       CGCATAGATC GGCAAGTGCA CAAACAATAC TTAAATAAAT ACTACTCAGT NTΔ#21(1296) 
NTΔ_3267 nt     CGCA...... GGCAAGTGCA CAAACAATAC TTAAATAAAT ACTACTCAGT Ref sequence 
 
7_F1_1073       CGCATAGATC GGCAAGTGCA CAAACAATAC TTAAATAAAT ACTACTCAGT NTΔ#1(1297) 
8_F1_1075       CGCATAGATC GGCAAGTGCA CAAACAATAC TTAAATAAAT ACTACTCAGT NTΔ#7(1297 
9_F1_777        CGCATAGATC GGCAAGTGCA CAAACAATAC TTAAATAAAT ACTACTCAGT NTΔ#8(1297 
10_F1_1075      CGCATAGATC GGCAAGTGCA CAAACAATAC TTAAATAAAT ACTACTCAGT NTΔ#11(1297 
11_F1_1138      CGCATAGATC GGCAAGTGCA CAAACAATAC TTAAATAAAT ACTACTCAGT NTΔ#12(1297 
12_F1_1067      CGCATAGATC GGCAAGTGCA CAAACAATAC TTAAATAAAT ACTACTCAGT NTΔ#22(1297 
NTΔ_3267 nt     CGCA...... GGCAAGTGCA CAAACAATAC TTAAATAAAT ACTACTCAGT Ref sequence 
 
A 
B 
Query  61    CTCAGTTGAAAGGTTAGAGGGCAAAATTGTTGGCATGAATTCACCTCAATTCGCCAGTAT  120 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1271  CTCAGTTGAAAGGTTAGAGGGCAAAATTGTTGGCATGAATTCACCTCAATTCGCCAGTAT  1330 
 
 
Query  60    AGTGTAGGCTCAGTTGAAAGGTTAGAGGGCAAAATTGTTGGCATGAATTCACCTCAATTC  119 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1263  AGTGTAGGCTCAGTTGAAAGGTTAGAGGGCAAAATTGTTGGCATGAATTCACCTCAATTC  1322 
 
 
A 
B 
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Figure 4.12.  Identification of two substitution mutations within coding region of TRP1 marker in NTΔ-
TRP1 constructs (strain 1296) by alignment of F1 sequence reads. 
Alignment of F1 sequence reads from six NTΔ-TRP1 (strain 1296) constructs shows substitution of 
nucleotide T with C in NTΔ clone #7 (5) at position 457 and in clone #21 (6) at position 462 of reference 
sequence. Conversely sequencing of PCR products from genomic DNA of NTΔ constructs #4 (2), #5 (3) 
and #6 (4) (strain 1296-TR) did not show any mutation. 
 
 
Figure 4.13.  Identification of three substitution mutations within coding region of TRP1 marker in NTΔ-
TRP1 constructs (strain 1297) by alignment of F1 sequence reads. 
Alignment of F1 sequences from six NTΔ-TRP1 (strain 1297) constructs shows substitution of nucleotide 
A with G in NTΔ clone #7 (8) at position 676 and in clone #11 (10) at position 821 of reference sequence. 
F1 sequences alignment in mutant NTΔ clone #1 (7) shows substitution of nucleotide C with T at position 
879 of construct.  The DNA sequencing of PCR fragment from NTΔ constructs #8 (9) could not read 
sequence after nucleotide 855. F1 sequence alignment in this mutant could not detect any mutation 
between positions 855 and 894.  
 
 
 
 
 
 
 
 
1_F1_1007         ACCAACATTTTCTGGCGTCAGTCCACCAGCTAACATAAAATGTAAGCTTTCGGGGCTCTC 
2_F1_1030         ACCAACATTTTCTGGCGTCAGTCCACCAGCTAACATAAAATGTAAGCTTTCGGGGCTCTC 
3_F1_1051         ACCAACATTTTCTGGCGTCAGTCCACCAGCTAACATAAAATGTAAGCTTTCGGGGCTCTC 
4_F1_1019         ACCAACATTTTCTGGCGTCAGTCCACCAGCTAACATAAAATGTAAGCTTTCGGGGCTCTC 
5_F1_1041         ACCAACATTTTCTGGCGTCAGTCCACCAGCTAACATAAAATGcAAGCTTTCGGGGCTCTC 
6_F1_1087         ACCAACATTTTCTGGCGTCAGTCCACCAGCTAACATAAAATGTAAGCcTTCGGGGCTCTC 
NTΔ_TRP1_Ref      ACCAACATTTTCTGGCGTCAGTCCACCAGCTAACATAAAATGTAAGCTTTCGGGGCTCTC 474 
7_F1_1073         TTCTTGCCACGACTCATCTCCATGCAGTTGGACGATATCAATGCCGTAATCATTGACCAG 
8_F1_1075         TTCTTGCCACGACTCATCTCCgTGCAGTTGGACGATATCAATGCCGTAATCATTGACCAG 
9_F1_777          TTCTTGCCACGACTCATCTCCATGCAGTTGGACGATATCAATGCCGTAATCATTGACCAG 
10_F1_1075        TTCTTGCCACGACTCATCTCCATGCAGTTGGACGATATCAATGCCGTAATCATTGACCAG 
11_F1_1138        TTCTTGCCACGACTCATCTCCATGCAGTTGGACGATATCAATGCCGTAATCATTGACCAG 
12_F1_1067        TTCTTGCCACGACTCATCTCCATGCAGTTGGACGATATCAATGCCGTAATCATTGACCAG 
NTΔ_TRP1_Ref      TTCTTGCCACGACTCATCTCCATGCAGTTGGACGATATCAATGCCGTAATCATTGACCAG 714 
 
7_F1_1073         TGAACTATTTTTATATGCTTTTACAAGACTTGAAATTTTCCTTGCAATAACCGGGTCAAT 
8_F1_1075         TGAACTATTTTTATATGCTTTTACAAGACTTGAAATTTTCCTTGCAATAACCGGGTCAAT 
9_F1_777          TGAACTATTTTTATATGCTTTTACAAGACTTGAAATTTTCCTTGCAATAACCGGGTCAAT 
10_F1_1075        TGAACTATTTTTATATGCTTTTACAAGACTTGAAATTTTCCTTGCAgTAACCGGGTCAAT 
11_F1_1138        TGAACTATTTTTATATGCTTTTACAAGACTTGAAATTTTCCTTGCAATAACCGGGTCAAT 
12_F1_1067        TGAACTATTTTTATATGCTTTTACAAGACTTGAAATTTTCCTTGCAATAACCGGGTCAAT 
NTΔ_TRP1_Ref      TGAACTATTTTTATATGCTTTTACAAGACTTGAAATTTTCCTTGCAATAACCGGGTCAAT 834 
 
7_F1_1073         TGTTCTCTTTCTATTGGGCACACATATAATACCCAGCAAGTCAGTATCGGAATCTAGAGC 
8_F1_1075         TGTTCTCTTTCTATTGGGCACACATATAATACCCAGCAAGTCAGCATCGGAATCTAGAGC 
9_F1_777          TGTTCTCTTTCTATTGGGCAC--------------------------------------- 
10_F1_1075        TGTTCTCTTTCTATTGGGCACACATATAATACCCAGCAAGTCAGCATCGGAATCTAGAGC 
11_F1_1138        TGTTCTCTTTCTATTGGGCACACATATAATACCCAGCAAGTCAGCATCGGAATCTAGAGC 
12_F1_1067        TGTTCTCTTTCTATTGGGCACACATATAATACCCAGCAAGTCAGCATCGGAATCTAGAGC 
NTΔ_TRP1_Ref      TGTTCTCTTTCTATTGGGCACACATATAATACCCAGCAAGTCAGCATCGGAATCTAGAGC 894 
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Figure 4.14.  A silent substitution mutation in NTΔ::TRP1 clone #7 (1296-TR). 
(A) Mapping of point mutation within construct sequence. 
Alignment of F1-sequence (query) with that of reference sequence (subject) and F1-chromatogram 
show replacement of nucleotide T with C at position 457 of the construct.   
(B) Mapping of the point mutation within TRP1 protein. 
TRP1 coding sequence (query) from NTΔ::TRP1 clone #7 was aligned to that of reference sequence 
(subject) from yeast plasmid to map point mutation on the protein.  This mutation at position 457 of 
mutant construct, corresponding to coding sequence position 519 of TRP1 marker will change codon 
173 of TRP1 marker from TTA to TTG, both encode for leucine amino acid (a silent mutation). 
 
 
 
 
 
 
F1 text sequence from F1 sequence read of the construct NTΔ#7(1296) 
Query  362   ATCACCAACATTTTCTGGCGTCAGTCCACCAGCTAACATAAAATGCAAGCTTTCGGGGCT  421 
             ||||||||||||||||||||||||||||||||||||||||||||| |||||||||||||| 
Sbjct  412   ATCACCAACATTTTCTGGCGTCAGTCCACCAGCTAACATAAAATGTAAGCTTTCGGGGCT  471 
 
F1 chromatogram  
 
 
Query  481  TCTGACTGGGTTGGAAGGCAAGAGAGCCCCGAAAGCTTGCATTTTATGTTAGCTGGTGGA  540 
            |||||||||||||||||||||||||||||||||||||| |||||||||||||||||||||      TRP1 DNA 
Sbjct  481  TCTGACTGGGTTGGAAGGCAAGAGAGCCCCGAAAGCTTACATTTTATGTTAGCTGGTGGA  540 
Query  121  VFPKDCNILLSAASQKPHSFIPLFDSEAGGTGELLDWNSISDWVGRQESPESLHFMLAGG  180 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||     TRP1 Protein 
Sbjct  121  VFPKDCNILLSAASQKPHSFIPLFDSEAGGTGELLDWNSISDWVGRQESPESLHFMLAGG  180 
 
codon 173 changed from TTA to TTG, both encode leucine amino acid 
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Figure 4.15.  A missense substitution mutation in the NTΔ::TRP1 clone #21 (1296-TR). 
(A) Mapping of point mutation within construct sequence. 
Alignment of F1-sequence (query) with that of reference sequence (subject) and F1-chromatogram 
show replacement of nucleotide T with C at position 462 of the construct.   
(B) Mapping of the point mutation within TRP1 protein. 
TRP1 coding sequence (query) from NTΔ::TRP1 clone #21 was aligned to that of reference sequence 
(subject) from yeast plasmid to map point mutation on the protein.  This mutation at position 462 of 
mutant construct, corresponding to coding sequence position 514 of TRP1 marker will change codon 
172 of TRP1 marker from AGC (serine) to GGC (glycine), a missense point mutation. 
 
 
 
 
 
F1 text sequence from F1 sequence read of the construct NTΔ#21(1296) 
Query  364   ATCACCAACATTTTCTGGCGTCAGTCCACCAGCTAACATAAAATGTAAGCCTTCGGGGCT  423 
             |||||||||||||||||||||||||||||||||||||||||||||||||| ||||||||| 
Sbjct  412   ATCACCAACATTTTCTGGCGTCAGTCCACCAGCTAACATAAAATGTAAGCTTTCGGGGCT  471 
 
F1 chromatogram (AAAATGTAAGCC) 
 
 
Query  481  TCTGACTGGGTTGGAAGGCAAGAGAGCCCCGAAGGCTTACATTTTATGTTAGCTGGTGGA  540 
            ||||||||||||||||||||||||||||||||| |||||||||||||||||||||||||| TRP1 DNA 
Sbjct  481  TCTGACTGGGTTGGAAGGCAAGAGAGCCCCGAAAGCTTACATTTTATGTTAGCTGGTGGA  540 
 
Query  121  VFPKDCNILLSAASQKPHSFIPLFDSEAGGTGELLDWNSISDWVGRQESPEGLHFMLAGG  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||.|||||||| TRP1 Protein 
Sbjct  121  VFPKDCNILLSAASQKPHSFIPLFDSEAGGTGELLDWNSISDWVGRQESPESLHFMLAGG  180 
Codon 172 changed from AGC to GGC, amino acid changed from S (Serine) to G (glycine) 
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Figure 4.16.  A missense substitution mutation in the NTΔ::TRP1 clone #1 (1297-TR). 
(A) Mapping of point mutation within construct sequence. 
Alignment of F1-sequence (query) with that of reference sequence (subject) and F1-chromatogram 
show replacement of nucleotide C with T at position 879 of the construct.   
(B) Mapping of the point mutation within TRP1 protein. 
TRP1 coding sequence (query) from NTΔ::TRP1 clone #1 was aligned to that of reference sequence 
(subject) from yeast plasmid to map point mutation on the protein.  This mutation at position 879 of 
mutant construct, corresponding to coding sequence position 97 of TRP1 marker will change codon 33 
of TRP1 marker from GCT (alanine) to ACT (threonine), a missense point mutation. This mutation was 
also confirmed in overlapping R1 sequence read. 
 
 
 
 
 
 
 
 
 
F1 text sequence from F1 sequence read of the construct NTΔ#1(1297) 
 
Query  783   CTCTTTCTATTGGGCACACATATAATACCCAGCAAGTCAGTATCGGAATCTAGAGCACAT  842 
             |||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||| 
Sbjct  839   CTCTTTCTATTGGGCACACATATAATACCCAGCAAGTCAGCATCGGAATCTAGAGCACAT  898 
 
F1 chromatogram with highlighted sequence GCAAGTCAGT  
 
Query  61   AGCACAGAGGCCGCAGAATGTGCTCTAGATTCCGATACTGACTTGCTGGGTATTATATGT  120 
            |||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||| TRP1 DNA 
Sbjct  61   AGCACAGAGGCCGCAGAATGTGCTCTAGATTCCGATGCTGACTTGCTGGGTATTATATGT  120 
 
Query  1    MSVINFTGSSGPLVKVCGLQSTEAAECALDSDTDLLGIICVPNRKRTIDPVIARKISSLV  60 
            ||||||||||||||||||||||||||||||||.|||||||||||||||||||||||||||  TRP1 Protein 
Sbjct  1    MSVINFTGSSGPLVKVCGLQSTEAAECALDSDADLLGIICVPNRKRTIDPVIARKISSLV  60 
Codon 33 changed from GCT to ACT, amino acid changed from A (Alanine) to T (Threonine) 
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Figure 4.17.  A silent substitution mutation in the NTΔ::TRP1 clone #7 (1297-TR). 
(A) Mapping of point mutation within construct sequence. 
Alignment of F1-sequence (query) with that of reference sequence (subject) and F1-chromatogram 
show replacement of nucleotide A with G at position 676 of the construct.   
(B) Mapping of the point mutation within TRP1 protein. 
TRP1 coding sequence (query) from NTΔ::TRP1 clone #7 was aligned to that of reference sequence 
(subject) from yeast plasmid to map point mutation on the protein.  This mutation (positioned at 
nucleotide 300) will change codon 100 of TRP1 marker from CAT to CAC, both encode for histidine 
amino acid, a silent point mutation. This mutation was also confirmed in overlapping R1 sequence read. 
 
 
 
 
 
 
 
 
 
 
F1 text sequence from F1 sequence read of the construct NTΔ#7(1297) 
Query  602   GCCACGACTCATCTCCGTGCAGTTGGACGATATCAATGCCGTAATCATTGACCAGAGCCA  661 
             |||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  660   GCCACGACTCATCTCCATGCAGTTGGACGATATCAATGCCGTAATCATTGACCAGAGCCA  719 
 
F1 chromatogram with highlighted sequence CTCATCTCCG 
 
Query  241  CCTAAGGAGGATGTTTTGGCTCTGGTCAATGATTACGGCATTGATATCGTCCAACTGCAC  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||   TRP1 DNA 
Sbjct  241  CCTAAGGAGGATGTTTTGGCTCTGGTCAATGATTACGGCATTGATATCGTCCAACTGCAT  300 
 
Query  61   KAYKNSSGTPKYLVGVFRNQPKEDVLALVNDYGIDIVQLHGDESWQEYQEFLGLPVIKRL  120 
            |||||||||||||||||||||||||||||||||||||||.||||||||||||||||||||  TRP1 Protein 
Sbjct  61   KAYKNSSGTPKYLVGVFRNQPKEDVLALVNDYGIDIVQLHGDESWQEYQEFLGLPVIKRL  120 
Codon 100 changed from CAT to CAC, both encode amino acid H (Histidine)  
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Figure 4.18.  A missenses substitution mutation in cdc13-1 NTΔ::TRP1 clone #11 (1297-TR). 
(A) Mapping of point mutation within construct sequence. 
Alignment of F1-sequence (query) with that of reference sequence (subject) and F1-chromatogram 
show replacement of nucleotide A with G at position 821 of the construct.   
(B) Mapping of the point mutation within TRP1 protein. 
TRP1 coding sequence (query) from NTΔ::TRP1 clone #11 was aligned to that of reference sequence 
(subject) from yeast plasmid to map point mutation on the protein.  This mutation positioned at 
nucleotide 155, will change codon 52 of TRP1 marker from ATT (isoleucine) to ACT (threonine), a 
missense point mutation. This mutation was also confirmed in overlapping R1 sequence read. 
 
 
 
 
 
 
 
 
 
 
F1 text sequence from F1 sequence read of the construct NTΔ#11(1297) 
 
Query  722   TATTTTTATATGCTTTTACAAGACTTGAAATTTTCCTTGCAGTAACCGGGTCAATTGTTC  781 
             ||||||||||||||||||||||||||||||||||||||||| |||||||||||||||||| 
Sbjct  780   TATTTTTATATGCTTTTACAAGACTTGAAATTTTCCTTGCAATAACCGGGTCAATTGTTC  839 
 
F1 chromatogram with highlighted sequence TTTCCTTGCAG 
 
 
 
Query  121  GTGCCCAATAGAAAGAGAACAATTGACCCGGTTACTGCAAGGAAAATTTCAAGTCTTGTA  180 
            ||||||||||||||||||||||||||||||||||.||||||||||||||||||||||||| TRP1 DNA 
Sbjct  121  GTGCCCAATAGAAAGAGAACAATTGACCCGGTTATTGCAAGGAAAATTTCAAGTCTTGTA  180 
 
Query  1    MSVINFTGSSGPLVKVCGLQSTEAAECALDSDADLLGIICVPNRKRTIDPVTARKISSLV  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||.||||||||  TRP1 Protein 
Sbjct  1    MSVINFTGSSGPLVKVCGLQSTEAAECALDSDADLLGIICVPNRKRTIDPVIARKISSLV  60 
Codon 52 changed from ATT to ACT, amino acid changed from I (Isoleucine) to T (Threonine) 
A 
B 
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Figure 4.19.  Identification of one substitution mutations outside TRP1 coding region in NTΔ::TRP1 clone 
#2 (strain 1296). 
 
(A) Identification of substitution mutations by multiple sequence alignment. 
Alignment of F1 sequences from six NTΔ::TRP1 (strain 1296) constructs shows a substitution mutation in 
NTΔ clone #2 which replaces nucleotide A with C at position 219 of the reference sequence.  This 
mutation is positioned within F4 primer of TRP1 marker of modular DNA and being within 3’part of 
deletion primer, not very reliable modification. 
(B) Confirmation of substitution mutation in NTΔ::TRP1 clone #2 (1296-TR) by F1-chromatogram. 
Alignment of F1-sequence (query) with that of reference sequence (subject) and F1-chromatogram 
show replacement of nucleotide A with C at sequence position 219.  This is the part of the forward 
deletion primer (F4 TRP1) with less chances of modification, however two sequencing reactions 
confirmed this modification. 
 
 
 
 
1_F1_1007         GTGGAAACTATCGCCTAAAAGAATTCGAGCTCGTTTAAcCCTCCTTACGCATCTGTGCGG 
2_F1_1030         GTGGAAACTATCGCCTAAAAGAATTCGAGCTCGTTTAAACCTCCTTACGCATCTGTGCGG 
3_F1_1051         GTGGAAACTATCGCCTAAAAGAATTCGAGCTCGTTTAAACCTCCTTACGCATCTGTGCGG 
4_F1_1019         GTGGAAACTATCGCCTAAAAGAATTCGAGCTCGTTTAAACCTCCTTACGCATCTGTGCGG 
5_F1_1041         GTGGAAACTATCGCCTAAAAGAATTCGAGCTCGTTTAAACCTCCTTACGCATCTGTGCGG 
6_F1_1087         GTGGAAACTATCGCCTAAAAGAATTCGAGCTCGTTTAAACCTCCTTACGCATCTGTGCGG 
NTΔ_TRP1_Ref      GTGGAAACTATCGCCTAAAAGAATTCGAGCTCGTTTAAACCTCCTTACGCATCTGTGCGG 240 
F1 text sequence from F1 sequence read of the construct NTΔ#2 (1296) 
Query  120  TCGCCTAAAAGAATTCGAGCTCGTTTAACCCTCCTTACGCATCTGTGCGGTATTTCACAC  179 
            |||||||||||||||||||||||||||| ||||||||||||||||||||||||||||||| 
Sbjct  191  TCGCCTAAAAGAATTCGAGCTCGTTTAAACCTCCTTACGCATCTGTGCGGTATTTCACAC  250 
 
F1 chromatogram with highlighted sequence CGAGCTCGTTTAAC 
 
A 
B 
 219 
 
 
 
Figure 4.20.  A substitution mutation in NTΔ::TRP1 clone #21 (1296-TR). 
Alignment of R1-sequence (query) with that of reference sequence (subject) and R1-chromatogram 
show replacement of nucleotide T with C at sequence position 1457 of the reference DNA.  This 
modification is positioned within GAL1 promoter sequence and was also confirmed in overlapping R2 
sequence.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.21.  A substitution mutation in NTΔ::TRP1 clone #7 (strain 1297-TR). 
Alignment of R2-sequence (query) with that of reference sequence (subject) and R2-chromatogram 
show replacement of nucleotide C with A at sequence position 2107.  This modification is positioned 
within cdc13-1 C-terminus coding sequence and will change codon 143 from GGC to GGA, both encode 
for amino acid glycine (a silent mutation). 
 
R1 text sequence from R1 sequence read (reverse complement) from the construct NTΔ#21 (1296) 
 
Query  132   TAGGATGATAATGCGACTAGTTNTTTAGCCTTATTTCTGGGGTAATTAATCAGCGAAGCG  191 
             |||||||||||||||| ||||| ||||||||||||||||||||||||||||||||||||| 
Sbjct  1441  TAGGATGATAATGCGATTAGTTTTTTAGCCTTATTTCTGGGGTAATTAATCAGCGAAGCG  1500 
 
The reverse complement of sequence ATAATGCGAC is GTCGCATTAT. 
 
R1 chromatogram with highlighted sequence GTCGCATTAT. 
 
R2 text sequence from R2 sequence read (reverse complement) from the construct NTΔ#7 (1297) 
Query  721   CTCAGAAAAATATTCAACAACGGGCTAAGAGATCTACAGAACGGACGCGATGAAAACCTT  780 
             |||||||||||||||||||||||||||||||||||||||||||| ||||||||||||||| 
Sbjct  2063  CTCAGAAAAATATTCAACAACGGGCTAAGAGATCTACAGAACGGCCGCGATGAAAACCTT  2122 
 
The reverse complement of sequence CAGAACGGA is TCCGTTCTG. 
 
R2 chromatogram with highlighted sequence TCCGTTCTG. 
 
cdc13-1 in NT deletion #7 (1297-TR) 
Query  421   CAGAACGGACGCGATGAAAACCTTTCGCAATACGGCATAGTTTGTAAGATGAATATAAAA  480 
             |||||||| |||||||||||||||||||||||||||||||||||||||||||||||||||  cdc13-1 C-terminus DNA 
Sbjct  421   CAGAACGGCCGCGATGAAAACCTTTCGCAATACGGCATAGTTTGTAAGATGAATATAAAA  480 
 
Query  121  QFETFDSKLRKIFNNGLRDLQNGRDENLSQYGIVCKMNIKVKMYNGKLNAIVRECEPVPH  180 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  Cdc13-1 C-terminus protein 
Sbjct  121  QFETFDSKLRKIFNNGLRDLQNGRDENLSQYGIVCKMNIKVKMYNGKLNAIVRECEPVPH  180 
Codon 143 changed from GGC to GGA, both encode amino acid G (Glycine) 
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Figure 4.22.  A deletion mutation (?) in NTΔ::TRP1 clone #2 (strain 1296) mutant. 
Alignment of R2-sequence (query) with that of reference sequence (subject) and R2-chromatogram 
show nucleotide A missing at sequence position 1706.  R2 chromatogram show two broad green peaks 
(less well resolved) which might indicates three A’s not two as mis-counted by computer program  This 
modification lies within deletion primer at the start of the cdc13-1 C-terminus coding sequence.  This 
mutation being in the beginning of the sequence read not very reliable however can shift frame of the 
encoded protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R2 text sequence from R2 sequence read of the construct NTΔ#2(1296) 
Query  61    ACCCGGATCTCAAAATGGCAGTATGGAGTTTGAAGAACATT-GCACCGACACGCAGG  116 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1665  ACCCGGATCTCAAAATGGCAGTATGGAGTTTGAAGAACATTAGCACCGACACGCAGG  1721 
 
The reverse complement of sequence GAACATT-GCACC is GGTGC-AATGTTC 
R2 chromatogram with highlighted sequence GGTGC-AATGTTC. 
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Homology analysis of C-terminus-truncated mutants with a theoretical (expected) sequence 
identified 24 substitution mutations (1-3 per sequence read).  In 12 of these mutations, a single 
nucleotide ‘C’ is replaced with ‘T’ at position 1763 of all constructs (100%).  This modification 
lies within the ADH1 terminator sequence and common in all tested mutants (Figure 4.23), 
might possibly be an alteration in the original sequence of the construct not reported in the 
sequences accessed online.  The two substitution mutations were identified at position 2213 
(TEF promoter) and occurred in two C-terminus-truncated mutants (#3 and #4) in which 
nucleotide ‘A’ was replaced with ‘G’ (Figure 4.24).  In the same way, two other substitution 
mutations that replaced nucleotide G →A identified at position 3115 and 3306, are common in 
4 (Figure 4.25 and 4.26) and 5 mutants (Figure 4.27) respectively.  The first one is located 
within the TEF terminator, but the second one, lying downstream of CDC13 at the start of the 
sequence read, is not very reliable (more like a computer program error in nucleotide read not a 
valid mutation).  None of these mutation occurred in the coding region of the protein (Cdc13-1-
C-terminus).  Moreover, there was no deletion mutation identified in C-terminus-truncated 
constructs and the EcoR1 site was also confirmed in the C-terminus-truncated mutants at 
position 1311 within the N-terminus (Figure 4.28). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure4.23.  Alignment of F3 sequences show substitution mutation (C to T) at position 1763 located 
within ADH1 terminator sequence in cdc13-1 CTΔ::ADH1-HIS3MX6 constructs. 
F3 sequences (1-12) in all tested mutants were generated by automated sequencing of PCR fragments 
from genomic DNA of cdc13-1 C-truncated mutants of strain 1296-TR (A) and 1297-TR (B).  Whereas CTΔ 
reference sequence was constructed from cdc13-1 N-terminus ORF sequence and modular DNA 
sequence from yeast plasmid, pFA6a-ADH1-HIS3MX6 as accessed from online resources. 
 
 
 
1_13_F3_819       TCAGGTTGCTTTCTCAGGTATAGTATGAGGTCGCTCTTATTGACCACACCTCTACCGGCA CTΔ#3(1296) 
2_14_F3_1067      TCAGGTTGCTTTCTCAGGTATAGTATGAGGTCGCTCTTATTGACCACACCTCTACCGGCA CTΔ#4(1296) 
3_15_F3_990       TCAGGTTGCTTTCTCAGGTATAGTATGAGGTCGCTCTTATTGACCACACCTCTACCGGCA CTΔ#6(1296) 
4_16_F3_869       TCAGGTTGCTTTCTCAGGTATAGTATGAGGTCGCTCTTATTGACCACACCTCTACCGGCA CTΔ#7(1296) 
5_13_F3_997       TCAGGTTGCTTTCTCAGGTATAGTATGAGGTCGCTCTTATTGACCACACCTCTACCGGCA CTΔ#9(1296) 
6_18_F3_988       TCAGGTTGCTTTCTCAGGTATAGTATGAGGTCGCTCTTATTGACCACACCTCTACCGGCA CTΔ#10(1296) 
CTΔ_HIS_Ref seq   TCAGGTTGCTTTCTCAGGTATAGCATGAGGTCGCTCTTATTGACCACACCTCTACCGGCA 1799 ref seque 
7_19_F3_971        GTCAGGTTGCTTTCTCAGGTATAGTATGAGGTCGCTCTTATTGACCACACCTCTACCGGC CTΔ#3(1297) 
8_20_F3_958        GTCAGGTTGCTTTCTCAGGTATAGTATGAGGTCGCTCTTATTGACCACACCTCTACCGGC CTΔ#4(1297) 
9_21_F3_1042       GTCAGGTTGCTTTCTCAGGTATAGTATGAGGTCGCTCTTATTGACCACACCTCTACCGGC CTΔ#7(1297) 
10_22_F3_1013      GTCAGGTTGCTTTCTCAGGTATAGTATGAGGTCGCTCTTATTGACCACACCTCTACCGGC CTΔ#8(1297) 
11_23_F3_967       GTCAGGTTGCTTTCTCAGGTATAGTATGAGGTCGCTCTTATTGACCACACCTCTACCGGC CTΔ#11(1297) 
12_24_F3_1031      GTCAGGTTGCTTTCTCAGGTATAGTATGAGGTCGCTCTTATTGACCACACCTCTACCGGC CTΔ#12(1297) 
CTΔ_HIS_Ref seq    GTCAGGTTGCTTTCTCAGGTATAGCATGAGGTCGCTCTTATTGACCACACCTCTACCGGC 1798 Ref seq. 
A 
B 
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Figure 4.24.  Two mutants of cdc13-1 CTΔ (#3 and #4 in strain 1296) show substitution of A with T at 
position 2213. 
 
Alignment of F3-sequences with that of CTΔ construct sequence show this substitution mutation (A and 
B), positioned within TEF promoter region of His marker (C and D). 
 
 
 
1_13_F3_819       CCTTTTAAAATCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAgCCATGG CTΔ#3(1296) 
2_14_F3_1067      CCTTTTAAAATCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAgCCATGG CTΔ#4(1296) 
3_15_F3_990       CCTTTTAAAATCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAACCATGG CTΔ#6(1296) 
4_16_F3_869       CCTTTTAAAATCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAACCATGG CTΔ#7(1296) 
5_13_F3_997       CCTTTTAAAATCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAACCATGG CTΔ#9(1296) 
6_18_F3_988       CCTTTTAAAATCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAACCATGG CTΔ#10(1296) 
CTΔ_HIS_Ref seq   CCTTTTAAAATCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAACCATGG 2219 Ref seq 
 
7_19_F3_971        TCCTTTTAAAATCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAACCATG CTΔ#3(1297) 
8_20_F3_958        TCCTTTTAAAATCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAACCATG CTΔ#4(1297) 
9_21_F3_1042       TCCTTTTAAAATCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAACCATG CTΔ#7(1297) 
10_22_F3_1013      TCCTTTTAAAATCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAACCATG CTΔ#8(1297) 
11_23_F3_967       TCCTTTTAAAATCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAACCATG CTΔ#11(1297) 
12_24_F3_1031      TCCTTTTAAAATCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAACCATG CTΔ#12(1297 
CTΔ_3365           TCCTTTTAAAATCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAACCATG 2218 Ref seq) 
Sequence read with F3 primer (query) and its chromatogram from mutant CTΔ#3 (1296-TR)  
Query  541   TCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAGCCATGGCAGAACCAGC  600 
             ||||||||||||||||||||||||||||||||||||||||||| |||||||||||||||| 
Sbjct  2170  TCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAACCATGGCAGAACCAGC  2229 
 
F3 chromatogram with highlighted sequence GAACATAAACA shows nucleotide G at position 603 
 
 
Sequence read with F3 primer (query) and its chromatogram from mutant CTΔ#4 (1296-TR)  
Query  544   GATACAGTTCTCACATCACATCCGAACATAAACAGCCATGGCAGAACCAGCCCaaaaaaa  603 
             |||||||||||||||||||||||||||||||||| ||||||||||||||||||||||||| 
Sbjct  2179  GATACAGTTCTCACATCACATCCGAACATAAACAACCATGGCAGAACCAGCCCAAAAAAA  2238 
 
F3 chromatogram with highlighted sequence ACATAAACA, shows nucleotide G at position 602 
A 
B 
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Figure 4.25.  Identification of substitution of G with A at position 3115 in four mutants of cdc13-1 CTΔ 
(1296-TR) by alignment of R3 sequences. 
R3-sequences alignment from all tested mutants with that of CTΔ construct sequence show this 
substitution mutation in four CTΔ clones #6 (3), #7 (4), #9 (5) and #10 (6) in strain 1296-TR.  This 
mutation is positioned within TEF terminator region of His marker. All six tested clones in strain 1297-
TR (7-12) do not show this mutation. 
 
 
 
 
 
 
1_13_R3_728       TgCTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAGCTCGAATTCGACATGAT CTΔ#3(1296) 
2_14_R3_969       TgCTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAGCTCGAATTCGACATGAT CTΔ#4(1296) 
3_15_R3_1035      TACTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAGCTCGAATTCGACATGAT CTΔ#6(1296) 
4_16_R3_1096      TACTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAGCTCGAATTCGACATGAT CTΔ#7(1296) 
5_13_R3_1030      TACTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAGCTCGAATTCGACATGAT CTΔ#9(1296) 
6_18_R3_1041      TACTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAGCTCGAATTCGACATGAT CTΔ#10(1296) 
CTΔ_3365          TGCTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAGCTCGAATTCGACATGAT 3175 Ref seq 
 
7_19_R3_927        TGCTGGTCGCTATACTGCTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAGCT CTΔ#3(1297) 
8_20_R3_1059       TGCTGGTCGCTATACTGCTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAGCT CTΔ#4(1297) 
9_21_R3_977        TGCTGGTCGCTATACTGCTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAGCT CTΔ#7(1297) 
10_22_R3_1032      TGCTGGTCGCTATACTGCTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAGCT CTΔ#8(1297) 
11_23_R3_1040      TGCTGGTCGCTATACTGCTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAGCT CTΔ#11(1297) 
12_24_R3_1014      TGCTGGTCGCTATACTGCTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAGCT CTΔ#12(1297) 
CTΔ_3365           TGCTGGTCGCTATACTGCTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAGCT 3158 Ref seq 
Sequence read with R3 primer (query) and its chromatogram from mutant CTΔ#6(1296-TR)  
Query  841   GTGCGCAGAAAGTAATATCATGCGTCAATCGTATGTGAATGCTGGTCGCTATACTACTGT  900 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||| |||| 
Sbjct  3060  GTGCGCAGAAAGTAATATCATGCGTCAATCGTATGTGAATGCTGGTCGCTATACTGCTGT  3119 
The reverse complement of sequence CGCTATACT is AGTATAGCG.  
R3 chromatogram with highlighted sequence AGTATAGCG, shows nucleotide T (A) at position 227 (3115 
position of the construct)  
 
Sequence read with R3 primer (query) and its chromatogram from mutant CTΔ#7 (1296-TR) 
Query  923   AATGCTGGTCGCTATACTACTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAG  982 
             |||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||| 
Sbjct  3097  AATGCTGGTCGCTATACTGCTGTCGATTCGATACTAACGCCGCCATCCAGTTTAAACGAG  3156 
The reverse complement of sequence CTGTCGATTCGATA is TATCGAATCGACAG.  
R3 chromatogram with highlighted sequence TATCGAATCGACAG shows nucleotide T (complementary of A) 
at position 222 (3115 position of the construct)  
 
A 
B 
A 
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Figure 4.26.  Confirmation of substitution mutation at sequence position 3115 in CTΔ::HIS3MX6 clones 
(1296-TR). 
Alignment of R3-sequences (query) with that of reference sequence (subject) and R3-chromatogram 
from four CTΔ clones, #6 (A), #7 (B), #9 (C) and #10 (D) show replacement of nucleotide G with A at 
sequence position 3115 in TEF terminator region of His3MX6 marker. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sequence read with R3 primer (query) and its chromatogram from mutant CTΔ#9 (1296-TR) 
Query  781   AGAAAGTAATATCATGCGTCAATCGTATGTGAATGCTGGTCGCTATACTACTGTCGATTC  840 
             ||||||||||||||||||||||||||||||||||||||||||||||||| |||||||||| 
Sbjct  3066  AGAAAGTAATATCATGCGTCAATCGTATGTGAATGCTGGTCGCTATACTGCTGTCGATTC  3125 
 
The reverse complement of the sequence CTGTCGATTC is GAATCGACAG. 
R3 chromatogram with highlighted sequence GAATCGACAG shows nucleotide T (complementary of A) at position 223 
(3115 position of the construct)  
 
Sequence read with R3 primer (query) and its chromatogram from mutant CTΔ#10 (1296-TR) 
Query  781   GCGCAGAAAGTAATATCATGCGTCAATCGTATGTGAATGCTGGTCGCTATACTACTGTCG  840 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||| 
Sbjct  3062  GCGCAGAAAGTAATATCATGCGTCAATCGTATGTGAATGCTGGTCGCTATACTGCTGTCG  3121 
 
The reverse complement of the sequence GGTCGCTATACT is AGTATAGCGACC. 
R3 chromatogram with highlighted sequence AGTATAGCGACC shows nucleotide T (complementary of A) 
at position 223 (3115 position of the construct)  
 
C 
D 
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Figure 4.27.  Identification of substitution of G with A at position 3306 in fiver clones of cdc13-1 CTΔ by 
alignment of R3 sequences. 
 
 
 
 
R3-sequences alignment from tested mutants in strain 1296-TR (1-6) and in strain 1297-TR (7-12) with 
that of CTΔ construct sequence show this substitution mutation in five CTΔ clones #9 (5, #3 (7), #4 (8), 
#7 (9) and #8 (10).  This mismatched nucleotide is located in the start of R3 sequence and not reliable. 
 
 
 
Figure 4.28.  Confirmation of EcoR1 restriction site at position 1311 of the cdc13-1 CTΔ::ADH1-HIS3MX6 
constructs in strain 1296-TR and 1297-TR. 
Alignment of F2 sequences from twelve clones show conserved EcoR1 site in all tested mutants 
sequences (aligned by MUSCLE, multiple sequence alignment tool 
(http://www.ebi.ac.uk/Tools/msa/muscle/). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1_13_R3_728       ------------------------------------------------------------ CTΔ#3(1296) 
2_14_R3_969       ------------------------------------------------------------ CTΔ#4(1296) 
3_15_R3_1035      ------------------------------------------------------------ CTΔ#6(1296) 
4_16_R3_1096      ------------------------------------------------------------ CTΔ#7(1296) 
5_13_R3_1030      CGAAGGAAAAGGaAAAGAnnGag------------------------------------- CTΔ#9(1296) 
6_18_R3_1041      CGAAGGAAAA-GGAAAGAGGGGAnTGtnAAG----------------------------- CTΔ#10(1296) 
CTΔ_3365          CGAAGGAAAAGGGAAAGAGGGGAgTGgtAAGaagcaagagtcaatgaaaggtcttccttc 3353 Ref seq 
 
7_19_R3_927        nGGAACGTTTTCACACnAAGGnnAAGGAAAAGAGGGAG---------------------- CTΔ#3(1297) 
8_20_R3_1059       TGGAACG-TTTCACACGAAGGAAAAGGAAAAGAGGGAGGtnaaG---------------- CTΔ#4(1297) 
9_21_R3_977        TGGAACG-TTTCACACGAAGGAAAAGGAAAAGAGGGAGGnnG------------------ CTΔ#7(1297) 
10_22_R3_1032      TGGAACGTTTTCACACGAAGGAAAAGGAAAAGAGGGgGagGnnGt--------------- CTΔ#8(1297) 
11_23_R3_1040      TGGAACG-nTTCACACGAAGGAAAAGGgAAAagaGGgGGaGGTnAagna----------- CTΔ#11(1297) 
12_24_R3_1014      TGGAACG-TTTCA----------------------------------------------- CTΔ#12(1297) 
CTΔ_3365           TGGAACGTTTTCACACGAAGGAAAAGGGAAAGAGGGgaGtGGTaAgaagcaagagtcaat 3338 Ref seq 
1_13_F2_798      TGGCATGAAT TCACCTCAAT TCGCCAGTAT AAATGAGTTC AAATATTGCA CTΔ#3(1296) 
2_14_F2_1025     TGGCATGAAT TCACCTCAAT TCGCCAGTAT AAATGAGTTC AAATATTGCA CTΔ#4(1296) 
3_15_F2_1035     TGGCATGAAT TCACCTCAAT TCGCCAGTAT AAATGAGTTC AAATATTGCA CTΔ#6(1296) 
4_16_F2_995      TGGCATGAAT TCACCTCAAT TCGCCAGTAT AAATGAGTTC AAATATTGCA CTΔ#7(1296) 
5_13_F2_1033     TGGCATGAAT TCACCTCAAT TCGCCAGTAT AAATGAGTTC AAATATTGCA CTΔ#9(1296) 
6_18_F2_1061     TGGCATGAAT TCACCTCAAT TCGCCAGTAT AAATGAGTTC AAATATTGCA CTΔ#10(1296) 
 
7_19_F2_960      TGGCATGAAT TCACCTCAAT TCGCCAGTAT AAATGAGTTC AAATATTGCA CTΔ#3(1297) 
8_20_F2_1034     TGGCATGAAT TCACCTCAAT TCGCCAGTAT AAATGAGTTC AAATATTGCA CTΔ#4(1297) 
9_21_F2_1057     TGGCATGAAT TCACCTCAAT TCGCCAGTAT AAATGAGTTC AAATATTGCA CTΔ#7(1297) 
10_22_F2_1064    TGGCATGAAT TCACCTCAAT TCGCCAGTAT AAATGAGTTC AAATATTGCA CTΔ#8(1297) 
11_23_F2_1059    TGGCATGAAT TCACCTCAAT TCGCCAGTAT AAATGAGTTC AAATATTGCA CTΔ#11(1297) 
12_24_F2_997     TGGCATGAAT TCACCTCAAT TCGCCAGTAT AAATGAGTTC AAATATTGCA CTΔ#12(1297) 
CTΔ_3365         TGGCATGAAT TCACCTCAAT TCGCCAGTAT AAATGAGTTC AAATATTGCA 1350 Ref seq 
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4.3.2. Studying telomere length patterns in CDC13 and STN1 
deletion mutants in the presence of EXO1 deletion. 
4.3.2.1. Extraction of total DNA and Xho1 digestion of genomic DNA 
Southern blot hybridisation of telomeric DNA patterns were studied in Xho1-digested genomic 
DNA from the mutants without essential telomere binding proteins Cdc13 and Stn1 (either 
alone or in combination), or without either the N- or C-terminus of the essential protein 
(Cdc13).  The genomic DNAs isolated from wild type yeast strains (strains 640 and 641 with 
CDC13) and Cdc13-1 mutants (strains 1296-TR and 1297-TR) were used as controls.  Yeast 
cells primarily selected on dropout media were then grown on YEPD medium for 3 days at 
different temperatures - 23°C, 30°C or 37°C - as required.  DNA was isolated from a loopful of 
cells, resuspended slowly at 4°C and analysed on agarose gels. 
Figure 4.29 shows the results of a representative gel with genomic DNA isolated from cdc13Δ 
and/or stn1Δ mutants in the presence of exo1Δ.  The high molecular weight intact bands on the 
analytical gel represented the desired genomic DNA.  Similarly, the genomic DNA was 
prepared from cdc13-1-N-and C-terminus deletion mutants and from original strains of 
survivors, 1296-TR and 1297-TR. 
 
 
 
Figure 4.29.  A representative analytical gel after electrophoresis of genomic DNA from wild type and 
mutant strains with cdc13 and/or stn1 deletion in the presence of exo1Δ. 
For each sample, 2 µl of genomic DNA was examined on a 0.7% agarose gel. 
lanes M1: 1 kb marker (Invitrogen) 1 µg (0.1 µg/µl); 1-2: total DNA from strains 640 and 641 (WT); 3-4: 
total DNA from strains 1272 and 1273 (exo1Δ); 5-6: total DNA from haploids strains #14 and #21 (stn1Δ 
exo1Δ rad24Δ); 7-8: total DNA from strains 2607 and 2608 (cdc13Δ exo1Δ); 9-10: total DNA from strains 
2684 and 2685 (cdc13Δ stn1Δ exo1Δ rad24Δ). 
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The mutant cultures were selected on dropout media.  Single, well separated colonies were 
cultivated onto YEPD plates for three days at 30°C.  For stn1Δ (haploids #14 and #21), two 
types of colonies with slight differences in colour, light and dark shades, were observed.  Light 
coloured colonies were selected and subcultured for the isolation of DNA.  The fresh cultures 
from plate (passage 3) were used to isolate total DNA.  The extracted genomic DNA was 
dissolved in 100 µl 1x TE buffer at 4°C overnight.  Two independent DNA samples, from wild 
type (strains 640 and 641, lanes 1 and 2), exo1Δ (strains 1272 and 1273, lanes 3 and 4), cdc13 
deletions (strains 2607 and 2608, lanes 7 and 8), stn1 deletions (haploids #14 and #21, lanes 5 
and 6) and cdc13 stn1 combined deletions (strains 2684 and 2685, lanes 9 and 10) were 
analysed on agarose gel.  The agarose gel electrophoretic results with uncut DNA clearly 
showed single intact band of high molecular weight (above 12 kb) containing ~1-2 µg of DNA 
in each lane in all analysed samples. 
 
After confirmation of DNA integrity on analytical gels, genomic DNA from wild type and other 
mutants including cdc13-1 N- and C-truncated clones was digested overnight with Xho1 
restriction enzyme.  Six independent mutants with N-terminus and C-terminus deletions were 
analysed for both 1296-TR and 1297-TR strains.  Digestion was performed with 5 µl genomic 
DNA in 20 µl reaction volume with Xho1 enzyme.  Small amounts (10-20%) of DNA from the 
digested samples were examined electrophoretically.  Figure 4.30A showed the results of 
digested DNAs from wild type (lanes 1, 2), EXO1 deletion mutants (lanes 3, 4) CDC13 deletion 
(lanes 5, 6), STN1 deletion (lanes 7, 8, 11-14), combined deletions of CDC13 and STN1 with 
EXO1 and RAD24 deletions (lanes 9, 10), cdc13-1 EXO1 deletion mutants (lanes 15, 16) and 
cdc13-1 N-terminus deletion (NTΔ) mutants in strain 1296-TR (lanes 17-22).  Similarly 
digested DNA from cdc13-1 C-terminus deletion mutants in strain 1296-TR (lanes 1-6), cdc13-
1 NTΔ (lanes 7-12), cdc13-1 CTΔ (lanes 13-18) mutants in strain 1297-TR and uncut DNA 
samples (lanes 20-22) are shown in Figure 4.30B. 
The digested DNA approximately equal amount, were subjected to Southern blot followed by 
hybridisation with a Y’+TG probe and detection of signals on X-ray film. 
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Figure 4.30.  A representative gel after electrophoresis of digested genomic DNA, samples for Southern 
blot analysis. 
Cells were cultivated for three days on YEPD plates at 30°C.  Total DNA isolated from cells of passage-3., 
digested overnight with Xho1 enzyme and examined on a 0.8% agarose gel.  Digested DNA (2 µl) with 1 
µl undigested genomic DNA was examined on analytical gels. 
M1 represents 1 kb DNA ladder and M3 represents λ DNA digested with HindIII used as size references. 
(A) Agarose gel electrophoresis of Xho1digested genomic DNA. 
Lanes 1-2: digested genomic DNA samples from strains 640 and 641 (WT); 3-4: 1272 and 1273 (exo1Δ); 
5-6: 2607 and 2608 (cdc13Δ exo1Δ); 7-8: #14 and #21 (haploids, stn1Δ exo1Δ rad24Δ; 9-10: 2684 and 
2685 (cdc13Δ stn1Δ exo1Δ rad24Δ); 11-12: #14 x2 (haploid, light and dark shades colonies; 13-14: #21 x2 
(haploid, light and dark shades colonies); 15-16: 1296-TR and 1297-TR respectively (cdc13-1 exo1Δ); 17-
22: cdc13-1 N-terminus deletion in strain 1296-TR (cdc13-1-NTΔ #2, #4, #5, #6, #7, #21 clones 
respectively. 
(B) DNA gel resolution of genomic DNA samples from cdc13-1-N or C truncated deletion constructs. 
Lanes 1-6: (cdc13-1 CTΔ clones #3, #4, #6, #7, #9, #10 in strain 1296-TR); 7-12: (cdc13-1-NTΔ clones #1, 
#7, #8, #11, #14 and #22 in strain 1297-TR); 13-18: (cdc13-1-CTΔ clones #3, #4, #7, #8, #11, #12 in strain 
1297-TR; 20-21: uncut DNA from strains 640 and 641 (WT); 22: 1272 (exo1Δ). 
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4.3.2.2. Preparation of the probe for Southern blot hybridisation analysis 
4.3.2.2.1. Transformation of E. coli NM522 by plasmid 987 
To prepare the probe for Southern blot hybridisation analysis, the plasmid 987 harbouring the 
Y’+ TG fragment was multiplied in bacterial cells (E.coli K-12 strain NM522).  The 
transformed cells were grown overnight on selective medium with 100 mg/L of ampicillin at 
37°C (Figure 4.31).  Ampicillin-resistant colonies were picked up and used to set overnight 
cultures in nutrient broth with ampicillin.  Overnight grown cells were used for the extraction of 
plasmid DNA on a midi prep columns. 
 
 
Figure 4.31.  A representative plate showing growth of transformed E. coli (with plasmid DNA, p987) on 
ampicillin containing selective medium. 
The competent cells of host bacteria, E. coli K12 (200 µl) were transformed with 2 µl of the diluted 
plasmid DNA 987 (with cloned Y’+TG fragment).  The mixture of cells and DNA (transformed mixture 50 
µl) was plated on nutrient agar medium with 100 µg/ml ampicillin and incubated overnight at 37°C to 
obtain ampicillin-resistant colonies.  Random colonies were picked to set cultures for isolation of 
plasmid DNA. 
 
4.3.2.2.2. Extraction and digestion of plasmid DNA 
The plasmid DNA 987 was extracted from host E. coli overnight culture with a Qiagen kit.  
DNA was suspended in sterile 1x TE buffer (10 mM Tris-Cl, pH 8.0, 1 mM EDTA).  The 
purified DNA was digested with BamH1 and Xho1 enzymes to release the 1 kb fragment.  
Uncut DNA and digested DNA were analysed on a 0.8% agarose gel to confirm the completion 
of digestion.   
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4.3.2.2.3. Purification of the DNA probe 
The Xho1 and BamH1 digested plasmid p987 products were resolved on 0.8% agarose gel.  The 
uncut and cut DNA (Figure 4.32A, lanes 1 and 2 respectively) were separated 
electrophoretically on the agarose gel.  The required 1 kb DNA fragment was excised from the 
gel (Figure 4.32B) and the DNA was extracted from agarose using QIAquick gel extraction kit.  
Figure 4.33 shows the result of an analytical gel with uncut plasmid (lanes 1 and 2), cut plasmid 
(lane 3) and purified 1 kb DNA fragment (lane 4).  The approximate concentration of purified 
fragment was estimated to be 10-15 ng/µl.  Approximately 10-15 µl of the DNA was labelled 
with the Amersham gene images AlkPhos direct labelling and detection system.  This randomly 
labelled DNA was used as a probe for Southern blot hybridisation analysis. 
 
 
Figure 4.32.  The separation and cut out of the 1 kb fragment on an analytical gel following the plasmid 
DNA digestion to obtain the probe fragment. 
 
The plasmid DNA 987 was digested with BamH1 and Xho1 enzymes to cut out the 1 kb Y’+TG fragment.  
Uncut DNA and digested DNA were separated on a 0.8% agarose gel.  The ~1 kb fragment was excised 
from the gel and purified with a QIAquick gel extraction kit. 
Lanes M1: 1 kb DNA ladder; M3: λ DNA digested with HindIII, used as a size references; 1: uncut plasmid 
987 DNA (3 µl); 2: BamH1 and Xho1digested plasmid DNA (150 µl). 
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Figure 4.33.  The estimation of amount of the 1 kb fragment after electrophoresis in comparison with 
uncut and cut plasmid. 
The 1 kb fragment was gel purified using a QIAquick gel extraction kit (cat. no. 28704) by following the 
user manual.  The purified fragment, 2 µl (lane 4) was analysed on the gel along with uncut plasmid DNA 
(lanes 1 and 2) and digested DNA (lane 3), 5 µl of each.  M1 represents 1 kb DNA ladder and M3 
represents λ DNA digested with HindIII, used as size references. 
 
4.3.2.3. A comparative analysis of telomeric DNA from CDC13 and STN1 
single, combined and partial deletion mutants in the absence of EXO1 
To understand more about the mechanism of growth of mutants lacking essential telomere 
capping protein Cdc13 and/or Stn1, or mutants with defective Cdc13 with the N- or C-terminus 
truncated at 30°C, telomeric DNA patterns were examined.  The blot analysis of the Stn1 
(Figure 4.34, lanes 5 and 6) and Cdc13 (lanes 9 and 10) deletion mutants alone and in 
combination (lanes 7 and 8) showed similar diffused and smeary telomere DNA patterns, 
comparable to type I survivors (Figure 4.35).  Two N-truncated cdc13-1 mutants in strain 1296-
TR also exhibited somewhat similar patterns of telomere DNA, with smeary and very short 
terminal DNA (Figure 4.34 B and C, lanes 13 and 14).  In contrast, the other two N-truncated 
mutants in strain 1297-TR (Figure 4.34 B, lanes 17 and 18) presented different telomeric DNA 
patterns with distinct bands in the range of 1-5 kb with obvious Y’5.5 kb and 6.5 kb bands, 
more like type II survivors shown in Figure 4.35.  In Figure 4.34 B, the wild type control 640 
(lane 1), original strain 1297-TR (lane 12) and Exo1 deletion mutants (lanes 3 and 4) showed 
distinct 6.5 kb, 5.5 kb and terminal 1.3 kb bands.  However, terminal DNA fragments were not 
obvious in the two N- (lanes 17 and 18) and C-truncated mutants (lanes 15, 16, 19, and 20), 
which revealed their telomeric pattern similar to type II survivors but with unique patterns in 
each with very few similarities between them. 
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Figure 4.34.  An analysis of yeast telomeric DNA from Cdc13 and Stn1 deficient mutants in comparison 
to mutants of Cdc13-1 with truncated N-terminus (cdc13-1-NTΔ) and C-terminus (cdc13-1-CTΔ) in the 
absence of Exo1. 
Total DNA was extracted from cells grown on YEPD medium at 30°C from passage 3.   
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DNA was digested with Xho1 enzyme overnight and separated on agarose gel for telomeric DNA analysis 
by Southern bloting.  Two independent mutants were analysed for each deletion including N- (lanes 13-
14 and 17-18) and C-terminus deletion (lanes 15-16 and 19-20).   
Wild type strains 640 and 641 (CDC13) were used as positive controls (lanes 1 and 2) whereas Exo1 
deletion mutants were negative control (lanes 3 and 4).  Stn1 and Cdc13 single deletion (lanes 5, 6 and 
9, 10) and combined deletion (lanes 7 and 8) mutants are presented.   
Digestion was performed with 5 µl genomic DNA in a 25 µl reaction volume with Xho1 restriction 
enzyme.  Digested DNA (8-12 µl) was resolved on a 0.8 % agarose gel at 40 volts overnight. 
(A) Agarose gel analysis of digested genomic DNA from Cdc13 and Stn1 deletion mutants, Cdc13-1 N- 
and C-terminus truncated mutants along with controls. 
(B) Telomere Southern blot analysis of DNA in the above gel with a Y’+TG probe (randomly labelled 
telomeric repeat DNA). 
(C) Short time exposure of above blot, showing two N-truncated mutants (lanes 13 and 14) with distinct 
fragments of 5.5 kb and 6.5 kb with a Y’+TG probe (telomeric repeat DNA). 
 
 
 
Figure 4.35.  Telomere DNA patterns in wild type and temperature-resistant cdc13-1 cells maintaining 
telomere length through recombination. 
Wild type and type I survivors amplify sub-telomeric Y’ repeats (lanes 1 and 3 respectively) whereas 
cdc13-1 and type II survivors amplify the terminal TG1-3 repeats (lane 2) and show bigger than 1 kb 
telomeric DNA fragments upon digestion.  The probe hybridises to the telomeric end of the Y’ repeat (~1 
kb) and to ~120 bp sequence of TG repeat (Maringele and Lydall, 2003). 
 
(A) Schematic representation of the end of the yeast chromosome with Y’ repeat, position of XhoI site 
and hybridisation probe (black bar), (the Figure was taken from Ngo and Lydall, 2010). 
(B) Southern blot with Y’+TG probe (the Figure taken from Zubko and Lydall, 2006).  
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4.3.2.4. Comparison of telomeric DNA patterns in cdc13Δ and cdc13-1 N- 
and C-terminus-truncated mutants  
The cdc13-1 exo1Δ mutants showed a growth retardation phenotype at 30°C and displayed a 
permissive temperature of less than 30°C.  However, their temperature-resistant survivors were 
able to grow at 37°C.  It has been determined earlier that Cdc13 deletion mutants in the absence 
of Exo1 could grow normally at both 23°C and 30°C.  To examine any differences in telomeric 
DNA composition the genomic DNA was isolated from N- and C-truncated mutants grown at 
30°C, and analysed by Southern blot hybridisation.  Figure 4.36 shows the results of 
electrophoretic separation of digested DNA samples and their hybridisation after using the 1 kb 
Y’+TG probe.  The Y’-terminal restriction fragments (Y’-TRFs) migrate at about 1.3 kb, and 
some of the other bands correspond to non-Y′-TRFs (Parenteau and Wellinger, 1999).  The 
temperature resistant cdc13-1 cells from original strain 1296-TR (lane 2) generated telomeric 
DNA patterns similar to type II survivors which showed discrete bands with amplified terminal 
TG repeats detectable after digestion with Xho1 (Zubko and Lydall, 2006).  The cells from wild 
type and strain 1297-TR (lanes 1 and 29 respectively) produced similar patterns (with amplified 
Y’ terminal repeat fragments, but with a smearing tracks in 1297-TR like in type I survivors).  
Two individual strains of Cdc13 deficient mutants (lanes 15 and 16) showed a diffused and 
smeary telomeric DNA similar to that in type I survivors without any distinct bands.  All N-
truncated mutants exhibited 5.5 kb and 6.5 kb fragments.  However, the smaller fragments 
within the range of 1-5 kb showed variations in size without any specific trend.  The four N-
truncated mutants in strain 1296 (lanes 4-7) and two N-truncated mutants in strain 1297 (lanes 9 
and 14) also showed diffused and smeary telomeric DNA patterns similar to those in CDC13Δ 
mutants (type I survivor pattern).  Two N-truncated mutants from strain 1296 manifested 
slightly similar banding pattern in the size range of 1-2.5 kb, with a common ~4.2 kb fragment 
(lanes 3 and 8), while other N-terminus deleted mutants in strain 1297 (lanes 10-13) exhibit an 
overall unique telomeric repeat pattern similar to that in type II survivors.  Similarly, telomeric 
DNA patterns among C-truncated mutants exhibited the 5.5 kb Y’ fragment, however, the 6.5 
kb fragment was not obvious in the two mutants (lanes17 and 18).  Overall, type II specific 
telomeric DNA patterns were observed in all C-truncated mutants except one (lane 24) that 
presented a mixed pattern of telomere DNA.  The terminal TG repeat fragments in strain 1296-
TR C-truncated mutants exhibited the bands spread between ~1.3 kb to 2 kb clumped towards 
the end as compared to slightly wider spread of bands with a ~1.2 kb to 3 kb range in C-
truncated mutants of 1297-TR.  Among C-truncated mutants in strain 1296, based on the size 
homology of terminal TG repeats and bigger than 5 kb fragments, the mutant #3 shared some 
similarity with #4 (lanes 17 and 18), mutant  # 6 with # 9 (lanes 19 and 20), and mutant #7 with 
#10 (Figure 4.36B and C, lanes 21 and 22).  However, 1297-TR C-truncated mutants did not 
show any common banding patterns among themselves, each showing a unique telomeric 
pattern.  It was concluded from the above results that all Cdc13 C-truncated mutants displayed 
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homology with telomerase-independent, recombination-dependent type II survivors.  In 
contrast, only half of the N-truncated mutants manifested homology with type II survivors, 
while rest of the N-truncated mutants exhibited diffuse and smeary telomeric pattern without an 
obvious terminal 1.3 kb fragment (characteristic of type I survivors).  The diffuse DNA could be 
single-stranded DNA, generated at high temperature. 
 
Figure 4.36.  Telomeric DNA patterns in cdc13Δ and their comparison to those in cdc13-1 N- and C-
truncated mutants in the absence of Exo1. 
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Total DNA was extracted from cells grown on YEPD media at 30°C.  DNA fragments after digestion with 
Xho1 enzyme (overnight) were separated on agarose gel for telomeric analysis by Southern blot 
hybridisation.  Six independent mutants were analysed for N- (lanes 3-8 and 9-14) and C-terminus 
deletion mutants (lanes 17-22 and 23-28).  CDC13Δ are in lanes 15 and 16.  Wild type strains 640 (lanes 
1 and 30) and strains 1296-TR and 1297-TR (lanes 2 and 29 respectively) were used as controls. 
Digestion was performed with 5 µl genomic DNA in a 25 µl reaction volume with Xho1 restriction 
enzyme.  Digested DNA (8-12 µl) was resolved on a 0.8 % agarose gel at 36 volts overnight. 
(A) An agarose gel analysis of digested genomic DNA from cdc13Δ, cdc13-1 N- and C-truncated mutants 
along with controls. 
(B) Telomere Southern blot hybridisation from the above gel using a Y’+TG probe (randomly labelled 
telomeric repeat DNA) after a longer exposure to the film, 3 days. 
(C) Southern blot analysis (short exposure to the film, 1 day). 
 
4.3.2.4.1. Effect of elevated temperature on telomeric DNA patterns of cdc13-1 N- 
and C-truncated mutants from 1296-TR 
Figure 4.37 represents the results of comparative analysis of telomeric DNA from N- and C-
truncated cdc13-1 mutants in strain 1296-TR grown at 23°C and 37°C.  The DNA of truncated 
mutants grown at 37°C showed more resistance to digestion under similar conditions.  These 
trends were obvious in both N- (lanes 9-14) and C-truncated mutants (lanes 25-30) at 37°C; 
however, more consistent patterns were exhibited between C-truncated mutants (lanes 25-30).  
Two N-truncated mutants at 23°C (lanes 5 and 7) also showed partial digestion of DNA.  In 
contrast two telomeric fragments 5.5 kb and 6.5 kb were prominent in all Xho1 digested samples 
while the distinct terminal fragment (1.3 kb) was present only in the wild type (lanes 1, 31 and 
32) and strain 1296 (lane 17).  Overall, the N-truncated mutants exhibited diffuse telomeric 
patterns (in the range of 0.5-4 kb or even smaller fragments with weak intensity) similar to the 
cdc13 full gene deletion mutant (lane 15).  C-truncated mutants grown at 23°C showed 
telomeric structure similarity to the strain 1296-TR (lane 17) with more distinct terminal bands 
in the range of 1-2 kb. 
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Figure 4.37.  Telomeric DNA patterns of cdc13-1 N- and C-truncated mutants from strain 1296-TR grown 
at normal and elevated temperatures. 
Analysis of yeast telomeric DNA was performed from N-truncated (cdc13-1-NTΔ) and C-truncated 
(cdc13-1-CTΔ) mutants in the absence of Exo1 in strain 1296-TR.  Total DNA was extracted from passage 
3 cells grown on YEPD medium at 23°C and 37°C.  Genomic DNA (Xho1 digested) was resolved on 
agarose gel overnight (A), followed by DNA blotting and probing for telomeric Southern blot analysis 
A 
B 
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using the labelled Y’+TG probe (1kb) (B).  Six independent mutants from N- (lanes 3-8 and 9-14 at 23°C 
and 37°C respectively) and C-terminus deletion mutants (lanes 19-24 and 25-30 at 23°C and 37°C 
respectively) were analysed.  Lanes 15 and 16 represent DNA from the cdc13Δ exo1Δ mutant (strain 
2607) at 23°C and 37°C respectively and lanes 17 and 18 similarly show DNA from the 1296-TR strain.  
M1 represents 1 kb marker (non-labelled).  At both ends of the gel/blot lanes 1, 2 and 31, 32 represent 
DNA from wild type strains (641 and 640 respectively). 
(A) Agarose gel analysis of digested genomic DNA from cdc13-1 N- and C-truncated mutants grown at 
23°C and 37°C in strain 1296-TR along with controls. 
(B) Telomere TRFs analysis using a Y’+TG probe. 
 
4.3.2.4.2. Effect of elevated temperature on telomeric DNA patterns of cdc13-1 N- 
and C-truncated mutants from 1297-TR strain 
Figure 4.38 represents the results of comparative analysis of telomeric DNA from N- and C-
truncated cdc13-1 mutants in strain 1297-TR grown at 23°C and 37°C.  The DNA of truncated 
mutants from 37°C showed more resistance to digestion (partial digestion) under similar 
conditions.  These trends were obvious in both N- (lanes 9-14) and C-truncated mutants (lanes 
25-30) at 37°C.  Two N-truncated mutants at 23°C (lanes 3 and 5) also showed partial digestion 
of DNA.  At 23°C, two telomeric fragments of 5.5 kb and 6.5 kb were prominent in all Xho1 
digested samples from both truncations whereas the 1.3 kb terminal fragment was shown by the 
wild type (lanes 1, 2, and 31) and strain 1297 (lane 17).  Overall, all N-truncated mutants (lanes 
3-14) at 23°C and 37°C respectively and C-truncated mutants (lanes 25-30) at 37°C only, 
reflected diffused telomeric patterns (in the range of 0.5-5 kb) like Cdc13 full gene deletion 
(lane 15 and 16) and C-truncated mutants at 23°C manifested telomeric structures similar to the 
strain 1297-TR (lane 17), with more distinct terminal bands in the range of 1-3 kb. 
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Figure 4.38.  Telomeric DNA patterns of cdc13-1 N- and C-truncated mutants from strain 1297-TR grown 
at normal and elevated temperatures. 
Analysis of yeast telomeric DNA from N-truncated (cdc13-1-NTΔ) and C-truncated (cdc13-1-CTΔ) 
mutants was carried out in the absence of Exo1 in the strain 1297-TR.  Total DNA was extracted from 
passage 3 cells grown on YEPD medium at 23°C and 37°C.  Genomic DNA (Xho1 digested) was resolved 
on agarose gel overnight (A), followed by DNA blotting and probing for telomeric Southern blot analysis 
using the labelled Y’+ TG probe (B).  Six independent mutants from N- (lanes 3-8 and lanes 9-14 at 23°C 
and 37°C respectively) and C-terminus deletion mutants (lanes 19-24 and 25-30 at 23°C and 37°C 
respectively) were analysed.  Lanes 15 and 16 represent DNA from cdc13Δ exo1Δ mutant (strain 2607) 
at 23°C and 37°C respectively and lanes 17 and 18 shows DNA from the 1297-TR parental strain.  M1 
represents 1 kb marker (non-labelled).  At both ends of the gel/blot, lanes 1, 2 and 31, 32 represent 
DNA from the wild type strains (640 and 641 respectively). 
(A) Agarose gel analysis of XhoI digested genomic DNA from cdc13-1 N- and C-truncated 
mutants grown at 23°C and 37°C in strain 1297-TR along with controls. 
(B) Telomere TRFs blot analysis using Y’+TG probe. 
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4.4. Conclusions 
 The analyses of DNA sequences in N- and C-truncated mutants support the expected 
sequences in most C-truncated and N-truncated generated mutants. 
 DNA sequence showed no change in nucleotide sequence in three cdc13-1-NTΔ clones 
(mutants #4, #5 and #6 in strain 1296-TR) potentially useful for extended studies.  Out of 
the five substitution mutations identified in the coding region of the TRP1 marker in NTΔ 
clones two were founded to be silent (NTΔ clone #7-1296 and clone #7-1297) with three 
missense mutations. One substitution mutation was located in the GAL1 promoter region 
and another one was positioned outside the coding region of TRP1 marker.  One silent 
mutation was identified in the C-terminus half of Cdc13-1 (clone #7-1297).  Whereas 
single deletion mutation shown in one mutant (clone #2-1296), positioned within deletion 
primer of C-terminus of cdc13-1 ORF (protein frame shift) was interpreted as mis-counted 
error from the sequencing chromatogram. 
 The analysis of C-terminus-truncated mutants revealed only one valid substitution 
mutations, common in four clones and was positioned within the TEF terminator of 
HIS3MX6 marker.  Sequence analyses of all tested CTΔ mutants, confirmed the intact 
EcoR1 site in the N-terminus-half of the gene. 
 Southern blot hybridisation analysis of the Stn1 and Cdc13 deletion mutants, single and in 
combination showed similar diffused and smeary telomere DNA patterns comparable to 
type I survivors with distinct 5.5 and 6.5 kb bands indicating the nature of telomere 
elongation in these strains may be through amplification of sub-telomeric Y’ repeats. 
 Analysis of N-truncated cdc13-1 mutants revealed mixed telomeric DNA patterns, smeary 
with short terminal DNA and telomeric DNA with distinct bigger than 1 kb DNA bands 
characteristic of type I and type II survivors.  These observations demonstrate that telomere 
length maintenance in these mutants occurs possibly through recombination (amplification 
of Y’ repeats or the terminal TG1-3). 
 C-truncated cdc13-1 mutants displayed similarity with type II survivors (indicating 
telomere maintenance through amplification of the terminal TG1-3) as manifested by their 
unique telomeric DNA patterns similar to those in type II survivors. 
 Overall, the telomeric DNA patterns in cdc13-1 N-truncated mutants are similar to the 
cdc13 full gene deletion mutants while telomeric DNA patterns in C-truncated mutants 
showed similarity to the cdc13-1 mutants (strains 1296, 1297). 
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Chapter 5 
Cellular responses of CDC13 and STN1 mutants 
to different stress factors 
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5.1. Introduction 
Yeast are eukaryotes that are highly adaptable to different environments and can survive under 
adverse conditions.  This ability of S. cerevisiae makes it an ideal organism for dissecting the 
genomic and molecular bases of adaptive responses (Gladieux et al., 2014).  Adaptive 
phenotypes under different endogenous or exogenous genotoxic agents reflect the underlying 
complex genetic and genomic processes (Alfoldi and Lindblad-Toh, 2013). 
To respond to abrupt changes, the yeast expression programme maintains its internal milieu by 
inducing or supressing groups of genes (genomic expression pattern) under specific 
environmental stresses (Gasch et al., 2000).  The physiological effects of the stresses reflect the 
cellular mechanisms that cells use to cope with these stresses and the nature of distinct traits the 
cell acquired to adapt (Olson-Manning et al., 2012). 
It has been identified in previous studies that genes involved in similar cellular processes are 
similarly expressed and show common sequence motifs of the transcription factors and 
promoters involved in their regulation (Gasch et al., 2000).  The similar responses of the group 
of genes under the same environmental stress, however, might depend upon different signalling 
pathways that regulate these genes in a condition-specific or gene-specific way.  Beside the cell 
type, the nature and duration of the stress collectively determines the activation of protective 
(survival pathways) or destructive (programmed cell death) cellular responses (Fulda et al., 
2010). 
The cell cycle of the yeast is under tight regulation of cell cycle checkpoint genes that eliminate 
errors in DNA replication and maintain cell viability.  Previous studies have shown that 
exposure to genotoxic agents (toxic chemicals and radiation) affects the progression of cells 
through the cell division cycle (Alic et al., 2001). 
Previous studies have also revealed that genotoxic agents [methyl methanesulfonate (MMS) and 
hydroxyurea (HU)] disrupt multiple cell cycle checkpoint responses resulting in replication 
stress while replication stress signals activate the S-phase checkpoint accompanied by cell 
sensitivity to the replication inhibitor (Gasparyan et al., 2009).  In contrast hydrogen peroxide 
(H2O2) induces G2 arrest through RAD9 mediated pathway (Flattery-O'Brien and Dawes, 1998). 
These genotoxic agents act at different pathways of cell cycle checkpoints, e.g., G1-S phase, S 
phase or G2-M phase, to trigger the underlying regulatory mechanism.  The cell cycle 
checkpoint responses are reflected by sensitivity patterns of the phenotypical growth of the 
mutant.  
In yeast S. cerevisiae, the essential roles of telomere capping proteins Cdc13 and Stn1 in DNA 
replication are still under investigation.  Cdc13 interacts physically with the Stn1 protein to 
regulate the telomere length.  The temperature-sensitive mutant’s alleles, cdc13-1 and stn1-13 at 
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the restrictive temperature generate single-stranded DNA that activates the damage response 
pathway and arrests cell cycle (Garvik et al., 1995).  The loss of Cdc13 function induces 
recombination and leads to Mec1-dependent cell cycle arrest.  The Stn1 deletion stimulates 
Rad9, a checkpoint mediator protein, and activates Mec3 modulated G2-M checkpoints. 
To explore further the possible roles of Cdc13 and Stn1 in the stress-response pathways through 
the cell cycle checkpoints, S. cerevisiae mutant cells deficient in Stn1and Cdc13 proteins or 
mutant cells with N- and C-terminus truncated alleles of cdc13-1 were allowed to grow in 
chronic conditions in the presence of exogenous DNA damaging agents (i.e., UV and MMS, 
HU), or under the oxidative stress (H2O2) and were analysed for their phenotypical growth 
patterns.  The sensitivities of different mutants were determined under DNA replication stress 
induced by MMS or HU, oxidative stress caused by H2O2 and DNA damaging effects by 
exposing cells to UV irradiation. 
 
5.2. Aims and objectives 
This part of the study was focused on determining the sensitivity of different yeast mutants, 
(cdc13Δ and stn1Δ single mutants or in combination, and also cdc13-1- N- and C-terminus 
deletion mutants) to different genotoxic agents like UV irradiations, MMS, H2O2 and HU. 
This aim involves the following objectives: 
 To study the response of cdc13 and stn1 deletion mutant cells (in the presence of exo1 
deletion) to genotoxic agents. 
 To compare the genotoxic effects in N- and C-terminus truncated cdc13-1 conditional 
mutants. 
 To investigate the effects of the genotoxic agents on cdc13-1 N- and C-terminus truncated 
haploid and diploids mutants (heterozygous). 
 
The following exogenous genotoxic agents with varying concentrations were implemented in 
toxicity assays. 
 UV irradiations: environmental DNA-damaging agent. 
 MMS: DNA alkylating agent/ DNA-damaging agent. 
 H2O2: oxidizing agent (oxidative stress causing agent). 
 HU: DNA replication inhibitor. 
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5.3. Results 
The yeast strains used in this study are listed in Table 4.1 (Chapter 4).  The additional diploids 
#31 and #32 used for toxicity assays were generated in crosses between N- and C-truncated 
haploid mutants of 1296-TR and 1297-TR strains respectively, and PCR verified for both N- 
and C-terminus of cdc13-1 in diploid cells. 
 
5.3.1. The effects of genotoxic agents on the growth of cdc13 and 
stn1 deletion mutants. 
5.3.1.1. Effects of UV on the growth of conditional mutants lacking Cdc13 
and Stn1 proteins. 
To determine the effects of UV irradiation, a potent DNA damaging environmental factors, on 
the growth of yeast cells, the cdc13 and/or stn1 deletion mutants of S. cerevisiae were analysed 
under different UV exposures.  The preliminary experiments were performed to determine the 
effective dose of UV irradiation by comparing phenotypic growth inhibition patterns of cdc13Δ 
and stn1Δ mutants’ cells with those in exo1Δ (1272) and WT (640) controls. 
 
The YEPD plates spotted with serial dilutions of 8 cultures (two sets - one set for each 
temperature regime) were exposed to UV irradiation (x100 µJ/cm
2
) (in UV time exposure 
mode) from a UV dose of 10 J/m
2
 to one of 100 J/m
2 
(UV10-UV 100).  The plates were 
incubated at 23°C and 30°C for 3 and 5 days.  The growth inhibition in stn1Δ (haploid #14, #21) 
and stn1Δ cdc13Δ (2684 and 2685) mutants in the absence of rad24 (a component of checkpoint 
proteins) and exo1 initiated at the minimum UV exposure of 10 J/m
2
, with severe inhibition 
exhibited between UV 20 J/m
2 
and UV 30 J/m
2 
exposure and with no growth at UV 40 J/m
2
 or 
above at 23°C for 3 days (Figure 5.1).  Similar growth patterns in response to UV sensitivity 
were observed for these mutants at 23°C for 5 days with minimal growth recovery at UV 30 
J/m
2
 and 40 J/m
2
.  Conversely, the wild type control (WT, 640) and exo1Δ mutant (1272), 
showed no obvious growth inhibition at lower exposures, with least inhibition at UV 40 J/m
2
 
and 50 J/m
2
, with significant growth arrest at UV 60 J/m
2 
and at higher exposures at 23°C for 3 
days.  However, the partial recovery of these control cells was well pronounced at 23°C and 
30°C for 5 days.   
 
In cdc13Δ mutant strains 2607 and 2608, the sensitivity to UV initiated at high UV exposures 
(UV 50 J/m
2
 and 60 J/m
2
), and was more obvious at UV 70 J/m
2
 at 23°C after 3 days incubation 
when compared to 23°C for 5 days, indicating some recovery of growth after longer incubation.  
In all strains, control and mutants cells displayed no growth or minimal growth at UV 100 J/m
2
.  
The cdc13Δ mutants in the absence of exo1 (2607 and 2608) displayed weak resistance to UV 
100 J/m
2
 similar to controls (640) and exo1 deletion mutants (1272).  The exo1 deletion mutant 
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(1272) showed slightly more resistance to UV (UV 70) as compared to WT, obvious at 23°C 
after 5 days incubation only. 
 
Overall, the strain 2685 (combined deletion of stn1 and cdc13 in the absence of exo1 and rad24) 
revealed maximum sensitivity to UV when compared to stn1Δ (#14 and #21) and cdc13Δ (2607 
and 2608) mutants.  In the previous study, the rad24Δ mutant cells were shown to be sensitive 
to UV (Lydall and Weinert, 1995).  So it was difficult to conclude whether this high sensitivity 
displayed by the stn1Δ cdc13Δ (2685) mutants was actually a combined deletions response or it 
was the effect of the rad24Δ background. 
 
 
Figure 5.1.  Effect of UV irradiation (10-100 J/m
2
) on the growth of cdc13 and stn1 deletion mutants. 
Eight strains including mutants and controls (640, 1272, 2607, 2608, #14, #21, 2684 and 2685) were 
analysed for UV sensitivity of cdc13 and stn1 deletion mutants.  Five-fold serial dilutions of the strains in 
sterile water were spotted onto YEPD medium plates and exposed to different doses of UV irradiations 
(in UV time exposure mode, 10 J/m
2 
to 100 J/m
2
).  The UV irradiated plates were incubated for 3-5 days 
at 23°C and 30°C before being photographed. 
 
Further experiments were carried out to draw conclusive results of the UV sensitivity of these 
mutants.  The results presented in Figure 5.2, clearly showed the resistance of the cdc13Δ 
mutant cells (consistent in both strains 2607 and 2608) to UV 25 J/m
2
 and 50 J/m
2
 when 
compared with stn1Δ mutants (#14 and #21) and stn1Δ cdc13Δ (2684 and 2685) mutants, 
however, cdc13Δ mutants manifested similar to WT and exo1Δ mutants resistance at high 
temperature (30°C) and after longer incubation (5 days at 23°C and 30°C; Figure 5.2B).  The 
comparison of stn1 deletion mutants between haploid #14 and #21, however, manifested 
WT (640) 
exo1Δ (1272) 
cdc13Δ exo1Δ (2607) 
cdc13Δ exo1Δ (2608) 
stn1Δ exo1Δ rad24Δ (haploid #14) 
stn1Δ exo1Δ rad24Δ (haploid #21) 
stn1Δ cdc13Δ exo1Δ rad24Δ (2684) 
stn1Δ cdc13Δ exo1Δ rad24Δ (2685) 
WT (640) 
exo1Δ (1272) 
cdc13Δ exo1Δ (2607) 
cdc13Δ exo1Δ (2608) 
stn1Δ exo1Δ rad24Δ (haploid #14) 
stn1Δ exo1Δ rad24Δ (haploid #21) 
stn1Δ cdc13Δ exo1Δ rad24Δ (2684) 
stn1Δ cdc13Δ exo1Δ rad24Δ (2685) 
WT (640) 
exo1Δ (1272) 
cdc13Δ exo1Δ (2607) 
cdc13Δ exo1Δ (2608) 
stn1Δ exo1Δ rad24Δ (haploid #14) 
stn1Δ exo1Δ rad24Δ (haploid #21) 
stn1Δ cdc13Δ exo1Δ rad24Δ (2684) 
stn1Δ cdc13Δ exo1Δ rad24Δ (2685) 
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slightly variable UV (UV 25 J/m
2
 and 50 J/m
2
) susceptibility.  The haploid #14’s cells appeared 
to be more UV sensitive as compared to cells from haploid #21.  This difference in sensitivity 
pattern was obvious at 23°C and 30°C for 3 (Figure 5.2A) and 5 days (Figure 5.2B).  To test 
whether this response was because of a smaller initial cell number, further assays were 
conducted at the same UV exposure (UV 25 J/m
2
 and 50 J/m
2
) and also at higher UV exposures 
(UV 25, 50, 55, 50, 65 and 70 J/m
2
; Figure 5.3AB).  However, these intra-mutant UV sensitivity 
differences were repeatedly observed.  Altogether, it was obvious that double deletion mutants 
cdc13Δ stn1Δ were more sensitive to UV than either cdc13Δ or stn1Δ mutants with some 
reservation regarding the presence of rad24Δ. 
 
Figure 5.2.  Effect of selective UV irradiation (25, 50 and 100 J/m
2
) on the growth of cdc13 and stn1 
deletion mutants. 
Eight strains including mutants and controls (640, 1272, #14, #21, 2607, 2608, 2684 and 2685) were 
analysed for UV sensitivity of cdc13 and stn1 deletion mutants.  Five-fold serial dilutions of the strains in 
sterile water were spotted onto YEPD medium plates and exposed to three different doses of UV 
irradiation (in UV time exposure mode, 25 J/m
2
, 50 J/m
2
 and 100 J/m
2
).  The UV irradiated plates were 
incubated for 3-5 days at 23°C and 30°C before being photographed.  Strain numbers are indicated in 
brackets. 
(A) Incubation of plates for 3 days at 23°C and 30°C. 
(B) Incubation of plates for 5 days at 23°C and 30°C. 
A 
B 
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Figure 5.3.  Effect of UV irradiation (25-70 J/m
2
) on the growth of cdc13 and stn1 deletion mutants. 
Eight strains including mutants and controls (640, 1272, #14, #21, 2607, 2608, 2684 and 2685) were 
analysed for UV sensitivity of cdc13 and stn1 deletion mutants.  Five-fold serial dilutions of the strains in 
sterile water were spotted onto YEPD medium plates and exposed to six different doses of UV 
irradiation (in UV time exposure mode, 25, 50, 55, 60, 65 and 70 J/m
2
).  The UV irradiated plates were 
incubated for 3-5 days at 23°C and 30°C before being photographed.  Strain numbers are indicated in 
brackets. 
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5.3.1.2. Effect of MMS on the growth of cdc13 and stn1 deletion mutants 
MMS is another potent DNA-damaging agent.  Previous studies have shown that MMS can 
cause random DNA fragmentation.  In S. cerevisiae MMS induces heat-labile damage in 
recombination-deficient cells (Lundin et al., 2005). 
The study described in this section was conducted to determine the responses of cdc13 and stn1 
deletion mutants’ cells to chronic exposure of the DNA alkylating agent, MMS.  Freshly 
prepared YEPD plates containing three different concentrations of MMS (0.010%, 0.015% and 
0.020%; w/v) were spotted with serial dilutions of 8 cultures (two sets, one for each temperature 
regime).  The plates were incubated at 23°C and 30°C for 3 and 5 days.  The growth of stn1Δ 
(haploid #14, #21) and stn1Δ cdc13Δ (2684 and 2685) mutants in the background of rad24Δ and 
exo1Δ was moderately inhibited at 0.010% concentration of MMS, with severe inhibition 
observed at 0.015% and 0.020% MMS after 3 days of incubation at 23°C (Figure 5.4A).  All 
mutants displayed severe sensitivity to MMS at 0.015 and 0.020% of MMS at 23°C after 3 days 
of incubation.  In contrast, cdc13Δ mutants (strains 2607 and 2608) in the background of exo1Δ 
deletion displayed relative resistance to MMS, prominent at 23°C after 5 days of incubation as 
compared to 3 days of incubation at 23°C (Figure 5.4A).  However, this pattern of resistance 
gradually decreased with increased susceptibility of cdc13Δ mutant cells at increasing doses of 
MMS (0.020%) after longer incubation (5 days) at lower temperature (23°C).  The cdc13Δ 
exo1Δ mutant cells also exhibited similar trends of MMS resistance, obvious at 0.010%, 0.015 
and 0.020% of MMS at 30°C after 3-5 days of incubation (Figure 5.4B).  However, no distinct 
susceptibility was observed with increasing dose (0.020%) at 30°C after a longer incubation of 5 
days.  Similarly, the stn1Δ (haploid #14, #21) and stn1Δ cdc13Δ (2684 and 2685) mutants cells 
displayed sensitivity to all three doses of MMS (0.010%, 0.015% and 0.020%) but to variable 
extents at 30°C after incubation of 3-5 days (Figure 5.4B).  The wild type and the exo1Δ 
deletion mutants were mildly arrested in their growth at low temperature (23°) after 3 days of 
incubation, obvious at 0.020% MMS, however, most of these cells restored their growth after 5 
days of incubation at 23° (Figure 5.4A).  Taken together, the growth of the wild type (640) and 
exo1 deletion mutant (1272) were negligibly affected at 0.010%, 0.015% and 0.020% 
concentrations of MMS after 3-5 days of incubation at 30°C (Figure 5.4B). 
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Figure 5.4.  Effect of MMS (0.01-0.02%) on the growth of cdc13 and stn1 deletion mutants. 
Eight strains including mutants and controls (640, 1272, #14, #21, 2607, 2608, 2684 and 2685) were 
analysed for MMS-mediated sensitivity of cdc13 and stn1 deletion mutants.  Five-fold serial dilutions of 
the indicated yeast strains in sterile water were spotted onto YEPD agar plates containing 0.010%, 
0.015% and 0.020% of MMS.  The plates were incubated for 3-5 days at 23°C and 30°C before being 
photographed.  Strain numbers are indicated in brackets. 
(A) Incubation of plates for 3-5 days at 23°C. 
(B) Incubation of plates for 3-5 days at 30°C. 
 
 
The susceptibility of all cdc13Δ, stn1Δ and stn1Δ cdc13Δ mutants was further tested at one 
higher dose of MMS (0.015%, 0.020% and 0.030%; w/v) (Figure 5.5).  One plate was also 
exposed to a UV dose of 15 J/m
2 
(UV 15).  The plates were incubated at 23°C and 30°C for 3 
and 5 days. 
 
The growth of stn1Δ (haploid #14, #21) and stn1Δ cdc13Δ (2684 and 2685) mutants in the 
background of rad24Δ and exo1Δ was moderately inhibited at 0.015% (w/v) of MMS with 
severe inhibition observed at 0.020 and 0.030% at 23°C after 3 days of incubation (Figure 5.5).  
The similar growth patterns in response to MMS sensitivity were observed for stn1Δ and stn1Δ 
cdc13Δ mutants and controls at 23°C for 5 days with partial growth recovery at 0.020% and 
A 
B 
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0.030% MMS.  However, the stn1Δ (haploid #14, #21) and the stn1Δ cdc13Δ (2684 and 2685) 
mutants’ cells displayed less sensitivity at 0.020% of MMS as compared to 0.030% of MMS at 
30°C after 3-5 days of incubation. 
 
In contrast, cdc13 deletion mutants (strains 2607 and 2608) in the background of exo1Δ 
displayed obvious resistance to MMS, which was pronounced at 0.020% of MMS after 3 days 
of incubation at 23°C and 30°C.  However, the sensitivity of cdc13Δ mutant cells to 0.030% 
MMS was less obvious at the higher temperature (30°C).   
There was some growth restoration of cdc13Δ exo1Δ mutant cells after longer incubation of 5 
days at 23°C and 30°C.  The sensitivity patterns of all mutants and controls at UV 15 J/m
2 
(23°C 
and 30°C) were comparable to MMS 0.015% after 3 and 5 days of incubation at 23°C and to 
MMS 0.020% after 3 and 5 days of incubation at 30°C. 
 
The variable susceptibilities presented by stn1Δ (haploid #14 versus #21) and stn1Δ cdc13Δ 
(combined deletions, 2684 versus 2685) mutants in earlier experiments, were still obvious 
however, to a lesser extent, revealing mutant #14 (stn1Δ rad24Δ exo1Δ) to be slightly more 
sensitive as compared to mutant #21 and mutant strain 2685 (stn1Δ cdc13Δ rad24Δ exo1Δ) as 
compared to mutant 2684 to MMS at 23°C and 30°C after 3 and 5 days incubation (Figure 
5.5AB).  This differential sensitivity pattern was well pronounced with the low dose of MMS 
(0.010%) at 23°C and 30°C after 3 and 5 days incubation Figure 5.5AB). 
 
It was clear that cdc13Δ mutants showed more resistant to MMS than other two mutants (more 
obvious at longer incubation, e.g., 23°C after 5 days (Figure 5.5A) and also at higher 
temperature, e.g., 30°C after 3-5 days) (Figure 5.5B) indicating different underlying 
mechanisms.  Moreover, at an increased concentration of MMS i.e., 0.030%, the cdc13Δ mutant 
cells also became susceptible to MMS after 3 days of incubation at 23°C and 30°C.  However, 
the extent of the sensitivities was difficult to determine because of the variable phenotypes in 
stn1Δ mutants #14 and #21 and cdc13Δ stn1Δ (combined deletions) in strains 2684 and 2685 in 
the background of exo1Δ rad24Δ. 
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Figure 5.5.  Effect of selective MMS (0.015, 0.02 and 0.03%) and UV on the growth of cdc13 and stn1 
deletion mutants. 
Eight strains including mutants and controls (640, 1272, #14, #21, 2607, 2608, 2684 and 2685) were 
analysed for MMS-mediated sensitivity of cdc13Δ and stn1Δ mutants.  Five-fold serial dilutions of the 
strains in sterile water were spotted onto YEPD agar plates containing 0.015%, 0.020% and 0.030% of 
MMS.  One plate was also exposed to UV irradiation (UV 15 J/m
2
).  Plates were incubated for 3-5 days at 
23°C and 30°C before being photographed.  Strain numbers are indicated in brackets. 
(A) Incubation of plates for 3-5 days at 23°C. 
(B) Incubation of plates for 3-5 days at 30°C. 
 
5.3.1.3. Effect of H2O2 on the growth of cdc13 and stn1 deletion mutants 
H2O2 is an oxidising DNA-damaging agent that is also used as a biocide.  It can generate 
hydroxyl radicals that react with various cellular components including biomolecules like DNA, 
RNA, proteins and especially lipids (Alic et al., 2001) and create oxidative stress to the cell.  
Based on its damaging characteristics, it is used to model chronic oxidative damage to cells 
through oxidative stress and to investigate the effect of its toxicity on the viability of cells with 
different mutations.  It has been reported in recent studies that, based on its concentration, H2O2 
genotoxicity works through two distinct mechanisms that generate free radicals which react 
with proximal DNA and cause damage.  At low concentrations, it damages DNA and at higher 
concentrations it oxidises proteins and lipids and cell membranes.  Yeast cells exposed to 
oxidative stress or DNA damaging agents respond through impaired progression of cell cycle or 
cell cycle arrest under cell cycle checkpoint mechanisms (Weinert, 1998).  H2O2 induced cell 
(A) 
(B) 
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cycle arrest at the G2 phase is dependent on radiation-sensitive RAD9 gene (Weinert and 
Hartwell, 1988). 
This study was carried out to investigate the effect of H2O2 on the growth of cdc13Δ and stn1Δ 
mutants’ cells.  The freshly prepared YEPD plates containing three different concentrations of 
H2O2 (2 mM, 3 mM and 4 mM; w/v) were spotted with serial dilutions of 8 cultures (two sets, 
one for each temperature regime).  The plates were incubated at 23°C and 30°C for 3 and 5 
days.  The growth of stn1Δ mutants (haploid #14 and #21) in the presence of rad24Δ exo1Δ was 
the most abundant on 3 mM H2O2, and still observed on 4 mM H2O2 after 3 and 5 days of 
incubation at 23°C and 30°C where other strains did not grow at all (Figure 5.6AB). 
 
Figure 5.6.  Effect of H2O2 (2 mM, 3 mM and 4 mM) on the growth of cdc13Δ and stn1Δ mutants. 
Eight strains including mutants and controls (640, 1272, #14, #21, 2607, 2608, 2684 and 2685) were 
analysed for H
2
O
2
-mediated sensitivity of cdc13Δ and stn1Δ mutants.  Five-fold serial dilutions of the 
strains in sterile water were spotted onto YEPD agar plates containing 2 mM, 3 mM and 4 mM of H
2
O
2
.  
Plates were incubated for 3-5 days at 23°C and 30°C before being photographed.  Strain numbers are 
indicated in brackets. 
(A) Incubation of plates for 3-5 days at 23°C. 
(B) Incubation of plates for 3-5 days at 30°C. 
 
A 
B 
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The stn1Δ mutant #14 manifested slightly more resistance to H2O2 at 3 and 4 mM H2O2 when 
compared to mutant #21, in contrast to the MMS sensitivity pattern, where #14 showed an 
increased level of sensitivity as compared to #21.  The cdc13Δ mutants and cdc13Δ stn1Δ 
mutant cells were moderately inhibited at 3 mM H2O2; the cdc13Δ mutants (2607 and 2608) 
manifested slightly more sensitivity as compared to the cdc13Δ stn1Δ mutants (2684 and 2685).  
In cdc13Δ exo1Δ mutants (2607 and 2608) H2O2-mediated growth inhibition at 3 mM 
concentration was more pronounced after 3 days of incubation as compared to 5 days of 
incubation at 23°C.  The growth of wild type (640) and exo1Δ deletion mutant (1272) were also 
mildly affected at 3 mM H2O2 after 3-5 days of incubation at 23°C and 30°C.  Overall the same 
toxicity patterns were exhibited at 23°C and 30°C with minimal or no growth at longer 
incubation (5 days) or at higher temperature (30°C).  The growth of all mutants and controls 
was severely inhibited at increased doses of H2O2, 5 mM and 8 mM (Figure 5.7), with minimal 
growth of stn1Δ mutant at 5 mM showing its resistance to H2O2 even at higher concentration as 
compared to other mutants and controls.  Based on these results it could be suggested that STN1 
gene might play some unknown role distinct from the CDC13 gene through a different 
mechanism associated with tolerating oxidative stress. 
 
 
Figure 5.7.  Effect of H
2
O
2 (3 mM, 5 mM and 8 mM) on the growth of cdc13Δ and stn1Δ mutants. 
Eight strains including mutants and controls (640, 1272, #14, #21, 2607, 2608, 2684 and 2685) were 
analysed for H
2
O
2-mediated sensitivity of cdc13 and stn1 deletion mutants.  Five-fold serial dilutions of 
the strains in sterile water were spotted onto YEPD agar plates containing 3 mM, 5 mM and 8 mM of 
H
2
O
2
.  Plates were incubated for 3-5 days at 23°C and 30°C before being photographed.  Strain numbers 
are indicated in brackets. 
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5.3.1.4. Effect of HU on the growth of cdc13Δ and stn1Δ deletion mutants 
HU is a potent replication inhibitor.  In yeast S. cerevisiae HU inhibits DNA replication by 
inhibiting ribonucleotide reductase and blocks DNA synthesis by preventing dNTP pool 
expansion at G1-S phase of cell cycle (Koc et al., 2004). 
This study was aimed to examine the response of cdc13 and stn1 deletion mutants’ cells to HU.  
The freshly prepared YEPD plates containing different concentrations of HU were spotted with 
serial dilutions of 8 cultures (two sets, one for each temperature regime).  The plates were 
incubated at 23°C and 30°C for 3 and 5 days. 
 
The preliminary results with 10 mM, 25 mM and 30 mM of HU (w/v) showed mild inhibition of 
growth to varying extents in all mutants as compared to wild type and exo1Δ mutants.  The 
cdc13Δ stn1Δ mutants (2684 and 2685) in the presence of exo1Δ and rad24Δ showed a 
moderate susceptibility to HU with a slight increase in inhibition of growth as compared to 
either stn1Δ (#14 and #21) or cdc13Δ mutants (2607, 2608) marked at 30 mM HU after 3 and 5 
days of incubation at 23°C.  There was a general trend of growth restoration after 5 days of 
incubation in mutants and wild type strains.  However, the stn1Δ mutant #14 exhibited less 
growth restoration as compared to mutant stn1Δ cdc13Δ (2684) after 5 days of incubation at 
23°C and 30°C.  The cdc13Δ mutants (2607 and 2608), however, displayed slightly increased 
resistance to HU at 30 mM as compared to other mutants. 
 
Toxicity assays with increased doses of HU (10 mM, 25 mM and 50 mM; w/v) (Figure 5.8) 
revealed the same trends of growth inhibition with stn1Δ cdc13Δ (2684 and 2685) showing 
more pronounced HU-induced growth inhibition at 23°C (Figure 5.8) and 30°C (Figure 5.8) 
after 3 days of incubation.  The stn1Δ mutants, haploid #14, showed slightly more sensitivity to 
50 mM HU when compared to mutant #21, with the sensitivity pattern comparable to MMS-
induced sensitivity of stn1Δ mutants (#14 with an increased level of sensitivity as compared to 
#21, earlier in this section).  Similarly, the inhibition of growth in the stn1Δ mutant #14 was 
comparable to the cdc13Δ stn1Δ mutant strain 2684 at 23°C and 30°C after 3 days of incubation 
but this pattern changed after 5 days of growth where combined deletion mutants exhibited 
increased growth restoration as compared to stn1Δ mutant #14.  The cdc13Δ mutants (2607 and 
2608) persistently displayed slightly increased resistance to HU at 50 mM as compared to other 
mutants.  Further assays at even higher concentrations of HU (50 mM, 75 mM and 100 mM 
HU; w/v) (Figure 5.9AB) clearly showed that strains containing stn1Δ cdc13Δ (2684 and 2685) 
mutations with exo1Δ rad24Δ were completely inhibited in the presence of 100 mM HU at 23°C 
and 30°C after 3 and 5 days of incubation with a mild restoration of cell growth after 5 days of 
incubation at 23°C and 30°C.  The strains stn1Δ (#14 and #21) mutants showed much better 
growth sensitivity, than strains with combined deletions (2684 and 2685) and slightly less 
growth as compared to cdc13Δ mutants (2607 and 2608) at 23°C.  Results also showed that at 
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23°C (Figure 5.9A) and 30°C (Figure 5.9B) the growth of cdc13Δ mutants (2607 and 2608) 
were partially inhibited in the presence of increased concentrations of 50, 75 and 100 mM HU 
(pronounced at 23°C) after 3 and 5 days of incubation, though it still manifested resistance as 
compared to WT, exo1Δ and 2684 and 2685 strains (cdc13Δ stn1Δ).  The growth of wild type 
(640) and exo1Δ mutants (1272) were not, or negligibly, affected at 30, 50 or 100 mM 
concentration of HU after 3-5 days of incubation at 23°C and 30°C. 
 
The stronger inhibition of growth in combined deletion mutants stn1Δ cdc13Δ (2684 and 2685) 
suggests that cdc13Δ and stn1Δ might contribute to the sensitivity via different pathways. 
 
 
Figure 5.8.  Effect of low concentration of HU (10 mM, 25 mM and 50 mM) on the growth of cdc13Δ and 
stn1Δ mutants. 
Eight strains including mutants and controls (640, 1272, #14, #21, 2607, 2608, 2684 and 2685) were 
analysed for HU-mediated sensitivity of cdc13Δ and stn1Δ mutants.  Five-fold serial dilutions of the 
strains in sterile water were spotted onto YEPD agar plates containing 10 mM, 25 mM and 50 mM of HU.  
Plates were incubated for 3-5 days at 23°C and 30°C before being photographed.  Strain numbers are 
indicated in brackets. 
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Figure 5.9.  Effect of higher doses of HU (50 mM, 75 mM and 100 mM) on the growth of cdc13Δ and 
stn1Δ mutants. 
Eight strains including mutants and controls (640, 1272, #14, #21, 2607, 2608, 2684 and 2685) were 
analysed for HU-mediated sensitivity of cdc13Δ and stn1Δ mutants.  Five-fold serial dilutions of the 
strains in sterile water were spotted onto YEPD agar plates containing 50 mM, 75 mM and 100 mM of 
HU.  Plates were incubated for 3-5 days at 23°C and 30°C before being photographed.  Strain numbers 
are indicated in brackets. 
 
5.3.2. Synergistic effect of genotoxic agents on the growth of 
different deletion mutants  
5.3.2.1. Synergistic effect of UV and MMS on the growth of cdc13Δ and 
stn1Δ mutants  
It was shown earlier in this chapter that cdc13Δ mutants (2607 and 2608) were more resistant to 
MMS as compared to stn1Δ (#14 and #21) and stn1Δ cdc13Δ (2684 and 2685) mutants.  
However, to see the combined effect of UV and MMS, freshly prepared YEPD plates 
containing different concentrations of MMS (0.010 %, 0.015 %, and 0.020 %; w/v) were spotted 
with serial dilutions of 8 cultures (two sets, one for each temperature regime).  The plates were 
exposed to different doses of UV (25, 50, 60 and 75 J/m
2
).  The results clearly showed that low 
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concentration of MMS (0.010%) enhanced the genotoxic effect of UV on the growth of all 
deletion mutants (Figure 5.10A-D).  The combined effects of MMS with UV enhanced the 
inhibitory effects cooperatively, e.g., UV exposure of 25 J/m
2 
at MMS 0.010% concentration 
increased the sensitivity to the level exhibited at MMS 0.015%-0.020% or UV 75 J/m
2
 at 23°C 
after 3 and 5 days of incubation (Figure 5.10AB) or comparable to MMS 0.015% or UV 50 J/m
2
 
at 30°C after 3 and 5 days of incubation (Figure 5.10CD).  However, differences between 
sensitivity of cdc13Δ and stn1Δ single mutants were not distinguishable at 23°C after 3 days 
because of the strong inhibition of growth. 
 
Under conditions of the combined treatment, the cdc13Δ mutants (2607 and 2608) also 
exhibited resistance to MMS (0.010%) at UV 25 J/m
2
, as compared to stn1Δ (#14 and #21), 
stn1Δ cdc13Δ exo1Δ rad24Δ (2684 and 2685), which were more obvious at 30°C after 3 and 5 
days of incubation.  The stn1 deletion mutant #14 appeared to be more sensitive than #21.  The 
cdc13Δ and stn1Δ mutant, 2685 strain exhibited increased sensitivity to MMS as compared to 
the 2684 strain.   
It could be concluded that both genotoxic agents enhanced lethality of the cells cooperatively. 
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Figure 5.10.  Combined effects of MMS and UV on the growth of cdc13Δ and stn1Δ mutants. 
Eight strains including mutants and controls (640, 1272, #14, #21, 2607, 2608, 2684 and 2685) were 
analysed for MMS+UV-mediated sensitivity of cdc13Δ and stn1Δ mutants.  Five-fold serial dilutions of 
the strains in sterile water were spotted onto YEPD agar plates containing 0.010%, 0.015%, 0.020% of 
MMS.  Plates were exposed to different doses of UV irradiation (25, 50, 60 and 75 J/m
2
) and incubated 
for 3-5 days at 23°C and 30°C before being photographed.  Strain numbers are indicated in brackets. 
(A) At 23°C after 3 days of incubation. 
(B) At 23°C after 5 days of incubation. 
(C) At 30°C after 3 days of incubation. 
(D) At 30°C after 5 days of incubation. 
D 
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5.3.2.2. Synergistic effect of UV and H2O2 on the growth of cdc13Δ and stn1Δ 
mutants 
The stn1Δ (#14 and #21) mutants exhibited resistance to H2O2 as compared to stn1Δ cdc13Δ 
(2684 and 2685) mutants and cdc13Δ mutants (2607 and 2608) as shown earlier in this chapter.  
To determine the combined effect of UV and H2O2, the freshly prepared YEPD plates 
containing different concentrations of H2O2 (2 mM, 3 mM and 4 mM; w/v) were spotted with 
serial dilutions of 8 cultures.  The plates were exposed to UV (in UV time exposure mode) with 
different doses of UV (25 50, 60 and 75 J/m
2
).  The results showed that H2O2 at higher doses of 
4 mM enhanced the resistance of stn1Δ (#14 and #21) to UV 25 J/m2 (Figure 5.11A-D).  
However, the growth of other mutants, stn1Δ cdc13Δ (2684 and 2685) and cdc13Δ (2607 and 
2608), was severely inhibited at this concentration of H2O2 under the effect of UV.  The growth 
of stn1Δ (#14 and #21) mutants was comparable to growth of wild type and exo1Δ mutants at 4 
mM H2O2 and UV 25 J/m
2
 at 23°C (Figure 5.11AB) and 30°C (Figure 5.11CD) after 3 and 5 
days of incubation.  However, at lower concentration of H2O2 (2 mM), the growth pattern of all 
mutants and controls were comparable to growth exhibited under the respective UV exposure.  
It could be concluded from these results that H2O2 enhanced the resistance of stn1Δ (#14 and 
#21) mutants under the effect of UV in a concentration-dependent manner. 
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Figure 5.11.  Combined effect of H2O2 and UV on the growth of cdc13Δ and stn1Δ mutants. 
Eight strains including mutants and controls (640, 1272, #14, #21, 2607, 2608, 2684 and 2685) were 
analysed for H2O2+UV-mediated sensitivity of cdc13Δ and stn1Δ mutants.  Five-fold serial dilutions of the 
strains in sterile water were spotted onto YEPD agar plates containing 2 mM, 3 mM, 4 mM of H2O2.  
Plates were exposed to different doses of UV irradiation (25, 50, 60 and 75 J/m
2
) and incubated for 3-5 
days at 23°C and 30°C before being photographed.  Strain numbers are indicated in brackets. 
 
(A) At 23°C after 3 days of incubation. 
(B) At 23°C after 5 days of incubation. 
(C) At 30°C after 3 days of incubation. 
(D) At 30°C after 5 days of incubation. 
C 
 
D 
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5.3.2.3. Synergistic effect of UV and HU on the growth of cdc13Δ and stn1Δ 
mutants  
In this section, the cooperative effect of HU was determined in the presence of UV.  It was 
shown earlier in this chapter that combined deletion stn1Δ cdc13Δ (2684 and 2685) mutants 
exhibited severe growth arrest in the presence of HU (50 mM or above) as compared to stn1Δ 
(#14 and #21) or dc13Δ mutants (2607 and 2608) at 23°C or 30°C for 3 and 5 days.  At 
increased concentration of HU (50 mM, 75 mM and 100 mM HU) the cdc13Δ mutants (2607 
and 2608) appeared to be slightly susceptible to HU, however, comparatively less than stn1Δ 
(#14 and #21).  The synergetic effects of UV and HU were tested at different concentrations of 
HU (50 mM, 75 mM and 100 mM HU; w/v) combined with UV exposures of different doses 
(25, 50, 60 and 75 J/m
2
). 
The results showed that 50 mM HU enhanced the genotoxic effect of UV on the growth of all 
deletion mutants and controls at 23°C and 30°C after 3 and 5 days of incubation (Figure 5.12A-
D).  The combined effects of HU with UV exposure of 25 J/m
2 
enhanced the inhibitory effects 
cooperatively, e.g., UV exposure of 25 j/m
2
 with 50 mM of HU increased the sensitivity to the 
level exhibited between UV 60 and UV 75 at 23°C (Figure 5.12AB) and 30°C (Figure 5.12CD) 
after 3 and 5 days of incubation.  However, 50 mM HU increased the resistance of the stn1Δ 
mutant (#14 and #21) to UV 25 exhibited at 23°C and 30°C after 3 and 5 days of incubation to a 
lesser extent.  This could be the concentration-dependent effect of HU similar to the effect of 
H2O2 at 4 mM concentration shown in the previous section.  This phenomenon of HU 
resistance, however, was not distinguishable at 50 mM, 75 mM or 100 mM HU in the absence 
of UV. 
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Figure 5.12.  Combined effect of HU and UV on the growth of cdc13Δ and stn1Δ mutants. 
Eight strains including mutants and controls (640, 1272, #14, #21, 2607, 2608, 2684 and 2685) were 
analysed for HU +UV-mediated sensitivity of cdc13Δ and stn1Δ mutants.  Five-fold serial dilutions of the 
strains in sterile water were spotted onto YEPD agar plates containing 50 mM, 75 mM and 100 mM 
(w/v) of HU.  Plates were exposed to different doses of UV irradiation with 25, 50, 60 and 75 J/m
2
of UV 
and incubated for 3-5 days at 23°C and 30°C before being photographed.  Strain numbers are indicated 
in brackets. 
(A) At 23°C after 3 days of incubation. 
(B) At 23°C after 5 days of incubation 
(C) At 30°C after 3 days of incubation. 
(D) At 30°C after 5 days of incubation. 
C 
D 
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Looking at the response of cdc13Δ and stn1Δ mutants on MMS, H2O2 and HU, it could be 
hypothesised that a) sensitivity to both MMS and HU might be under the control of the same 
pathways, b) sensitivity to H2O2 could possibly be under a different controlling mechanism, c) 
increased sensitivity of combined deletion could be due to the effect of either rad24Δ or due to 
interaction of cdc13Δ and stn1Δ cooperatively. 
 
5.3.3. The effects of genotoxic agents on the growth of cdc13-1 
mutants lacking N- or C-terminus 
5.3.3.1. Effects of UV on N- and C-terminal truncated variants of cdc13-1  
These studies were carried out to compare the growth pattern of cdc13-1 mutants lacking the N- 
or C-terminus under the effect of UV.  Initial experiments were performed to determine the 
effective dose of UV irradiation by exposing N- and C-terminus deleted (NTΔ and CTΔ) 
variants of cdc13-1 to a range of UV exposures.  Two YEPD plates (P1 and P2) each spotted 
with serial dilutions of 8 cultures containing parent strains (1296-TR and 1297-TR), wild type 
(640 and 641), cdc13Δ (2607 and 2608), cdc13-1-NTΔ and cdc13-1-CTΔ mutants (two 
construct from each parent strain) were exposed to different doses of UV irradiation (2, 4, 6, 8, 
10, 20, 30, 50 and 100 J/m
2
).  The plates were incubated at 23°C and 30°C for 3 and 5 days.   
The mutants cdc13Δ, cdc13-1-NTΔ and -CTΔ exhibited distinct patterns of growth inhibition 
initiated at UV 10 J/m
2
, obvious at UV 30 J/m
2
 and severe growth arrest at UV 50 J/m
2
 at 23°C 
and 30°C after 3 days of incubation.  The cdc13Δ (2607 and 2608) mutants showed the 
maximum sensitivity to UV with the least growth as compared to NTΔ and CTΔ mutant at UV 
30 J/m
2
 and 50 J/m
2
, well pronounced at 23°C with minimal growth recovery at UV 30 J/m
2
 and 
50 J/m
2
) as compared to 30°C after 3 days of incubation.  Similarly, cdc13-1-NTΔ mutants also 
displayed severe inhibition of growth, with slightly better growth as compared to cdc13Δ (2607 
and 2608) at UV 30 J/m
2
 and 50 J/m
2
.  In contrast, cdc13-1-CTΔ mutants displayed significant 
resistance to UV with growth patterns comparable to the original strains 1296-TR, 1297-TR and 
wild type strains (640 and 641) at UV 30, 50 and 100 J/m
2
 at 23°C and 30°C after 3 days of 
incubation.  However, cdc13-1 mutants strains (1296-TR and 1297-TR) manifested pronounced 
resistance to UV with growth comparable to wild type (640 and 641), obvious at 30°C after 3 
days of incubation.  Similar trends of growth arrest were observed at 23°C and 30°C after 5 
days of incubation.  However, some restoration of growth was observed in all mutants and in 
the wild type after a longer incubation of 5 days at 23°C or at the higher temperature of 30°C 
after 3-5 days of incubation. 
Considering the effective range of UV exposures (30 J/m
2
 or above), further experiments were 
performed with the above mentioned mutants and controls to elucidate the inhibition of growth 
observed in preliminary experiments.  Figure 5.13 presents the gradual increase in inhibition of 
growth with increasing exposures to UV (from UV 30 to UV 100 J/m
2
) in a dose-dependent 
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manner.  The maximum growth arrest was observed in case of cdc13Δ mutants (2607 and 2608) 
in the range of UV 50-UV 70 J/m
2
.  cdc13-1-NTΔ also exhibited moderate growth arrest in the 
same UV range, while CTΔ mutants displayed comparatively weak sensitivity in this UV range.  
The growth decline patterns in four cdc13-1-NTΔ mutants from two parent strains (with cdc13-
1 exo1Δ) consistently manifested the similar trends.  The wild type (640 and 641) and strains 
1296-TR and 1297-TR also showed moderate sensitivity to UV 60 J/m
2
 and above with least 
growth at UV 100 J/m
2
.  However, these distinct trends in UV sensitivity and resistance were 
more pronounced at 23°C as compared to 30°C.  The parent strains also displayed increased 
resistance to UV to varying extents as compared to wild type (640 and 641) at higher UV 
exposure (100 J/m
2
). 
Further analysis of these mutants at narrow selective UV exposures (25, 50, 55, 60, 65 and 70 
J/m
2
) also revealed the same distinct trends among cdc13Δ, cdc13-1-NTΔ and cdc13-1-CTΔ 
mutants, with maximum, moderate and least sensitivities to UV.  However at this range of UV 
exposure, the sensitivity difference was less distinct between wild type and parent strains 
(Figure 5.14).  This difference however could only be limited at higher UV exposures (UV 100 
J/m
2
).  The growth in parent and wild type strains were slightly less, however the overall 
sensitivity of cdc13-1-CTΔ were still comparable to wild type and parent strains, well 
pronounced at UV 65 J/m
2
 and UV 70 J/m
2
 at 23°C after 3 and 5 days of incubation. 
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Figure 5.13.  Effect of wide-range of UV irradiation (10, 15, 20, 30, 40, 50, 60, 70 and 100 J/m
2
) on the 
growth of cdc13-1 N- and C-terminus truncated mutants of 1296-TR and 1297-TR strains. 
Sixteen strains on two plates (P1 and P2) including mutants and controls (1296-TR x2, 2607, 2608, 
cdc13-1-NTΔ x2 (1296) and cdc13-1-CTΔ x2 (1296), 640, 641, 1297-TR x2, cdc13-1-NTΔ x2 (1297) and 
cdc13-1-CTΔ x2 (1297) were analysed for UV sensitivity.  Five-fold serial dilutions of the strains in sterile 
water were spotted onto YEPD medium plates and exposed to nine different doses of UV irradiation (in 
UV time exposure mode, 10, 15, 20, 30, 40, 50, 60, 70 and 100 J/m
2
).  The UV irradiated plates were 
incubated for 3-5 days at 23°C and 30°C before being photographed.  Strain numbers are indicated in 
brackets. 
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Figure 5.14.  Effect of selective UV irradiation 25, 50, 55, 60, 65, and 70 J/m
2
) on the growth of cdc13-1 
N- and C-terminus truncated mutants in 1296-TR and 1297-TR strains. 
Sixteen strains on two plates (P1 and P2) including mutants and controls (640, 1296-TR, 2607, 2608, 
1296-cdc13-1-NTΔ x2 and 1296-cdc13-1-CTΔ x2, 640, 1297-TR, 1297-cdc13-1-NTΔ x2 and 1297-cdc13-1-
CTΔ x2) were analysed for UV sensitivity of cdc13-1 N- and C-terminus truncated mutants.  Five-fold 
serial dilutions of the indicated yeast strains in sterile water were spotted onto YEPD medium plates and 
exposed to six different doses of UV irradiation (in UV time exposure mode, 25, 50, 55, 60, 65 and 70 
J/m
2
).  The UV irradiated plates were incubated for 3-5 days at 23°C and 30°C before being 
photographed.  Strain numbers are indicated in brackets. 
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A final experiment was carried out to determine the effect of UV irradiation on a few more 
cdc13-1 N- and C-terminus truncated mutants from cdc13-1 strains (1296-TR and 1297-TR).  
Figure 5.15 represented the results of UV-mediated growth responses of six cdc13-1-NTΔ and 
CTΔ mutants at three UV exposures (UV 25, UV 50 and UV 100 J/m2).  The distinct trends of 
growth inhibition of two N- and C-terminus truncated mutants were more pronounced at 
exposure of UV 50 J/m
2
, at 23°C and 30°C after 3 and 5 days of incubation (Figure 5.15AB).  
The UV resistance of C-truncated mutants was also comparable to the wild type and parent 
strains at exposure UV 50 J/m
2
.  Interestingly, both CTΔ mutants displayed slightly more 
growth at UV 100 J/m
2
, which was significant at 30°C after 3 and 5 days of incubation.  The 
four other NTΔ and CTΔ deletion mutants (P4 and P5) exhibited the same distinct pattern of 
UV sensitivity with increased growth inhibition in NTΔ mutants as compared to CTΔ mutants 
with few exceptions (Figure 5.15CD), that could be due to an unequal number of initial cells.  
These distinct sensitivity patterns were more pronounced at the lower temperature (23°C as 
compared to 30°C), and with the shorter incubation period (3 days as compared to 5 days) 
(Figure 5.15C).  Significant growth restoration was observed in four NTΔ and CTΔ mutants at 
23°C after 5 days of incubation and at 30°C after 3 and 5 days of incubation.  The distinct 
sensitivity pattern became less obvious after the longer incubation of 5 days due to the partial 
recovery of arrested cells. 
Based on these observations, it was concluded that there were at least three domains in the 
Cdc13 protein that contributed to the resistance to UV.  However, on the basis of comparable 
sensitivities among wild type (slightly less resistant) and CTΔ mutants it could be hypothesised 
that C-domain could contain a suppressor of WT resistance to UV that might make CTΔ 
mutants more resistant to UV at high doses. 
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Figure 5.15.  Effect of UV irradiation (25, 50, and 100 J/m
2
) on the growth of cdc13-1 N- and C-terminus 
truncated mutants in 1296-TR and 1297-TR strains. 
Different strains on four plates (P1, P2, P4 and P5) including mutants and controls [640, 1296-TR, 2607, 
2608, cdc13-1-NTΔ x2 (1296), cdc13-1-CTΔ x2 (1296) (P1); 640, 1297-TR, cdc13-1-NTΔ x2 (1297) and 
cdc13-1-CTΔ x2 (1296) (P2), cdc13-1-NTΔ x4 (1296), cdc13-1-NTΔ x4 (1296) (P4) and cdc13-1-NTΔ x4 
(1297), cdc13-1-CTΔ x4 (1297) (P5)] were analysed for UV sensitivity.  Five-fold serial dilutions of the 
strains in sterile water were spotted onto YEPD medium plates and exposed to three different doses of 
UV irradiation (in UV time exposure mode, 25, 50, and 100 J/m
2
).  The UV irradiated plates were 
incubated for 3-5 days at 23°C and 30°C before being photographed.  Strain numbers are indicated in 
brackets. 
(A) Plates 1 and 2 (P1 and P2) 3-5 days of incubation at 23°C. 
(B) Plates 1 and 2 (P1 and P2) 3-5 days of incubation at 30°C. 
(C) Plates 4 and 5 (P4 and P5) 3-5 days of incubation at 23°C. 
(D) Plates 4 and 5 (P4 and P5) 3-5 days of incubation at 30°C. 
D 
C 
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5.3.3.2. Effects of MMS on the growth of cdc13-1 mutants lacking N- or C-
terminus 
This study was conducted to determine the MMS-mediated growth responses of cdc13-1-NTΔ 
and cdc13-1-CTΔ mutants’ cells. 
Serial dilutions of 32 different cultures including 12 cdc13-1-NTΔ and CTΔ mutants of 1296-
TR and 1297-TR strains, wild type strain (640), cdc13-1 strain (1296-TR and 1297-TR) and 
cdc13Δ exo1Δ mutants strains (2607 and 2608) were spotted on YEPD plates containing three 
different concentrations of MMS (0.010%, 0.015% and 0.020%; w/v).  The plates were 
incubated at 23°C and 30°C for 3 and 5 days. 
The results showed that cdc13Δ exo1Δ (2607 and 2608) mutants were more sensitive to MMS 
when compared with cdc13-1-NTΔ mutants which in turn were slightly more susceptible to 
MMS as compared to cdc13-1 CTΔ (Figure 5.16).  Additionally, MMS-mediated growth arrest 
was influenced by three factors; concentration of MMS, incubation temperature and incubation 
time.  For example, maximum inhibition of growth was observed at the highest concentration of 
MMS (0.020%), at the lowest temperature (23°C) and after the shortest incubation time (3 
days). 
The cdc13Δ exo1Δ (2607 and 2608) mutants displayed a moderate growth arrest at 0.010% 
MMS, with a significant growth inhibition in response to 0.015% MMS.  However, severe 
inhibition of growth was observed at 0.020% of MMS at 23°C and 30°C after 3 and 5 days of 
incubation with a highest inhibition level detected at 23°C after 3 days of incubation.  The 
pronounced inhibition of cdc13Δ at 0.020% MMS as compared to 0.015% MMS, however, was 
not recovered (or partially recovered) after 5 days of incubation at 23°C.  The cdc13-1-NTΔ 
mutants demonstrated sensitivity to all tested doses of MMS (0.010%, 0.015% and 0.020%; 
w/v) but appeared to be more susceptible to 0.015% and 0.020% MMS, obvious at 23°C and 
30°C after 3 days of incubation (Figure 5.16A).  In contrast, cdc13-1-CTΔ mutants displayed a 
partial resistance to 0.020% MMS with growth patterns comparable to cdc13-1 strain (1296-TR 
and 1297-TR) and wild type strain (640) that was less pronounced at the lower temperature 
(23°C) as compared to 30°C.  All mutants and the wild type showed inhibition of growth to 
some extent at 23°C after 3 and 5 days of incubation.  The wild type strain 640 appeared to be 
more sensitive to MMS with inhibited growth, obvious at 0.015% and 0.020% (w/v) at 23°C 
after 3 and 5 days of incubation.  However, the wild type and parent strains presented no or 
minimal growth inhibition at 30°C after 3 and 5 days of incubation.   
The MMS sensitivity patterns observed among cdc13Δ exo1Δ, cdc13-1-NTΔ and cdc13-1-CTΔ 
mutants were slightly less pronounced at 30°C as compared to 23°C after 5 days of incubation, 
and obvious only at 0.015% and 0.020% of MMS (Figure 5.16B).  However, more restoration 
of cell growth was noticed at 30°C after 5 days of incubation.   
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The four other NTΔ and CTΔ deletion mutants (P4 and P5) also exhibited the distinct pattern of 
MMS-mediated sensitivity; slightly increased inhibition in NTΔ as compared to CTΔ, more 
obvious at 23°C and 30°C after 3 days of incubation (Figure 5.16C).  The significant growth 
restoration was observed in four NTΔ and CTΔ mutants after 5 days of incubation at 23°C and 
30°C, and the distinct sensitivity pattern became less obvious due to recovery of arrested cells.  
After 5 days incubation the distinct sensitivity patterns were much less pronounced at 23°C and 
30°C (Figure 5.16D).   
Overall, the results manifested a similar trend as was observed earlier with UV-mediated 
sensitivity in NTΔ and CTΔ mutants.  The CTΔ mutant also manifested resistance to 0.020% 
MMS at 23°C, with the growth comparable to that in the wild type (640) indicating that the 
presence of the C-domain might contribute to the mechanisms of the sensitivity of wild type 
cells. 
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Figure 5.16.  Effect of MMS (0.010%, 0.015% and 0.020%; w/v) on the growth of cdc13-1-NTΔ and CTΔ 
mutants of 1296-TR and 1297-TR strains. 
Different strains on four plates (P1, P2, P4 and P5) including mutants and controls [640, 1296-TR, 2607, 
2608, cdc13-1-NTΔ x2 (1296) and cdc13-1-CTΔ x2 (1296) (P1); 640, 1297-TR, 2607, 2608, cdc13-1-NTΔ x2 
clones (1297) and cdc13-1-CTΔ x2 clones (1297) (P2); cdc13-1-NTΔ x4 clones (1296) and cdc13-1-CTΔ x4 
clones (1296) (P4); and cdc13-1-NTΔ x4 clones (1297) and cdc13-1-CTΔ x4 clones (1296) (P5)] were 
analysed for MMS-mediated sensitivity.  Five-fold serial dilutions of the indicated yeast strains in sterile 
water were spotted onto YEPD medium plates containing three different concentrations of MMS 
0.010%, 0.015% and 0.020%; w/v).  The plates were incubated for 3-5 days at 23°C and 30°C before 
being photographed.  Strain numbers are indicated in brackets. 
(A) Plates 1 and 2 (P1 and P2) 3 days of incubation at 23°Cand 30°C 
(B) Plates 1 and 2 (P1 and P2) 5 days of incubation at 23°Cand 30°C 
(C) Plates 4 and 5 (P4 and P5) 3 days of incubation at 23°Cand 30°C 
(D) Plates 4 and 5 (P4 and P5) 5 days of incubation at 23°Cand 30°C 
D 
C 
277 
 
5.3.3.3. Effect of H2O2 on the growth of cdc13-1 mutants lacking N- or C-
terminus 
To determine the H2O2-mediated oxidative stress responses on the growth of cdc13-1-NTΔ and 
cdc13-1-CTΔ mutant cells, serial dilutions of 16 different cultures were spotted on YEPD plates 
containing three different concentrations of H2O2 (2 mM , 3 mM and 4 mM; w/v).  The plates 
were incubated at 23°C and 30°C for 3 and 5 days. 
The results showed that all mutants and wild type strains were severely inhibited in their growth 
at 4 mM H2O2 at 23°C and 30°C after 3 and 5 days of incubation (Figure 5.17).  The result also 
indicated that cdc13Δ exo1Δ (2607 and 2608) mutants were moderately arrested at 3 mM H2O2 
at 23°C and 30°C after 3 and 5 days of incubation, to a higher extent at 23°C.  cdc13-1-NTΔ 
mutants were slightly more sensitive to 3 mM of H2O2 as compared to cdc13-1-CTΔ mutants.  
Strains 1296-TR and 1297-TR exhibited slightly better growth at 23°C and 30°C after 3 and 5 
days of incubation, indicating their increased resistance to 3 mM H2O2 as compared to the wild 
type (640).  The growth rate of cdc13-1-CTΔ at 3 mM H2O2 was comparable to the wild type at 
23°C and 30°C after 3 and 5 days of incubation.  A slight effect of H2O2 on the growth of all 
mutants was also observed at 2 mM, when cells were incubated at 23°C and 30°C for 3 days.  
However, due to growth restoration, this effect was not obvious after 5 days of incubation.  The 
inhibitory effect of H2O2 was concentration dependent and become pronounced at the 
concentration of 3 mM.  At a higher concentration of H2O2 (5 mM) the growth of all mutants 
and controls was severely inhibited, however there was weak growth of cdc13-1-CTΔ mutants 
indicating their resistance as compared to the wild type.  This might be further evidence for the 
existence of C-terminus domain that might contribute to wild type sensitivity to H2O2, 
consistent with the MMS and UV effects on cdc13-1-CTΔ mutants. 
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Figure 5.17.  Effect of H2O2 (2 mM, 3 mM and 4 mM; w/v) on the growth of cdc13-1-N- and C-terminus 
truncated mutants in strains 1296-TR and 1297-TR. 
Different strains on two plates (P1, P2) including mutants and controls [640, 1296-TR, 2607, 2608, 
cdc13-1-NTΔ (1296) x2 clones, cdc13-1-CTΔ (1296) x2 clones (P1) and 640, 1297-TR, 2607, 2608, cdc13-
1-NTΔ (1299) x2 clones, cdc13-1-CTΔ (1297) x2 clones (P2] were analysed for H2O2-mediated sensitivity.  
Five-fold serial dilutions of the strains in sterile water were spotted onto YEPD medium plates containing 
three different concentrations of H2O2 (2 mM, 3 mM and 4 mM; w/v).  The plates were incubated for 3-5 
days at 23°C and 30°C before being photographed.  Strain numbers are indicated in brackets. 
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5.3.3.4. Effect of HU on the growth of cdc13-1 mutants lacking N- or C-
terminus 
In this study, cdc13-1-NTΔ and cdc13-1-CTΔ mutants (12 of each) were tested for their 
response to the presence of HU, a DNA replication inhibitor.  YEPD agar plates containing 
different concentrations of HU (10 mM, 25 mM and 30 mM; w/v) were spotted with serially 
diluted cultures.  The plates were incubated at 23°C and 30°C for 3 and 5 days. 
At 10, 25 and 30 mM, (w/v) HU concentration, all mutants and controls exhibited inhibition of 
growth to some extent that varied with concentration and temperature (Figure S5.7).  The higher 
growth inhibition was observed at 30 mM of HU at 23°C after 3 days of incubation (Figure 
S5.7A).  The cdc13Δ exo1Δ mutants (2607 and 2608) and cdc13-1-NTΔ mutants displayed a 
moderate inhibition of growth in the presence of HU as compared to the wild type (640 and 
641) and parent strains (1296-TR and 1297-TR) and to the cdc13-1-CTΔ mutants which was 
more obvious at 30 mM HU at 23°C after 3 days of incubation.  In contrast, cdc13-1-CTΔ 
mutants revealed minimal growth susceptibility to HU with a better growth pattern comparable 
to the wild type (640 and 641) and strains (1296-TR and 1297-TR).  The wild type and parent 
strains, however, exhibited no or negligible growth arrest at 23°C and 30°C after 3 and 5 days of 
incubation at all tested concentration of HU (Figure S5.7AB).  The distinct pattern of HU-
mediated growth, with weak, moderate and increased susceptibility of cells in cdc13-1 CTΔ, 
cdc13-1 NTΔ, and cdc13Δ exo1Δ mutants (2607 and 2608) respectively, were less obvious after 
5 days (Figure S5.7BD).  The resistance of cdc13-1-CTΔ mutants to HU-mediated toxicity was 
consistently reflected by all 12 analysed mutants, a phenomenon in agreement with previous 
results with UV, MMS and H2O2.  Similar trends were discovered with remaining cdc13-1-NTΔ 
and cdc13-1-CTΔ mutants [four of each type with either parent strain (1296-TR or 1297-TR)] 
(Figure S5.7CD). 
At increased doses of HU (10 mM, 25 mM and 50 mM; w/v) (Figure S5.8) , a similar pattern of 
growth inhibition was revealed with cdc13Δ exo1Δ mutants (2607 and 2608) showing a 
pronounced growth inhibition at 23°C and 30°C after 3 days of incubation as compared to NTΔ 
and CTΔ mutants (Figure S5.8AC).  However, the inhibition patterns at 50 mM HU were more 
profound at 23°C and 30°C after 3 days of incubation as compared to 30 mM HU-mediated 
inhibition that was observable only at 23°C after 3 days of incubation.  However, after 5 days of 
growth, most of the inhibition shown at day 3 was restored, resulting in a less distinguishable 
inhibition pattern of growth (Figure S5.8BD).  
Finally, these results were justified with even higher concentrations of HU (50 mM, 75 mM and 
100 mM; w/v).  The inhibition of growth was distinct at 23°C and 30°C after 3 and 5 days of 
incubation (Figure 5.18).  The cdc13Δ mutants (2607 and 2608) were severely inhibited in their 
growth while partial growth arrest, to varying extents, was shown by cdc13-1-NTΔ and cdc13-
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1-CTΔ mutants.  The wild type (640) and parent strains (1296-TR and 1297-TR) presented no 
or mild inhibition in their growth at 23°C and 30°C after 3 (Figure 5.18AC) and 5 days of 
incubation (Figure 5.18BD).  The growth patterns of cdc13-1-CTΔ mutants were consistent in 
all 12 analysed CTΔ mutants and were comparable in their HU-mediated growth susceptibility 
to wild type strain (640).  The three cdc13-1-NTΔ (1296-NTΔ #2 and #6, 1297-NTΔ #8) 
however, showed slight resistance to inhibition, which could be due to the variable number of 
starter cells used for serial dilution (Figure 5.18CD).  All other mutants were consistent in their 
growth inhibition pattern. 
Taken together, cdc13Δ mutants, cdc13-1-NTΔ and cdc13-1-CTΔ mutants exhibited severe, 
moderate and mild phenotypic growth inhibition respectively under the toxic effect of HU.  The 
distinct growth patterns observed were consistent with earlier results obtained with the 
exogenous genotoxic agent UV, DNA damaging, MMS and H2O2. 
Based on these results, it could be concluded that there are at least 3 domains in the Cdc13 
protein that might contribute to WT-sensitivity to UV, MMS, H2O2 and HU.  Moreover, the 
resistance pattern of CTΔ, comparable with wild type strain, indicates that the C-domain might 
also contain a suppressor of WT-resistance to UV, MMS and HU. 
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Figure 5.18.  Effect of HU (50 mM, 75 mM and 100 mM) on the growth of cdc13-1 N- and C-terminus 
truncated mutants of 1296-TR and 1297-TR strains. 
C 
D 
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Different strains on five plates (P1, P2, P4, P5 and P6) including mutants and controls [640, 1296-TR , 
2607, 2608, cdc13-1-NTΔ x2 clones, (1296), cdc13-1-CTΔ x2 clones (1296), (P1); 640, 1297-TR, cdc13-1-
NTΔ x2 clones (1297), cdc13-1-CTΔ x2 clones (1297), (P2); cdc13-1-NTΔ x4 clones (1296), cdc13-1-CTΔ x4 
clones (1296), (P4); cdc13-1-NTΔ x4 clones (1297), cdc13-1-CTΔ x4 clones (1297), (P5) and 640, 641, 
1296-TR x2, 1297-TR x2, 2607 and 2608 (P6) ] were analysed for HU-mediated sensitivity.  Five-fold 
serial dilutions of the indicated yeast strains in sterile water were spotted onto YEPD medium plates 
containing three different concentrations of HU 50 mM, 75 mM and 100 mM).  The plates were 
incubated for 3-5 days at 23°C and 30°C before being photographed.  Strain numbers are indicated in 
brackets. 
(A) Plates 1 and 2 (P1 and P2) after 3 days of incubation at 23°C and 30°C. 
(B) Plates 1 and 2 (P1 and P2) after 5 days of incubation at 23°C and 30°C. 
(C) Plates 4, 5 and 6 (P4, P5 and P6) after 3 days of incubation at 23°C and 30°C. 
(D) Plates 4, 5 and 6 (P4, P5 and P6) after 5 days of incubation at 23°C and 30°C. 
 
5.3.4. The effects of genotoxic agents on the growth of cdc13-1 N- 
or C-terminus truncated (haploids) in comparison with diploid (NTΔ x 
CTΔ) mutants 
5.3.4.1. Effects of UV on cdc13-1 mutants lacking NTΔ or CTΔ (haploids) 
and diploid mutants 
Two diploid (#31 and #32) mutants harbouring the NTΔ/CTΔ alleles were analysed and 
compared to haploids, cdc13Δ exo1Δ (2607 and 2608), cdc13-1-NTΔ and cdc13-1-CTΔ mutants 
in their growth responses after exposures to UV 25, UV 50 and UV 100 J/m
2
, at two different 
temperature regimes (23°C and 30°C), after 3 and 5 days of growth.  As illustrated in Figure 
5.19AB, the haploids cdc13Δ exo1Δ mutants (2607 and 2608) were severely inhibited in their 
growth at a UV exposure of 100 J/m
2 
(UV 100); they showed no growth at UV 100 J/m
2
 and 
weak growth at UV 50 J/m
2
 at 23°C and 30°C after 3 and 5 days of incubation.  In comparison, 
the haploid cdc13-1-NTΔ mutants also had severe growth arrest, and cdc13-1-CTΔ mutants 
with moderate growth arrest manifested their distinct sensitivity pattern at UV 25, 50 and 100 
J/m
2
 at 23°C and 30°C after 3 and 5 days.  The haploid cdc13-1-CTΔ also exhibited mild to 
moderate growth at UV 100 J/m
2
 significantly obvious as compared to growth of wild type (640 
and 641) strains that exhibited limited growth at UV 100 J/m
2
 at 23°C and 30°C within 3 and 5 
days.  Strains 1296-TR and 1297-TR as well as wild type (640 and 641) strains exhibited weak 
growth after UV 100 J/m
2
, representing severe growth arrest, and much better growth after UV 
25 and 50 J/m
2
 representing no or limited growth arrest.  Strains 1296-TR and 1297-TR (P6) 
exhibited slightly less susceptibility to UV as compared to wild type (640 and 641) but slightly 
more sensitivity as compared to cdc13-1-CTΔ [1296-CTΔ #9, #10 (P7), 1297-CTΔ #11, #12 
(P8)] at UV 100 at 23°C after 3 days of incubation (Figure 5.19A).  In contrast, the two diploids 
[#31 and #32 (P7 and P8)] exhibited intermediate inhibition of growth at UV 50 and 100 J/m
2
 at 
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23°C and 30°C after 3 and 5 days.  The diploid #31 manifested slightly less growth (when 
compared with diploid #32), more obvious at UV 50 and 100 at 23°C after 3 days of growth 
(Figure 5.19A).  The growth pattern in diploid #31 indicated that the growth inhibition was 
either equal or slightly more when compared with cdc13-1-NTΔ mutants but slightly less when 
compared to cdc13-1-CTΔ mutants, also comparable with wild type at UV 100 after 3 days of 
incubation at 23°C.  Similarly, in diploid number #32, the inhibition in growth was slightly 
more when compared with the wild type but less than in the cdc13-1-CTΔ mutant. 
Overall, diploid #31 displayed comparatively more inhibition of growth when compared with 
diploid #32.  In general, diploids displayed intermediate growth, when compared with cdc13-1-
CTΔ and cdc13-1 NTΔ. 
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Figure 5.19.  Effect of UV irradiation (25, 50, and 100 J/m
2
) on the growth of cdc13-1 N- and C-terminus 
truncated (haploids) in comparison to diploid mutants.  
A 
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Different strains on three plates (P6, P7 and P8) including mutants and controls [640, 641, 1296-TR x2, 
1297-TR x2, 2607, 2608 (P6); 2607, 2608, cdc13-1-NTΔ (1296) x2 clones, cdc13-1-CTΔ (1296) x2 clones, 
diploid #31, diploid #32 (P7); 2607, 2608, cdc13-1-NTΔ (1297) x2 clones, cdc13-1-CTΔ (1297) x2 clones, 
diploid #31, diploid #32 (P8)] were analysed for UV-mediated sensitivity.  Five-fold serial dilutions of the 
strains in sterile water were spotted onto YEPD medium plates and exposed to three different doses of 
UV irradiation (25, 50, and 100 J/m
2
).  The UV irradiated plates were incubated for 3-5 days at 23°C and 
30°C before being photographed.  Strain numbers are indicated in brackets. 
(A) Plates 6, 7 and 8 (P6, P7 and P8) after 3 days of incubation at 23°C and 30°C. 
(B) Plates 6, 7 and 8 (P6, P7 and P8) after 5 days of incubation at 23°C and 30°C. 
 
5.3.4.2. Effect of MMS on cdc13-1 mutants lacking NTΔ or CTΔ (haploids) 
and diploid mutants 
The MMS stress-mediated growth responses were determined for two diploids (#31 and #32, 
containing the cdc13-1 N- and C-terminus deleted allele of the cdc13-1 gene) growing at three 
concentrations of MMS (0.010%, 0.015% and 0.020%; w/v). The haploid mutants cdc13Δ 
exo1Δ (2607 and 2608), cdc13-1-NTΔ and cdc13-1-CTΔ were used for comparison with wild 
type strains (640 and 641) and mutant strains 1296-TR and 1297-TR.  All serially diluted 
cultures were spotted on YEPD agar plates (P6, P7 and P8) containing above mentioned 
concentration of MMS and incubated at two different temperature regimes (23°C and 30°C) 
during 3 and 5 days.  As shown in Figure 5.20, the haploid cdc13Δ exo1Δ mutants (2607 and 
2608) showed sensitivity to all three concentrations of MMS and were severely inhibited in 
their growth at 0.015% MMS (mild growth) and 0.020% MMS (no growth) at 23°C as 
compared to 30°C after 3 days of incubation (Figure 5.20A).  In comparison, the haploid cdc13-
1-NTΔ and cdc13-1-CTΔ mutants, manifested their distinct sensitivity pattern (more growth in 
CTΔ as compared to NTΔ) at 0.010%, 0.015% and 0.020% MMS at 23°C and 30°C after 3 days 
of incubation (Figure 5.20A).  Strains 1296-TR and 1297-TR (P6) exhibited obviously less 
susceptibility to 0.015% and 0.020% MMS at 23°C.  The haploid cdc13-1-CTΔ [1296-CTΔ #9, 
#10 (P7), 1297-CTΔ #11, #12 (P8) also exhibited stronger resistance to 0.020% MMS (obvious 
at 23°C and 30°C after 3 days of incubation), as compared to strains 1296-TR and 1297-TR 
(P6) and wild type strains.  Wild type strains (640 and 641), however, were less resistant at an 
increased concentration of MMS 0.020%.  The diploids [#31 and #32 (P7 and P8)] appeared to 
be mildly inhibited in their growth under the effect of MMS and exhibited an intermediate level 
of growth inhibition at 0.010%, 0.015% and 0.020% MMS at 23°C and 30°C after 3 days and 5 
days of incubation.  The diploid #31 showed slightly less growth (possibly due to fewer cells in 
the starter culture as the growth difference was also shown in controls) when compared with 
diploid #32.  There was partial growth restoration after 5 days of incubation at 23°C and 30°C 
but the inhibitory pattern of all mutants and controls were still comparable (Figure 5.20B).  The 
growth pattern in diploids indicated that the MMS stress- mediated growth inhibition was either 
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equal to or slightly more when compared to cdc13-1-NTΔ mutants but slightly less when 
compared with cdc13-1-CTΔ mutants and wild type at 0.020% MMS at 23°C after 3 and 5 days 
of incubation.  Overall, diploids manifested intermediate inhibition of growth phenotype, 
contributed from both alleles of cdc13-1, CTΔ and NTΔ, and possibly reflected the effect of 
allele dosage. 
 
 
 
Figure 5.20.  Effect of MMS (0.010%, 0.015% and 0.020%; w/v) on the growth of cdc13-1 N- and C-
terminus truncated mutants (haploids) in comparison to diploid mutants of 1296-TR and 1297-TR 
strains. 
A 
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Different strains on three plates (P6, P7 and P8) including mutants and controls [640, 641, 1296-TR x2, 
1297-TR x2, 2607, 2608 (P6); 2607, 2608, cdc13-1-NTΔ (1296) x2 clones, cdc13-1-CTΔ (1296) x2 clones, 
diploid #31, diploid #32 (P7); 2607, 2608, cdc13-1-NTΔ (1297) x2 clones, cdc13-1-CTΔ (1297) x2 clones, 
diploid #31, diploid #32 (P8)] were analysed for MMS-mediated sensitivity.  Five-fold serial dilutions of 
the indicated yeast strains in sterile water were spotted onto YEPD medium plates containing three 
concentrations of MMS, (0.010%, 0.015% and 0.020%; w/v).  The plates were incubated for 3-5 days at 
23°C and 30°C before being photographed.  Strain numbers are indicated in brackets. 
(A) Plates 6, 7 and 8 (P6, P7 and P8) after 3 days of incubation at 23°C and 30°C. 
(B) Plates 6, 7 and 8 (P6, P7 and P8) after 5 days of incubation at 23°C and 30°C. 
 
5.3.4.3. Effects of H2O2 on cdc13-1 mutants lacking NTΔ or CTΔ (haploids) 
and on diploid (NTΔ/CTΔ) mutants 
This part of the study aimed to determine the effects of H2O2 on the growth of diploids 
containing both alleles (cdc13-1-NTΔ and cdc13-1 CTΔ) in comparison with haploid, cdc13-1-
NTΔ and CTΔ mutants.  Serially diluted cultures were spotted on the YEPD agar plates (P6, P7 
and P8) contained three different concentrations of H2O2, (2 mM, 3 mM and 4 mM), and 
incubated at two different temperature (23°C and 30°C) for 3 and 5 days. 
All cultures were severely inhibited in their growth at 4 mM H2O2, while mild inhibition of 
growth was observed at 2 mM H2O2 at 23°C and 30°C after 3 and 5 days of incubation (Figure 
5.21).  However, differential growth patterns were observed at 3 mM H2O2 reflecting distinct 
individual responses of cdc13Δ exo1Δ (2607 and 2608), cdc13-1-NTΔ [1296-NTΔ #4 and #5 
(P7); 1297- NTΔ #7 and #8 (P8)] and cdc13-1-CTΔ [1296-CTΔ #9 and #10 (P7); 1297-CTΔ 
#11 and #12 (P8)] mutants (haploid) and diploids (#31 and #32; P7 and P8) strains, wild type 
(640 and 641; P6) and strains 1296-TR and 1297-TR; P6. 
The haploid cdc13Δ exo1Δ mutants (2607 and 2608) were the most sensitive to 3 mM H2O2 
(Figure 5.21).  The haploid cdc13-1-NTΔ and cdc13-1-CTΔ mutants also manifested a partial 
growth inhibition, with slightly less growth in the NTΔ mutant (P7, P8) as compared to CTΔ 
mutant (P7, P8), more obvious at 3 mM H2O2 at 23°C and 30°C after 3 days of incubation 
(Figure 5.21A).  The wild type strains (640 and 641; P6) exhibited slightly more sensitivity to 3 
mM H2O2 as compared to strains 1296-TR and 1297-TR; (P6), more obvious at 23°C.  
However, the sensitivity difference between cdc13-1-CTΔ (P7 and P8) and cdc13-1-NTΔ (P7 
and P8) deletion mutants were not very distinguishable at 23°C after 3 and 5 days of incubation.   
The haploid cdc13-1-CTΔ mutants on 3 mM and 4 mM H2O2 were comparable in growth 
inhibition to strains 1296-TR and 1297-TR (P6) and wild type strains as well as to the diploid 
strains (#31 and #32) that displayed some resistance to 3 mM H2O2 and also to 4 mM H2O2 (to 
some degree) as mild growth was observed at 4 mM H2O2 comparable to the growth of cdc13-1-
CTΔ mutants (haploid), obvious after the longer incubation (at 23°C after 5 days of incubation) 
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and at higher temperature (30°C after 3 and 5 days of incubation).  The partial recovery of 
growth was observed after 5 days of incubation at 23°C and 30°C but it did not mask the 
distinct inhibitory growth pattern displayed after 3 days of incubation (Figure 5.21B).  The 
inhibition of growth in diploids was comparable to the growth exhibited by cdc13-1-CTΔ or 
better than NTΔ mutants at 30°C after 3 and 5 days of incubation. 
Overall, the growth of the diploids on H2O2 exceeded the growth of the two haploids with C- 
and N- truncated cdc13-1 and all other strains in the experiment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.21.  Effect of H2O2 (2 mM, 3 mM and 4 mM) on the growth of cdc13-1 N- and C-terminus 
truncated haploids in comparison to diploid mutants of 1296-TR and 1297-TR strains. 
Different strains on three plates (P6, P7 and P8) including mutants and controls [640, 641, 1296-TR x2, 
1297-TR x2, 2607, 2608 (P6); 2607, 2608, cdc13-1-NTΔ (1296) x2 clones, cdc13-1-CTΔ (1296) x2 clones, 
diploid #31, diploid #32 (P7); 2607, 2608, cdc13-1-NTΔ (1297) x2 clones, cdc13-1-CTΔ (1297) x2 clones, 
diploid #31, diploid #32 (P8)] were analysed for sensitivity to H2O2 in order to compare it in cdc13-1 N- 
and C-terminus truncated haploids and diploid mutants.  Five-fold serial dilutions of the strains in sterile 
water were spotted onto YEPD medium plates containing three concentration of H2O2 (2 mM, 3 mM and 
4 mM).  The plates were incubated for 3-5 days at 23°C and 30°C before being photographed.  Strain 
numbers are indicated in brackets. 
(A) Plates 6, 7 and 8 (P6, P7 and P8) after 3 days of incubation at 23°C and 30°C. 
(B) Plates 6, 7 and 8 (P6, P7 and P8) after 5 days of incubation at 23°C and 30°C. 
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290 
 
Effect of HU on cdc13-1 mutants lacking NTΔ or CTΔ (haploids) and on diploid 
(NTΔ/CTΔ) mutants 
To determine growth responses to HU in diploids (#31 and #32) and haploids, the cdc13-1 
NTΔ, cdc13-1-CTΔ and cdc13Δ (2607 and 2608) mutant cultures were tested at two 
concentrations of HU (25 mM and 50 mM; w/v).  Serially diluted cultures were spotted on HU 
containing YEPD agar plates (P7 and P8) incubated at 23°C and 30°C for 3 and 5 days  
As shown in Figure 5.22, there was a slight to moderate effect of inhibition of growth at 50 mM 
HU after 3 days of incubation at 23°C and 30°C, (obvious in last two to three dilutions of all 
cultures when compared to controls).  The haploids cdc13Δ exo1Δ mutants (2607 and 2608) 
showed partial sensitivity to both concentrations of HU, more obvious at 50 mM, HU (partial 
growth in last three dilutions) at 23°C as compared to 30°C after 3 days of incubation (Figure 
5.22A).  In comparison, the haploid cdc13-1-NTΔ and cdc13-1-CTΔ mutants with mild growth 
arrest, manifested their distinct sensitivity pattern (more growth in CTΔ as compared to NTΔ) at 
50 mM HU at 23°C and 30°C after 3 days of incubation (Figure 5.22A).   
Due to growth restoration after 5 days of incubation at 23°C and 30°C, the inhibition trends 
were less comparable (Figure 5.22B).  The growth of diploids was either equal or slightly 
enhanced when compared to cdc13-1-NTΔ mutants (P7, at 23°C after 3 days) but obviously less 
when compared to cdc13-1-CTΔ mutants at 50 mM HU at 23°C after 3 and 5 days of 
incubation.   
Overall, the observed growth inhibition trends in haploids and diploids were consistent with 
previous experiments with UV and MMS.  The cdc13Δ mutants showed the maximum 
inhibition in growth, while medium inhibition was observed in cdc13-1 NTΔ.  The cdc13-1-
CTΔ mutants, however, displayed the best growth and maximum resistance to HU, obvious at 
23°C after 3 days of incubation.  The diploid [#31 and #32 (P7 and P8)] appeared to be mildly 
inhibited in their growth under the effect of HU.  In diploids, the growth inhibition was not very 
significant.  They presented the intermediate growth inhibition as compared to haploids obvious 
at 30°C after 3 and 5 days of incubation that could be the result of an allele dosage effect as 
seen in the previous experiments. 
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Figure 5.22.  Effect of HU (25 mM, and 50 mM) on the growth of cdc13-1 N- and C-terminus truncated 
haploids in comparison to diploid mutants of 1296-TR and 1297-TR strains. 
Different strains on three plates (P6, P7 and P8) including mutants and controls [640, 641, 1296-TR x2, 
1297-TR x2, 2607, 2608 (P6); 2607, 2608, cdc13-1-NTΔ (1296) x2 clones, cdc13-1-CTΔ (1296) x2 clones, 
diploid #31, diploid #32 (P7); 2607, 2608, cdc13-1-NTΔ (1297) x2 clones, cdc13-1-CTΔ (1297) x2 clones, 
diploid #31, diploid #32 (P8)] were analysed for sensitivity to HU in order to compare it in cdc13-1 N- 
and C-terminus truncated haploids and diploid mutants.  Five-fold serial dilutions of the strains in sterile 
water were spotted onto YEPD medium plates containing two concentrations of HU (25 mM, and 50 
mM).  The plates were incubated for 3-5 days at 23°C and 30°C before being photographed.  Strain 
numbers are indicated in brackets. 
(A) Plates 6, 7 and 8 (P6, P7 and P8) after 3 days of incubation at 23°C and 30°C. 
(B) Plates 6, 7 and 8 (P6, P7 and P8) after 5 days of incubation at 23°C and 30°C. 
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5.4. Conclusions: 
 The similar responses of cdc13Δ (more resistant) and stn1Δ (less resistant) mutants to 
UV, MMS and HU indicate the existence of sensitivity control under the same pathways. 
 The resistance to oxidative stress (H2O2) in STN1 deletion mutants as compared to 
CDC13 deletion mutants indicates the involvement of different mechanism to cope the 
oxidative stress.  
 Increased sensitivity of combined deletion to UV, MMS and HU could be due to the 
effects of either rad24Δ or due to interaction of cdc13Δ and stn1Δ cooperatively. 
 The peculiar sensitivity trends in N- and C-terminus mutants of Cdc13-1, implies that 
different domains exist in the Cdc13 protein that contribute to UV resistance. 
 The slightly less resistance of wild type as compared to C-terminus truncated mutants of 
Cdc13-1 protein indicate the presence of suppressor of WT-resistance to UV, MMS and 
replication inhibitor HU.  
 The growth inhibition trends in heterozygous diploid containing N- and C-terminus of 
Cdc13-1 suggest the allele dosage effect to DNA damaging and replication inhibitor 
stress factors. 
In summary, mutants without essential telomere capping proteins Cdc13 and Stn1, and N- 
and C-terminus truncated variants of Cdc13-1 show distinct patterns of sensitivity to 
DNA replication inhibitors (MMS and HU), DNA damaging agents (UV) and oxidative 
stress factor (H2O2).  These cellular responses to genotoxic agents highlight potentially 
new roles of telomere capping proteins, Cdc13 and Stn1. 
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Chapter 6 
Chronological lifespan studies 
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6.1. Introduction 
In yeast chronological lifespan (CLS) assays measure the time cells can remain viable in the 
post-replicative stationary phase (Piper, 2006, Fabrizio and Longo, 2003).  These assays provide 
direct screening of genes involved in longevity pathways and identify chronologically long-
lived gene deletions.  
 
In the past, yeast has been used to study basic cellular processes such as DNA repair, the cell 
cycle, the mechanism of cellular interaction, cell signalling and differentiation (Piper, 2006, 
Vachova et al., 2012).  At present, budding yeast, Saccharomyces cerevisiae is used as an ideal 
eukaryotic model to study ageing at the organismal, cellular and molecular level (Jazwinski, 
2002, Guarente and Kenyon, 2000, Kaeberlein et al., 2007).  The phenomenon of ageing is a 
result of the complex interplay of molecular and cellular processes (Uzunova et al., 2013).  The 
CLS of yeast is measured as the survival time of cells in a non-dividing stationary phase and has 
been implicated into identification of genes and pathways involved in the regulation of ageing.  
In yeast, nutrient-sensing the Tor/Sch9 and the Ras/adenylate cyclase/PKA (protein kinase A) 
pathways are involved in the mechanisms of lifespan regulation (Guarente and Kenyon, 2000).  
Yeast can survive in adverse conditions in different environments.  The Ras/cAMP pathway 
controls the adaptation in response to nutrient limitation (Pedruzzi et al., 2000).  Analogous to 
these pathways, in higher eukaryotes are the ‘insulin/IGF-I (insulin-like growth factor) like’ 
pathway that regulates longevity (Dorman et al., 1995). 
Yeasts are highly adaptable eukaryotes and can survive for more than three months without 
showing a decrease in cellular viability under normal conditions (Lillie and Pringle, 1980).  
Traditionally, two media have been used to study the CLS of yeast: synthetic complete medium 
(SC/SDC) (Fabrizio et al., 2004, Fabrizio and Longo, 2003) and nutrient-rich, YEPD medium 
(Longo and Fabrizio, 2012).  The SDC medium promotes short survival with high metabolism.  
In contrast, YEPD leads to reduced metabolism with longer survival.  Both media were utilised 
in this study to find measureable differences in cellular viability of Cdc13- and Stn1-deficient 
strains. 
 
Maintenance of telomere integrity ensures the genomic stability of cells.  Loss of protective 
proteins or the presence of defective protein unmasks the telomere that activates DNA damage 
checkpoint signalling pathways.  The activation of exonucleolytic degradation on the uncapped 
telomere can lead to genomic instability and early senescence, the hallmarks of ageing (Mason 
and Skordalakes, 2010, Aubert and Lansdorp, 2008). 
 
Cdc13 binds to telomere G-rich tails through a sequence specific central OB- 
(oligosaccharide/oligonucleotide binding) fold essential for its capping function (Eldridge and 
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Wuttke, 2008).  The interaction between Cdc13 and Stn1 is mediated through C-terminal 
located conserved OB4-fold (Sun et al., 2011).  The structural analysis of Cdc13 has revealed 
another conserved region/OB1 fold in its N-terminal end (Sun et al., 2011), that might bind with 
Po1I; catalytic subunit of pol α primase complex (Qi and Zakian, 2000).  Cdc13 protein also 
interacts with Est1 through its recruitment domain, second fold in N-terminus that facilitate 
telomerase recruitment to telomere. 
Cdc13 N- and C-terminal ends interact with different components of telomere capping 
machinery, implying their different structural motifs or domains.  In this study, the chronologic 
lifespan of different yeast strains lacking Cdc13 and Stn1 were compared to WT to find possible 
roles of telomere capping proteins in cellular senescence and ageing.  CLS of N- and C-
terminus deletions were also investigated to dissect the role of both halves of the Cdc13 protein 
in cellular senescence under different paradigms, including calorie restriction. 
In yeast, chronological ageing is strictly temperature-dependent.  To facilitate ageing studies, 
strains were tested for appropriate growth temperature and also for sensitivity of mutants to 
higher temperature. 
 
6.2. Aims and objectives 
The main focus of this part of work was to determine differences in chronological lifespans of 
mutants, lacking essential telomere capping proteins, Stn1and Cdc13, under present laboratory 
conditions. 
This aim involves the following objectives: 
 To test the mutant strains at a range of temperatures to determine appropriate conditions 
allowing facilitation of CLS studies at higher temperature (above 23˚C). 
 To test the sensitivity of the mutants to higher temperature (30˚C) and to compare it with 
that at low temperature (23˚C). 
 To test the viability of the mutants after short-term of preserving in glycerol. 
 To measure the CLS of mutant strains without essential telomere capping proteins, Stn1 
and Cdc13. 
 To measure the CLS of mutants with N- and C-terminal deletion variants of protein 
Cdc13-1. 
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6.3. Results 
CLS of S. cerevisiae wild type, EXO1 deletion, STN1 deletion, CDC13 deletion and cdc13-1 
without N- and C-terminus were studied.  Yeast strains used in this study are listed in Table 4.1 
(Chapter 4). 
 
6.3.1. The cultivation of yeast cells in solid and liquid media 
cdc13 and stn1 single and combined mutants were cultivated on YEPD agar and in broth media 
to determine cell growth rate, efficiency and cellular viability.  Overnight cultures (set with 
approximately equal numbers of cells) grown in YEPD broth at 30°C showed variable growth 
rates.  Total cell numbers were confirmed spectrophotometrically by measuring the optical 
densities (OD660) in 1 ml of cultures.  Combined deletion mutants with genotype cdc13∆ stn1∆ 
exo1∆ rad24∆ showed three to four times less OD660 as compared to the wild type implying 
only 25% (DLY 2684 with p<0.00008) and 30% (DLY 2685 with p<0.00014) of the growth rate 
compared to the controls (DLY 640) (Figure 6.1).  Reduced cell number was also observed in 
single mutants with STN1 deletion (DLY 2625: 34%; DLY 2626: 23% survival, with p<0.0004 
and p<0.00009 respectively, highly significant) as compared to the wild type.  However, strains 
DLY 2607 and 2608 with CDC13 and EXO1 deletions, and strains 1272 and 1273 with EXO1 
deletion did not show a significant difference (p< 0.8, 0.2, 0.2 and 0.2 respectively) in growth 
(101%, 98%, 102% and 103% respectively) on YEPD agar (Figure 6.3) and broth media. 
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Figure 6.1.  Spectrophotometric analysis of cell densities in overnight cultures.  Variable OD660 values 
correlate with different cell numbers in the wild type (WT) and mutant strains.  The cell number is 
expressed as percentage of the control (WT) cells considered as 100%, and the differences in cell 
numbers in mutants were calculated from controls.  Results are expressed as mean ± SEM (n=5).  The 
cell number variations in strains 641, 1272, 1273, 2607 and 2608 are statistically non-significant (p 
>0.05), whereas low cell number in strains 2625, 2626, 2684 and 2685 with p values 0.00042, 0.00009, 
0.00008, 0.00014, respectively, shows statistically highly significant variations as compared to the wild 
type (p < 0.0001). 
 
The differences in growth capacity and, therefore, final cell numbers of different mutants were 
correlated with variable number of colony-forming units on YEPD agar medium (Figure 6.2).  
Colony formation was reduced in stn1 deletion mutants (stn1∆, strains 2625 and 2626) and 
cdc13 and stn1 combined deletion mutant (strain 2685) as compared with wild type.  Colony 
morphology also appeared altered in mutant strains as compared to the wild type; in particular, 
colony shape was irregular and “flowery” in strains 2625 and 2685 as compared to the wild type 
(640), which was smooth and circular (Figure 6.3). 
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Figure 6.2.  The abundance of the colony formation by different strains propagated on YEPD medium 
after overnight (o/n) incubation at 30°C. 
Mutant stn1∆ exo1∆ cdc13-1 (strains DLY 2625 and DLY 2626) and cdc13∆ stn1∆ exo1∆ rad24∆ 
(strain DLY 2685) showed less effective colony formation, heterogeneous (various) cell sizes (4, 5 and 
7) as compared to the wild type strains DLY 640 and 641 (1 and 2).  Overnight-grown cultures from a 
single colony were diluted in 1:2 in YEPD broth and 5 µl of each diluted culture was spotted on a 
YEPD agar plate and incubated at 30°C.  Scale bar equal to 20 mm. 
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Figure 6.3.  Colony morphologies in WT and mutant strains grown on YEPD agar medium. 
Mutant strains stn1∆ (2625) and stn1∆ cdc13∆ (2685) (2 and 3 respectively) showed “flowery” colony 
shapes with wavy margins as compared to uniform circular colonies in wild type strain 640 (1).  Scale bar 
equal to 20 mm.  Cultures were grown for 3 days before being photographed. 
 
6.3.2. Spot tests 
Yeast strains selected for the ageing studies (mutants with CDC13 and STN1 deletions and wild 
type) showed variable growth patterns on YEPD agar plates and broth at 23°C in preliminary 
cultivation assays.  Spot tests were carried out to assess the viability of these strains at a range 
of temperatures to determine the optimal temperature regimes to grow mutant strains in order to 
facilitate chronological lifespan (CLS) studies (Figure 6.4).  Yeast ageing slows at low 
temperature, and therefore it takes longer (up to 3-6 months) to study CLS at low temperature as 
compared to high temperature (Fabrizio and Longo, 2003, Piper, 2006). 
Serial dilutions (5-fold serial dilution) of cells from fresh cultures (five cultures of each mutant 
set with single independent colony) were spotted on YEPD plates using replica plating and 
incubated for 3-5 days at defined temperatures (23°C-40°C) to determine the viability of 
cultures in different dilutions.  Mutant strain 2625 (exo1∆ stn1∆ cdc13-1) showed mild 
sensitivity to high temperature growing slightly better at 23°C as compared to 36°C and 38°C 
(colonies 1˗4 on plates 1-4).  However, colony 5 (plate 3) did not exhibited marked sensitivity 
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to high temperature.  The mutant strain 2685 (cdc13∆ exo1∆ stn1∆ rad24∆) grew better at 36°C 
and 38°C as compared to 23°C; other mutant strains [1272 and 1273 (exo1∆), 2607 (exo1∆ 
cdc13∆] and wild type strain (640) did not show any sensitivity to high temperatures (36°C-
38°C). 
 
 
Figure 6.4.  Growth of mutant and wild type strains at different temperatures. 
Five independent colonies (1-5) were analysed for their growth at 23°C to 40°C.  Yeast cultures were 
serially (five-fold) diluted, cell number equalised by measuring OD660, spotted onto YEPD agar plates and 
incubated at the indicated temperatures for 3-5 days before being photographed.  Scale bar equal to 20 
mm. 
 
For further verification of temperature sensitivity, another spot test was conducted with 
temperature-sensitive (ts) controls i.e., strains 1108 (ts) and 1296 (ts), to establish whether less 
growth in stn1∆ containing mutants (strains 2625, 2685) was a valid finding.  Two mutant 
strains were selected for stn1∆ exo1∆ cdc13-1 (2625 and 2626) and stn1∆ cdc13∆ exo1∆ 
rad24∆ (2684 and 2685) deletion each.  The results showed that strain 2625 did not grow well 
at low temperature (23°C) and showed better growth at 30°C (Figure 6.5, plate 1, A and B).  
Reduced growth in mutant strain 2625 (exo1∆ stn1∆ cdc13-1) could result from reduced cell 
numbers or reduced rate of growth, or high mortality in this strain.  However, another stn1 
deletion mutant, strain 2626 (stn1∆ exo1∆ cdc13-1), did not grow well at both temperatures at 
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the same cell density (plate 2, A and B).  Similarly strains 2684 and 2685 (cdc13∆ exo1∆ stn1∆) 
grew better at 30°C as compared to 23°C: other mutant strains 1272 and 1273 (exo1∆), 2607 
(exo1∆ cdc13∆), and wild type (640) did not show any sensitivity to high temperature (30°C).  
Strains 1108-ts (cdc13-1) and 1296-ts (exo1∆ cdc13-1) were temperature sensitive (ts), used as 
experimental controls, did not grow at 30°C due to sensitivity to high temperature.  Strain 2605 
was a temperature-resistant (TR) survivor, used as a control that could grow at high 
temperature.  
It was determined from spot analysis results that mutant strains were not sensitive to high 
temperature i.e., 30°C and all yeast strains could grow well; hence CLS studies can be 
facilitated at 30°C rather than 23°C.  On the basis of spot test experiment, the strain 2625 was 
selected to use in ageing experiments as the STN1 deletion mutant instead of strain 2626.  
 
 
 
 
Figure 6.5.  Spot test analysis to check sensitivity of different mutants at 23°C and 30°C. 
Two independent isolates of the same mutation, experimental and control were tested for their 
sensitivity to 30°C in comparison with 23°C.  Serially diluted cultures with equal number of cells, 
estimated by measuring OD660, were spotted onto YEPD agar plates in replicates and incubated at 23°C 
and 30°C for three days before being photographed. Strain numbers are indicated in brackets.  Scale bar 
equal to 20 mm.  
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6.3.3. Testing viability of yeast cultures after preservation in 
glycerol 
Viability tests were carried out to examine if different growth rates take place in different 
deletion mutants.  The viability of cultures preserved in glycerol could be affected over a period 
of time.  Therefore, it was important to investigate the viability of stn1 and cdc13 deletion 
mutants kept in 25% glycerol at ˗80°C (in comparison with the wild type strain) before 
investigating any potentially reproducible differences in chronological survival.  This test was 
performed also to establish how long a strain can be preserved without affecting its viability.   
Yeast strains selected for this experiment included control strain 640 and mutants 1273 (exo1∆), 
2607 (exo1∆ cdc13∆) and 2685 (cdc13∆ exo1∆ stn1∆ rad24∆).  These mutant strains were 
selected due to their reduced growth and high mortality rates.  The combined deletion mutants 
(STN1 and CDC13) grow slowly as compared to the wild type and EXO1 deletion mutant.  It is 
possible to grow fast growing strains overnight at a particular temperature (30°C) and preserve 
them at ˗80°C until slow growing strains achieve the same cell density prior to set CLS 
experiments in broth medium with equal cell numbers. 
The cultures of haploid strains were grown overnight at 30°C from single colonies (see Methods 
section 2.3.1.8 for details).  The approximate cell number in the o/n culture was calculated by 
measuring cell densities and confirmed with the haemocytometer cell count.  Table 6.1 shows 
the relevant absorbance of experimental strains at OD660 (with approximate absorbance 0.6 at 
OD660).  
Table 6.1.  Total number of cells per 1 ml as measured by using spectrophotometer and 
haemocytometer. 
Strain Genotype OD660 No of cells /ml 
(spectrophotom
eter) 
No of cells /ml 
(haemocytometer) 
640 Wild type 0.641 9,330,000 8,361,111 
1273 exo1∆ 0.663 9,660,000 10,555,556 
2607 exo1∆ cdc13∆ 0.640 9,330,000 10,250,000 
2685 cdc13∆ exo1∆ stn1∆ 
rad24 
0.647 9,500,000 11,250,000 
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For comparison, cell suspensions from freshly grown cultures (washed cells) were prepared in 
water and 25% glycerol with approximately equal numbers of cells (calculated per 1 ml by 
spectrophotometer absorbance) in all strains. 
Two set of samples (water and 25% glycerol with 5 aliquots of each) with concentration of 
approximate 1000 cells/ml, preserved at -80°C were tested for viable cell count on YEPD agar 
plates over a period of one week.  Viable cell count was calculated by counting CFUs from 50 
µl of suspension on each half of a YEPD plate of two replicates for zero time periods (0H), one 
hour (1H), one day (1D), three days (3D) and one week (1W) samples.  The average viable cell 
count (from duplicate) at 0H was considered 100% and taken to calculate % viability for 
different time periods. 
 
The percent survival in water and glycerol are presented in Figure 6.6 and showed the survival 
comparison between wild type and different mutants in water and glycerol over a period of one 
week.  The single deletion mutant strain 2607 without Cdc13 showed a gradual loss of viability 
in water samples; 65% loss within a period of one week whereas glycerol samples showed a 
lower decrease in viable colony count over the same time, with 19% loss in viability.  The wild 
type strain 640 also exhibited a significant reduction in viable count in water samples with 60% 
loss in viability as compared to 29% loss in glycerol samples over a period of 1 week.  The 
strain 1273 with EXO1 deletion however, did not show a remarkable loss in viability (only 8%) 
in glycerol samples.  In comparison, water samples in this mutant manifested 32% viability loss.  
The strain 2685, without two core proteins, Cdc13 and Stn1 did not show proper growth at this 
cell density in water and in glycerol ~50% reduction in viability was observed over a time of 3 
days.  The strain 2685 without two core proteins, Cdc13 and Stn1 at the same initial cell density 
showed a very high mortality rate with very low viable count in water and in glycerol; with a 
50% reduction in viability over a period of 3 days in glycerol samples whereas there was no any 
growth in water samples.  Gradual loss of viable cells in mutant stains in glycerol and water 
suggested that this approach might not be suitable to store mutant cells for CLS studies. 
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Figure 6.6.  The loss of viability in yeast strains stored at ˗80°C in glycerol and water. 
Diluted suspensions (of washed cells) in glycerol and water with approximately equal number of cells 
(estimated by measuring OD660) from frozen samples for different time periods were plated 50 µl on 
both halves of YEPD plates and incubated for 2-3 days before being counted.  Average viable colony 
count was estimated per 50 µl volume of water and glycerol.  The percentage of viable count was 
calculated considering 0 hour viable count as 100%.  Results are expressed as mean ± SEM (n=4). 
640 (wild type strain), 1273 (EXO1 deletion mutant), 2607 (EXO1 CDC13 deletion mutant), 2685 (EXO1 
CDC13 STN1 deletion mutant). 
 
6.3.4. CLS studies in synthetic complete (SC) medium (postdiauxic 
phase) 
 
CLS studies were carried out adopting the method reported by Fabrizio and Longo (2003), with 
a few modifications as reported by Murakami et al. (2008).  Six strains of yeast (S. cerevisiae) 
were used for chronological ageing experiment (Table 6.2).  Wild type strain (640) was used as 
an experimental control for single (cdc13∆ or stn1∆) or combined deletion mutants (cdc13∆ 
stn1∆) without essential telomere capping proteins Cdc13 and Stn1, to reveal the impact of 
these genes and their mutations on telomere uncapping, rate of growth, cell mortality, ageing 
and cellular senescence that leads eventually to cell death.  
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Table 6.2.  Relevant genotypes of strains used in CLS studies. 
 
Strains 
DLY 
Strain’s relevant genotype Strain’s essential genotype 
1 
640 WT 
MAT a ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3 
GAL+ psi+ ssd1-d2 RAD5 
2 
1272 exo1∆ MAT alpha exo1::LEU2 
3 
1273 exo1∆ MAT alpha exo1::LEU2 
4 
2607 exo1∆ cdc13∆ MAT not known (initially alpha) cdc13::HIS exo1::LEU2 
5 
2625 exo1∆ stn1∆ cdc13-1 MAT not known (initially alpha) cdc13-1 stn1::HIS exo1::LEU2 
6 
2685 exo1∆ cdc13∆ stn1∆ rad24∆ MAT alpha cdc13::HIS stn1::HIS exo1::LEU2 rad24::TRP  
 
All strains were grown in YEPD medium with 2% glucose at 30°C, with shaking.  Total number 
of cells in overnight-grown cultures was estimated by measuring the spectrophotometric 
absorbance at OD660 (Table 6.3).  For fast-growing cultures (cultures #1 to #20) absorbance 
were measured at dilution 1:2 (500 culture and 500 µl medium), while for slow-growing 
cultures (cultures #21 to #30) the absorbance at OD660 was measured directly from 1 millilitre 
overnight culture (without any dilution).  For CLS measurement, all cultures were adjusted to an 
approximately equal number of washed cells ~1x10
6
/ml, (based on OD660) in 20 ml of SC broth 
(Protocol S2.1).  Whereas 50 µl o/n culture to inoculate 5 ml volume of SC medium (Murakami, 
2008) or cell number density of ~1.85x10
5
/ml at inoculum has been reported in other studies. 
The ageing cultures were maintained at 30°C with constant agitation for 4 weeks with pooling 
samples for colony counts at particular intervals (at 3 days, 6 days, 9 days, 12 days and so for 
four weeks). 
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Table 6.3.  Parameters of inoculums in SC medium (with approximately equal cell numbers). 
 
Key No Strains 
DLY 
OD660 
(o/n culture) 
 
Vol. of o/n 
culture used 
for 
inoculums 
(µl) 
 
OD660 
at day 3 
Auxotrophies 
requirement 
1 640 1.695 196 1.799 HLTU 
2 640 1.680 198 1.784 HLTU 
3 640 1.661 200 1.770 HLTU 
4 640 1.640 202 1.783 HLTU 
5 640 1.663 200 1.776 HLTU 
6 1272 1.695 196 1.091 H-TU 
7 1272 1.672 199 1.782 H-TU 
8 1272 1.693 196 1.000  H-TU 
9 1272 1.643 202 1.770 H-TU 
10 1272 1.708 194 1.792 H-TU 
11 1273 1.684 196 1.777 H-TU 
12 1273 1.685 197 1.793 H-TU 
13 1273 1.670 199 1.719 H-TU 
14 1273 1.698 196 1.789 H-TU 
15 1273 1.707 195 1.786 H-TU 
16 2607 1.569 212 1.638 --TU 
17 2607 1.687 197 1.657 --TU 
18 2607 1.698 196 1.681 --TU 
19 2607 1.692 196 1.630 --TU 
20 2607 1.706 195 1.639 --TU 
21 2625 1.253 530 1.563 --TU 
22 2625 1.393 477 1.530 --TU 
23 2625 1.412 470 1.469 --TU 
24 2625 1.752 379 1.458 --TU 
25 2625 1.220 544 1.507 --TU 
26 2685 1.460 454 1.492 ---U 
27 2685 1.518 437 1.494 ---U 
28 2685 0.806 824 1.502 ---U 
29 2685 1.272 522 1.550 ---U 
30 2685 0.850 781 1.516 ---U 
 
Cultures (o/n) #1-#20 were diluted (1:2) to measure OD660 while cultures #21-#30 were measured for OD 
without dilution.  To estimate cell number in 3 day-grown culture, all cultures (#1-#30) were diluted 
(1:2) to measure OD660. 
 
 
It has been reported earlier that cell division stops after 2-3 days, cells enter in stationary phase 
or arrest in the G0 phase and ethanol starts accumulating in the medium (Fabrizio and Longo, 
2003).  Cultures were examined microscopically at day 3, day 6 and day 30 (Figures 6.7-6.11) 
for stationary phase cell arrest.  Un-budded cells were prominent in day 3 and day 6 cultures, 
while big, flattened, aged cells were observed in day 30 cultures in all strains.   
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Figure 6.7.  Microscopy of ageing culture of the strain DLY 640. 
Digital images of 3, 6 and 30 days cultures of strains 640 (WT, control) as manifested by the 
representative replicas (#1 and #5).  Many budded cells were observed in three days culture as 
compared to a few cells with small buds in 6 day culture.  In 30 days-aged culture most of the cells were 
un-budded, with scarce buds and large vacuoles.  Cultures were grown in SC medium supplemented for 
their auxotrophies at 30°C in a shaking incubator for 30 days.  The pictures were taken with a Zeis KF 
microscope at a magnification of 400x fitted with a Nikon Coolpix 4500 camera (4 Megapixels 4x optical 
zoom). 
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Figure 6.8.  Microscopy of ageing culture of the strain DLY 1272. 
Digital images of 3, 6 and 30 days cultures of strain 1272 (exo1 deletion mutant) as manifested by the 
representative replicas (#6 and #7).  Many budded cells were observed in three days’ culture as 
compared to few cells with small buds in 6 day culture.  In 30 days’ aged culture most of the cells were 
un-budded, with scarce buds and large vacuoles.  Cultures were grown in SC medium supplemented for 
their auxotrophies at 30°C in a shaking incubator for 30 days.  The pictures were taken with a Zeis KF 
microscope at a magnification of 400x fitted with a Nikon Coolpix 4500 camera (4 Megapixels 4x optical 
zoom). 
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Figure 6.9.  Microscopy of ageing culture of the strain DLY 1273. 
Digital images of 3, 6 and 30 days cultures of strains 1273 (exo1 deletion mutant) as manifested by the 
representative replicas (#11 and #15).  Many budded cells were observed in three days’ culture as 
compared to few cells with small buds in 6 day culture.  In 30 days aged culture, most of the cells were 
un-budded, with scarce buds and large vacuoles.  Cultures were grown in SC medium supplemented for 
their auxotrophies at 30°C in a shaking incubator for 30 days.  The pictures were taken with a Zeiss KF 
microscope at a magnification of 400x fitted with a Nikon Coolpix 4500 camera (4 Megapixels 4x optical 
zoom). 
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Figure 6.10.  Microscopy of ageing culture of the DLY strain 2607. 
Digital images of 3, 6 and 30 days cultures of strain 2607 (exo1∆ cdc13∆ mutant) as manifested by the 
representative replicas (#16 and #17).  Many budded cells were observed in three days’ culture as 
compared to a few cells with small buds in 6 day culture.  In 30 days aged culture most of the cells were 
un-budded, with scarce buds and large vacuoles.  Cultures were grown in SC medium supplemented for 
their auxotrophies at 30°C in a shaking incubator for 30 days.  The pictures were taken with a Zeiss KF 
microscope at a magnification of 400x fitted with a Nikon Coolpix 4500 camera (4 Megapixels 4x optical 
zoom). 
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Figure 6.11.  Microscopy of ageing culture of the strain DLY 2625. 
Digital images of 3, 6 and 30 days cultures of strains 2625 (exo1∆ stn1∆ cdc13-1 mutant) as manifested 
by the representative replicas (#11 and #15).  Many budded cells were observed in three days’ culture 
as compared to few cells with small buds in 6 day culture.  In 30 days aged culture, most of the cells 
were un-budded, with scarce buds and large vacuoles.  Cultures were grown in SC medium 
supplemented for their auxotrophies at 30°C in a shaking incubator for 30 days.  The pictures were 
taken with a Zeiss KF microscope at a magnification of 400x fitted with a Nikon Coolpix 4500 camera (4 
Megapixels 4x optical zoom). 
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Figure 6.12.  Microscopy of ageing culture of the strain DLY 2685. 
Digital images of 3, 6 and 30 days cultures of strain 2685 (exo1∆ stn1∆ cdc13∆ rad24∆ mutant) as 
manifested by the representative replicas (#28 and #29).  Many budded cells were observed in three 
days’ culture as compared to few cells with small buds in 6 day culture. In 30 day aged culture most of 
the cells were un-budded, with scarce buds and large vacuoles.  Cultures were grown in SC medium 
supplemented for their auxotrophies at 30°C in a shaking incubator for 30 days.  The pictures were 
taken with a Zeiss KF microscope at a magnification of 400x fitted with a Nikon Coolpix 4500 camera (4 
Megapixels 4x optical zoom). 
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Figure 6.13 shows genotypic markers testing by replica plating at the start (A) and at the end 
(B) of ageing study, to ensure the maintenance of the genotype throughout the experiment. 
Strains 1272 and 1273 (exo1∆) showed growth on YEPD and dropout media in the absence of 
leucine [replicas 1 and 3 (A) and 1 and 4 (B)] indicating the presence of the LEU2 marker gene 
for de novo synthesis of l-leucine amino acid while strains 2607 (exo1∆ cdc13∆) and 2625 
(cdc13-1 exo1∆ stn1∆) were auxotrophic to nutrition markers tryptophan and uracil (replica 4 
and 5 (A) 5 and 6 (B) and can grow in media that do not contain histidine and leucine.  Strain 
2685 (cdc13∆ exo1∆ stn1∆ rad24∆ TR) did not manifest growth in the absence of uracil, replica 
5 (A) and 6 (B) but grew on the media deficient in histidine or leucine or tryptophan showing 
the presence of marker genes HIS3, LEU2 and TRP1.  None of the strains showed any growth in 
the absence of uracil while strain 640 (wild type) could grow only in the presence of all marker-
related components in YEPD medium YEPD only.  Master plate and its replicas 1 and 2 on 
YEPD medium (B) also represents the comparative growth of all individual cultures from a 
particular strain (1-6) at the end of the CLS experiment; e.g., strain 1272, colony 1 did not show 
any growth, while all replicas of strain 2625 showed less growth on YEPD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 314 
 
 
Figure 6.13.  Replica plating on YEPD and dropout media for confirmation of appropriate metabolic 
markers of experimental strains with their auxotrophies. 
Master plates (YEPD medium) were streaked with cultures/suspension from individual colonies (1-5) at 
the start and end of the CLS experiment from all strains and were incubated to get light growth which 
was replica plated on YEPD and dropout media.  Replica plates were incubated at 23°C for 5 days before 
being photographed.  Numbers 1-5 represent the culture number from five independent colonies for 
each strain. 
(A) Replica plating at the start of CLS studies. 
(B) Replica plating at the end of CLS studies. 
 
Towards the end of experiment, mutant strains took longer for colonies to appear (4-5 days 
incubation at 30°C).  The sizes of the colonies were observed as comparatively larger at the start 
of experiment (Figure 6.14A) as compared to small colony size with number of minute colonies 
observed in aged cultures at the end of CLS (Figure 6.14B), as a result of a progressive decrease 
A 
B 
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in the rate of cell division during senescence (Enomoto et al., 2002).  The mutant strains 2625 
and 2685 manifested colonies with wavy margins as compared to smooth margins on colonies 
of strains 640 (wild type) or 1272 or 1273 (EXO1 deletion) mutants.  The sizes of colonies in 
mutant strains DLY 2607, 2625 and 2685 were relatively small as compared to DLY 640 (wild 
type), 1272 and 1273 (EXO1 deletion mutant) strains.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.14.  Digital images of colonies on YEPD plates from the representative cultures as exhibited at 
the start and end of CLS studies. 
The samples were pooled from the ageing cultures (30 in total), serially diluted to get ~1000 cells/ml 
density and 50 µl from each sample was plated on YEPD medium in duplicates.  The plates were 
incubated at 30° C for 3 days with 2 additional days for strains 2607, 2625 and 2685 (due to their slow 
growth rate) towards the end of experiment, before being photographed.  Colonies were counted 
manually.  Averages of each count were used to calculate the total viable count in 50 µl or 1 ml of 
culture.  Scale bar equal to 20 mm. 
(A) Plates showing colonies at day 6 of CLS experiment. 
(B) Plates showing colonies (aged cells) at day 30 of CLS experiment. 
A 
B 
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The viable cell counts were estimated from plating 50 µl at specific dilutions at different time 
points for 30 days and colony count data was tabulated for further analysis.  Average viable 
counts/50 µl from five replicas were taken into account to calculate the total viable cell number 
in 1 ml by multiplying it by the dilution factor.   
 
In wild type (strain 640), EXO1 deletion mutants (strains 1272 and 1273) and CDC13 and/or 
STN1 deletion mutants individual replicas showed similar trends, of viability (at day 3), rate of 
growth and ageing patterns (Figure 6.15A-F).  In strain 640, viable counts reached their 
maximum values on day 9 after culture dilution (Figure 6.15A).  Similarly, in EXO1 deletion 
mutants (strains 1272 and 1273), 60% of cultures (6 out of 10 replicas) showed their maximum 
value on day 9 (Figure 6.15B and C).  However, replica number 6 (strain 1272) showed a 
maximum viable count on day 3 and aged earlier than all replicas, with 0 survival value on day 
12 (outlier; Figure 6.15B).  The strains 2607 and 2685 also manifested the similar trends of 
viability and ageing among individual replicas (Figure 6.15D and F).  The strain 2625 however 
showed some fluctuations at different time points (Figure 6.15E). 
 
The total numbers of viable cells in 1 ml and the average values of these for each strain from 
five individual replicas were calculated for each time period.  Despite keeping the same initial 
cell number (1x10
6
, by measuring at OD660) in all cultures, the total number of viable cells in 1 
millilitre volume showed variable cell numbers in different mutant strains at day 3 of CLS 
studies.  For example the strain 2625 (STN1 deletion) on day 3 showed the least viable cells per 
ml, 2.5 times less as compared to combined mutant 2685 and 4 times less as compared to 2607 
(CDC13 deletion) that could be due to either the highest mortality or slow rate of growth.  Cell 
number variations among strains 1272 and 1273 (p= 0.67 and 0.91 respectively, p>0.05) were 
statistically non-significant when compared with controls (640, WT), whereas strains 2625, 
2607, and 2685 (p= 0.0013, 0.048 and 0.008 respectively, p< 0.05) represented decreased cell 
numbers, statistically significant as compared to the wild type.  However, the low initial viable 
cell number at day 3 in strains 2625 and 2685 did not grow further over longer incubation after 
day 9, indicating early senescence in these strains. 
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Figure 6.15.  The trends of viable cells’ decline estimated in 1 ml (five individual replicates) of wild type 
and mutant strains over a period of 30 days. 
Each graph shows total number of viable cells in 1 ml from 5 replicas of the strain, WT or a mutant.  The 
absolute values for cell numbers are presented. 
(A) DLY 640, (B) DLY 1272, (C) DLY 1273, (D) DLY 2607, (E) DLY 2625, (F) DLY 2685. 
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The average viable cell number in 1 ml versus sample pooling days manifested day 9 with 
maximum value (saturation state) for most of the cultures.  After day 9, there was very sharp 
decline in viable (total) cell number in all cultures.  On day 12 of the ageing experiment, mutant 
strains lacking Cdc13 or Stn1 showed increased loss in viable counts at a much faster rate as 
compared to viable cells in the wild type and Exo1 mutants.  These patterns of growth continued 
with further loss of viability in a total number of cells until the last day counts of the 
experiment, day 30 (Figure 6.16). 
 
 
 
Figure 6.16.  The gradual loss of viable cells in different strains over a period of 30 days. 
Cells were kept in SC media during a period of CLS studies.  The viable cell counts (CFUs) were estimated 
in 50 µl of the ageing culture for 30 days.  Total viable cell number in 1 ml was calculated from average 
viable counts/50 µl by multiplying it by the dilution factor.  The wild type strain (640), and EXO1 deletion 
mutants 1272 and 1273 (p= 0.821 and 0.91616 respectively, p values >0.05) and strain 2607 (CDC13 
deletion; p= 0.5689) showed no significant difference in viable count at day 9, whereas strains 2625 
(STN1 and EXO1 deletion) and 2685 (CDC13, STN1 and EXO1 deletions; p= 0.0038, 0.0172 respectively; 
p<0.05) exhibited statistically significant decrease in cell numbers as compared to the wild type.  Results 
are expressed as mean ± SEM (n=5). 
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Most of the cultures exhibited a maximum value (of colony count) on day 9 after dilution (20 
cultures out of 30; 67%), a few (6 out of 30 samples; 20%) showed 100% values on day 6 of 
CLS experiments and 13% replicas (4 samples out of 30) reached to maximum value on day 3 
after dilution.  For simplicity, the percentage of viable cell numbers was calculated from 
average viable counts in 50 µl and considering day 9 viable counts as 100%. 
 
The percent survival of individual replicas of each strain versus chronological age considering 
100% survival as day 0 (0 age point) revealed that different mutants without essential capping 
proteins aged more progressively than wild type.  Wild type strain (640) aged slowly showing a 
typical survival curve “descending staircase” shape of chronological survival.  The overall 
pattern for 5 replicates of strain 640 was more consistent as compared to other mutants.  Strains 
1272 and 1273 with the EXO1 deletion also aged at a slow rate showing more cell fluctuations 
among individual replicates and slightly longer survival.  In a single deletion mutant (cdc13Δ) 
most of the cells died at age point 3, three days after their maximum value, showing a sharp loss 
in cell survival.  Similarly, strain 2685 without CDC13 and STN1 genes also exhibited a sharp 
decline in viability at age point 3, with few fluctuations that could be due to survivors that can 
grow at higher temperature as cells appeared on plates after 5 days incubation, rather than 2-3 
days.  
 
Figure 6.17 shows the comparison of survival between different mutants during their 
chronological lifespan.  Age points in CLS experiments were assigned with reference to day 9 
cell viability.  For example, age point 0 represents the day when strains have the highest cell 
numbers (100%).  The presence of EXO1 deletion in strains 1272 and 1273 did not have any 
pronounced effect on ageing as compared to the wild type.  Wild type strain 640 exhibited 
~38% viable cell number on age point 3, with approximately 60% viability loss whereas EXO1 
deletion in strains 1272 and 1273 showed 35% and 30% viability respectively within 3 days 
after saturation.  Comparatively, there was a sharp reduction in viability in strain 2607 at age 
point 3 (with viable value 6.45, the lowest survival in all strains).  Again, at age point 6, strain 
2607 was the fastest ageing strain with survival value ~ 4% and strain 2685 with 12% viable 
cells became the second most rapidly ageing strain.  In strain 2625, without Stn1 protein, 34% 
of cells were still viable at this stage.  The pattern of survival difference exhibited between these 
three strains at age point 3 was maintained throughout the rest of the chronological life-span 
experiment until age point 21 where most of the cells were dead (Figure 6.17). 
 
 321 
 
 
 
Figure 6.17.  Survival (%) of all strains displaying gradual loss of cell survival during chronological ageing. 
 
Wild type strains did not sustain longer survival in this experiment and showed less survival as 
compared to EXO1 deletion mutants (strains 1272 and 1273).  However, in a repeated 
experiments (Figure 6.18), the wild type strain displayed longer survival with slightly different 
ageing patterns among STN1 (strain 2625) and CDC13 (strain 2607) deletion mutants.  At age 
point 6, the fastest ageing strain was 2685 with combined deletions of STN1 and CDC13; strain 
2607 (CDC13 deletion) showed better survival as compared to strain 2625 (with STN1 deletion 
in the presence of Cdc13-1 mutation). 
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Figure 6.18.  Average survival of cdc13 and stn1 mutants compared with the wild type strain. 
 
 
It can be concluded that despite some fluctuations, mutant strains showed a reduction of 
viability in comparison to the wild type.  Each mutation has its own effect and different 
mutations together (strain 2685 with CDC13, STN1, EXO1 and RAD24 deletion mutations) 
enhanced the effect of other mutations additively.  Strain 2685, without of Cdc13 and Stn1 
proteins, exhibited ~ 3% survival at age point 6 as compared to 10% and 23% survival 
manifested by strains 2625 and 2607 respectively with the removal of Stn1 and Cdc13 
respectively (Figure 6.18).  Further at age point 9, STN1 deletion exhibited 2.5 times more 
viability as compared to the combined deletion, whereas CDC13 removal exhibited 81 times 
higher viability as compared to the combined deletion mutant 2685 (0.16% , 0.41% and 13% 
survival for strains 2685, 2625 and 2607 respectively), while 16% of the wild type cells were 
still viable.  These results showed that deletion mutants without essential capping proteins 
display reduced survival ability, however, there were few fluctuation of survival curve possibly 
due to generation of survivors at higher temperatures. 
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6.3.5. Carrying out CLS experiments in water  
To reduce fluctuations in the survival curve observed at certain time points during CLS study in 
SC medium, further assays were performed to carrying out CLS experiments in water under 
calorie restriction.  The first experiment was performed with wild type strain 640 (Protocol 
S2.2).  The culture was cultivated for o/n (~18 hours) in YEPD broth at 30°C from a freshly 
grown (mixture of 4-5) colonies.  After washing the cells, 3 aliquots of 15% glycerol stock were 
prepared and kept at -80°C for further dilution in SD medium.  Three independent cultures of 
strain 640 were inoculated with 15% glycerol stock of cells at 1:20 in 10 ml of SD medium in a 
way that all cultures were ready to start CLS measurements on the same day.  They were set up 
so that they had been grown for 9 days (9-D), 6 days (6-D) and 3 days (3-D) in duplicates, 
referred as 1 and 2 by the start of these experiments.  The saturated cultures of 3-D, 6-D and 9-
D grown cells were washed and transferred to sterile water to keep the cells in the stationary 
phase under calorie restrictions.  The cells were equalised in all 6 samples by measuring the OD 
at 660 nm as shown in Table 6.4. 
 
Table 6.4.  Estimation of the number of cells in 3, 6 and 9 day cultures from strain 640 (WT) by 
measuring the OD660. 
 
Serial 
No 
Strain 640 
(grown for 3, 6 
and 9 days) 
OD660 
 
Cell number 
(estimated/ml) 
1 3-D (1)*
1
 1.018 1.926x10
7
 
2 3-D (2)*
2
 1.037 2x10
7
 
3 6-D (1) 1.021 1.926x10
7
 
4 6-D (2) 1.030 1.963x10
7
 
5 9-D (1) 1.007 1.890x10
7
 
6 9-D (2) 0.968 1.736x10
7
 
 
*
1
indicates replicate 1 
*
2 
indicates replicate 2 
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For ageing study the cells were incubated at 30°C with slow shaking (50 rpm), and CLS was 
monitored for a period of 52 days (0 to 52) with pooling aliquots at an interval of three days.  
The viability of the cells was assessed quantitatively at two different dilutions (dilution factor 
15625 and 3125), with a low and high number of cells in a 20 µl volume.  Two dilutions of cell 
suspension were plated on YEPD medium to count the viable cells from CFUs.  Figure 6.19 
shows the colony count after 3 days of incubation at 30°C from high and low dilution at day 19 
of CLS measurement.   
Figure 6.19.  An example of plates for colony count at day 19 of CLS studies involving wild type strain 
640. 
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Digital images were taken from colonies on YEPD medium from day 19 of CLS assays.  They represent 
cells from 3-days (plates 1, 2, 7 and 8), 6-days, (plates 3, 4, 9 and 10) and 9-days (5, 6, 11 and 12) 
cultures with high and low cell number.  Colonies were counted from 5-fold diluted cultures from the 
last two dilutions #5 low (3125), #6 high (15625).  Average values of each count were used to calculate 
the total viable count in 20 µl by multiplying it by the respective dilution factor.  Images 2 and 8 showed 
contamination (small colonies in background) on D 19 of CLS while other cultures have smooth margin 
circular colonies typical of 640 (wild type).  The plates were incubated at 30° C for 2-3 days before being 
photographed. 
 
For each sample, the average cell count was calculated from two independent preparations.  
Colony count data was collected for 17 ageing points over a period of 52 days.  Considering day 
0 values as maximum, the percentages of survival were calculated.  The average of survival (%) 
from low and high numbers of cells and combined average of percent for 3-D, 6-D and 9-D are 
presented in Figure 6.20. 
Results showed a sharp decrease in viability of cells at day 7 of CLS in low (L) and high (H) 
cell number samples.  Both dilutions, showed a gradual decline of viable cell number over the 
entire period of the CLS, and there were no significant differences in viability on last day (day 
52) of the CLS (11%, 12% and 24% with low cell number as compared with 12%, 20% and 
16% with high cell number in 3-D, 6-D and 9-D samples respectively).  However, the survival 
curves were more consistent with high cell number (Figure 6.20B) with markedly less 
fluctuation as compared with low cell number (Figure 6.20A).  The 3-D cultures manifested the 
lowest survival as compared with 9-D samples in both dilutions consistently and also in overall 
average survival curve (Figure 6.21).  The relative pattern of survival remained similar from day 
22 to day 52, with a further decrease in viable cell count and increased decline in 3-D as 
compared to 9-D culture.  In contrast, 6-D culture exhibited marked fluctuations at different 
time points. 
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Figure 6.20.  Percentage survival of strain 640 (WT) displaying loss of cell survival during chronological 
ageing in two different dilution at 30°C  
The cells were kept in water at 30°C with slow agitation for a period of 52 days.  The relative viability is 
expressed as a percentage of CFUs (maximum of viable cells at day 0 was considered as 100% survival).  
Results are expressed as mean ± SEM (n=2). 
(A) Decline of viable cell count at low number of cells (dilution factor 15625) over a period of 52 days. 
(B) Decline of viable cell count at high number of cells (dilution factor 3125) over a period of 52 days. 
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Figure 6.21.  Average survival of strain 640 (WT) from low and high CFUs during chronological ageing in 
water at 30°C. 
The cells were kept in water at 30°C with slow agitation for a period of 52 days.  The relative viability is 
expressed as a percentage of CFUs (viable cells (maximum) at day 0 were considered as 100% survival).  
Percent survival was determined from two populations with low and high cell number.  Results are 
expressed as mean ± SEM (n=4). 
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6.3.6. Viabilities of yeast mutants after exposure at 40°C and 
45°C in water  
Further two experiments were conducted with strains 640 (WT), 2607and 2608 (cdc13Δ) and 
2685 (cdc13Δ stn1Δ) exposed at 40°C and 45°C in an attempt to reduce the time required to 
detect differences in the CLS in water under calorie restriction (low metabolism in stationary 
phase) following Protocol S2.3.  For quantitative measurements of viability, an equal number of 
cells (based on OD at 660 nm) from G1 phase were exposed to 40°C and 45°C in a shaking 
water bath over a period of 9 and 7 hours.  Samples were pooled after every one hour for 
analysis and were transferred to ice for half an hour and then to 4°C for 48 hours (G1 phase).  
After two days, 50 µl of 10-fold serially diluted cells were plated on each half of a YEPD plate.  
The plates were incubated for 3-5 days at 30°C.  The viability was estimated by calculating the 
CFUs.  The average colony count from 0 to 7 hr/9 hr was calculated from the last two dilutions 
#4 and #5 (10
-4
 and 10
-5
) for strains 640, 2607 and 2608 and dilution #3 and #4 (10
-3
 and 10
-4
) 
for strain 2685. 
The relative viability was calculated from the average values from low dilution (with higher 
number) of cells.  The viability of wild type cells (640) dropped to 90% as compared to 49% in 
strain 2685 (Figure 6.22) for the cells exposed to 40°C during 9 hrs.  However, the relative 
viability in other two mutant strains, 2607 and 2608 showed an increase in viable cell number 
(163% and 149% respectively) at time point 9 hr with a marked fluctuation at all points of the 
CLS measurement.  On the other hand, the cell exposed to 45°C, strain 2685 exhibited 0% 
survival as compared to 74% survival in strain 640 (WT) at time point 7 hr (Figure 6.23).  The 
CDC13 deficient mutants, 2607 and 2608, however, showed 104% and 103% survival at this 
time point indicating an increase in cell number as compared to the wild type.  Based on these 
results, further experiments were carried out with a traditional standard protocol as 
recommended by Fabrizio and Longo (2003) under calorie restriction at 4°C to detect viability 
differences between different mutants lacking essential capping proteins. 
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Figure 6.22.  Viability dynamics after treatment of cells at 40°C. 
The cells were incubated in water bath at 40°C with slow agitation for a period of 9 hours.  The relative 
viability is expressed as a percentage (maximum of viable cells at 0 hr was considered as 100%).  Results 
are expressed as mean ± SEM (n=2). 
 
 
Figure 6.23.  Relative viabilities of cells after treatments at 45°C. 
The cells were incubated in water bath at 45°C with slow agitation for a period of 7 hours.  The relative 
viability is expressed as a percentage (maximum of viable cells at 0 hr was considered as 100%).  Results 
are expressed as mean ± SEM (n=2). 
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6.3.7. CLS assay with yeast culture at 4°C in water (stationary 
phase) 
Chronological lifespan of wild type, cdc13Δ, stn1Δ, and truncated variants of cdc13-1 mutant 
strains were studied in the stationary phase under a calorie restriction paradigm (water), as has 
been reported in previous studies (Fabrizio and Longo, 2003, Smith et al., 2007, Santos et al., 
2012) following Protocol S2.4.  Two independent strains were used for each mutation (Table 
6.5).  The 22 overnight cultures each set with a mixture of few colonies (4-5), were grown at 
30°C in YEPD broth which was further diluted in 30 ml of YEPD broth in flasks by keeping an 
equal cell number as assessed by measuring optical densities at 660 nm.  All cultures (1-22) 
were grown in YEPD medium at 30°C for 6 days until saturation.  The cells were washed, 
equalised by measuring OD at 660 nm and transferred to water at 4°C to measure CLS under 
calorie restriction in the stationary phase. 
Table 6.5.  The setup of CLS experiment with mutants lacking CDC13 and/or STN1 and truncated variant 
of cdc13-1. 
 DLY Strains OD660 
 
(at 
inoculation) 
o/n culture 
(volume diluted 
in 
30 ml of YEPD 
broth) 
YEPD broth 
1 640 (WT) 0.090 500 µl 30 ml 
2 641 (WT) 0.107 500 µl 30 ml 
3 1272 (exo1Δ) 0.092 400 µl 30 ml 
4 1273 (exo1Δ) 0.086 400 µl 30 ml 
5 2607 (cdc13Δ exo1Δ) 0.105 500 µl 30 ml 
 2608 (cdc13Δ exo1Δ) 0.120 500 µl 30 ml 
6 1296-TR1 (cdc13-1 exo1Δ) 0.092 400 µl 30 ml 
7 1296-TR2 (cdc13-1 exo1Δ) 0.100 400 µl 30 ml 
8 cdc13-1-NTΔ-1296 (#4) 0.104 500 µl 30 ml 
10 cdc13-1-NTΔ-1296 (#5) 0.114 500 µl 30 ml 
11 cdc13-1-CTΔ-1296 (#9) 0.089 400 µl 30 ml 
12 cdc13-1-CTΔ-1296 (#10) 0.087 400 µl 30 ml 
3 1297-TR1 (cdc13-1 exo1Δ) 0.098 400 µl 30 ml 
14 1297-TR2 (cdc13-1 exo1Δ) 0.100 400 µl 30 ml 
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15 cdc13-1-NTΔ-1297 (#7) 0.110 500 µl 30 ml 
16 cdc13-1-NTΔ-1297 (#8) 0.113 500 µl 30 ml 
17 cdc13-1-CTΔ-1297 (#11) 0.094 400 µl 30 ml 
18 cdc13-1-CTΔ-1297 (#12) 0.093 400 µl 30 ml 
19 #14 (haploid with stn1Δ) 0.100 1200 µl 30 ml 
20 #21 (haploid with stn1Δ) 0.167 1200 µl 30 ml 
21 2684 (cdc13Δ stn1Δ exo1Δ 
rad24Δ) 
0.154 600 µl 30 ml 
22 2685 (cdc13Δ stn1Δ exo1Δ 
rad24Δ) 
0.152 2400 µl 30 ml 
 
Strains used in CLS studies and overnight culture used to dilute broth. 
6.3.7.1. Morphological characteristics of colonies from different mutants of 
CDC13 and STN1 and N- and C-truncated variants of cdc13-1  
The cdc13Δ and stn1Δ cells exhibited irregularly-shaped colonies with wavy margins as 
compared to circular colonies with smooth margins in the wild type (640, 641) and EXO1 
deletion (1272 or 1273) strains (Figure 6.24).  The wavy margined colonies were evident in 
stn1Δ, haploids #14 and #21 and combined deletion mutants strains, 2684 and 2685 - , more so 
in strain 2685, presumably reflecting genetic instability (Enomoto et al., 2002). 
The margins of the colonies of cdc13-1-NTΔ were also obviously irregular as compared to those 
in colonies from cdc13-1-CTΔ mutants (Figure 6.25).  The morphological characteristics of 
colonies of the mutants used in the CLS studies are shown in Table 6.6. 
6.3.7.2. Occurrence of small colonies in cdc13Δ, stn1Δ, cdc13-1-NTΔ and 
cdc13-1-CTΔ mutants  
Variable in size colonies were observed in cdc13Δ and stn1Δ mutants as compared to the wild 
type (Figure 6.24).  The marked differences in colony size were clearly evident in mutants 
lacking STN1 ((#14 and #21) or STN1 and CDC13 (strains 2684 and 2685) as compared to wild 
type (strain 640 and 641) and EXO1 deficient mutants (strains 1272 and 1273).  The occurrence 
of very small (tiny) colonies as compared to large colonies was apparent in stn1Δ (#14 and #21) 
and cdc13Δ stn1Δ exo1Δ rad24Δ (2684 and 2685).  However, the size differences were less 
obvious in cdc13Δ exo1Δ (strains 2607 and 2608) mutants. 
Similar phenotypical differences were also observed among cdc13-1 N- and C terminal deletion 
variants of 1296-TR and 1297-TR.  The cdc13-1-N-terminal truncated mutants manifested 
various sizes of colonies (obvious in all 4 NTΔ mutants analysed) as compared to cdc13-1-C-
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terminal mutants and cdc13-1 original strains (Figure 6.25).  The relative abundance of minute 
colonies was evident as compared to large size and a few colonies, with enormous size at low 
cell numbers (10
-4
 dilutions) in cdc13-1 NTΔ clones of both 1296-TR) and 1297-TR) strains.  
However, the variations in colony size were not very obvious in C-terminal truncated clones, in 
which there were slight differences in colony size.   
The small colonies upon further sub-culturing also revealed a mixture of tiny and large colonies 
on solid medium (data not shown) with respect to large and small size cells within minute 
colonies.  The differences in size between individual, small and large colonies were 
approximately ~3 to 7 fold among stn1Δ (#14 and #21) and cdc13-1 NTΔ mutants, whereas they 
were ~2-3 fold among cdc13Δ, and cdc13Δ stn1Δ and cdc13-1 CTΔ mutants. 
 
 
Figure 6.24.  Morphological variations of shape and colony size in mutants lacking Cdc13- and Stn1 as 
compared to wild type and EXO1 deletion strains. 
WT (strains 640 and 641), exo1Δ (strains 1272 and 1273), exo1Δ cdc13Δ (strains 2607 and 2608), exo1Δ 
rad24Δ stn1Δ (strains #14 and #21) and exo1Δ rad24Δ cdc13Δ stn1Δ (strains 2684 and 2685). 
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Figure 6.25.  Morphological variations of shape and colony size in cdc13-1 N- and C-terminal deletion 
variants of 1296-TR and 1297-TR. 
cdc13-1 exo1Δ (strains 1296-TR and 1297-TR). 
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Table 6.6.  Morphological characteristics of colonies from CDC13 and STN1 deletion mutants, in 
comparison with wild type. 
Strain 
 
 
Colour Margin Shape Culture Size  
(in 3 day 
grown 
colonies at 
30°C) 
1296-TR 
12967-TR 
Pale creamy Smooth edged  Round 
shape 
Almost 
homogenous, 
rare small 
colonies 
Bigger size 
colonies  
(~3-4 mm)  
cdc13-1-NTΔ-1296-TR and 
cdc13-1-NTΔ-1297-TR 
Pinkish 
colour 
indicating 
adenine 
synthesis 
deficiency 
Broken edges or 
wavy margins 
Irregular 
shape 
non-
homogenous 
with big and 
small colonies 
Small  
(0.5-2 mm), 
medium  
(2-2.5 mm) 
and large  
(4 mm) size 
colonies 
cdc13-1-CTΔ-1296-TR  
cdc13-1-CTΔ-1297-TR 
Mixture of 
pink and 
creamy 
colonies 
Round but 
slightly wavy 
margin 
Round 
shape, 
More like 
CDC13 
deletion 
mutants 
Almost 
homogenous, 
with the same 
size of colonies 
bigger (3-4 
mm), size 
slightly 
smaller than 
WT colonies, 
more similar 
to 1296-TR 
Wild type strains 
(640 and 641)  
Pale creamy Smooth edges Round Homogenous, 
similar size 
colonies 
Bigger in size 
(4-6 mm) 
exo1Δ mutants 
(1272 and 1273) 
Same as WT Smooth edges Round Homogenous, 
similar size 
colonies 
Bigger in size, 
(4-6 mm) 
cdc13Δ exo1Δ 
(2607 and 2608) 
Pinkish in 
colour  
Wavy margins Irregular  Non 
homogenous, a 
mixture of big 
and small 
colonies 
Big size  
(4-6 mm) 
and small 
size (0.5-2 
mm)  
stn1Δ exo1Δ 
(#14 and #21 haploids) 
Pale, mixture 
of dark and 
light colour 
colonies 
Wavy margins, 
slightly less wavy 
as compared to 
stn1Δ cdc13Δ 
exo1Δ rad24Δ 
mutants  
Irregular  Non 
homogenous, a 
mixture of big 
and small 
colonies 
Mixture of 
small (0.5-2.5 
mm) and 
large (3-3.5 
mm) 
stn1Δ cdc13Δ exo1Δ 
rad24Δ mutants 
(2684 and 2685) 
Dark pale 
colonies in 
strain 2684, 
turns pinkish 
with ageing 
Wavy margin Star 
shape 
Non 
homogenous, a 
mixture of big 
and small 
colonies 
Mixture of 
small and 
large 
Whitish in 
strain 2685 
Wavy 
margin/broken 
edges 
Star 
shape 
Non 
homogenous, a 
mixture of big 
and small 
colonies 
Mixture of 
small, minute 
and a few 
large sized; 
smaller in 
size as 
compared to 
colonies in 
strain 2684 
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6.3.7.3. Analysis of genetic markers by replica plating on YEPD and dropout 
media 
All strains (1-22) used in the final part of CLS studies (Table 6.5) were analysed for their 
genetic markers on YEPD and dropout media to confirm the presence of the appropriate 
markers and their auxotrphies (Figure 6.26).  Four colonies of similar size represented by four 
streaks (1-4) were selected from ageing cultures and tested for their metabolic markers. 
Figure 6.26A shows the result of replica plating of the first 10 samples (1-10) after 5 days of 
growth at 23°C.  The wild type strains 640 and 641 (streaks 1 and 2) did not show any growth 
on any of the dropout media owing to their auxotrophies for these markers (replicas 2, 3, 4 and 
5).  Strains 1272 and 1273 (exo1::LEU2) confirmed the presence of the LEU2 gene by growing 
on dropout media lacking leucine (streaks 3 and 4 in replicas 3).  Strains 2607 and 2608 
(exo1::LEU2 cdc13::HIS3) were auxotrophic for tryptophan and uracil (replicas 4 and 5) and 
grew on media without histidine and leucine (streaks 5 and 6 in replicas 2 and 3).  The strains 
1296-TR (cdc13-1 exo1::LEU2) exhibited auxotrophies for histidine, tryptophan and uracil 
(streaks 7 and 8, replicas 2, 4 and 5) but grew on media without leucine indicating the presence 
of the marker gene LEU2.  The cdc13-1-NTΔ-1296-TR clones #4 and #5 (cdc13-1 NTΔ::TRP1 
exo1::LEU2) were auxotrophic for histidine and uracil and grew on media lacking tryptophan 
(due to integration of tryptophan marker by substituting N-terminus of cdc13-1) and leucine 
(streaks 9 and 10, replicas 3 and 4).  None of the strains showed any growth in the absence of 
uracil (replica 5) while strains 640 and 641 (wild type) grew only in the presence of the four 
essential marker related components on YEPD medium. 
 
The results for the next 10 samples (streaks 11-20) are shown in Figure 6.26B.  Streaks 11, 12, 
17 and 18 corresponding to cdc13-1-CTΔ clones #9, #10 and #11, #12 of 1296-TR and 1297-
TR (cdc13-1-CTΔ::HIS3 exo1::LEU2) showed growth on dropout media without histidine 
(replica 2) and leucine (replica 3) confirming the proficiency for leucine synthesis and the 
integration of the histidine gene.  In contrast, cdc13-1-NTΔ-1297-TR clones #7 and #8 (cdc13-1 
NTΔ::TRP1 exo1::LEU2) were unable to grow in the absence of histidine and uracil but showed 
growth on media without leucine and tryptophan, confirming the presence of tryptophan and 
leucine marker genes (streaks 15 and 16, replica 3 and 4).  In contrast, strain 1297-TR (cdc13-1 
exo1::LEU2) did not grow in the absence of histidine, tryptophan and uracil nutrition markers 
(streaks 13 and 14, replica 2, 4 and 5) but did grow in the medium without leucine (replica 3) 
confirming the presence of LEU2 gene.  Similarly, STN1 deletion mutants (exo1::LEU 
stn1::HIS rad24::TRP1) mutants confirmed the presence of all three marker genes in strains #14 
and #21 (streaks 19 and 20, replica 2, 3 and 4).  All strains were auxotrophic for uracil (replica 
5). 
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Haploid mutants #14 and #21, stn1∆ exhibited two types of colonies, dark and light in colour, 
on YEPD medium.  Four dark and light coloured colonies from haploids #14 (streaks 19ab) and 
#21 (streaks 20ab) were analysed for markers (Figure 6.26C).  All colonies showed growth on 
dropout media lacking histidine, leucine and tryptophan (streaks 19a to 20b in replicas 2, 3 and 
4) confirming their genetic markers.  However, one patch - represented by streak number 20a 
(1) - did not show any growth on dropout medium lacking leucine indicating the conversion of 
the LEU marker (from leu
+
 to leu
-
).  The strain 1273 (exo1::LEU2) showed a few, fast-growing 
colonies (in comparison to the normal sized colonies; Figure 6.27).  The marker analysis of 
these big size colonies (streak 4/1273) revealed the presence of marker genes URA3 in addition 
to LEU2 (indicating the conversion of ura
-
 to ura
+
, replicas 3 and 5) owing to their heavy growth 
on media without these two ingredients.  Strains 2684 and 2685 (exo1::LEU stn1::HIS 
cdc13::HIS rad24::TRP1) grew in the media without histidine, leucine or tryptophan 
confirming the presence of these marker genes HIS3, LEU2 and TRP1. 
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Figure 6.26.  Analysis of genetic markers by replica plating on YEPD and dropout media in randomly 
picked colonies from ageing samples. 
(A) Replica plating of samples #1-10 (strains 640, 641, 1272, 1273, 2607, 2608, 1296-TR and two clones 
of cdc13-1-NTΔ-1296-TR), each with four colonies (1-4). 
(B) Replica plating of samples #11-20 (two clones of cdc13-1-CTΔ-1296-TR mutants, strains 1297-TR, two 
clones of cdc13-1-NTΔ , two clones of cdc13-1-CTΔ, #14 and #21 stn1 deletion mutants), each with four 
colonies (1-4). 
(C) Replica plating of samples #19-22 (stn1 deletion mutants #14, dark- and light-coloured colonies, #21, 
dark- and light-coloured colonies; strain 1273, enormous sized colonies; strains 2684 and 2685), each 
with four colonies (1-4).  
Plates were incubated at 23°C for 5 days before being photographed. 
C 
B 
A 
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Figure 6.27.  Strain DLY 1273 (exo1::LEU2) EXO1 deletion mutant with fast growing Ura
+
 revertants. 
The culture of EXO1 deletion mutant shows a few enormous size colonies.  Marker analysis revealed the 
phenotypes of these colonies as leu+ ura+ not leu+ ura
-
 as anticipated, indicating the instability of the 
uracil marker. 
 
6.3.7.4. PCR confirmation of CDC13 through detection of cdc13-1 N-
terminus and C-terminus fragments 
Gel electrophoresis of PCR products (Figure 6.28A) shows the CDC13 N-terminal-specific 
fragment of ~378 bp in wild type strains 640 and 641 (lanes 3 and 4), EXO1 deletion mutant 
strains 1272 and 1273 (lanes 5 and 6), cdc13-1 mutant strain 1296-TR (lanes 9 and 10), cdc13-
1-CTΔ-1296 clones #9 and #10 (lanes 13 and 14), cdc13-1 mutant strain 1297-TR (lanes 15 and 
16), cdc13-1-CTΔ-1297 clones #11 and #12 (lanes 19 and 20), STN1 deletion mutant (lanes 21 
and 22) and two diploids (lanes 25 and 26) from crosses between N- and C-terminus mutants 
(NTΔ-1296 clone #4 x CTΔ-1297 clone #11 and CTΔ-1296 clone #9 x NTΔ-1297 clone #7) 
respectively.  There was no amplification for strains 2607 and 2608 (cdc13Δ, lanes 7 and 8), 
cdc13-1-NTΔ-1296 clones #4 and #5 (lanes 11 and 12), cdc13-1-NTΔ-1297 #7 and #8 (lanes 17 
and 18) and CDC13 and STN1 combined deletions mutants strains 2684, 2685 (lanes 23 and 
24). 
 
Similarly, PCR products (Figure 6.28B) showed the CDC13 C-terminal-specific fragment of 
~276 bp in wild type strains 640 and 641 (lanes 3 and 4), EXO1 deletion mutant strains 1272, 
1273 (lanes 5, 6), cdc13-1 mutant strain 1296-TR (2 lanes, 9 and 10), cdc13-1-NTΔ-1296 
mutants clone #4 and #5 (11, 12), strain 1297-TR, 2 lanes (15, 16), cdc13-1-NTΔ-1297 clone #7 
and #8 (17, 18), STN1 deletion haploids #14 and #21 (21, 22) and two diploids from cdc13-1 N- 
and C-truncated mutants (25 and 26).  However, no C-terminus specific fragment was observed 
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in lanes 7 and 8 (strains 2607 and 2608), lanes 13 and 14 (cdc13-1-CTΔ-1296 clones #9 and 
#10), lanes 19 and 20 (cdc13-1-CTΔ-1297 clones #11 and #12) and lanes 24 and 25 (strains 
2684 and 2685), as expected.   
 
The cells from subculture of a single colony were suspended in sterile water (20 µl), and 
denatured in boiling water for 10 minutes.  The supernatant was separated after centrifugation 
and used as a template for PCR.  The PCR was carried out using N1-N2 and C1 and C2 primers 
(from the N- and C-terminus of CDC13 respectively), in independent reactions in 25 µl of 
reaction volume using 3 µl of denatured suspension.  The PCR amplified products, (10 µl from 
each sample), were analysed on a 1.5% agarose gel.  
 
 
 
Figure 6.28.  PCR detection of cdc13-1 N- and C-terminals in samples used in the CLS assay: 
electrophoretic analysis of PCR products from two sets of PCR performed using N- and C-terminal-
specific primers (N1-N2 and C1-C2 primers pairs) on agarose gel. 
PCR reaction was carried out in a 25 µl volume with 2-3 µl of denatured genomic DNA from cells of 
sample strains including CDC13 and STN1 deletion mutants.  From each reaction, 10 µl of PCR product 
was analysed on a 1.5% agarose gel along with reference markers.   
Lanes M1: 1 kb ladder (Invitrogen); 1-2: NTC, -ve controls; 3-6: PCR products from cells of strains 640, 
641 (WT), 1272 and 1273 (EXO1 deletion), positive controls; 7-8: PCR products with strains 2607 and 
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2608 (CDC13 deletion mutants), negative controls; 9-14: PCR products with strain 1296-TR (2 lanes), 
cdc13-1-NTΔ-1296 (clones #4 and #5), cdc13-1-CTΔ-1296 (clones #9 and #10), two lanes for each; 15-20: 
PCR fragments with strains 1297-TR (2 lanes), cdc13-1-NTΔ-1297 (clones #7 and #8), cdc13-1-CTΔ-1297 
(clones #11 and #12), two lanes for each; 21-22: PCR fragments with haploid #14 and #21 (stn1 
deletion); 23-24: PCR products with cells of strain 2684 and 2685 (cdc13 and stn1 double deletion 
mutants); 25-26: PCR products with cells of diploids (from a cross of N- and C-truncated Cdc13-1 
mutants); M2: 100 bp ladder (NEB). 
(A) Agarose gel analysis of the PCR fragments (~378 bp) from the PCR carried out using CDC13 N-
terminal-specific primer pair (N1 and N2). 
(B) Agarose gel analysis of the PCR fragments (~276 bp) from the PCR carried out using CDC13 C-
terminal-specific primer pair (C1 and C2). 
 
6.3.7.5. CLS measurement 
For measuring viable count, each sample (1-22) was split into 3 replicates.  Each replica was 
diluted to a density of ~1000 cells/ ml.  Two measurements were taken for each replica after 
every 5 days until day 40, and then after every 10 days until day 90.  To measure cellular 
viability, two aliquots of 50 µl were taken from each sample (4°C) and plated on each half of a 
YEPD plate, then cultivated at 30°C for 3 days with additional 2 days of incubation towards the 
end of the CLS measurements.  CFUs were counted for individual replicates, and the average 
values of three replicas were used to calculate the mean value for each strain, which was used to 
assess the percentage of survival and also to calculate the total cell viability per ml at each age 
point. 
 
The colony count data from the CLS assay were collected during 90 days and recorded for 
further analysis.  The total number of cells at each age point was calculated by multiplying the 
average number of cells by correspondent dilution factor.  The percentage of survival was 
calculated to show the decline in the number of viable cells of different mutants over the entire 
period of the CLS.  Results were plotted as line charts representing the percentage of survival 
and the age over the period of the CLS (Figures 6.29-6.31). 
To compare the impact of different deletions on chronological lifespan, two strains were 
selected for each mutation e.g., 2607 and 2608 for cdc13Δ , #14 and #21 for stn1Δ, 2684 and 
2685 for cdc13Δ stn1Δ, along with two wild type controls (640 and 641) and two exo1Δ mutants 
(1272 and 1273).  Figure 6.29 presents CLS results for mutants lacking Cdc13 and Stn1essential 
telomere capping proteins, under calorie restriction.  Strain 2685 in the absence of Cdc13, Stn1, 
Rad24 and Exo1 proteins, manifested the highest mortality on day 5 of the survival curve with 
~17% survival only as compared to 98%, 83% in Cdc13-1-deficient strains (2607 and 2608), 
and 92% and 88% in Stn1-lacking strains, (#14 and #21).  This rapid decline of viability clearly 
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showed the additive effects of the two capping proteins (five-fold) as compared to the viabilities 
loss in the absence of either protein Cdc13 or Stn1.   
At day 15, there was a clear segregation of mutant strains without essential telomere capping 
proteins and other controls, WT (640 and 641) and mutants lacking Exo1 protein (1272 and 
1273).  All four controls showed much better survival (77%-87%, of viability of cells) whereas 
mutants with uncapped telomeres exhibited a remarkable decrease in viability showing 10% to 
45% survival with two exceptions (strain 2684 with 64% and strain 2607 with 76% survival).  
These patterns of ageing and mortality continued until day 40 with a slow rate of ageing in 
controls as compared to a faster decline of viability in mutants with telomere capping 
dysfunctions.  Strain 2685 at day 40 showed only 0.15% survival and almost 100% mortality, 
whereas strain 2684, exhibited a sharp decline of viability between day 35 and day 50, still 
manifesting 27% survival with 73% viable cell loss (statistically significant with p value of 
0.0015 as compared to WT).  However, strain 2684 aged at a much faster rate between day 50 
and day 90, exhibiting 17%, 15%, 11%, 11% and 10% of survival at day 50, day 60, day 70, day 
80 and day 90 of CLS.   
Both Stn1 deficient mutants (#14 and #21) and one Cdc13 deficient mutant (2608) presented 
consistently fast rates of ageing over the entire period of 90 days.  Haploid #14 showed the 
highest decline, with 18% survival, 2608 with 24% survival, and haploid #21 with 31% survival 
at day 40.  Keeping the same trends of mortality rate and ageing, these three mutants (in the 
absence of either single essential protein), haploid #14, strain 2608 and haploid #21, exhibited 
10%, 16% and 16% survival respectively at day 90 of CLS (statistically highly significant with 
p values of 0.0074, 0.0084 and 0.0071 respectively).  In contrast, the second Cdc13-lacking 
mutant (2607) showed 48% survival at day 90 (with 32% survival difference from strain 2608) 
as compared to WT (68% survival).  The difference was statistically significant (p=0.0112).  
This might suggest that not only Cdc13 but also some other factors are also involved into 
regulation of senescence.  
All controls (WT 640 and 641) and mutant lacking Exo1 protein (1272 and 1273) displayed a 
gradual viability decline, keeping a consistent pattern of survival between day 10 and 25.  Strain 
1273 showed slightly better survival at day 25 (78%), as compared to WT 640 and 641 and 
1272 manifesting 76%, 73% and 69% survival respectively, without significant differences 
[with p value of 0.334 (641), 0.070 (1272) and 0.260 (1273)].  The WT 640 later showed a slow 
rate of mortality with better survival as compared to 1273, 641 and 1272 between day 30 and 90 
(68%, 64%, 52% and 52% survival respectively). 
Unexpectedly, the same mutations did not show the same effect in two strains at different 
ageing points.  All strains and mutants showed individual variations.  The two WT strains (640 
and 641) displayed 1% to 16% difference from each other at different days of the CLS.  
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Similarly, Exo1 deficient strains 1272 and 1273 showed a 12% difference in survival, and 
Cdc13 lacking mutants displayed a 31% difference between strains 2607 and 2608 at age point 
90.  Overall, at day 90 of the CLS, 6% to 31% survival differences were seen between different 
groups of two strains with same mutation.  These inter-strain variations in the presence of same 
mutation could result from epistatic interactions between the mutations understudy and genetic 
determinants in the genome (Lehner, 2011). 
Overall, the absence of two essential capping proteins Cdc13 and Stn1 (2685), resulted in the 
highest mortality rate, and led to a shorter CLS (35-40 days with 0.15% survival) as compared 
to the deletion of Stn1 alone (longer CLS of 90 days with 10-16% survival) or Cdc13 alone 
(CLS of 90 days with 16-48% survival).  The dramatic loss of viability and the faster rate of 
ageing in single and combined mutants highlighted the significance of these capping proteins in 
the protection of the telomeres and cumulative effects of these mutations in determining the 
chronological survival. 
 
Figure 6.29.  Survival (%) in single and combined deletion mutants (Cdc13 and Stn1) over a period of 90 
days. 
Cells were grown at 30°C in a shaking incubator for six days until saturation, washed with sterile water, 
and then kept in sterile water at 4°C for the whole period of the CLS studies.  Samples were pooled and 
diluted in water and plated on YEPD plates to estimate the viable counts.  Colonies were counted, and 
relative viability was calculated over a period of 90 days, taking the 0 day count as 100%. 
Figure 6.30A shows the CLS for cdc13-1 full gene deletion strain (2608) and its NTΔ and CTΔ 
variants from the strain 1296-TR.  The average viability of cdc13-1-NTΔ-1296 was 
dramatically reduced as compared to CTΔ-1296 at age points 5-20 with 56% viability as 
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compared to 65% at day 20 of the CLS.  However, the cell survival difference gradually became 
reduced and remarkably low with further ageing from day 25 to day 60 (with the difference of 
2%, 4%, 1%, 1%, 6% and 3%).  The strain 1296-TR displayed less viability as compared to 
CTΔ, but better survival as compared to NTΔ until age point 25.  Then, it gradually appeared to 
be closer to NTΔ from age points 60 and 90.  At day 90, cdc13-1 mutant (strain 1296-TR) 
showed a survival of 29% as compared to 30% survival in NTΔ and 20% in CTΔ.  The 
viabilities of, both mutants were significantly lower as compared to wild type (641) and EXO1 
deletion mutant (1273) but were higher when compared to strains 2685, #14 and 2608. 
However, when survival values for individual NTΔ and CTΔ clones were plotted, the result was 
somewhat different (Figure 6.30B).  Both CTΔ clones showed a similar pattern of survival with 
higher viability than that in NTΔ, from age point 5 to age point 20 (with survival difference of 
2%-8% at different age points).  However, further down the survival curves individual NTΔ 
clones exhibited wide fluctuations, with a 9-21% difference in viability.  At age point 90, CTΔ 
clone #10 manifested 26% survival as compared to 14% shown by CTΔ clone #9.   
Similarly, NTΔ clones #4 and #5 showed variable survival loss with a viability difference of 9-
21% at various age points.  Both NTΔ and CTΔ clones showed significantly lower survival as 
compared to WT (640 and 641) and higher survival as compared to CDC13 deletion (2608) 
(lower than that for strain 2607).  However, no particular trend was evident for N- and C-
truncated mutants of strain 1296. 
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Figure 6.30.  Viability loss in the CDC13 deletion mutant and its comparison with N- and C-truncated 
variants of 1296-TR over a period of 90 days in CLS studies. 
Cells were grown at 30°C shaking incubator for one week, washed with sterile water and kept at 4°C for 
the whole period of the CLS studies.  Samples were pooled and diluted in water and plated on YEPD 
plates to estimate the viable counts.  Colonies were counted, and relative viability was calculated for a 
period of 90 days by taking the 0 day count as 100%. 
(A) Average viabilities of NTΔ and CTΔ mutants of strain 1296 
(B) Viability% of individual NTΔ and CTΔ clones of strain 1296 during chronological ageing 
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The average percentage of viabilities for NTΔ and CTΔ variants in strain 1297-TR are shown in 
Figure 6.31A.  The average survival of NTΔ was clearly higher as compared to CTΔ, with a 
difference of 29-37% in viability at different age points- from age point 15 to age point 50.  
However, a sharp decline in viable cell number was shown between age point 50 and age point 
90, with a difference of 8-21% (remarkably less when compared to 29-37% in the first half of 
the survival curve).  Finally, cell survival in NTΔ dropped to 18% as compared to 10% in CTΔ.  
For comparison, the CTΔ manifested a sharp decline of the survival at age point 10, with a 57% 
drop of survival (from 97% viable cells to 40%).  However, a gradual decrease of viability was 
apparent from age point 15 to age point 90, (10% survival at age point 90 of the CLS. 
The parental strain 1297-TR manifested a less than average viability as compared to NTΔ but 
better survival (as compared to CTΔ) until age point 90.  It appeared to be closer to NTΔ 
(similar to 1296-TR) from age points 15 to 70.  At day 90, it showed a survival of 12% as 
compared to 18% in NTΔ and 10% in CTΔ.  The survival rates were significantly lower as 
compared to the wild type (641) and Exo1 deletion mutant (1273) but were higher when 
compared to strains 2685, #14 and 2608. 
The survival pattern of individual NTΔ and CTΔ clones also showed the same trends as seen 
with combined average survival of two clones Figure 6.31B.  The both CTΔ clones showed a 
consistently similar pattern of survival with remarkably lower viability compared to that of 
NTΔ, from age point 15 to age point 70 (with a survival difference of 0.32%-6% at different age 
points).  However, individual NTΔ clones exhibited a few fluctuations at the start of survival 
curve between age point 5 and 20 showing viabilities differences of 11-21% between the two 
clones.  The viability pattern changed at age point 25, and clone #7 showed a slightly higher 
survival further down the curve as compared to clone #8 with a difference of 1-12% at different 
age points.  At age point 90, NTΔ clone #7 manifested 23% survival as compared to 13% shown 
by NTΔ clone #8.  In contrast to N- and C-truncated variants of 1296, the NTΔ and CTΔ of 
1297 strain exhibited a clear survival trend: NTΔ with higher survival values as compared to 
CTΔ.  The percentage of survival in NTΔ and CTΔ clones were lower as compared to both WT 
(640 and 641) strains.  However, CTΔ clones manifested a lower survival as compared to the 
CDC13 deletion (2608). 
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Figure 6.31.  Viability loss in CDC13 deletion mutant and its comparison with two N- and C-truncated 
variants of 1297-TR over a period of 90 days in CLS studies. 
(A) Average viabilities of cdc13-1 NTΔ and CTΔ mutants of strain 1297. 
(B) Viabilities of individual NTΔ and CTΔ clones of strain 1297 during chronological ageing. 
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6.4. Conclusions: 
This study has documented the following novel findings. 
 The dramatic loss of viability and the faster rate of ageing in, STN1 and CDC13 deletion 
mutants (single and combined) under different conditions, including calorie restriction, 
highlighted the significance of these capping proteins in the protection of the telomeres and 
cumulative effects of these mutations in determining the chronological survival. 
 
 Significant differences in viability observed in N- and C-terminal deletion variants of 
cdc13-1 mutant reveal different roles of structural motifs or domains in cellular senescence 
and ageing. 
 
 The marked differences in colony size and irregularly-shaped colonies with wavy margins 
in single (stn1Δ or cdc13Δ, – more so in mutants lacking STN1) and combined deletion 
(cdc13Δ stn1Δ exo1Δ and rad24Δ) mutants as compared to uniformly sized circular 
colonies with smooth margins in the wild type might reflect genetic instability. 
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Chapter 7 
Overall discussion and future plan of work 
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7.1 Generation of CDC13 deletion/modification 
mutants 
Deletion of a gene or ORF sequence is one of the approaches used in systematic functional 
analysis of genes to study the effect of deletion of a particular gene on cellular functions.  In 
modern genetic analysis generating a null allele or inactivation of a chromosomal gene require 
‘ex vivo’ synthesis of a gene-targeting construct using multiple cloning steps.  In yeast, efficient 
homologous recombination systems enable genomic integration and manipulations of a foreign 
gene of interest (Rothstein, 1991, Huber et al., 2014).  One-step PCR-targeted 
modification/deletion of a specific gene by means of DNA transformation in yeast is a 
commonly used technique to understand gene function.  Previously, it has been reported that the 
cdc13-1 temperature-sensitive (ts) allele of CDC13 with single amino acid missense mutation 
within DNA binding domain (DBD; 557-694 aa), shows a decrease in the maximum permissive 
temperature, and cdc13-1 mutants can grow only at a lower temperature (Hughes et al., 2000).  
Cells die at higher temperature due to the accumulation of ssDNA, recombination and cell cycle 
arrest.  However, cdc13-1 temperature-resistant (TR) survivors in the absence of exonuclease 
activity at telomere can grow at higher temperatures (Zubko and Lydall, 2006).   
 
Depending on experimental needs numerous selectable markers are employed in the yeast 
manipulation such as prototrophic, autoselection, counterselectable and markers conferring drug 
resistance (Siewers, 2014).  Plasmids with different markers (kanamycin resistance, histidine, 
tryptophan and leucine prototrophy) are available commercially to be used as templates for the 
amplification of the deleting module (Wach et al., 1997, Longtine et al., 1998). 
 
In the 1
st
 set of experiments, the cdc13-1 full gene of the S. cerevisiae mutants (strains 1296 and 
2605) containing prototrophic marker LEU (cdc13-1 exo1::LEU2 RAD5 trp1-1 leu2-3,112 his3-
11,15 ura3) was deleted.  The heterologous marker module HIS3MX6 used for this purpose is 
able to complement S. cerevisiae his3 mutation and has been reported to work better as a 
selectable marker with less chances of undergoing homologous recombination (less than 5% 
incorrectly targeted transformants) with the host yeast genome (Wach et al., 1997).   
 
Chimeric primers were used for the amplification of the deletion module.  Each primer 
consisted of two parts; a 5’ target gene-specific sequence and 3’ marker-specific sequence.  The 
gene-specific guided deleting sequences at the 5’ ends allows homologous recombination at the 
desired locus within the genome and requires range of 35-51/30-50/38-50 nucleotides in length, 
while 3’ sequences used for amplification of the marker could be 17-22 nucleotides in length 
(Wach et al., 1997, Baudin et al., 1993, Lorenz et al., 1995).  In previous studies, even smaller 
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primers with 5’end consisting of 30-35 nucleotides have been used to synthesize PCR product 
with HIS3 marker (Baudin et al., 1993).  However, M. S. Longtine et al., (1998) have suggested 
that the longer target-/gene-specific flanking sequences may improve the efficiency of 
homologous recombination.  Primers used in this study to generate ~ 1409 bp linear DNA to 
delete full cdc13-1 had 46 (forward) and 40 (reverse) nucleotides from upstream and 
downstream regions of the CDC13 gene (5’ ends) with 20 nucleotides (3’ ends) homologous to 
the histidine marker from the reported sequences (Longtine et al., 1998).  In this study, the 
potassium acetate precipitated, ethanol washed PCR DNA was used to transform cdc13-1 
mutants, however, crude PCR mixture can also be used to transform yeast cells as was reported 
previously (Baudin et al., 1993, Gietz et al., 1992).  Host yeast strains used for DNA 
transformation should contain non-reversible mutant allele against selectable marker gene 
otherwise, it could be difficult to maintain the yeast with, or screen for, the integration of 
foreign selectable markers in homologous recombination experiments (Lorenz et al., 1995).  
The strains 1296 and 2605 used in the transformation experiments contain his3-11,15 mutation 
for selectable marker HIS3MX6 gene  In preliminary experiments, transformation efficiency of 
yeast cells as a result of homologous recombination was very low and produced only one 
histidine
+
 transformant out of 2.53x10
6
 cells.  These results are consistent with a previous study 
that showed one to two His
+
 clones by using 3 µg of PCR product with HIS3 marker module of 
S. kluyveri origin (Wach et al., 1997).  However, variable levels of genuine transformants (5-
10%) are reported by other studies (Lorenz et al., 1995), 16-80% (Baudin et al., 1993), and 20-
95% (Longtine et al., 1998).  Increased incubation time for transformation (from 15 to 30 min) 
and a higher quantity of DNA (from 1 to ~3 µg) appeared to increase the number of 
transformants by almost 11 fold in strain 1296-TR in the current study.   
 
In gene manipulation studies different techniques are employed for the confirmation of target 
sequence deletion or alteration with the integration of marker module in the recipient genome.  
Putative clones could be screened on the basis of selectable markers (phenotypic analysis) and 
examined on DNA level either through traditional Southern blotting technique for the detection 
of the marker integration and gene modification (Baudin et al., 1993) or examined by rapid 
analytical PCR for the integration of the PCR module in the yeast genome (genetic analysis) 
(Wach et al., 1997).  Diagnostic primers from the ORF of CDC13/cdc13-1 were used for the 
genotypic detection of disrupted gene.  Systematic PCR analysis of 10 His
+
 transformed cells 
from strain 1296-ts and its TR survivors (cdc13-1 exo1::LEU2) showed that all tested clones 
from ts-cells were PCR positive for cdc13-1 mutation while all tested TR-transformats were 
PCR negative for cdc13-1gene confirming the deletion of gene in only TR cells of strain 1296.  
However, it was not determined whether these cdc13-1-His
+
 ts-cells were generated as a result 
of non-homologous recombination of HIS3MX6 marker with host genome or were autonomous 
revertants due to conversion of auxotrophic mutation or other recombination.   
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The appearance of His
+
 pseudotransformants due to unavoidable background of gene 
conversion has been reported previously with less than 5% frequency (Wach et al., 1997).  The 
deletion of genotypic cdc13-1 gene in all tested His
+
 1296-TR clones indicated that the yield of 
correctly targeted transformants with heterologous HIS3 marker of non S. cerevisiae origin 
could be above 95% (100% in case of TR cells).  However, cdc13-1 disruption with HIS3 
heterologous maker was not quite successful in this study.  These results suggest that absence of 
cdc13-1 knockout in temperature sensitive cells of strain 1296, may be due to its essential 
functions in telomere capping and DNA stability at low temperature.   
 
Overall, cdc13 full gene deletion mutants were developed successfully at high temperature 
(36C°) in strains of survivors 1296-TR and 2605-TR: (genotype cdc13-1::HIS3 exo1::LEU2).  
This indicates that yeast cells can grow and divide without essential telomere capping protein 
Cdc13 conditionally in the absence of exonuclease activities (exo1Δ) on uncapped telomere in 
survivors (TR cell), in agreement with the previous finding that Cdc13 might be dispensable in 
exo1Δ mutants in temperature resistant survivors (Zubko and Lydall, 2006).  Similarly, another 
study reported that inactivation of checkpoint machinery (by deletion of RAD9) and attenuation 
of telomeric DNA resection pathways (by deletion of both SGS1 and EXO1) are sufficient to 
allow cells to grow in the absence of Cdc13 telomere capping protein (Ngo and Lydall, 2010). 
The telomere cap is adaptable.  Loss of nucleases activities at uncapped telomere (exo1Δ) and 
inactivation of DNA damage checkpoint pathways (rad24Δ) either promote telomere capping 
and maintenance through Cdc13-independent mechanism by involving other capping proteins in 
absence of Cdc13 or Cdc13-mediated capping that is not needed in this case (Zubko and Lydall, 
2006).  A recent report has also shown that diverse groups of proteins including CST complex, 
NMD and DDR proteins are involved in telomere capping and replication.  The essential roles 
of Cdc13 protein in telomere capping may be bypassed in the presence of inactive DDR and 
NMD (Holstein et al., 2014). 
 
These finding criticises the essential roles of Cdc13 in cell survival and point towards the 
involvement of alternative mechanisms in telomere maintenance.  It can be hypothesised that at 
a conditional Cdc13 uncapping other proteins might compensate Cdc13-mediated capping via 
an alternative mechanism to maintain telomeres and ensure genomic stability.  In future studies, 
it would be interesting, to investigate the mechanism that exists in temperature-resistant cdc13-1 
cells to maintain telomeres in the absence of Cdc13 and makes cell survival possible.   
 
Cdc13 protein binds to telomeric specific ssDNA TG-rich DNA tail with high specificity and 
affinity.  Its interaction with Stn1 through its C-terminal specific domain ensures genomic 
integrity by protecting telomere ends from nucleases attacks.  The sequence analysis of Cdc13 
has shown five different conserved OB domains including OB1, RD, OB2, OB3 (DBD) and 
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OB4 from N- to C-terminus (Anderson et al., 2002, Mitchell et al., 2010, Mason et al., 2013).  .  
N-terminal region is considered crucial part of Cdc13 (Hsu et al., 2004).  Previous studies have 
established that N-terminal OB1 fold of Cdc13 is involved in its interaction with Pol1 (a 
catalytic subunit of polymerase α) for C-rich strand re-synthesis and telomerase RNA associated 
protein Est1 for G-strand lengthening and regulate telomere length (Qi and Zakian, 2000).  
While it’s C-terminal OB4 domain is utilised to interact with Stn1 protein for the essential roles 
in telomere end capping and telomerase recruitment.  Cdc13 bind to single stranded DNA 
through its OB3 (DBD) domain for its capping function.  Cdc13 exists as a dimer in the 
solution.  A newly discovered OB2 domain between recruitment fold and DNA binding domain 
is appeared to involve in Cdc13 dimerization.  The disruption of OB2 fold affects the binding of 
Stn1 and Cdc13 and telomere maintenance (Sun et al., 2011).  Although Cdc13 have been 
studied extensively in relation to telomere capping functions, the precise role of its N- and C-
terminal in telomere length regulation and ageing and senescence are still not clear. 
 
To further understand the roles of Cdc13 and molecular dissection of its functions, N- and C-
termini truncated variants of Cdc13-1 were generated in this study.  The CDC13 N-terminal half 
(1386 nt corresponding to 462 aa) truncated mutants were attempted to generate using 
modulating plasmid pFA6a-TRP1-PGAL1 in recipient yeast strains: 1296-TR, 1297-TR (cdc13-
1 exo1::LEU2) and 1272 (CDC13 exo1::LEU2).  Cells from these three strains were tested for 
growth at 23°C and 36°C.  The fast growing survivors were observed in strain 1296 and 1297 
with heterogeneous growth pattern (large and small colonies, with rough edges) but not in the 
tested strain 1272 (homogenous growth with equal sized smooth edged colonies), which 
apparently showed no difference in growth at 23°C and 36°C.  This type of growth could 
indicate genetic instability and senescence.  When examined for their auxotrophic markers, all 
three strains showed spontaneous revertants for trp1 marker with varying frequencies, rare for 
histidine marker (only one cell out of 26x10
6 
cells in strain 1296-TR).  High frequency of trp1 
revertants (2.88x10
-6
 in strain 1296-TR as compared to 0.46x10
-6
 in 1297-TR) could be 
correlated with increased incidence of false positive transformants (75% in 1296-TR as 
compared to 63% in strain 1297-TR respectively). 
 
cdc13-1 N- and C-terminus deleting DNA fragments of ~1.576 kb (TRP1-PGAL1) and ~1.6 kb 
(ADH1-HIS3MX6) respectively DNA were PCR synthesized using 68-71 nt hybrid primers and 
trp1- and his-plasmids DNA templates.  In contrast to potassium acetate/ethanol precipitated 
PCR product that was used to delete cdc13-1 full gene, phenol-chloroform extracted and ethanol 
precipitated (~1-3 µg) linear DNA fragments were used to transform yeast cells for N- and C-
terminal specific truncation.  Analytical PCRs negative for cdc13-1 N-terminus (PCR
-
 for 378 
bp fragments) and positive for TRP1 marker module (PCR
+
 for ~1.5 kb fragments) indicates 
truncation of cdc13-1 N-terminal region with integration of marker module.  The results 
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demonstrated that out of randomly tested Trp1
+
 (T
+
L
+
) clones, 25% (6/24) T
+
L
+
 transformants 
were true mutants for N-terminus truncation with target specific homologous recombination in 
survivors strain 1296-TR as compared to 37.5% (9/24) in strain 1297-TR.  All other tested T
+
L
+
 
transformants (PCR negative for TRP1 gene) were considered false positive (spontaneous 
revertants) generated possibly as a result of endogenous marker gene conversion, (rather than 
recombinants).  There was no false positive mutant as a result of non-homologous 
recombination of TRP1 marker gene.  Although there are reports that the TRP1 marker of S. 
cerevisiae origin can recombine efficiently with the endogenous trp1 locus (Longtine et al., 
1998, Sikorski and Hieter, 1989) and should be used in strains that contain TRP1 deletion i.e., 
trp1Δ-63 or trpl-Δ1.  Another yeast vector, pFA6a-HIS3MX6-PGAL1 was also tried for CDC13 
N-terminal truncation with histidine module but without success in obtaining true clones i.e. 
0/30 screened His
+ 
transformants in strain 1296-TRand 1297-TR and 0/10 in strain 1272.  
 
Similarly, the second half of CDC13 ORF (from 1387-2775 nt corresponding to 462 aa) was 
disrupted by using heterologous histidine (ADH1-HIS3MX6) marker to generate C-terminus 
deletions of cdc13-1 mutant under ADH1 terminator.  The results of integrative DNA 
transformation for C-terminus deletion demonstrated high frequencies of true mutants, 86.67% 
(13/15) and 100% (15/15), in strains 1296-TR and 1297-TR respectively as a result of target 
specific homologous recombination.  Low background of spontaneous revertants for histidine 
marker mutation resulted higher frequency of HIS
+
 C-truncated mutants.  However, two false 
positive, H
+
L
+
 (13.33%) mutants were also observed in strain 1296-TR.  Further analysis using 
analytical PCR for the ADH1-HIS3MX6 marker showed that one of the pseudo positive mutant 
was generated as a result of NHR (PCR
+
 for marker) while other, PCR negative for marker was 
determined to be revertant.  No true construct (0/77) with C-truncated CDC13 was achieved in 
the tested H
+
L
+
 transformants in strain 1272 (non-survivor strain).  However detection of 14 
(18.18%) H
+
L
+
 false positive mutants (also PCR
+
 for marker) indicate non homologous 
integration of marker in chromosome; other could be revertants (> 80%) due to marker gene 
conversion. 
 
The CDC13 disruption results indicated that endogenous trp1-1 deletion locus is not very stable 
and generated unavoidable background because of gene conversion of auxotrophic mutations 
which decrease the yield of correctly targeted tansformants: 25-37% yield with TRP1 marker as 
compared to 87-100% with HIS marker.  Taken together, PCR based homologous 
recombination approach and rapid screening assay involving PCR detection of mutants directly 
from the colonies can be efficient for generating mutants of yeast for functional analysis.  
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The N-terminus truncated variants of cdc13-1 generated in this study are expected to exclude 
OB1 motif (1-190) and RD (227-340/340) domains and most of the OB2 fold (344-494).  While 
C-terminus deleted construct of cdc13-1 are presumed to exclude small part of OB2 fold (463 
onwards) and whole of the OB3/DBD (494-694) and the OB4 fold (694-924) (Anderson et al., 
2002, Mitchell et al., 2010, Mason et al., 2013, Sun et al., 2011).  OB2 motif is disrupted in 
both N- and C-terminus truncated alleles of cdc13-1generated in this study.  Previous study has 
shown that introducing point mutations in full length Cdc13 protein at OB2 fold prevent Cdc13 
N-dimerization that leads to telomere shortening.  Mutations within DBD affect its DNA 
binding ability and cause telomere elongation (Mitchell et al., 2010).  The N- and C-disrupted 
alleles of Cdc13-1 generated in this study may provide an invaluable tool for exploring the 
important roles of different motifs of Cdc13 with respect to its N or C-terminus on uncapped 
telomeres. 
 
7.2 Generation of Stn1 mutants and diploids cells using 
genetic crosses 
Genetic crosses are routinely carried out using haploid strains of opposite mating type to 
generate new meiotic recombination of existing mutations for phenotypic analysis.  They are 
studied for the interaction of different mutations and combined effects of two or more gene 
deletions.  The diploid cells are sporulated in the presence of 1-2% potassium acetate and non-
fermentable carbon source under starvation of nitrogen to generate four cell asci containing 
haploid meiotic products (Rothstein et al., 1977). 
 
To further explore the role of Stn1 protein haploids progeny of stn1Δ, triple mutants in new 
combination (CDC13 stn1::HIS exo1::LEU2 rad24::TRP1) were generated by crossing two 
haploids mutants.  The process of generation of mutants involved inducing sporulation of 
diploid cells, dissection of tetrads, and separation of individual spores by using 
micromanipulation tools.  It is necessary for genetic analysis to get all four spores from the 
same ascus.  However, in the present study it was not possible to carry out segregation analysis, 
because of high mortality of spores (31 spores germinated out of 328 spores separated resulting 
in 9% viability).  Random analysis of spores was carried out to find the required genetic 
combination (cdc13∆ stn1∆ rad24∆ yku70∆ or stn1∆ exo1∆).  Genetic analysis of viable spores 
by replica plating segregated all spores in five groups of different mutations but none with the 
desired combination with yku70∆.  Presence of only two spore progenies with gene combination 
stn1∆ exo1∆ rad24∆ CDC13 (#14 and #21) indicates low frequency of viable recombinants.  
The presence of wild type CDC13 in this combination was confirmed by using PCR and 
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analytical gel electrophoresis for the confirmation of gene specific fragments.  Stn1 deletion 
haploids showed heterogeneous colony growth with small and large colonies and were further 
studied for their chronological lifespan and cellular responses to oxidative and genotoxic 
stresses.  Diploid cells were also generated by crossing N- and C-truncated haploids of Cdc13-1 
mutants.  However, the sporulation of these heterozygous diploid cells failed to generate haploid 
progeny, could be because of deleterious effect of protein misfolding resulting in impaired 
meiosis. 
 
7.3 Maintenance of telomere in the absence of Cdc13 
and Stn1 
Maintenance of telomere capping is essential for genomic stability and the survival of 
eukaryotic cells.  Fission yeast can survive telomere dysfunction-mediated chromosome fusion 
by generating independent replicating circular chromosome (Wang and Baumann, 2008).  
Unprotected telomere in yeast can be repaired by recombination-dependent break-induced DNA 
replication (McEachern and Haber, 2006).  Budding yeast can maintain their linear chromosome 
in the absence of telomere capping proteins through recombination-dependent or -independent 
mechanisms (Zubko and Lydall, 2006) or in the absence of telomerase through recombination 
based ALT mechanisms (Teng and Zakian, 1999).   
Telomere capping protection counteracts the proliferative barrier imposed by DDR machinery.  
Dysfunctional telomere triggers DDR, cell cycle arrest and contributes to cellular senescence 
and ageing.  It was shown previously that survivors can grow at low rate in telomerase deficient 
mutants (tlc1Δ) or cdc13-1 rad9Δ exo1Δ cells in the absence of functional Cdc13 (Teng et al., 
2000).  Further simultaneous inactivation of nucleases activities of Sgs1 (the RecQ helicase in 
budding yeast) and Exo1 together with cell cycle checkpoint activity of Rad9 allow cell to grow 
in the absence of capping function of Cdc13 (Ngo and Lydall, 2010). 
The overexpression of an OBFC1 (homolog of yeast Stn1 protein) mutant results in elongated 
telomeres in human cells, implicating OBFC1 in telomere length regulation (Wan et al., 2009).  
In this study deletion of Stn1 and/or Cdc13 in the absence of nucleases activities manifested 
common diffuse and smeary telomere DNA patterns at 30°C, more diffuse in the stn1Δ exo1Δ 
rad24Δ deletion mutants with a major smear observed between 0.3 kb and 2 kb.  These 
telomeric DNA patterns were different from type I survivors of WT, EXO1 deletion mutants 
(strains 1272 and 1273) and cdc13-1 exo1Δ (strain 1297-TR) in not having distinct terminal 
fragment.  Type I survivors mainly maintain their telomere through recombination mediated 
mechanism and by amplifying sub-telomeric Y’ repeats (Maringele and Lydall, 2004).   
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The presence of broad smear in STN1 deletion mutants observed in this study could correspond 
to a subset of TRFs of similar sizes, in accordance with possible conservation of sub-telomeric 
sequences between a subset of chromosomes.  Alternatively, the smeary DNA could be ssDNA 
(extra-chromosomal DNA) in agreement with a previous report where marked increase in 
ssDNA was observed in cells lacking STN1 function (Grossi et al., 2004).  However, it needs to 
be verified by hybridization of non-denatured DNA by using ssDNA probe.  It was shown 
previously that cdc13-1 stn1Δ exo1Δ rad24Δ and cdc13Δ stn1Δ exo1Δ rad24Δ mutants at high 
temperature (36°C) and at late passages also generate ssDNA similar to but in higher amount as 
observed in type I and type II survivors.  The generation of ssDNA could also be Rad52 
dependent that is involved in homologous recombination (Zubko and Lydall, 2006).  The 
presence of increased level of ssDNA (an indication of increased accumulation of damages) in 
stn1Δ exo1Δ rad24Δ mutant as compared to stn1Δ cdc13Δ exo1Δ rad24Δ mutants or cdc13Δ 
exo1Δ grown at 30°C indicates that Stn1 might has different role in telomere capping and cell 
survival.  This observation is supported from a recent study that showed that Stn1 can bind to 
telomere in Cdc13 independent manner in the presence of inactive DDR and NMD, and bypass 
the need of Cdc13 for its capping functions (Holstein et al., 2014). 
The distinct banding patterns with unique fragments of 1 kb-5 kb with obvious Y’ 5.5 kb and 
6.5 kb fragments without prominent terminal DNA fragments in N- and C-truncated Cdc13-1 
mutants in both strains 1296 and 1297 exhibited telomeric DNA patterns resembling to type II 
survivors.  Presence of predominantly type II survivors suggests that dysfunctional telomere in 
the presence of defective capping protein Cdc13-1 restore telomere function through 
amplification of telomeric repeats (TG1-3), using recombination-based mechanisms or ALT 
(Teng and Zakian, 1999).  The patterns of telomere DNA were similar to those in checkpoint-
deficient cdc13-1 cells (cdc1-1 mec1 strain) at 29°C, which survive through homologous 
recombination triggered by the accumulation of DNA damage, and telomerase-deficient, 
recombination dependent (cdc13-1 cells with Rad52) type II survivors as shown previously 
(Grandin et al., 2001).  However the cdc13-1 exo1Δ mutant (original strain 1296-TR) displayed 
telomeric structure resembling to type II survivors whereas strain 1297-TR with similar 
genotype revealed telomeric DNA structure similar to type I survivors (more like WT) at 30°C 
indicating the effect of other determinants in the genome.  N-truncated mutants of Cdc13 from 
both strains of cdc13-1 exo1Δ exhibited more smeary and diffused background (could be 
ssDNA, need further verification) as compared to C-truncated mutants at 30°C and showed 
similarity to cdc13Δ exo1Δ mutants. 
Further growth of N-terminus truncated variant of cdc13-1 exo1Δ (strains 1296-TR and 1297-
TR) cultured at 23°C and 37°C for passage 3 (~60-75 divisions) showed telomeric DNA 
structure that resembled those of cdc13Δ exo1Δ mutant at respective temperatures.  Telomeric 
DNA from mutants (N- and C-terminus truncated) grown at 37°C offered more resistance to 
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digestion as compared to those grown at 23°C.  Increased level of diffuse and smeary telomeric 
DNA (more like type I survivors) without obvious terminal fragment, might indicate the 
accumulation of ssDNA with successive culturing at 37°C.  Telomeric DNA of C-terminus 
truncated mutants grown at 23°C and 37°C showed resemblance to DNA patterns of original 
cdc13-1 exo1Δ mutant (similar to recombination-proficient type II survivors).  Appearance of 
weak smeared DNA at 37°C was also obvious in C-terminus variants of cdc13-1 exo1Δ.  At 
passage 3 the overall trends in telomeric DNA structure of N- and C-terminus mutants of 
Cdc13-1 appeared to be in transition from type II like telomere to type I like telomere as the 
individual fragments (> 1 kb) turned more diffuse and smeary with distinct 5.5 kb and 6.5 kb 
fragments.  The disappearance of bigger than 1 kb fragments but the presence of distinct 5.5 kb 
and 6.5 kb fragments further suggested the maintenance of telomere at passage 3 with the 
amplification of sub-telomeric-Y’ repeats, and degradation of X-repeats. 
The N-terminus truncated Cdc13-1 mutants (1-462 aa) used in this study are without OB1 fold, 
RD motif and most of the OB2 domains.  Loss of Cdc13-Pol1 interaction is correlated with 
telomere elongation (Qi and Zakian, 2000).  The RD motif plays an important role in telomerase 
recruitment through its interaction with Est1 protein.  Intact OB2 fold of Cdc13 is required for 
Cdc13-Stn1 interaction for telomere maintenance (Sun et al., 2011).  The loss of N-terminus 
could prevent access of telomerase to telomere overhangs and blocking of extension of G 
strand, which are required for continuous cell division. 
The C-terminus truncated Cdc13-1 mutants (463-924 aa) are without complete DBD (OB3) and 
OB4 domains and a part of OB2 domain.  The absence of DBD could affect binding of Cdc13 
with ssDNA, loss of its capping function and exonucleolytic degradation.  The essential 
function of Stn1 is considered to promote telomere end protection through its binding with 
Cdc13p and is supported by the finding that truncation of C-terminal (123 aa) failed to support 
viability, however, endogenous expression of stn1 allele with extensive truncation of C-
terminus (removal of 208 aa) allowed cell to grow (Petreaca et al., 2007).  Stn1 interacts with 
Pol12 to maintain telomere end protection and length regulation (Grossi et al., 2004).  The 
deletion of OB4 fold could result in the loss of interaction of Cdc13-Stn1, loss of telomere end 
protection and maintenance.  These events could lead to genomic instability and early 
senescence. 
The N- and C-truncated Cdc13-1 mutants generated in this study may provide useful tools to 
investigate genomic instability in response to telomere uncapping in the presence or absence of 
different domains of Cdc13.  These results also support that the attenuation of nucleases Exo1 
and Rad24 is sufficient to allow yeast cells to grow and to divide in the absence of telomere 
capping by Cdc13 or Stn1, or both (Zubko and Lydall, 2006) indicating the plasticity of 
telomere capping and the maintenance of telomere by other alternative mechanism of capping. 
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7.4 Cellular responses of cells lacking Cdc13 and Stn1 
to genotoxic agents 
Genetic interaction analysis is commonly used to study gene function, the role of genes in 
different cellular pathways and to identify functionally related or functionally redundant genes 
(Memarian et al., 2007).  Lethality of a double deletion mutant verifies genetic and functional 
relationships between two genes.  Genotoxic stresses affect growth patterns reflecting distinct 
traits that cells acquired to adapt to adverse environment (Olson-Manning et al., 2012).  Cell 
cycle checkpoints of yeast: G1 phase, S phase and G2-M regulate cell cycle progression (Alic et 
al., 2001).  Cells undergo cell cycle arrest in response to defects in DNA replication, 
chromosome segregation, DNA damages, nuclear migration, and spindle errors under the 
control of cell checkpoints (Weinert, 1998b, Weinert, 1998a). 
Mutant cells display sensitivity and resistance to a wide range of exogenous genotoxic agents.  
Analysing the growth of a mutant yeast strain in the presence or absence of the sub-lethal 
concentration of a genotoxic agent is a fast and efficient way to determine the targets of 
inhibitory compounds.  Yeast cells exposed to oxidative stress or DNA damaging agents 
respond by arrest of cell cycle progression via cell cycle checkpoint mechanisms.  Different 
toxic chemicals activate G1 phase, S phase or G2-M phase cell cycle checkpoints (Harrison and 
Haber, 2006). 
The UV-induced DNA damages occur through photo-dimerization of proximal pyrimidines 
bases (Kladwang et al., 2012).  These DNA lesions have adverse effects on genomic and non- 
coding RNA (Wurtmann and Wolin, 2009).  In S. cerevisiae, hydroxy urea (HU) inhibits 
ribonucleotide reductase function and blocks DNA replication.  As a result, DNA synthesis is 
blocked by preventing dNTP pool expansion at G1/S phase of cell cycle (Koc et al., 2004).  
Methyl methanesulfonate (MMS) and HU disrupt multiple cell cycle checkpoint responses 
resulting in replication stress.  Replication stress signal activates S phase checkpoint 
accompanied by cell sensitivity to the replication inhibitor (Gasparyan et al., 2009).  The 
sensitivity of cells to MMS also increases significantly when other DNA repair pathways are 
compromised (Lundin et al., 2005).  Hydrogen peroxide is used to model chronic oxidative 
damage to cell through oxidative stress and induces G2-M arrest through different mechanisms 
that involve RAD9 mediated pathway.  DNA is considered to be a primary cellular target for 
many cytotoxic agents.  DNA strand breaks, a major class of DNA damage, can be induced by 
endogenous and exogenous genotoxic agents (Rasouli-Nia et al., 2004).   
The phenotypical growth patterns of mutant strains lacking Cdc13 and Stn1 (single or in 
combination) and N- and C-terminus truncated variants of cdc13-1 were monitored at 23°C and 
30°C in the presence of different DNA damaging agents i.e., UV and MMS, HU (DNA 
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replication inhibitor) H2O2  (oxidative stress factor).  Responses of mutants lacking Cdc13 
and/or Stn1 (in the absence of exonuclease activity) to genotoxic agents UV, MMS and HU 
were, distinct from WT, whereas combined deletion mutants of cdc13Δ stn1Δ (in the absence of 
EXO1 and RAD24 genes) showed the highest sensitivity as compared to stn1Δ mutants (in the 
absence of RAD24 and EXO1 genes) and cdc13Δ mutants (in the absence of EXO1 gene).  The 
strong growth inhibition observed in combined deletions mutants as compared to moderate 
sensitivity of Stn1 lacking mutants might suggest the interaction between Cdc13 and Stn1 
cooperatively, with some reservation regarding the presence of rad24Δ or involvement of both 
proteins via different pathways to the overall sensitivity.   
In previous studies, it has been shown that overproduction of Stn1 protein makes cells highly 
sensitive to the replication inhibitors HU and MMS (Gasparyan et al., 2009).  However, in the 
present study the absence of Stn1 made cells sensitive to UV, MMS and HU (S phase 
checkpoint) but highly resistant to H2O2 (G2-M checkpoint pathways) as compared to combined 
deletion mutants (cdc13Δ stn1Δ), cdc13Δ mutants (in the absence of EXO1 gene), exo1Δ 
mutants and wild type strains suggesting that the resistance to H2O2 could possibly be under a 
novel controlling mechanisms.  The sensitivity to HU and MMS in stn1Δ deletion mutants 
observed in this study is contradictory to the previous results where over expression of Stn1 lead 
to the same effects (Gasparyan et al., 2009).  Alternatively, there are different mechanisms of 
sensitivity in cases of overexpression and the lack of Stn1.  Overall, it could be suggested that 
there is interplay between amounts of Stn1 and some other proteins including Cdc13 in the cell. 
However this hypothesis needs further exploration. 
The essential capping function of Cdc13 can be bypassed by overexpression of N-terminal OB 
fold of Stn1, and its interaction with Ten1 that allowed cell to grow and divide in the absence of 
Cdc13 (Petreaca et al., 2006).  It is obvious that Cdc13 and Stn1 proteins have independent 
contribution into sensitivity to HU (because the removal of both proteins leads to more dramatic 
effect of sensitivity to HU (but not to MMS or UV where stn1Δ mutants are as sick as cdc13Δ 
stn1Δ combined mutants).  Overall, the results on sensitivity to MMS and HU (both impacting 
DNA stability) indicate that these two proteins might contribute to the maintenance of DNA 
integrity – may be playing roles in DNA repair, or some other mechanisms.  Understanding 
these mechanisms in future research is important in terms of showing other roles of these 
essential proteins (behind telomere protection).  This observation is further supported by a 
recent study suggesting that STN1 and TEN1 play more critical roles in CST complex as 
compared to CDC13 and the requirement of Stn1 cannot be bypassed with the inactivation of 
DDR and NMD pathways (Holstein et al., 2014). 
The behaviour of the STN1 and CDC13 deletion mutants on H2O2 is opposite to that on MMS 
and UV in a way that single mutant of cdc13Δ showed moderate sensitivity implying that Cdc13 
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plays a role in normal homeostasis towards tolerance to oxidative stress in WT cells.  
Paradoxically, these results on more tolerance to H2O2 in Stn1 mutants indicate that presence of 
Stn1 protein reduces tolerance to oxidative stress in WT cells.  Based on these results, it could 
be suggested that STN1 gene might play some unknown role distinct from the CDC13 gene 
through a different mechanism associated with tolerating oxidative stress. 
The comparison of stress effects in cdc13Δ mutants, and cdc13-1 N- and C-terminus truncated 
variants also disclosed different extent of growth inhibition to UV, MMS, HU and H2O2.  The 
highest sensitivity was observed in cdc13Δ mutants with mild effect in its cdc13-1 CTΔ allele 
manifesting slightly more resistance as compared to wild type and EXO1 deletion mutants.  
These trends are consistent with those for all tested oxidative (H2O2) and genotoxic stresses 
(UV, MMS, HU).  The resistance pattern of C-terminus truncated cdc13-1 allele indicates that 
the C-domain might also contain a suppressor of WT-resistance to UV, MMS and HU.  
Genotoxicity-induced sensitivity patterns of the diploids cells (heterozygous on both cdc13-1 N- 
and C-terminus truncations alleles) show intermediate growth inhibition when compared with 
cdc13-1 N- and C-terminus truncated haploids under UV, MMS and HU.  This suggests that the 
allele dosage effect in diploids could play a role in some regulatory pathways.  In response to 
oxidative stress of H2O2, increased growth of diploids from the C- and N-truncated cdc13-1 
haploids reflect either allele dosage effect or a hybrid vigour. 
Similar to telomeric DNA patterns, the genotoxicity trends in cdc13-1 C-terminus deletion 
mutants and cdc13-1 exo1Δ mutants (strains 1296-TR and 1297-TR) were very much alike, a 
phenomenon could be attributed to the presence of point mutation of cdc13-1 that disrupts the 
dimerization of protein and is common in both proteins.  Comparably, the sensitivity responses 
manifested by cdc13-1 N-terminus truncated mutants to damage causing agents are similar to 
those in full gene deletion mutant, cdc13Δ exo1Δ (strains 2607 and 2608) though less severe. 
This could be due to the involvement of N-terminus residing domains OB1 which recruits Pol1 
and/or RD that binds to Est1 in telomere length regulation.  Alternatively, it might indicates that 
an amino-terminal region of Cdc13 (C-truncated cdc13-1) is sufficient for its essential functions 
in cell survival as compared to its carboxyl C-terminal region (N-truncated cdc13-1).  This is in 
agreement with a previous study which showed that lack of N-terminal 1-252 amino acids cause 
defects in successive cell growth and arrest cell cycle in G2-M phase (Hsu et al., 2004).  
Another more likely explanation could be that in stn1 allele, lack of 123 residues from C-
terminal region of Stn1 does not support viability of cells as compared to its allele with more 
extensive deletions with the removal of additional 185 C-terminal residues which allows growth 
at endogenous level (Petreaca et al., 2007).  Therefore, Cdc13-1 C-terminal region might 
negatively regulate the essential function or destabilizes Cdc13 mutant protein in the absence of 
N-terminal. 
 361 
 
7.5 Chronological lifespan in the absence of Cdc13 and 
Stn1  
The direct effect of the disruption and removal of essential genes CDC13/STN1 individually and 
in combination (cdc13Δ stn1Δ) in the absence of EXO1 and RAD24 genes was investigated to 
find out any impact on chronological lifespan (CLS).  Yeasts can switch rapidly between non-
reproductive, G0 arrested phase under starvation to a high metabolic rapid proliferative phase in 
the presence of nutrients (Piper, 2006).  Yeasts survive and age in postdiauxic or stationary 
phase characterised by high resistance to cellular stresses (Werner-Washburne et al., 1996).  
The CLS assays measure the survival of yeast cells arrested in stationary (G0) phase over time, 
and provide a model to study ageing of non-dividing cells in higher eukaryotes (Werner-
Washburne et al., 1996, Maclean et al., 2003).  Previous studies have reported that in natural 
isolates of S. cerevisiae, genotypic variations accounts for about 22% of the total variation of 
RLS.  CLS and RLS appear to be regulated by overlapping but distinct mechanism (Fabrizio 
and Longo, 2003).  CLS of natural isolates (average ~ 7.4 days) are significantly shorter as 
compared to laboratory strains (Qin and Lu, 2006).   
In yeast S. cerevisiae CLS assays are conducted at a population level.  Yeast cultures are grown 
either in SDC/SC or YEPD media (high metabolism) in the presence of glucose.  For CLS 
measurements, the saturated cultures are either kept in the same media or are transferred in 
water (under calorie restriction in stationary phase).  The initial logarithmic growth phase has 
been reported to affect the ability of cells to enter the stationary phase and influence CLS 
measurements (Maclean et al., 2003).  Cells from different strains are grown in glucose 
containing media (YEPD or SC) to post logarithmic phase of growth where cell start entering 
the stationary phase, characterised by un-budded cells (>80%) under microscope.  For the 
majority of strains it may take 24-48 hours to enter to stationary phase but it may vary in 
different strains (Qin and Lu, 2006).  The three day and six day cultures in this study were 
examined, and many budded cells were observed indicating that many cells still did not reach 
the low metabolism stationary phase. 
Despite variations in survival, (possibly due to unavoidable manual errors) the fast decline was 
observed in average viability count within the first 3 days after saturation of cultures of both 
single and double deletion mutants.  Quick drop in cell survival (%) within the first 3 days in all 
ageing cultures including wild type and EXO1 deletion mutants (controls) could be due to 
diauxic switch (shifting from fermentable carbon source to non-fermentable glycerol under 
respiratory metabolism) that is consistent with a previous study (Pedruzzi et al., 2000). 
Overall, the results of CLS studies highlighted the importance of different capping proteins 
(Cdc13 and Stn1) in cell survival and ageing beside telomere maintenance.  The loss of 
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telomere functions in the absence of capping proteins Cdc13 and Stn1 resulted in the gradual 
loss of cell survival.  Each gene showed its own specific role either independently or in 
combination with other genes.  The presence of capping proteins is important for the normal 
growth of cells with minimum rate of senescence as has been demonstrated with wild type strain 
(640).  The removal of Cdc13 and Stn1 in deletion mutants has obviously increased the rate of 
senescence over the period of the CLS studies as compared to the wild type strain.  The removal 
of the two proteins (Cdc13 and Stn1) has different deleterious effects on cell survival.  The 
simultaneous removal of both STN1 and CDC13 in the absence of EXO1 and RAD24 (strain 
2685) exhibited high mortality rate with fast ageing as compared to single mutants.  The slow 
rate of ageing in EXO1 deletion mutants (strain 1272 and 1273) comparable to the wild type 
(significantly low as compared to fast ageing mutants) indicated the negligible effect of exo1∆ 
on ageing.  The strain 2685 has the rad24 mutation.  Rad24 cell cycle checkpoint protein has 
been associated with processing of ssDNA at telomere (Lydall and Weinert, 1995).  The rad24∆ 
cells show delay in the process and repair of broken ends due to delay in resection of DSB ends 
in rad24 mutants compared to resection in wild type (Aylon and Kupiec, 2003).  The absence of 
Rad24 could also contribute to a higher rate of senescence in combined deletion mutants.  These 
results emphasise the importance of checkpoint genes in the cell cycle and their roles in 
enhancing the rate of ageing.  Similarly, removal of Stn1 alone in cdc13-1 (strain 2625) mutant 
resulted in early ageing of cells at a lesser rate whereas the strain 2607 with CDC13, and, EXO1 
deletions showed 2 times faster ageing compared to stn1∆ but 4 times faster than in the 
combined deletions mutants.  These patterns of ageing with the lowest survival value in strain 
2685 and the highest survival in strain 2607 observed at age point 6 were maintained until the 
end of CLS assay over a period of one month.  The differences in values of survival, however, 
were only significant from age points 9-12.  Due to fast rate of ageing in all cultures, the 
differences in survival were not significant after this point.  However, it is evident that each 
gene contributes to the overall process of ageing to some extent by causing slow rates of growth 
and cellular senescence.  At age point 12, slightly higher survival % was observed in cdc13∆ 
(strain 2607) as compared to the other two mutants.  It suggests that the mutant lacking Stn1 
protein (in cdc13∆ stn1∆ or in stn1∆ mutants) aged faster compared to the cdc13∆ mutant, 
which may be due to the cumulative effect of both deletions. 
In traditional CLS methods, ageing cultures are maintained at low temperature (4°-8°C) in water 
in the stationary phase after early growth in YEPD medium until saturation i.e., entering in 
stationary phase after 3-6 days of growth (Piper, 2006).  However, it takes longer (several 
months) to determine cell lifespan at low temperature (Fabrizio et al., 2004, Fabrizio and 
Longo, 2003).  Higher temperatures (35C°-37°C) have been recommended for the initial 
measurements of survival to see any potential difference (Piper, 2006, Murakami et al., 2008).  
It was the reason for using temperature 30°C in preliminary experiments in this study.  
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However, it prompted unavoidable high fluctuations in viability at different time points 
(reflected in CFUs counts and resulting in survival curves).  Due to fluctuations of CFUs the 
shapes of chronological survival curves do not always resemble ‘descending stair case’, a 
feature of a regular survival curve (Qin and Lu, 2006).  The experimentation with yeast cells 
aged in SDC/SC media is simple, with low chances of contamination due to low pH of the 
media while incubation in water at low temperature is risky for longer period of time with high 
chances of contamination (Fabrizio and Longo, 2007).  It was also observed in this study while 
carrying out CLS experiment using wild type strain 640 in water at 30C° when one of the 
samples (3 days grown culture) appeared contaminated at day 18 resulting in the elimination of 
sample.  
The stationary phase survival of S. cerevisiae is temperature dependent.  Longer survival is 
observed at low temperature under starvation.  Loosing viability could be very slow at low 
temperature (for cells pre-grown on glycerol medium), and it takes very long time to measure 
CLS (Piper, 2006).  High temperature (between 35°C -37°C) is used for the early measurement 
of stationary survival that could be reproducible at 30°C for measureable differences in survival.  
In this study, heat inactivation of single and double deletion mutants and wild type at high 
temperature (40°C and 45°C) were attempted to detect measureable differences in CLS in water 
within a short time.  Samples were pooled after every hour for CFUs count (within 7-9 hours).  
Due to marked fluctuations in viability (especially in cdc13Δ) this protocol could not be adapted 
to monitor CLS at high temperature. 
For the second stage of this study, stationary survival measurements were carried out at 4°C in 
water to avoid growth fluctuations and to find out possible differences between these mutants.  
The viability fluctuations observed at different time points may be due to the fraction of arrested 
cells that may re-enter the cell cycle after using nutrients released from dead cells, as it occurs 
in nature under adverse conditions (Fabrizio et al., 2004).  This phenomenon could be detected 
because of the sudden increase in survival by (10- to 100 fold) in SD media.  SD media, 
however, promotes a shorter lifespan characterised by high metabolism followed and rapid cell 
death (Fabrizio and Longo, 2003) that was observed in this study by the sharp decline in the 
survival at age point 3.  Initial growth in rich media like YEPD, induce large fluctuations in 
viability, a common problem that could be overcome by incubating the culture in water and 
washing the culture to minimise the chances of survivor re-growth in long term survival 
experiments (Fabrizio et al., 2004). 
Ageing is characterised by morphological and physiological changes: change in cell size (as big 
size in old cells) slowdown of cell cycle and protein synthesis, loose and wrinkled appearance 
of cells.  Appearance of aged colonies after longer incubation (required additional 1-2 days in 
the mutants lacking Stn1 or Stn1 Cdc13) towards the end of the CLS experiment indicates the 
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change in rates of growth in these mutants with capping dysfunctions in agreement with 
previous studies where older cells take longer and entered the cell cycle slowly (Fabrizio et al., 
2004).  Different genetic mutations in yeast can cause observable differences in morphological 
characteristics during growth of cells e.g., difference in colony size and shape (Memarian et al., 
2007).  In CLS experiments mutants without essential telomere capping proteins showed rough 
edges of their colonies with a mixture of small and large colonies, more obvious in stn1Δ or 
stn1Δ cdc13Δ as compared to cdc13Δ.  In wild type and EXO1 deletion mutants, all colonies 
were round shaped with a smooth surface.  The rough edges of colonies may be due to 
senescence of cells (McEachern and Blackburn, 1996) in ageing cultures owing to genomic 
instability due to telomere uncapping.  The occurrence of small colonies in combined deletion 
mutants, and stn1Δ mutants was also enhanced towards the end of the experiment obvious in 
combined deletion mutants and could be due to cooperative effect of removal of two essential 
genes.  Similar affects were also observed in N- and C-truncated mutants of cdc13-1 with 
obvious difference in colony size (heterogeneous) and shape observed in N-truncated mutants.  
Further studies are required to determine the fate of these small colonies and their correlation 
with ageing. 
CLS experiments using mutants with telomere capping dysfunction disclosed significant 
differences in survival as assessed in viability assays under two conditions, in SC medium 
and in water over a period of 30 days and 90 days respectively.  In SC medium at 30°C quick 
decline in survival (%) with highest mortality observed in combined deletion, cdc13Δ and 
stn1Δ mutant (strain 2685, with ~3% survival), as compared to stn1Δ cdc13-1 mutant (strain 
2625, with 10% survival) and cdc13Δ mutant (strain 2607, with 23% survival) at day 6 of 
CLS assay, indicates the impact of telomere uncapping (removal of essential proteins) on 
ageing of the mutant cells.  Most of the cells in control strains 1272 (exo1Δ), 640 (WT) and 
1273 (exo1Δ) were still viable with higher values of survival i.e. ~33%, 36% and ~44% 
respectively at this age point. 
The slow reduction in viability in water at 4°C with survival of ~3% attained in combined 
mutant (strain 2685) in comparison with 20% and 34% viability in stn1Δ rad24Δ exo1Δ mutants 
(haploid #14 and 21) and 71% and 30 % survival in cdc13Δ exo1Δ (strain 2607 and 2608) at day 
30, indicated the similar trend as was observed in SC medium.  These patterns of survival with 
highest mortality in combined deletion mutants as compared to either single deletion mutants (in 
the absence of Stn1 or Cdc13) continued until day 90 with further significant reduction in 
survival rates, as compared to WT.  The variations in survival rate in two Cdc13 deletion 
mutants (strain 2607 and 2607) might indicate the epistatic interactions from cryptic mutations 
and the role of other genetic determinants within genome (Gibson and Dworkin, 2004).  The 
dramatic loss of viability and faster ageing in combined deletion mutants also highlighted the 
additive effects of the two capping proteins in chronological survival.  EXO1 deletion (63% and 
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75% survival at day 35) did not show any pronounced effect on the CLS as compared to wild 
type strains (75% and 71%). 
The observed difference in survival in SC medium (at 30°C) and in water (at 4°C) lead to 
conclusion that maintenance of ageing cultures for CLS measurement in SC medium prompts 
fast decline of viability with marked difference in survival within two weeks.  However, CLS 
measured in water promote longer slow rate survival with obvious differences that could be 
observed between 30 to 60 days.  The first approach (SC medium at 30°C) is, therefore, could 
be utilised for a quick screen of mutants in short time, to investigate any potential difference in 
survival whereas the CLS measurement in water at 4°C could be used for the reproducible 
results with less fluctuations in survival curve. 
Furthermore, the marked difference in viability in N- and C-truncated variants of Cdc13-1 as 
compared to WT and control mutants without Exo1 protein also suggested their role in ageing 
and cellular senescence.  The N-terminus end of Cdc13 is considered essential for the viability 
of cell (Hsu et al., 2004).  However, its deletion showed slightly better average survival as 
compared to C-truncated Cdc13-1 allele, indicating different roles of Cdc13 termini in cell 
survival and specifically the involvement of C-terminus in cell longevity. 
In yeast RLS studies on cell level (with ~60-100 virgin cells) were conducted to investigate the 
proliferative potential of cells in different mutants and also to investigate the correlation 
between CLS and RLS in the absence of essential genes.  Preliminary experiments with the wild 
type and double deletion mutant (cdc13∆ stn1∆ exo1∆ rad24∆) were attempted to carry out 
RLS by micromanipulation (data not shown).  The mortality rate of newly separated daughter 
cells used as virgin cells was very high: almost 80-95 % cells after isolating daughter cells could 
not survive.  The experimental conditions are required be adapted in order to overcome the 
viability problems of micromanipulated cells in future studies. 
 
7.6 Conclusions  
In this study, detrimental impacts of deficiencies in telomere capping proteins, Cdc13 and Stn1, 
on chronological lifespan and on the tolerance to oxidative and genotoxic stress factors (UV, 
MMS, HU and H2O2) were shown using budding yeast as a model organism.  In the light of 
well-established essentiality of Cdc13 and Stn1 for the survival, this study was focussed on 
questioning roles of these proteins as well as N- and C-termini of Cdc13-1 in aging and 
telomeric DNA metabolism.   
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The analyses of sequences in N- and C-truncated mutants support the expected sequences in 
most of the generated mutants that can be used in further extended studies.  The presence of 
intact EcoR1 site was also confirmed in the N-terminus of cdc13-1 gene in all tested mutants. 
The incidence of diffused and smeary telomere DNA patterns in cdc13∆ and/or stn1∆ mutants 
(type I survivors like) and type II survivors like in N- and C-truncated variants of Cdc13-1 (in 
strains 1296-TR and 1297-TR) indicates the instability of telomere at 23°C and 30°C.  The 
mutants without capping proteins or with defective Cdc13 proteins showed short survival spans 
with cumulative effects in the presence of combined deletion (stn1∆ and cdc13∆) with the 
absence of Exo1 and Rad24 linking the role of cell cycle checkpoints in the activation of 
signalling pathways regulating ageing.  The distinct patterns of sensitivity in these mutants in 
response to UV, HU and MMS might indicate the involvement of S phase checkpoint in the 
signalling pathways triggered by genotoxic agents.  Stn1 deletion mutants, however indicate 
different underlying mechanisms associated with resistance to oxidative stress (H2O2).  The 
H2O2-resistance pattern of C-terminus truncated cdc13-1 mutants indicates that the C-domain 
might also contain a suppressor of WT-resistance to UV, MMS and HU. 
 
The results of this study highlight potentially new roles of Cdc13 and Stn1 that are related to 
senescence and ageing, and to cellular responses to genotoxic agents and will contribute to 
existing knowledge on Cdc13 and Stn1 in relation to telomere capping and to better understand 
the function of their homologs in higher eukaryotes. 
 
7.7 Future work plan 
Future developments from the current work would include further clarification and more 
extended elaboration of the obtained results.  In the present study, the nucleotide sequences of N 
and C-truncated mutants of the disrupted cdc13-1 were determined through DNA sequencing.  
Analysis of expression of the mutated proteins in N- and C-truncated variants of Cdc13-1 by 
using SDS-PAGE and Western blot in future studies will provide further insights into results of 
the present work. 
Cellular analyses of mutants generated in this study are required to measure the RLS of these 
mutants and also to find any correlation between CLS and RLS.  It would be interesting to 
analyse gene expression of disrupted cdc13-1 quantitatively by measuring the mRNA levels in 
N- and C-truncated mutants using real time PCR approach.  Furthermore, the interaction 
between Stn1 and Ten1 proteins in the presence of disrupted Cdc13-1 can be elucidated by 
analysing the expression of STN1 and TEN1 on RNA level and more specifically on protein 
level. 
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Construction of Cdc13 N- and C-deletion cassettes with tag (HA tag or c-myc tag) will facilitate 
accurate detection of expressed proteins in Western blot analysis and also to conduct 
comparative analysis of the recombinant proteins in mutants with/without tag to determine 
effects of protein tagging if any on the expression of fusion proteins. 
 
Cdc13 interact with Stn1, Ten1 and Pol1 proteins through its different domains.  New partial 
deletion constructs of Cdc13, Stn1and Ten1 can also be generated by PCR mediated technique 
to further elucidate the functions of individual domains of Cdc13 [OB1, RD, OB2, OB3 (DBD) 
and OB4], Stn1 (OB5) and Ten1 (OB6) proteins and to analyse their biological functions in 
context of ageing and cellular senescence.  Further combination of these deletion mutants can be 
generated by performing genetic crosses to study interaction between Cdc13, Stn1 and Ten1 
proteins and the effect of these mutations on other biological aspect of cells such as CLS, RLS, 
and responses to different genotoxic agents to link molecular interaction, genetic instability, 
cellular senescence and checkpoint controls with new insights into molecular functions of these 
essential proteins.   
 
Systematic analysis of truncated mutants for their telomeric DNA lengths could be conducted 
after growing these mutants at different temperatures such as 23°C, 26°C, 30°C and 37°C for 
different passages (p3, p6, p9 and p12) in comparison with original strain (cdc13-1) and cdc13 
deletion mutants to observe the effect of multiple passages on telomere DNA length/pattern and 
also to explore cellular responses to short and long term absence of the protein.  
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Supplementary Methods and Protocols 
 
Method S2.1.  Preparation of Yeast Extract Peptone Dextrose (YEPD) agar and broth medium 
with adenine (0.5 L). 
YEPD agar medium (500 ml) required:  
 
Yeast Extract (#LP0021) 5 g 
Bacteriological peptone (LP0037) 10 g  
Agar Bacteriological N1 (LP0037) 10 g 
All above ingredients were mixed in distilled water with final volume up to 0.5L, followed by 
autoclaving with regime B at 121°C for 15 minutes.  Media was cooled and at about 60°C 
following sterile solutions were added in aseptic environment: 
 40% Dextrose* (Glucose) 25 ml 
 0.5% Adenine*(Sulphate) 7.5 ml 
To make homogenous composition, mixture was mixed immediately without bubbles.  Media 
was cooled down to 55°C and plates were poured.  The media plates were allowed to dry, 
wrapped in to avoid evaporation and stored at 4°C till use. 
To prepare YEPD broth method was followed as above without adding bacteriological agar. 
*40% Dextrose: 
200 g Glucose was dissolved in 500 ml final volume and solution was autoclaved at 121°C for 
15 minutes. 
* 0.5% Adenine (sulphate):  
0.5 g Adenine sulphate was dissolved in 100 ml final volume distilled water and autoclaved at 
121°C for 15 minutes. 
 
Method S2.2.  Preparation of Synthetic Defined or Synthetic Dextrose Minimal Medium (SD),  
agar and broth(1 L). 
Synthetic Defined medium (SD) used for chronological aging studies contained following 
components. 
 D-glucose 20 g 
 Yeast nitrogen base*(-AA/-AS) 1.7 g 
 Ammonium sulphate 5.0 g 
 Adenine(hemisulphate) 0.04 g 
S4 
 
Amino acids Concentration (g/L) 
 
 L-Arginine (HCl) 0.02 g 
 L-Aspartic acid 0.1 g 
 L-Glutamic acid(monosodium salt) 0.1 g 
 L-Histidine 0.1 g 
 L-Leucine 0.3 g 
 L-Lysine (mono-HCl) 0.03 g 
 L-Methionine 0.02 g 
 L-Phenylalanine 0.05 g 
 L-Serine 0.375 g 
 L-Threonine 0.2 g 
 L-Tryptophan 0.04 g 
 L-Tyrosine 0.03 g 
 L-Valine 0.15 g 
 Uracil 0.1 g 
 
All above components except glucose were mixed in distilled water with final volume of 1 L.  
The medium was autoclaved at 121°C for 15 minutes.  Following autoclaving medium was 
cooled down to about 60°C and 25ml of sterile 40% Dextrose (Glucose) was added. 
To make homogenous composition, medium was mixed immediately without bubbles, cooled 
down to 55°and plates were poured.  Plates were allowed to dry, wrapped in to avoid 
evaporation and stored at 4°C. 
 
To prepare Synthetic Defined (SD) broth method was followed as above without adding 
bacteriological agar. 
Amino acid auxotrophies were compensated for by adding 5X final concentration to dropout or 
synthetic complete medium (SC). 
 
*Yeast nitrogen base did not contain amino acids (AA) or ammonium sulfate (AS). 
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Method S2.3.  Preparation of Dropout agar and broth medium (0.5 L). 
 
Dropout agar medium was prepared by mixing following ingredients: 
 Dropout amino acid powders* 0.65 g  
 Yeast nitrogen base (without Amino acids and ammonium sulphate) 0.85 g  
 Ammonium sulphate 2.5 g  
 Agar Bacteriological N1 10g  
 1M NaOH 3 ml  
All above ingredients were mixed in distilled water with final volume up to 0.5 L, followed by 
autoclaving at 121°C for 15 minutes.  Media was cooled down and at about 60°C sterile 
solutions of dextrose was added in aseptic environment: 
 40% Dextrose (Glucose) 25 ml 
To make homogenous composition, media was mixed immediately avoiding any bubbles, cooled 
down to 55° and plates were poured.  The plates were allowed to dry at room temperature, 
wrapped in to avoid evaporation and stored at 4°C till use. 
To prepare Dropout broth method was followed as above without adding bacteriological agar. 
*Dropout amino acid powders: Combination of different amino acids in specific concentration 
as given below was used to make media with minimal requirements. 
Amino acids Quantity used for dropout powders 
 Adenine (hemisulphate) 2.5 g 
 L-Arginine (HCl) 1.2 g 
 L-Aspartic acid 6.0 g 
 L-Glutamic acid(monosodium salt) 6.0 g 
 L-Histidine 1.2 g 
 L-Leucine 3.6 g 
 L-Lysine(mono-HCl) 1.8 g 
 L-Methionine 1.2 g 
 L-Phenylalanine 3.0 g 
 L-Serine 22.5 g 
 L-Threonine 12.0 g 
 L-Tryptophan 2.4 g 
 L-Tyrosine 1.8 g 
 L-Valine 9.0 g 
 Uracil  1.2g 
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Any amino acid from above list can be dropped or missed to make medium deficient in that 
specific amino acid.  For example medium deficient in histidine was prepared by leaving 
histidine from the list and using all other amino acids to prepare minus (-) histidine dropout 
medium. 
 
Protocol S2.1.  CLS in SC medium (postdiauxic phase). 
 
 Streaking out cultures of control and experimental strains from frozen stock onto YEPD agar 
plates and cultivating at 30°C for 48 hrs or more to get well-separated single colonies. 
 Picking up single colonies and inoculating 5 ml liquid YEPD medium in a test tube (starter 
culture).  Growing o/n at 30°C in a shaker at 200 rpm. 
 Inoculating 5 ml of synthetic complete (SC) medium with 50 µl of starter culture (200 µl in 
20 ml SC in flask). 
 Setting out five replicates for each strain at this stage for the validity of the experiment. 
 Maintaining culture at 30°C with constant agitation for 4 weeks. 
Measuring cell survival/viability count through serial dilution and plating 
 Taking an aliquot of ageing culture at day 3, 6, 9, 12, 15, 18, 21 etc., for 4 weeks or more 
and estimating the viability count through colony-forming unit (CFU) after diluting the 
culture. 
 Pooling out culture aliquots and serially diluting them in sterile water to achieve a cell 
density ~1x10
3
-5x10
3
 cells/ml. 
 Spreading out 50 µl of diluted suspension on each half of a YEPD agar plate (Kaeberlein, 
2006 and incubating at 30°C for 3 days and counting cells for each strain.  Calculating 
viability based on the number of colonies arising (CFUs) on the YEPD. 
Data Analysis 
All cultures were presumed to be 100% viable at the day showing the maximum number of 
cells/ml. Averages and standard deviations for five biological replicates were calculated 
using Microsoft Excel 2010. 
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Protocol S2.2.  CLS experiments in water: CLS-Optimisation using strain 640 by keeping cells 
at 30°C CLS experiments in water.  
 Streaking out culture (640) on YEPD media and cultivating for three days at 23°C for well- 
separated colonies. 
 Picking up a few (4-5) colonies and setting up o/n culture in YEPD broth (10 ml).  
Cultivating at 30°C in a shaking incubator overnight. 
 Washing the culture three times with sterile water. 
 Making glycerol stock (15%) and freezing at -80°C until further dilution. 
 Inoculating three sets of cultures by diluting 500 µl of glycerol stock in 10 ml of SD broth 
supplemented with histidine, leucine, tryptophan and uracil (5 times) in a sterile universal.  
The cell number was kept between 1-2x10
6 
cells /ml (Fabrizio and Longo, 2004) and 2-6x10
8
 
(Qiu and Lu, 2006) according to OD660 = 0.1-0.2 (0.2 = 0.255x10
7
 cells /ml).  First two 
cultures for 9 days (9-D) were set and cultivating at 30°C in a shaking incubator at 50 rpm.  
After three days, two cultures were set for 6 days (6-D) and finally, after another three days, 
last two cultures were set for 3 days (3-D).  All cultures were grown to pass the logarithmic 
phase (24-48 hrs).  All cultures were ready at the same time to start CLS measurement.  At 
the end of 9, 6 and 3 days, all cultures were harvested by centrifugation. 
 Spinning out 10 ml culture for each sample at low speed (3800 rpm for 5 minutes) to harvest 
cell pellet. 
 Washing out cell pellet three times with sterile water by spinning at the same speed and re-
suspending in 10 ml sterile water. 
 Measuring absorbance at 660 nm to estimate cell number (starting cell concentration for CLS 
assay should be ~ 2-6x10
8
 cells/ml). 
 Keeping cell suspensions at 4°C (G1 phase) over night. 
  Transferring and keeping cells at 30°C for CLS assay and pooling out samples for viability 
count at three day intervals (0, 3 D, 6 D, 9 D and so on). 
Making serial dilution for plating: 
 Measuring OD660 of 1/5 diluted suspension (200 µl with 800 µl of sterile water). 
 Making 6 five-fold serial dilutions (40 µl suspensions (A-F) with 160 µl sterile water in a 
total volume of 200 µl in 96-well plates).  Expected cell number in sixth dilution was 6000 
cells/ml according to OD660. 
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 Plating 20 µl of last two dilutions (6th) and dilution 5th on each half of a YEPD plate (two 
plates) and cultivating at 30°C for three days before counting colonies. 
 Counting colonies and tabulating data for each count. Calculating average and % viability 
and plotting on graph to see viable cell number decline over the period of the assay. 
 
Protocol S2.3.  Protocol S2.3.  CLS-Optimisation: viability dynamics after exposure of cells to 
40°C/ 45°C in shaking water bath. 
 
 Streaking cultures of wild type (DLY 640) and cdc13 mutants (DLY 2607, 2608 and 2685 
strains) on YEPD medium and incubating plates for three days at 30°C for well-separated 
colonies. 
 Picking up a few (4-5) colonies and inoculating with them YEPD broth (10 ml) in a glass 
universals.  Growing at 30°C in a shaking incubator (at 150 rpm) overnight. 
 Diluting 400 µl, 500 µl, 500 µl and 800 µl of o/n cultures of strains DLY 640, DLY 2607, 
DLY 2608 and DLY 2685 respectively in 25 ml YEPD broth in flasks (1/4 volume ratio).  
Growing cultures for three days in shaking incubator (24-48 hrs, to pass the logarithmic 
phase).  
 Washing out the cultures three times with sterile water (first wash with 40 ml, second wash 
with 40 ml and third wash with 25 ml sterile water respectively) and centrifuging at 3000 
rpm for 5 minutes. 
 Re-suspending cell pellet in sterile water (strains 640 in 35 ml, 2607 in 30 ml, 2608 in 25 ml 
and 2685 in 15 ml respectively) to keep cell number approximately equal. 
 Measuring optical density at 660 nm to estimate the number of cells (starting cell 
concentration 2-6x10
8
 cells/ml). 
 Keeping cell suspension at 4°C (G1 phase) for 48 hours. 
 Setting cultures for analysis in a water bath at 40°C or 45°C.  Pooling out samples, 1ml each 
after every hour (for 7-9 hours) and transferring it first to ice for half an hour and then to 4°C 
overnight.   
 
Making serial dilutions for plating: 
 Measuring OD
660
 of 1/10 diluted suspension (500 µl culture with 4500 µl sterile water) to 
estimate number of cells /ml. 
 Making 5- and10-fold serial dilutions of 500 µl suspension in 5 ml sterile water (1:5, 500 µl 
culture+ 4500 µl sterile water, dilutions #1-#5 in a total volume of 5000 µl) in small bijou 
tubes. 
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 Expected cell number in wild type DLY 640 in dilution #3 was ~4000 cells/ml according to 
the absorbance 0.011 at OD
660
. 
 Plating 50 µl of last two dilutions (#4  and #5) for strains 640, 2607, 2608 and dilutions #3 
and #4 for strain 2685 on each half of a YEPD plate (two plates) and incubating at 30°C for 
three days before counting colonies. 
 
Protocol S2.4.  CLS experiments in water (4°C) under calorie restriction (stationary phase). 
(utilised for cdc13-1 NTΔ and CTΔ mutants and other cdc13Δ stn1Δ mutants) 
 
 Streaking out cultures from frozen stocks on YEPD plates and incubating at 30°C for 2-3 
days. 
 Inoculating 4-5 colonies in 5 ml of YEPD broth and growing in a shaking incubator at 30°C 
overnight (16-18 hrs). 
 Diluting overnight culture to a density of 1-2x106 cells /ml (OD660 0.1-0.2) in 25 ml of 
YEPD broth in a 125 ml flask (keeping culture to flask volume 1:5; for 30 ml culture, a 150 
ml flask should be used).  
 Growing cultures for 6 days at 30°C in a shaking incubator. 
 Washing out cells at 3000 rpm for 5 min (three times with 25 ml sterile distilled water). 
 Resuspending cell pellet in 25 ml of sterile distilled water and measuring OD660 using the 
appropriate dilution (1/20 dilution was used to measure OD at 660 nm: mixing 50 µl of 
culture with 950 µl of water in a final volume of 1 ml, or 150 µl of culture with 2850 µl of 
water in a final volume of 3 ml).  
 Equalising cell number in all cultures, based on the OD660 measurement. 
 Keeping cells at 4°C for the entire period of CLS and taking measurements after equal time 
intervals, 5 to 10 days.  
 
 
 
 
